data_2ytc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ytc _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.863 0.363 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 82.0 p -102.36 -11.68 18.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 16.7 m -84.84 141.92 30.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.181 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.555 HD23 ' CE3' ' A' ' 309' ' ' TRP . 19.8 mt -130.85 124.41 31.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.555 ' CE1' ' HE2' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -81.53 141.32 33.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.929 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 99.8 t -136.28 116.98 18.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.08 177.3 19.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 68.78 37.79 84.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.481 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.402 HD12 ' C ' ' A' ' 276' ' ' CYS . 31.4 mt -75.9 -59.8 2.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.4 149.95 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.483 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -40.96 -36.87 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 24.1 p -51.89 -43.0 63.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.469 ' CD1' HD21 ' A' ' 305' ' ' LEU . 76.4 mt -97.12 143.07 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.12 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.0 p -121.6 -178.29 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.109 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.94 -56.67 7.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 90.0 m -43.98 -50.67 8.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.82 -37.62 14.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 18.9 mt -80.52 -52.36 7.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 41.4 ttt-85 -43.91 -42.89 6.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -76.53 -44.27 35.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.627 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 45.3 t-80 -57.39 -33.12 67.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.443 ' CE2' HG13 ' A' ' 279' ' ' ILE . 76.5 m-85 -94.47 -41.39 9.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.438 ' CA ' HD12 ' A' ' 265' ' ' ILE . 1.8 t80 -42.71 -36.12 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.966 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 17.6 pt20 -54.13 -40.97 67.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.577 ' CD2' ' CB ' ' A' ' 290' ' ' ALA . 47.0 m-85 -63.75 -45.91 87.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.854 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 173.98 178.01 43.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.529 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -47.69 144.55 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.347 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.438 HD12 ' CA ' ' A' ' 260' ' ' TYR . 90.7 mt -115.45 109.56 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -52.34 -50.45 62.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.5 t -167.53 168.74 12.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 90.1 mt -144.38 108.65 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 54.7 m -103.14 99.08 8.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 43.1 t -91.93 110.81 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.434 ' CG1' ' HG2' ' A' ' 273' ' ' ARG . 51.2 t -94.53 99.96 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -60.09 -43.24 95.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.434 ' HG2' ' CG1' ' A' ' 271' ' ' VAL . 6.8 ptm180 -55.09 -26.54 38.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.454 ' O ' ' C ' ' A' ' 275' ' ' GLN . 73.7 mt-30 -117.29 17.75 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 274' ' ' GLN . 66.7 mt-30 34.25 43.94 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.402 ' C ' HD12 ' A' ' 246' ' ' LEU . 26.0 p -136.69 173.08 12.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -156.74 138.93 14.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -105.38 114.87 29.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.443 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.5 mm -98.06 118.03 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.162 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -104.42 140.4 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -119.43 146.38 45.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.34 -34.21 74.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 284' ' ' ARG . 29.5 p -127.68 118.18 23.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.171 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 283' ' ' THR . 13.6 tpt180 -36.72 -36.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 284' ' ' ARG . 6.1 tp60 -36.85 -65.69 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -59.11 -35.29 73.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.084 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.82 -57.39 12.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -52.33 -59.31 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 42.9 t -44.41 -61.61 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.577 ' CB ' ' CD2' ' A' ' 262' ' ' PHE . . . -57.42 -38.39 74.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.52 -69.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -54.08 -43.43 70.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -70.94 -3.72 20.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.448 ' HB3' ' CG2' ' A' ' 307' ' ' VAL . 33.2 m -112.3 -29.95 7.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -47.86 97.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.835 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 52.7 t30 45.17 25.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -120.57 -25.68 5.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.627 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 6.2 tp -72.53 99.83 2.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 25.5 mt -113.39 96.68 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.109 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.435 HG21 ' CD2' ' A' ' 258' ' ' HIS . 67.7 t -100.72 138.36 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 58.13 49.88 10.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.78 34.18 5.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 245' ' ' GLY . 16.1 ttt-85 -138.81 105.13 5.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 0.0 110.881 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -51.68 149.33 4.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.469 HD21 ' CD1' ' A' ' 250' ' ' ILE . 42.0 mt -133.52 134.93 44.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.77 102.2 14.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.448 ' CG2' ' HB3' ' A' ' 294' ' ' SER . 70.6 t -99.99 136.54 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.555 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 6.2 pttt -146.5 147.55 31.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . 0.555 ' CE3' HD23 ' A' ' 241' ' ' LEU . 64.9 m95 -55.29 142.71 30.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.478 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 60.0 mt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.923 0.392 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.414 HG23 ' N ' ' A' ' 284' ' ' ARG . 57.3 p -90.39 26.75 1.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.2 m -123.16 141.03 52.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.47 HD22 ' CB ' ' A' ' 291' ' ' ALA . 66.4 mt -124.1 139.88 53.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.555 ' CE1' ' CE ' ' A' ' 308' ' ' LYS . 0.6 OUTLIER -99.1 146.31 26.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 74.1 t -140.04 135.01 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -125.73 168.33 17.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 70.62 44.51 57.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.418 HD13 ' CA ' ' A' ' 276' ' ' CYS . 91.3 mt -80.29 -59.11 2.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.879 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.34 162.81 0.89 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.463 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -49.53 -38.39 30.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 35.6 p -50.63 -45.05 57.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.142 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.466 HG23 ' N ' ' A' ' 251' ' ' THR . 67.3 mt -95.44 143.95 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.466 ' N ' HG23 ' A' ' 250' ' ' ILE . 26.8 p -122.31 -175.23 3.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.454 ' CB ' HG22 ' A' ' 270' ' ' VAL . 37.6 tt0 -71.18 -57.18 4.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.6 m -45.33 -47.18 13.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.16 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -44.7 -50.67 9.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.0 -44.74 62.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.433 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 22.3 ttp180 -49.95 -46.05 51.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -75.7 -40.56 55.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.651 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 51.1 t-80 -61.06 -32.78 72.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.502 ' CD2' HG12 ' A' ' 279' ' ' ILE . 52.8 m-85 -94.32 -39.0 10.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -46.67 -38.02 9.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.439 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.2 pt20 -52.45 -38.22 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.562 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 79.0 m-85 -64.71 -43.97 91.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -178.97 -152.75 10.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.532 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -82.84 136.5 34.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 0.0 110.851 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.462 HG22 ' CG1' ' A' ' 268' ' ' ILE . 88.9 mt -105.35 112.95 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 -60.36 -48.98 79.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.4 t -165.13 159.02 17.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.16 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.462 ' CG1' HG22 ' A' ' 265' ' ' ILE . 59.5 mt -139.41 108.3 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 30.5 m -101.5 100.41 10.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.454 HG22 ' CB ' ' A' ' 252' ' ' GLU . 83.7 t -93.67 103.35 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 12.2 t -86.19 99.54 8.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -60.76 -48.26 82.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -11.02 2.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 275' ' ' GLN . 19.8 mm-40 -126.6 14.41 7.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.953 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 274' ' ' GLN . 71.4 mt-30 33.04 51.09 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.418 ' CA ' HD13 ' A' ' 246' ' ' LEU . 14.2 p -148.8 165.27 31.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.95 148.09 29.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 56.7 m-85 -118.05 108.74 15.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.568 HG23 ' CE2' ' A' ' 281' ' ' PHE . 5.0 mp -93.02 121.67 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -105.38 148.54 27.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.568 ' CE2' HG23 ' A' ' 279' ' ' ILE . 98.9 m-85 -127.44 139.29 52.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.9 77.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.078 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 284' ' ' ARG . 32.7 p -126.71 118.03 23.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.165 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 283' ' ' THR . 9.5 tpt180 -36.13 -35.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 284' ' ' ARG . 46.4 tp60 -36.58 -68.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -54.7 -48.44 72.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -46.88 -59.56 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -50.18 -54.12 23.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.947 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 16.5 t -50.79 -60.13 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.115 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.562 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -56.51 -36.53 69.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.065 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.47 ' CB ' HD22 ' A' ' 241' ' ' LEU . . . -54.66 -53.66 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -68.88 -28.65 66.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -92.03 5.41 50.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 65.7 p -119.08 -32.06 4.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.461 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.4 m-30 -55.1 109.42 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 41.05 33.88 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -130.96 -38.43 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.89 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.651 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 8.4 tp -65.48 100.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 58.4 mt -117.64 93.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.435 HG13 ' ND2' ' A' ' 301' ' ' ASN . 53.9 t -97.86 140.39 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.435 ' ND2' HG13 ' A' ' 300' ' ' VAL . 69.5 m-80 58.43 42.34 21.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.93 34.12 10.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.491 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -134.19 99.38 4.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.349 . . . . 0.0 110.831 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -44.17 148.47 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 43.4 mt -132.77 135.07 45.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.6 98.18 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 308' ' ' LYS . 49.7 t -100.89 140.17 20.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.555 ' CE ' ' CE1' ' A' ' 242' ' ' TYR . 9.6 pttt -147.86 150.65 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . 0.436 ' CE3' HD23 ' A' ' 241' ' ' LEU . 29.8 m95 -52.21 134.83 33.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.482 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 85.2 mt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.943 0.401 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.3 p -95.16 29.71 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.165 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.1 m -127.55 142.73 51.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.152 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.503 HD21 ' CD2' ' A' ' 309' ' ' TRP . 32.1 mt -134.16 124.63 26.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.93 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.603 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -82.89 143.11 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.98 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.4 t -135.79 127.66 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.104 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.91 176.3 16.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 72.15 37.25 59.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.508 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.447 HD11 ' CB ' ' A' ' 277' ' ' ALA . 93.4 mt -81.52 -57.43 3.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.28 162.03 0.16 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.463 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -35.43 29.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 110.872 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.7 p -51.64 -48.35 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.481 ' CD1' HD22 ' A' ' 305' ' ' LEU . 68.6 mt -95.03 142.8 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 30.9 p -115.57 -175.62 2.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -70.18 -56.7 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 98.4 m -44.96 -50.36 10.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.13 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.54 -41.1 4.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.7 mt -81.23 -55.12 4.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.406 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 19.2 ttm180 -39.72 -38.67 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -75.55 -44.07 45.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.867 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.57 ' CD2' HD12 ' A' ' 298' ' ' LEU . 30.5 t60 -58.82 -35.09 72.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.553 ' HA ' ' CD2' ' A' ' 262' ' ' PHE . 93.1 m-85 -91.48 -39.01 12.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.406 ' CB ' ' O ' ' A' ' 256' ' ' ARG . 1.1 t80 -44.35 -28.97 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.414 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 23.8 pt20 -64.48 -42.83 95.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.566 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 29.7 m-85 -59.5 -48.73 80.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 175.15 178.8 45.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.52 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -48.43 141.17 7.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 70.5 mt -111.26 110.77 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.152 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 280' ' ' GLN . 37.9 mtt-85 -52.79 -53.18 51.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.5 t -165.72 168.73 15.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 77.2 mt -142.81 111.96 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 50.0 m -104.06 98.91 8.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 65.4 t -90.99 105.43 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.159 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 14.9 t -91.12 100.73 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . 0.426 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 16.4 pt20 -59.69 -44.88 93.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.426 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 0.8 OUTLIER -56.47 -19.05 13.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 275' ' ' GLN . 8.7 mm-40 -122.95 14.23 9.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 274' ' ' GLN . 52.9 mt-30 34.37 46.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.965 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.41 ' C ' HD11 ' A' ' 246' ' ' LEU . 27.7 p -137.15 175.16 9.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . 0.447 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -155.2 132.15 10.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.541 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 35.3 m-85 -99.62 111.49 23.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.416 HG23 ' CZ ' ' A' ' 281' ' ' PHE . 4.9 mm -93.9 115.88 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.099 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 266' ' ' ARG . 40.1 tt0 -105.6 139.0 40.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.416 ' CZ ' HG23 ' A' ' 279' ' ' ILE . 95.6 m-85 -119.24 153.27 35.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.403 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -75.65 -34.47 60.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.105 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 284' ' ' ARG . 30.6 p -125.54 116.44 21.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 283' ' ' THR . 12.6 tpt180 -36.9 -34.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -38.48 -61.42 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.32 97.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -52.79 -59.98 3.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -48.13 -55.74 9.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 60.0 t -49.48 -61.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.566 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -52.87 -41.2 64.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.81 -52.72 59.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.63 -24.94 63.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.888 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -97.79 5.63 48.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 290' ' ' ALA . 81.5 p -117.8 -24.34 7.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 297' ' ' LYS . 2.8 m-85 -61.99 112.73 2.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 5.2 t30 40.51 25.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 295' ' ' PHE . 35.9 tttp -123.65 -36.69 2.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.57 HD12 ' CD2' ' A' ' 258' ' ' HIS . 14.9 tp -61.82 96.52 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 62.9 mt -120.47 95.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.423 ' CG2' HD11 ' A' ' 298' ' ' LEU . 61.1 t -103.67 134.19 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.18 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 57.5 54.88 6.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 41.8 33.07 1.02 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.0 ttm-85 -130.39 99.3 4.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.823 0.344 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -56.18 135.31 53.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.499 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 58.3 mt -120.23 135.66 54.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -91.95 99.05 11.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.441 ' CG2' HD23 ' A' ' 298' ' ' LEU . 79.5 t -94.58 136.74 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.499 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 1.0 OUTLIER -145.54 145.57 31.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . 0.503 ' CD2' HD21 ' A' ' 241' ' ' LEU . 61.6 m95 -54.56 141.06 32.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.539 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 78.1 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.859 0.361 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.8 p -102.11 31.0 4.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 28.2 m -131.89 148.31 52.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 31.1 mt -132.91 156.01 48.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.562 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.4 OUTLIER -109.75 147.74 32.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.415 HG23 ' C ' ' A' ' 242' ' ' TYR . 90.4 t -141.1 120.72 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.03 168.78 12.67 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.494 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.484 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 73.81 44.31 31.78 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.503 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.419 HD13 ' CB ' ' A' ' 277' ' ' ALA . 52.4 mt -77.52 -60.41 2.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.931 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.28 156.45 0.17 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.492 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -49.39 -29.27 6.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.39 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.1 p -59.19 -43.84 92.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.146 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 60.4 mt -96.87 143.49 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 29.5 p -124.9 173.94 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -58.38 -59.64 5.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 88.7 m -41.22 -56.68 2.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -42.62 -42.73 3.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 33.4 mt -77.46 -57.26 3.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -39.0 -43.97 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -75.99 -38.04 57.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.87 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.561 ' CE1' HD13 ' A' ' 298' ' ' LEU . 45.0 t-80 -60.11 -35.13 74.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.839 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -94.15 -43.41 8.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.845 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.418 ' CA ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -39.93 -36.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.919 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 29.4 pt20 -52.55 -46.2 66.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.926 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 290' ' ' ALA . 62.7 m-85 -56.18 -48.84 75.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.39 -143.29 4.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.463 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -93.6 128.64 39.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 110.855 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.418 HD11 ' CA ' ' A' ' 260' ' ' TYR . 57.6 mt -93.73 114.98 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 280' ' ' GLN . 9.9 mtt180 -60.62 -49.21 78.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.6 t -162.56 168.06 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.166 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 87.9 mt -146.07 110.66 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.4 m -104.37 99.88 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.415 HG11 ' CD1' ' A' ' 246' ' ' LEU . 85.7 t -92.5 107.65 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 14.8 t -91.97 100.76 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -58.67 -48.53 80.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -55.78 -26.65 47.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 275' ' ' GLN . 19.2 mm100 -110.6 11.3 22.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.44 ' C ' ' O ' ' A' ' 274' ' ' GLN . 80.5 mt-30 35.15 47.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 16.7 p -140.5 177.53 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . 0.419 ' CB ' HD13 ' A' ' 246' ' ' LEU . . . -156.84 137.23 12.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.076 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -106.13 111.07 23.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 6.1 mm -94.27 127.68 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 266' ' ' ARG . 9.1 tt0 -114.66 145.1 42.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.933 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.31 147.37 48.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.94 -37.04 78.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.141 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 284' ' ' ARG . 24.4 p -125.12 121.28 33.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 285' ' ' GLN . 12.0 tpt180 -37.88 -35.69 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 284' ' ' ARG . 1.4 tm0? -36.8 -67.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.23 79.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.084 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -50.51 -58.51 5.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.085 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -51.63 -62.43 1.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.504 HG12 ' CE1' ' A' ' 262' ' ' PHE . 37.7 t -41.95 -56.44 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -57.33 -41.45 80.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.68 -65.97 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.082 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.25 -39.88 70.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -78.44 1.63 21.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.442 ' HB3' ' CG1' ' A' ' 307' ' ' VAL . 3.6 m -117.15 -26.67 6.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -57.0 103.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 42.13 27.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -124.24 -26.15 4.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.561 HD13 ' CE1' ' A' ' 258' ' ' HIS . 5.4 tp -72.88 97.82 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.92 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 32.0 mt -115.58 92.33 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 258' ' ' HIS . 19.9 t -95.39 146.94 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 51.59 46.52 26.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.12 30.05 5.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -133.07 103.66 6.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 110.898 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -47.72 144.38 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.484 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 47.4 mt -129.93 137.24 50.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -89.29 111.75 22.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 308' ' ' LYS . 45.6 t -111.39 145.09 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.562 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 6.0 ptpp? -149.54 163.68 37.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -69.75 124.35 23.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.454 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 67.6 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.934 0.397 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.0 p -102.88 34.06 3.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.165 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 24.0 m -136.15 141.66 44.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.456 HD12 ' CA ' ' A' ' 291' ' ' ALA . 42.0 mt -128.81 125.9 38.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.577 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -80.44 150.07 29.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 97.6 t -138.57 137.4 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.114 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.68 -179.02 15.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 60.45 44.33 97.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.423 HD11 ' C ' ' A' ' 276' ' ' CYS . 21.8 mt -77.52 -60.27 2.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 110.905 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 62.97 150.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.492 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -42.1 -31.47 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.9 p -55.69 -42.3 75.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.447 ' CD1' HD22 ' A' ' 305' ' ' LEU . 69.2 mt -99.39 151.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.122 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 40.4 p -131.69 177.5 7.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.142 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -57.03 11.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.1 m -44.61 -55.5 5.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -43.74 -44.32 6.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.56 -48.51 32.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -46.09 -45.67 16.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -77.03 -37.7 54.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.567 ' CD2' HG23 ' A' ' 300' ' ' VAL . 46.6 t-80 -60.68 -35.01 75.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.845 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.47 ' CE2' HG13 ' A' ' 279' ' ' ILE . 69.7 m-85 -94.15 -41.11 9.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.898 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -41.97 -38.77 1.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.471 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 22.9 pt20 -48.53 -41.7 30.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.57 ' CE1' HG11 ' A' ' 289' ' ' VAL . 71.5 m-85 -63.34 -45.08 92.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 179.22 -154.92 14.73 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.476 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -78.74 144.8 34.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.794 0.33 . . . . 0.0 110.918 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.42 HG23 ' CG1' ' A' ' 268' ' ' ILE . 46.2 mt -110.55 119.27 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 282' ' ' ALA . 49.1 mtt180 -65.11 -52.2 56.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 4.0 t -164.35 149.7 10.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.42 ' CG1' HG23 ' A' ' 265' ' ' ILE . 76.2 mt -128.68 110.26 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 21.8 m -102.98 98.91 8.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.133 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.419 HG13 ' CD1' ' A' ' 246' ' ' LEU . 45.3 t -92.69 107.58 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 22.1 t -93.87 100.53 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . 0.442 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 14.7 pt20 -60.09 -42.66 95.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.442 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 4.1 ptm180 -59.19 -17.68 29.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 275' ' ' GLN . 46.2 mt-30 -123.38 15.52 9.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.856 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 274' ' ' GLN . 40.7 mt-30 33.63 47.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.423 ' C ' HD11 ' A' ' 246' ' ' LEU . 25.8 p -140.8 170.35 15.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -153.75 134.62 13.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 26.9 m-85 -101.83 108.43 19.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.47 HG13 ' CE2' ' A' ' 259' ' ' PHE . 6.0 mm -93.17 112.17 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.145 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -102.78 143.52 32.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.547 ' CD2' ' HB1' ' A' ' 286' ' ' ALA . 79.5 m-85 -121.03 156.65 31.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.43 ' HA ' ' NE ' ' A' ' 266' ' ' ARG . . . -77.26 -37.24 53.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 284' ' ' ARG . 23.9 p -124.06 119.53 29.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.454 ' NE ' ' HG3' ' A' ' 288' ' ' GLU . 14.4 tpt180 -36.0 -40.09 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 284' ' ' ARG . 30.8 tp60 -34.68 -63.15 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.93 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . 0.547 ' HB1' ' CD2' ' A' ' 281' ' ' PHE . . . -59.69 -41.65 91.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.074 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.11 -61.3 2.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.454 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 13.6 mt-10 -48.45 -57.3 6.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.57 HG11 ' CE1' ' A' ' 262' ' ' PHE . 57.6 t -45.58 -63.77 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.569 ' HB1' ' CD2' ' A' ' 262' ' ' PHE . . . -54.96 -35.33 64.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.136 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.489 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -54.55 -49.09 71.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.34 -25.53 59.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -92.41 5.73 49.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.429 ' OG ' ' CG1' ' A' ' 307' ' ' VAL . 54.6 p -115.79 -35.72 4.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.839 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.3 m-85 -50.35 109.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 40.07 34.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -133.71 -33.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.468 HD12 ' CE1' ' A' ' 258' ' ' HIS . 10.1 tp -67.62 98.3 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.419 HG23 ' N ' ' A' ' 304' ' ' ARG . 40.4 mt -118.35 93.34 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.117 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.567 HG23 ' CD2' ' A' ' 258' ' ' HIS . 47.1 t -91.67 136.8 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.083 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 56.15 46.26 21.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.854 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 49.38 29.67 10.99 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -130.41 100.95 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.419 ' N ' HG23 ' A' ' 299' ' ' ILE . 22.6 ttp180 -44.69 144.75 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.501 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 52.2 mt -129.19 135.84 49.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -86.4 105.99 17.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.429 ' CG1' ' OG ' ' A' ' 294' ' ' SER . 55.5 t -105.87 144.87 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.577 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 15.9 ptpt -150.47 171.28 17.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -82.85 119.63 24.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 13.8 mt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.886 0.374 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.444 HG21 ' N ' ' A' ' 284' ' ' ARG . 44.0 p -95.35 35.39 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.1 m -133.02 141.16 48.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.0 mt -126.32 159.04 34.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.57 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.4 OUTLIER -111.58 147.59 35.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 95.5 t -140.42 120.63 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.17 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 -178.83 20.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.462 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.47 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 58.65 50.29 68.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.41 HD11 ' C ' ' A' ' 276' ' ' CYS . 62.2 mt -86.16 -57.34 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.862 0.363 . . . . 0.0 110.963 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.53 163.71 0.54 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.452 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -52.6 -32.65 42.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.951 0.405 . . . . 0.0 110.891 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.7 p -54.89 -44.78 74.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.467 ' CD1' HD22 ' A' ' 305' ' ' LEU . 86.6 mt -97.87 142.18 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.203 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.434 ' N ' HG21 ' A' ' 250' ' ' ILE . 37.4 p -124.18 -178.64 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -65.12 -59.68 3.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 87.3 m -42.05 -55.73 3.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.188 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.56 -45.27 6.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 14.5 mt -72.17 -47.2 52.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.405 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 24.1 ttp180 -46.31 -45.19 17.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -76.09 -38.21 57.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.606 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 52.4 t-80 -60.23 -35.4 75.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.567 ' CE2' HG13 ' A' ' 279' ' ' ILE . 62.9 m-85 -94.22 -42.3 9.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.434 ' CA ' HD12 ' A' ' 265' ' ' ILE . 1.7 t80 -39.92 -35.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 20.3 pt20 -56.26 -44.38 79.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 290' ' ' ALA . 41.3 m-85 -55.22 -51.03 67.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.51 -141.89 3.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.43 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -93.15 125.5 37.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 110.901 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.434 HD12 ' CA ' ' A' ' 260' ' ' TYR . 48.7 mt -93.51 121.53 44.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.471 ' NE ' ' HA ' ' A' ' 282' ' ' ALA . 43.0 mtt-85 -68.25 -47.94 66.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.4 t -171.14 153.0 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.138 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 256' ' ' ARG . 83.6 mt -127.86 116.42 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 24.4 m -109.37 99.04 8.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 85.6 t -93.52 121.21 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 90.3 t -108.7 100.17 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.091 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -57.07 -42.12 80.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 20.2 ttt-85 -50.13 -38.26 38.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -108.35 8.72 27.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.867 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 42.82 52.52 5.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.41 ' C ' HD11 ' A' ' 246' ' ' LEU . 18.6 p -142.91 177.13 8.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -160.17 136.94 9.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -102.36 115.8 31.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.567 HG13 ' CE2' ' A' ' 259' ' ' PHE . 9.3 mm -95.94 113.2 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.172 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -101.04 147.9 25.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.514 ' CD2' ' HB1' ' A' ' 286' ' ' ALA . 96.4 m-85 -129.97 151.6 50.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.873 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.471 ' HA ' ' NE ' ' A' ' 266' ' ' ARG . . . -72.4 -41.27 66.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 29.7 p -120.34 122.78 41.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.119 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.444 ' N ' HG21 ' A' ' 239' ' ' THR . 17.7 tpt180 -38.29 -39.62 0.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.881 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -37.48 -59.3 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . 0.514 ' HB1' ' CD2' ' A' ' 281' ' ' PHE . . . -59.74 -41.43 90.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.044 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.5 57.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -53.77 -57.5 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 86.1 t -46.03 -63.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.526 ' HB3' ' CE2' ' A' ' 262' ' ' PHE . . . -53.02 -47.21 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -45.21 -67.17 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.095 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.8 -35.28 68.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -85.72 5.14 33.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 290' ' ' ALA . 4.7 m -119.07 -26.19 6.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 297' ' ' LYS . 2.9 m-85 -56.08 110.0 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 40.18 26.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 295' ' ' PHE . 19.1 tttm -124.91 -30.12 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.606 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 9.1 tp -67.53 100.56 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 50.1 mt -116.99 97.13 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.561 HG22 ' CD2' ' A' ' 258' ' ' HIS . 42.4 t -96.24 139.79 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.202 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.416 ' N ' HG13 ' A' ' 300' ' ' VAL . 74.7 m-20 52.36 47.74 24.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.65 27.56 6.21 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.46 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.1 ttt85 -127.44 101.52 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 110.821 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 45.3 ttp85 -43.83 146.82 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.47 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 45.3 mt -134.84 134.31 40.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -89.11 109.25 20.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 308' ' ' LYS . 81.7 t -106.63 142.96 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.159 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.57 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 13.3 ptpt -148.12 163.25 37.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -71.09 124.55 24.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.451 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 55.3 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.921 0.391 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.1 p -97.57 36.19 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.172 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 18.0 m -133.84 151.28 51.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 35.5 mt -137.12 134.95 36.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.57 ' HB2' ' CE1' ' A' ' 278' ' ' PHE . 0.2 OUTLIER -97.3 150.36 21.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.461 HG11 ' N ' ' A' ' 244' ' ' GLY . 59.1 t -142.26 139.85 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.461 ' N ' HG11 ' A' ' 243' ' ' VAL . . . -130.51 164.55 22.96 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.445 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 74.97 43.84 25.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.434 HD11 ' C ' ' A' ' 276' ' ' CYS . 94.3 mt -74.11 -61.74 1.75 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.884 0.373 . . . . 0.0 110.918 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.42 151.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.464 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -42.78 -34.43 0.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.888 0.375 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.6 p -57.08 -42.83 81.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.156 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.469 ' CD1' HD22 ' A' ' 305' ' ' LEU . 55.9 mt -94.88 143.59 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.447 ' N ' HG21 ' A' ' 250' ' ' ILE . 33.1 p -126.98 -176.81 3.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.159 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -65.89 -59.88 3.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.997 0.427 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.2 m -43.36 -50.89 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -40.89 -50.62 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.85 -53.49 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -41.07 -42.95 2.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -75.5 -46.43 32.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.567 ' CE1' HD12 ' A' ' 298' ' ' LEU . 52.3 t60 -54.71 -36.31 64.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -90.47 -44.42 9.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -40.08 -35.67 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.446 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 26.8 pt20 -54.54 -46.19 73.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.57 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 52.8 m-85 -56.01 -50.01 72.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -177.12 -154.99 12.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.473 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -75.64 141.73 42.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 71.1 mt -110.58 112.43 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.137 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -57.66 -50.15 74.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 10.5 t -164.03 168.15 19.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.154 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 77.3 mt -145.12 106.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 57.1 m -97.61 98.84 10.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 88.5 t -93.93 109.12 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.466 ' CG1' ' HG2' ' A' ' 273' ' ' ARG . 15.9 t -97.0 99.65 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -60.67 -46.39 90.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.466 ' HG2' ' CG1' ' A' ' 271' ' ' VAL . 25.4 ptt180 -55.46 -19.83 10.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.47 ' O ' ' C ' ' A' ' 275' ' ' GLN . 65.1 mm-40 -121.19 15.88 11.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 274' ' ' GLN . 29.1 mt-30 32.26 50.45 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.434 ' C ' HD11 ' A' ' 246' ' ' LEU . 25.9 p -145.92 167.15 23.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.854 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.95 156.52 42.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 56.4 m-85 -126.32 108.07 10.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.571 HG21 ' CE1' ' A' ' 281' ' ' PHE . 4.7 mp -93.69 120.93 43.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.111 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -107.82 146.66 31.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.571 ' CE1' HG21 ' A' ' 279' ' ' ILE . 87.9 m-85 -124.31 147.1 48.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.65 70.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.137 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 284' ' ' ARG . 39.4 p -129.12 118.05 21.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 283' ' ' THR . 16.2 tpt180 -36.31 -34.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 283' ' ' THR . 20.8 tp60 -37.94 -68.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.6 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.138 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -52.12 -60.69 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -46.88 -59.41 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 39.4 t -46.5 -60.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.57 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -55.08 -32.23 61.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.594 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -61.53 -46.04 91.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -72.76 -29.94 63.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 297' ' ' LYS . 18.5 mttt -87.0 -18.08 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 290' ' ' ALA . 78.8 p -92.72 -36.03 13.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.3 m-85 -54.08 109.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 1.8 m120 41.51 29.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 293' ' ' LYS . 9.6 mmmt -126.93 -37.69 2.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.567 HD12 ' CE1' ' A' ' 258' ' ' HIS . 12.7 tp -63.4 98.03 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.52 94.43 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.427 ' CG2' HD13 ' A' ' 298' ' ' LEU . 59.9 t -102.21 146.33 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.163 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.407 ' ND2' HG11 ' A' ' 300' ' ' VAL . 63.0 m-80 54.47 41.02 32.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.63 33.41 12.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.447 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 22.7 ttt-85 -134.25 97.65 3.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.308 . . . . 0.0 110.863 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -43.72 144.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.469 HD22 ' CD1' ' A' ' 250' ' ' ILE . 48.9 mt -128.81 136.23 50.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -85.7 103.64 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.47 139.45 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.178 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.562 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 2.9 pttt -150.25 147.34 27.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.95 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -53.14 148.94 7.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.488 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 82.3 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.914 0.388 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.436 HG23 ' N ' ' A' ' 284' ' ' ARG . 51.2 p -98.67 27.02 5.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 21.7 m -125.58 139.51 53.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 35.5 mt -131.1 123.97 29.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.963 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.593 ' CE1' ' HE2' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -81.65 154.89 25.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.928 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.405 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 75.1 t -139.76 134.83 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -123.04 -179.66 15.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 57.95 43.78 94.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.438 ' CD1' ' HB1' ' A' ' 277' ' ' ALA . 75.6 mt -83.81 -57.32 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 110.871 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.46 164.45 0.28 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.495 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -54.83 -31.19 59.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 110.828 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.409 ' OG1' ' NE ' ' A' ' 303' ' ' ARG . 23.2 p -56.83 -34.25 67.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 251' ' ' THR . 58.3 mt -104.78 138.83 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.123 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.465 ' N ' HG22 ' A' ' 250' ' ' ILE . 46.1 p -111.84 179.95 3.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -69.29 -52.04 31.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.8 m -50.06 -51.31 43.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.149 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -41.81 -42.16 2.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.9 mt -80.21 -50.24 10.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 -45.06 -41.55 7.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -76.92 -43.67 34.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.567 ' CE1' HD11 ' A' ' 298' ' ' LEU . 50.1 t-80 -58.69 -32.76 69.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -94.0 -38.85 10.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -46.35 -40.67 12.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.405 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.4 pt20 -48.61 -38.69 21.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.951 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 88.7 m-85 -65.86 -43.03 89.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 178.5 -153.73 13.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.506 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -80.87 141.24 34.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.794 0.331 . . . . 0.0 110.88 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 62.6 mt -110.32 111.28 35.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 280' ' ' GLN . 26.9 mtt-85 -53.91 -49.65 68.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 13.8 t -167.44 169.02 12.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 76.8 mt -144.95 111.25 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.3 m -105.31 98.94 8.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 82.0 t -91.69 107.4 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 95.1 t -92.81 99.97 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . 0.416 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 5.1 pt20 -59.75 -32.74 70.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.936 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.416 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 9.3 tpp85 -59.63 -38.47 81.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 275' ' ' GLN . 12.6 mt-30 -110.71 19.7 18.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 274' ' ' GLN . 60.0 mt-30 34.25 53.14 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.421 ' C ' HD11 ' A' ' 246' ' ' LEU . 31.1 p -143.56 165.7 26.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . 0.438 ' HB1' ' CD1' ' A' ' 246' ' ' LEU . . . -146.0 133.77 21.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.089 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 17.6 m-85 -99.31 108.19 20.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.873 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 3.8 mm -93.01 116.14 33.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 266' ' ' ARG . 34.9 tt0 -106.64 136.33 46.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.449 ' CD2' ' HB2' ' A' ' 286' ' ' ALA . 94.4 m-85 -113.72 153.16 29.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -77.63 -33.74 53.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.079 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 284' ' ' ARG . 34.4 p -128.75 118.72 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.129 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.468 ' NE ' ' HG3' ' A' ' 288' ' ' GLU . 15.4 tpt180 -35.99 -40.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 284' ' ' ARG . 0.7 OUTLIER -34.59 -62.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . 0.449 ' HB2' ' CD2' ' A' ' 281' ' ' PHE . . . -60.54 -42.29 96.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.086 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.25 -63.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.468 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 7.9 mt-10 -45.59 -54.3 7.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 39.2 t -50.7 -67.69 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.566 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -53.36 -29.41 34.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.065 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -55.11 -53.08 60.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -72.59 -26.45 61.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -90.25 5.23 47.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 89.8 p -117.13 -39.0 3.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 297' ' ' LYS . 3.1 m-85 -46.37 107.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 2.0 t30 40.12 27.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.876 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 295' ' ' PHE . 8.5 tmtt? -122.65 -32.85 3.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.567 HD11 ' CE1' ' A' ' 258' ' ' HIS . 8.1 tp -69.91 100.96 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.932 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 65.1 mt -120.11 93.1 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.506 HG21 ' CD2' ' A' ' 258' ' ' HIS . 60.1 t -96.33 142.35 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.121 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 50.96 55.03 10.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 40.54 33.13 0.53 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . 0.409 ' NE ' ' OG1' ' A' ' 249' ' ' THR . 31.0 ttm-85 -132.12 103.23 6.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.921 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 -54.07 144.88 18.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.5 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 23.6 mt -130.06 132.15 46.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -87.45 102.73 14.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 95.8 t -100.86 136.42 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.593 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -146.89 145.88 29.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -52.82 133.92 37.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.53 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 75.5 mt . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.884 0.373 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.9 p -99.65 29.38 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.421 HG21 ' N ' ' A' ' 241' ' ' LEU . 23.1 m -124.9 152.21 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.156 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.421 ' N ' HG21 ' A' ' 240' ' ' THR . 31.5 mt -137.01 127.05 25.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.964 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.574 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -88.9 145.43 25.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 84.3 t -139.07 133.87 40.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -122.59 167.95 14.99 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.547 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.92 42.49 44.97 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.425 HD13 ' C ' ' A' ' 276' ' ' CYS . 29.7 mt -77.7 -60.03 2.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.847 0.356 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.57 159.0 0.72 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.451 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -48.36 -32.97 8.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 79.4 p -55.92 -46.39 78.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.413 ' CD1' HD21 ' A' ' 305' ' ' LEU . 77.2 mt -93.1 150.51 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.059 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.6 p -132.8 -179.89 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -66.13 -58.19 5.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 79.4 m -44.11 -51.01 8.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.185 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -44.49 -48.13 10.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 13.8 mt -74.78 -45.16 45.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.929 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 50.1 ttt180 -49.09 -42.94 40.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -78.76 -43.39 25.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.535 ' CE1' HD11 ' A' ' 298' ' ' LEU . 64.9 t-80 -57.9 -33.83 69.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -94.38 -40.02 10.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.459 ' CA ' HD12 ' A' ' 265' ' ' ILE . 1.5 t80 -42.4 -36.56 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.467 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 16.3 pt20 -51.89 -41.07 61.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 290' ' ' ALA . 63.7 m-85 -60.88 -49.23 78.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -178.95 -163.45 30.06 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -69.74 130.51 42.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 0.0 110.883 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.459 HD12 ' CA ' ' A' ' 260' ' ' TYR . 79.1 mt -99.98 109.66 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 282' ' ' ALA . 22.7 mtt-85 -51.39 -53.07 40.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.0 t -164.07 165.41 22.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 98.3 mt -139.65 105.57 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.092 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.2 m -98.06 99.98 11.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.127 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 66.7 t -93.59 106.02 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.472 ' CG1' ' HG2' ' A' ' 273' ' ' ARG . 4.4 t -91.15 99.67 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -60.79 -47.76 84.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.472 ' HG2' ' CG1' ' A' ' 271' ' ' VAL . 6.0 ptm180 -55.18 -20.1 9.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.475 ' O ' ' C ' ' A' ' 275' ' ' GLN . 28.2 mm-40 -121.28 15.74 11.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 274' ' ' GLN . 31.6 mt-30 32.25 50.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.425 ' C ' HD13 ' A' ' 246' ' ' LEU . 22.6 p -142.51 168.24 20.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.28 153.41 38.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 53.5 m-85 -124.65 108.96 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.435 HG23 ' CE1' ' A' ' 281' ' ' PHE . 4.5 mp -94.72 120.7 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.126 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 266' ' ' ARG . 53.0 tt0 -109.49 147.47 32.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.513 ' CD2' ' HB3' ' A' ' 286' ' ' ALA . 87.8 m-85 -126.95 139.86 52.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.866 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.475 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -59.7 -36.29 76.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 284' ' ' ARG . 38.3 p -123.1 116.66 23.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 285' ' ' GLN . 14.5 tpt180 -36.0 -37.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 284' ' ' ARG . 0.9 OUTLIER -35.65 -63.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . 0.513 ' HB3' ' CD2' ' A' ' 281' ' ' PHE . . . -58.41 -39.89 80.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.083 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.07 -45.84 79.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.122 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -62.94 -54.04 44.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.437 HG13 ' CE1' ' A' ' 262' ' ' PHE . 49.0 t -50.42 -58.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -57.47 -45.26 85.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.079 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -41.61 -67.82 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.046 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.58 -40.85 69.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -76.94 1.84 16.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 290' ' ' ALA . 3.3 m -118.41 -25.0 6.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -57.13 104.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 15.3 m120 41.46 30.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -126.8 -32.83 2.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.535 HD11 ' CE1' ' A' ' 258' ' ' HIS . 5.0 tp -65.96 96.4 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 56.0 mt -114.7 95.58 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.82 142.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 57.9 41.4 24.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 49.86 33.19 19.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -134.93 104.4 5.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 110.889 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -49.96 145.06 5.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.413 HD21 ' CD1' ' A' ' 250' ' ' ILE . 27.1 mt -129.64 133.39 47.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.44 98.73 10.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 93.8 t -96.45 145.01 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.195 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.531 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 0.6 OUTLIER -158.42 145.39 17.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -52.32 148.97 5.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . 0.526 ' N ' HH11 ' A' ' 284' ' ' ARG . 69.3 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.886 0.375 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.459 HG22 ' N ' ' A' ' 284' ' ' ARG . 46.2 p -98.75 38.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 14.2 m -133.4 143.14 48.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.117 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.426 HD23 ' CB ' ' A' ' 291' ' ' ALA . 22.7 mt -133.28 122.18 23.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.914 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.606 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -79.84 143.65 34.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.955 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.2 t -133.36 131.4 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.134 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -121.58 176.8 16.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 64.15 44.33 95.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.547 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.418 HD13 ' CB ' ' A' ' 277' ' ' ALA . 92.7 mt -86.78 -56.32 3.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.828 0.347 . . . . 0.0 110.95 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.5 155.58 0.37 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.555 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -46.59 -34.25 4.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.847 0.356 . . . . 0.0 110.858 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.8 p -53.83 -56.71 15.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 251' ' ' THR . 76.3 mt -75.41 140.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.439 ' N ' HG22 ' A' ' 250' ' ' ILE . 32.9 p -117.15 179.64 3.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.109 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.74 -55.72 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 92.8 m -45.35 -47.22 13.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.41 -38.42 28.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 30.4 mt -83.82 -50.0 8.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 49.7 ttm-85 -46.65 -41.74 15.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.884 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -76.55 -43.2 40.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.561 ' CE1' HD13 ' A' ' 298' ' ' LEU . 56.7 t-80 -58.64 -33.8 70.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -94.19 -40.4 10.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.428 ' CB ' ' O ' ' A' ' 256' ' ' ARG . 1.5 t80 -42.01 -36.52 1.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.472 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.2 pt20 -51.98 -42.06 62.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 290' ' ' ALA . 63.1 m-85 -59.77 -49.93 75.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -175.23 -145.12 5.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -88.53 129.42 35.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.346 . . . . 0.0 110.918 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 65.3 mt -96.55 110.59 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.7 mtp85 -54.98 -54.55 41.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 11.9 t -162.14 166.49 25.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.153 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 87.1 mt -142.67 110.91 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 87.8 m -104.18 98.87 8.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.47 111.1 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.491 ' CG1' ' HG2' ' A' ' 273' ' ' ARG . 3.8 t -95.85 101.83 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -60.68 -47.13 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.491 ' HG2' ' CG1' ' A' ' 271' ' ' VAL . 4.7 ptm180 -53.18 -30.29 36.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 275' ' ' GLN . 55.7 mm-40 -112.76 13.64 19.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 274' ' ' GLN . 46.1 mt-30 34.91 53.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.417 ' C ' HD13 ' A' ' 246' ' ' LEU . 11.4 p -143.57 172.01 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . 0.418 ' CB ' HD13 ' A' ' 246' ' ' LEU . . . -152.77 132.1 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 18.4 m-85 -98.91 109.99 22.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 6.1 mm -94.14 116.29 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 266' ' ' ARG . 17.7 tt0 -105.86 141.71 36.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.407 ' C ' ' HG3' ' A' ' 266' ' ' ARG . 97.5 m-85 -119.56 151.95 37.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.16 77.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.087 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 33.8 p -126.08 126.17 43.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.131 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.526 HH11 ' N ' ' A' ' 238' ' ' ILE . 9.7 tpt180 -40.3 -32.19 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -40.99 -65.76 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.959 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.3 77.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.084 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.46 -58.06 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.101 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -48.82 -57.05 7.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.948 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.5 HG13 ' CE1' ' A' ' 262' ' ' PHE . 23.7 t -51.15 -54.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.57 ' HB3' ' CD2' ' A' ' 262' ' ' PHE . . . -57.06 -39.56 75.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.426 ' CB ' HD23 ' A' ' 241' ' ' LEU . . . -52.91 -66.38 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -53.42 -43.2 67.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -75.25 2.51 10.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.469 ' HB3' ' CG1' ' A' ' 307' ' ' VAL . 3.4 m -116.37 -30.9 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -52.43 95.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.1 m120 48.1 29.37 1.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 53.2 tttt -126.05 -31.01 2.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.561 HD13 ' CE1' ' A' ' 258' ' ' HIS . 5.4 tp -69.47 101.34 1.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 53.3 mt -118.72 94.4 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' A' ' 258' ' ' HIS . 53.5 t -93.53 133.36 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 57.31 54.32 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 41.84 32.11 0.89 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . 0.423 ' HD2' ' CD1' ' A' ' 250' ' ' ILE . 26.9 ttm-85 -130.57 102.08 5.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.779 0.323 . . . . 0.0 110.86 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -49.2 146.7 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.5 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 29.3 mt -134.03 133.62 41.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -87.98 101.91 14.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' A' ' 294' ' ' SER . 92.9 t -97.62 145.61 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.578 ' CE ' ' CE1' ' A' ' 242' ' ' TYR . 4.8 pttt -156.45 144.6 19.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.886 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -53.12 145.51 13.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.903 0.382 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.0 p -102.19 29.81 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.195 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.5 m -128.44 143.12 50.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 31.8 mt -131.96 124.69 29.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.509 ' CD1' ' HG3' ' A' ' 308' ' ' LYS . 0.3 OUTLIER -82.09 149.75 27.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.407 HG22 ' C ' ' A' ' 242' ' ' TYR . 66.8 t -140.28 129.32 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.124 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.69 173.75 14.93 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 65.68 51.45 47.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.517 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.459 ' CD1' HG13 ' A' ' 270' ' ' VAL . 79.3 mt -77.12 -61.58 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.12 145.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.476 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -40.13 -31.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.382 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 34.4 p -56.36 -45.9 80.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 61.8 mt -97.27 141.6 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 16.6 p -123.9 -177.5 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -66.46 -55.97 13.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 7.9 m -43.56 -59.14 2.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.464 ' HA ' ' ND2' ' A' ' 257' ' ' ASN . 18.7 m-20 -40.14 -59.28 1.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 14.9 mt -57.51 -52.12 66.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 41.8 ttt85 -48.87 -38.58 22.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . 0.523 ' C ' ' OD1' ' A' ' 257' ' ' ASN . 0.4 OUTLIER -77.97 -40.47 39.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.648 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 58.2 t-80 -61.57 -33.08 73.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.488 ' CE2' HG13 ' A' ' 279' ' ' ILE . 72.5 m-85 -94.31 -40.39 9.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.468 ' CA ' HD11 ' A' ' 265' ' ' ILE . 1.4 t80 -41.99 -35.48 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.937 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 26.2 pt20 -55.17 -50.2 69.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.568 ' CD1' HG12 ' A' ' 289' ' ' VAL . 56.9 m-85 -53.1 -50.16 65.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.837 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -172.72 -155.09 10.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.488 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -83.35 127.95 34.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.468 HD11 ' CA ' ' A' ' 260' ' ' TYR . 45.1 mt -93.61 114.19 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 280' ' ' GLN . 16.0 mtt180 -57.74 -50.61 72.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.5 t -165.45 170.96 13.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.124 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 86.8 mt -145.43 116.12 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 55.2 m -107.16 100.04 9.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.459 HG13 ' CD1' ' A' ' 246' ' ' LEU . 93.0 t -93.47 107.1 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.158 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 44.1 t -92.73 100.01 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.195 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -59.68 -38.76 82.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 -64.33 -10.22 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -130.44 6.0 4.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 41.81 45.11 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 14.1 p -137.24 166.62 23.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -146.21 135.68 23.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 26.2 m-85 -104.18 108.5 19.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.488 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.8 mm -91.72 119.87 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.17 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 266' ' ' ARG . 42.2 tt0 -107.77 141.92 38.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.475 ' CD1' ' HB1' ' A' ' 286' ' ' ALA . 97.2 m-85 -121.08 148.21 44.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.437 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -70.54 -37.36 74.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.096 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 284' ' ' ARG . 17.4 p -126.06 121.49 33.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 285' ' ' GLN . 12.6 tpt180 -36.93 -40.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 284' ' ' ARG . 36.4 tp60 -34.46 -63.9 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . 0.475 ' HB1' ' CD1' ' A' ' 281' ' ' PHE . . . -57.57 -44.88 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -50.78 -57.47 8.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.133 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -49.95 -65.04 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.568 HG12 ' CD1' ' A' ' 262' ' ' PHE . 59.7 t -39.08 -59.74 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.563 ' HB3' ' CD2' ' A' ' 262' ' ' PHE . . . -58.95 -37.69 77.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.101 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.585 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -49.9 -54.56 18.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -69.17 -28.59 66.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -90.3 4.98 49.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 58.2 p -117.37 -30.1 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 5.0 m-30 -55.57 105.76 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 40.67 29.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -124.4 -35.81 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.648 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 11.1 tp -67.04 93.33 0.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 42.5 mt -113.47 91.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 41.3 t -92.29 146.32 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 50.87 46.98 25.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.16 31.3 6.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -133.16 104.0 6.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 12.6 ttm-85 -50.11 148.64 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 21.9 mt -131.45 132.52 44.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.21 99.75 11.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.446 HG11 ' N ' ' A' ' 308' ' ' LYS . 72.9 t -101.92 140.37 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.509 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 11.7 pttt -149.17 149.07 30.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -52.77 136.3 33.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.913 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.5 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 34.0 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.882 0.373 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 284' ' ' ARG . 30.2 p -99.2 36.27 1.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 30.1 m -137.18 138.46 40.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 22.0 mt -125.28 156.94 37.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.564 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.3 OUTLIER -109.7 149.29 29.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 91.4 t -141.95 119.19 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.32 -175.04 20.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.534 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 55.69 45.82 84.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.509 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.406 HD11 ' C ' ' A' ' 276' ' ' CYS . 44.7 mt -78.62 -59.13 2.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 0.0 110.943 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 62.72 153.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.507 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -42.12 -37.93 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.86 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 43.3 p -49.4 -44.43 45.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.443 ' CD1' ' CD2' ' A' ' 305' ' ' LEU . 65.3 mt -97.17 146.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.138 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.7 p -126.23 -178.78 4.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -66.39 -57.28 7.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.8 m -47.15 -54.36 10.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -40.81 -45.77 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 9.1 mt -74.07 -45.64 48.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -48.8 -46.03 41.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -76.25 -38.69 55.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.565 ' CD2' HG21 ' A' ' 300' ' ' VAL . 43.4 t-80 -61.07 -34.56 75.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.498 ' CE2' HG13 ' A' ' 279' ' ' ILE . 58.4 m-85 -94.34 -39.67 10.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.863 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -43.48 -38.93 3.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.957 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.474 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 29.0 pt20 -50.28 -43.55 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 85.1 m-85 -60.54 -47.8 84.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -177.69 -167.01 35.21 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -69.03 127.22 32.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.343 . . . . 0.0 110.873 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 84.3 mt -95.72 110.67 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.4 mtp180 -54.01 -51.5 63.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.8 t -164.71 169.47 16.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.194 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 88.6 mt -145.87 114.29 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.18 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 85.3 m -109.18 99.02 8.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 96.2 t -92.65 111.01 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.2 101.4 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . 0.418 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 5.2 pt20 -59.23 -40.61 86.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.418 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 6.6 ptp85 -62.16 -21.55 65.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 275' ' ' GLN . 74.0 mt-30 -117.31 14.27 14.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.94 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 274' ' ' GLN . 71.3 mt-30 34.38 43.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.406 ' C ' HD11 ' A' ' 246' ' ' LEU . 21.7 p -141.04 173.51 11.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -157.36 140.28 15.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -105.12 121.86 44.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.498 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.1 mm -102.32 117.03 47.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.186 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 266' ' ' ARG . 16.3 tt0 -105.17 140.3 38.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.405 ' C ' ' HG3' ' A' ' 266' ' ' ARG . 97.5 m-85 -120.72 148.3 44.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.884 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.428 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -70.23 -34.01 72.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 284' ' ' ARG . 22.4 p -125.82 116.6 21.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.178 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.466 ' N ' HG22 ' A' ' 239' ' ' THR . 16.7 tpt180 -36.14 -39.3 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 284' ' ' ARG . 0.6 OUTLIER -33.56 -64.42 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.02 -46.68 82.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.097 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -50.5 -53.26 31.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.428 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 6.2 mt-10 -55.24 -48.87 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 42.1 t -57.88 -59.96 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.566 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -56.12 -33.97 65.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.16 -67.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.42 -39.71 73.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -75.08 1.59 12.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.472 ' HB3' ' CB ' ' A' ' 307' ' ' VAL . 3.4 m -115.81 -33.38 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.2 102.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 9.0 m120 44.23 31.72 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -129.83 -31.14 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.455 HD23 ' CG2' ' A' ' 307' ' ' VAL . 6.6 tp -70.06 103.69 2.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 27.0 mt -119.74 96.76 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.565 HG21 ' CD2' ' A' ' 258' ' ' HIS . 31.1 t -96.28 138.31 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.097 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 56.95 47.19 18.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.15 29.64 6.95 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.496 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 18.0 ttt85 -130.49 103.85 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.859 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -48.23 137.67 10.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.443 ' CD2' ' CD1' ' A' ' 250' ' ' ILE . 26.3 mt -124.19 133.55 53.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -87.54 107.24 18.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.472 ' CB ' ' HB3' ' A' ' 294' ' ' SER . 53.4 t -105.13 143.46 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.564 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -146.15 165.15 29.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -74.25 122.12 22.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 179.99 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 14.3 mt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.899 0.38 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.433 HG21 ' N ' ' A' ' 284' ' ' ARG . 51.0 p -90.95 23.47 3.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 26.4 m -121.14 141.76 50.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.155 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 26.7 mt -128.59 146.86 50.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.585 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -102.6 143.41 32.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 93.3 t -136.83 114.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.127 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -100.97 179.27 28.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.523 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.467 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 61.92 51.88 54.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.445 ' CD1' ' C ' ' A' ' 276' ' ' CYS . 88.0 mt -81.46 -59.65 2.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.11 149.97 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.459 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.9 -29.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.92 0.39 . . . . 0.0 110.842 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 23.8 p -57.94 -41.81 83.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 79.2 mt -99.13 146.16 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 40.6 p -127.04 -176.41 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.152 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -71.51 -56.23 6.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 96.0 m -45.01 -48.86 11.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -49.53 -50.91 39.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.7 mt -67.32 -43.55 81.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -51.49 -45.01 62.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -78.69 -33.02 47.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.57 ' CE1' HD11 ' A' ' 298' ' ' LEU . 38.2 t-80 -65.75 -34.87 79.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.436 ' CE2' HG13 ' A' ' 279' ' ' ILE . 60.4 m-85 -94.08 -37.58 11.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.473 ' CA ' HD11 ' A' ' 265' ' ' ILE . 1.3 t80 -44.77 -26.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.461 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 11.4 pt20 -63.96 -41.74 97.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.887 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.639 ' CD2' ' CB ' ' A' ' 290' ' ' ALA . 56.8 m-85 -62.21 -39.08 91.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 174.71 -154.35 18.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.491 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -79.0 141.69 37.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.87 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.473 HD11 ' CA ' ' A' ' 260' ' ' TYR . 70.9 mt -112.28 111.88 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 280' ' ' GLN . 20.5 mtt180 -59.97 -49.14 78.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.7 t -165.11 171.25 14.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.16 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 94.4 mt -144.4 106.96 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 26.4 m -96.61 100.66 12.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.136 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 94.6 t -94.79 109.54 22.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.082 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.44 99.91 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -40.62 89.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -50.35 -39.02 45.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -108.65 10.49 26.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 42.71 52.12 5.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.445 ' C ' ' CD1' ' A' ' 246' ' ' LEU . 25.7 p -140.58 168.66 19.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.29 130.23 15.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.126 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -100.14 109.56 21.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.436 HG13 ' CE2' ' A' ' 259' ' ' PHE . 2.9 mm -92.66 123.04 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.094 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 266' ' ' ARG . 38.6 tt0 -108.3 141.05 40.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -120.96 144.67 48.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.856 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.91 -37.09 78.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 284' ' ' ARG . 22.8 p -120.75 117.18 26.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.098 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.433 ' N ' HG21 ' A' ' 239' ' ' THR . 13.7 tpt180 -37.21 -38.83 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 284' ' ' ARG . 12.7 tp60 -37.79 -67.39 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -52.86 -43.15 65.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -52.44 -57.74 8.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -50.45 -63.15 1.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 28.8 t -41.21 -66.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.639 ' CB ' ' CD2' ' A' ' 262' ' ' PHE . . . -50.29 -46.4 55.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -47.26 -67.71 0.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -55.41 -38.76 69.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -84.28 6.07 24.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 290' ' ' ALA . 16.9 m -118.57 -13.22 9.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 297' ' ' LYS . 3.8 m-30 -71.27 113.92 8.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 41.9 25.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 295' ' ' PHE . 3.0 ttmm -126.21 -31.88 2.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.57 HD11 ' CE1' ' A' ' 258' ' ' HIS . 5.3 tp -71.62 101.4 2.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 304' ' ' ARG . 39.3 mt -115.88 95.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 32.8 t -90.36 136.61 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 53.74 51.19 15.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.61 28.84 2.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 18.2 ttt-85 -129.14 98.22 4.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 110.852 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.406 ' N ' HG22 ' A' ' 299' ' ' ILE . 32.2 ttp85 -42.25 145.9 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.467 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 49.7 mt -130.59 135.97 48.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -89.55 99.47 12.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 75.2 t -95.72 142.39 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.075 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 11.9 ptpt -145.77 171.94 14.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -85.06 122.02 28.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.469 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 65.4 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.96 0.41 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 284' ' ' ARG . 29.1 p -108.41 26.59 10.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 18.3 m -117.75 140.98 48.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.16 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 30.6 mt -128.49 133.24 48.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.603 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -97.92 140.72 31.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 89.5 t -135.5 127.31 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.51 174.89 16.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.436 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 70.66 42.29 62.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.483 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.418 ' CD1' HG12 ' A' ' 270' ' ' VAL . 24.3 mt -70.64 -62.9 1.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.826 0.346 . . . . 0.0 110.919 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.71 158.98 0.75 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.443 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -56.65 -15.58 4.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.8 p -74.26 -32.49 62.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.469 ' CD1' HD23 ' A' ' 305' ' ' LEU . 68.6 mt -108.97 145.26 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 12.4 p -128.56 177.19 7.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.151 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -59.55 -61.25 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 94.6 m -38.66 -56.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -40.31 -56.03 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.9 mt -65.42 -48.86 71.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.437 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 44.0 ttt180 -45.92 -43.13 13.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -79.46 -41.21 28.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.649 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 59.6 t-80 -57.91 -33.66 69.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 279' ' ' ILE . 60.1 m-85 -94.22 -42.8 8.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -42.29 -36.06 1.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.8 pt20 -54.3 -41.28 68.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.959 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 86.3 m-85 -64.84 -42.86 94.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 176.36 -172.22 45.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -61.47 142.27 57.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 110.922 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 70.6 mt -111.93 111.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -55.02 -50.25 69.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.8 t -168.85 162.24 11.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 256' ' ' ARG . 79.7 mt -138.4 108.46 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 92.4 m -99.63 100.34 11.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.418 HG12 ' CD1' ' A' ' 246' ' ' LEU . 76.8 t -92.62 103.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 82.6 t -86.4 99.88 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -60.25 -31.68 70.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -59.23 -38.08 79.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 275' ' ' GLN . 77.0 mt-30 -112.52 21.66 15.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.943 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.456 ' HA ' ' NE2' ' A' ' 275' ' ' GLN . 14.5 mm100 33.73 50.82 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.418 ' C ' HD11 ' A' ' 246' ' ' LEU . 29.3 p -140.62 167.9 21.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -146.14 146.8 31.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.559 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 33.7 m-85 -115.21 107.72 15.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.571 HG12 ' CD2' ' A' ' 259' ' ' PHE . 3.9 mp -90.86 121.03 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.144 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -106.94 142.95 35.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.564 ' CD2' ' HB2' ' A' ' 286' ' ' ALA . 96.9 m-85 -122.75 142.03 51.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.43 74.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.046 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 36.8 p -131.81 123.88 28.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.134 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.472 ' N ' HG22 ' A' ' 239' ' ' THR . 6.0 tpp85 -39.0 -33.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -37.97 -65.9 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . 0.564 ' HB2' ' CD2' ' A' ' 281' ' ' PHE . . . -58.23 -53.83 53.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -41.59 -63.45 0.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.096 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -46.3 -64.31 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.869 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 18.6 t -40.25 -62.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.564 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -57.02 -33.98 67.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.119 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.59 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -53.86 -60.71 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.131 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -63.79 -36.53 84.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.436 ' HD2' ' CE2' ' A' ' 262' ' ' PHE . 17.7 mttm -75.97 -8.49 57.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 29.6 m -114.18 -9.82 12.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.8 m-30 -65.4 105.71 1.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.835 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 21.1 m120 43.36 27.79 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -127.68 -28.61 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.649 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 4.7 tp -67.8 97.37 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.961 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 38.4 mt -116.13 94.53 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 49.8 t -95.85 145.2 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 50.93 50.03 19.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.9 34.18 5.47 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.534 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -136.9 108.92 7.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 110.883 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -56.84 143.69 36.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.469 HD23 ' CD1' ' A' ' 250' ' ' ILE . 43.0 mt -126.78 137.95 53.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.74 98.89 11.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.44 ' CG2' HD21 ' A' ' 298' ' ' LEU . 79.0 t -93.22 138.65 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.528 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.3 ptpt -151.56 141.52 22.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -50.7 135.19 23.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.944 0.402 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 284' ' ' ARG . 39.0 p -99.61 32.2 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 241' ' ' LEU . 9.4 m -130.22 149.37 51.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.406 ' N ' HG22 ' A' ' 240' ' ' THR . 28.8 mt -132.3 156.85 45.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.585 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.3 OUTLIER -108.36 146.18 33.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.43 HG21 ' C ' ' A' ' 242' ' ' TYR . 58.2 t -140.77 113.84 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.098 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -107.0 -177.42 22.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.453 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 57.7 47.33 89.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.477 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.428 ' CD1' ' C ' ' A' ' 276' ' ' CYS . 95.4 mt -83.22 -57.82 3.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 110.915 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.26 158.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.477 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -47.02 -33.95 5.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.912 0.387 . . . . 0.0 110.857 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.9 p -52.75 -44.38 66.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.88 143.52 12.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 42.7 p -121.83 -176.65 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -70.1 -57.09 5.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.5 m -44.55 -50.1 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.124 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -46.99 -42.67 18.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 21.1 mt -77.34 -48.92 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.403 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 28.0 ttm180 -46.46 -44.44 17.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -76.3 -40.11 52.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.487 ' CE1' HD12 ' A' ' 298' ' ' LEU . 51.3 t-80 -60.19 -34.45 73.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.837 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -94.22 -40.68 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 256' ' ' ARG . 1.6 t80 -42.05 -34.82 0.77 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.468 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.0 pt20 -54.16 -43.2 70.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.934 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.571 ' CZ ' ' HA ' ' A' ' 290' ' ' ALA . 60.8 m-85 -57.68 -50.93 71.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.62 -150.1 7.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -85.13 122.61 29.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 0.0 110.848 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 77.2 mt -90.71 116.88 32.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -63.11 -51.67 65.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.3 t -165.13 161.59 19.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 76.7 mt -137.71 109.72 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 60.7 m -100.45 99.58 10.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.148 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 93.4 t -91.13 115.11 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.163 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 5.0 t -97.18 102.04 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -60.23 -49.49 77.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -54.03 -30.14 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 275' ' ' GLN . 16.6 mt-30 -108.33 13.79 25.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 274' ' ' GLN . 43.6 mt-30 34.32 47.26 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.428 ' C ' ' CD1' ' A' ' 246' ' ' LEU . 20.7 p -142.2 177.54 8.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . 0.418 ' CB ' HD12 ' A' ' 246' ' ' LEU . . . -159.59 140.2 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -107.06 119.5 39.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 3.8 mm -98.51 118.63 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.15 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -104.47 141.23 36.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 286' ' ' ALA . 97.5 m-85 -122.88 150.52 42.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -71.2 -41.84 69.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 33.1 p -118.99 122.5 42.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.12 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.427 ' N ' HG23 ' A' ' 239' ' ' THR . 17.0 tpt180 -38.44 -35.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -39.55 -65.86 0.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . 0.472 ' HB3' ' CD1' ' A' ' 281' ' ' PHE . . . -53.67 -48.94 68.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -47.49 -63.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -43.42 -64.1 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.449 HG11 ' CE1' ' A' ' 262' ' ' PHE . 41.5 t -42.51 -58.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -54.6 -39.55 67.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -52.22 -65.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -54.7 -39.52 68.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -80.41 2.42 25.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.453 ' HB3' ' CG1' ' A' ' 307' ' ' VAL . 24.0 m -117.36 -26.58 6.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -58.19 102.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.0 m120 43.69 32.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -129.74 -31.09 2.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.487 HD12 ' CE1' ' A' ' 258' ' ' HIS . 4.9 tp -68.65 98.53 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 304' ' ' ARG . 28.4 mt -113.72 94.47 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.2 t -92.07 139.36 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 53.71 47.35 23.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.885 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.31 27.02 5.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 -126.92 97.63 5.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.772 0.32 . . . . 0.0 110.907 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.469 ' N ' HG23 ' A' ' 299' ' ' ILE . 34.3 ttm-85 -42.41 139.76 1.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 29.2 mt -126.7 138.09 53.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -87.99 113.66 23.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 308' ' ' LYS . 47.0 t -113.79 143.63 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 18.7 pttt -152.65 161.26 42.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -67.68 123.53 20.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.974 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 79.9 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.978 0.418 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.1 p -102.41 35.14 2.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 17.2 m -138.72 143.2 38.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.5 mt -129.11 141.72 51.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.564 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -104.64 137.02 43.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.06 131.62 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.156 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.59 158.23 15.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 82.84 37.87 12.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.434 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.41 HD11 ' C ' ' A' ' 276' ' ' CYS . 63.6 mt -63.62 -66.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.417 ' HA3' ' NH1' ' A' ' 303' ' ' ARG . . . 66.01 148.32 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.5 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.0 -37.88 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 0.0 110.845 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 50.9 p -52.9 -46.58 68.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.151 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.477 ' CD1' ' CD2' ' A' ' 305' ' ' LEU . 53.0 mt -94.24 143.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.115 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.2 p -129.31 177.31 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.15 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.503 ' OE1' ' CG2' ' A' ' 270' ' ' VAL . 3.7 tp10 -60.35 -61.14 2.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.1 m -41.43 -52.61 3.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.134 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.51 -51.5 5.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.0 mt -70.03 -45.26 67.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.94 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -48.88 -47.27 43.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -76.59 -38.93 54.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.559 ' CE1' HD13 ' A' ' 298' ' ' LEU . 34.6 t-80 -60.44 -34.24 73.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.573 ' CD2' HG12 ' A' ' 279' ' ' ILE . 51.3 m-85 -94.87 -41.34 9.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.838 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.418 ' CA ' HD13 ' A' ' 265' ' ' ILE . 2.0 t80 -41.8 -38.17 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 27.4 pt20 -52.32 -41.71 63.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.562 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 70.2 m-85 -63.25 -48.29 78.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 177.13 174.29 43.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.545 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -45.81 147.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.456 HG21 ' CG1' ' A' ' 268' ' ' ILE . 65.8 mt -117.03 112.35 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.8 mtp180 -55.19 -50.98 67.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.1 t -167.03 158.84 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.456 ' CG1' HG21 ' A' ' 265' ' ' ILE . 21.0 mt -136.2 110.31 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.07 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 91.2 m -105.14 126.33 51.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.503 ' CG2' ' OE1' ' A' ' 252' ' ' GLU . 25.5 t -109.8 123.48 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 22.8 t -106.75 99.93 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.144 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -59.89 -50.0 75.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 9.4 ptt85 -53.79 -24.83 16.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.457 ' O ' ' C ' ' A' ' 275' ' ' GLN . 17.8 mt-30 -116.68 10.98 14.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 274' ' ' GLN . 66.8 mt-30 33.34 53.79 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.41 ' C ' HD11 ' A' ' 246' ' ' LEU . 26.9 p -142.86 172.21 13.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -146.3 151.2 37.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.065 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 49.6 m-85 -121.47 108.24 13.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.573 HG12 ' CD2' ' A' ' 259' ' ' PHE . 4.5 mp -94.24 118.52 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.126 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 266' ' ' ARG . 7.9 tt0 -105.91 142.52 35.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.548 ' CD2' ' HB1' ' A' ' 286' ' ' ALA . 87.7 m-85 -121.49 149.95 42.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.39 91.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.069 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 284' ' ' ARG . 35.8 p -125.81 125.34 42.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.15 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.461 ' O ' ' C ' ' A' ' 285' ' ' GLN . 4.9 tpt180 -35.97 -39.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.843 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 284' ' ' ARG . 36.2 tp60 -32.87 -65.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.94 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . 0.548 ' HB1' ' CD2' ' A' ' 281' ' ' PHE . . . -56.56 -43.56 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.061 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.08 -60.88 2.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.102 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -47.58 -53.35 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 45.5 t -53.17 -54.87 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.157 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.562 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -60.39 -32.79 71.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.448 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -56.41 -50.99 70.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -70.87 -26.86 63.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.464 ' HD2' ' CE2' ' A' ' 262' ' ' PHE . 20.5 mttt -92.51 -1.34 57.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 290' ' ' ALA . 61.3 p -112.29 -32.14 6.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 2.9 m-85 -53.73 106.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 29.5 t30 40.84 34.0 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -131.02 -33.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.559 HD13 ' CE1' ' A' ' 258' ' ' HIS . 4.3 tp -66.9 98.17 0.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 53.8 mt -113.53 96.29 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.84 141.89 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 53.82 43.88 30.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 50.79 32.94 26.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.461 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . 0.417 ' NH1' ' HA3' ' A' ' 247' ' ' GLY . 30.4 ttt180 -135.0 108.31 7.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.873 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -51.42 146.37 7.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.477 ' CD2' ' CD1' ' A' ' 250' ' ' ILE . 31.1 mt -132.45 135.15 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.97 97.92 9.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.459 ' CG2' HD22 ' A' ' 298' ' ' LEU . 39.1 t -94.89 141.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.526 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.5 ptpt -153.47 145.27 23.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -50.9 143.98 9.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.922 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.444 -179.947 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 52.2 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.899 0.38 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 37.3 p -86.34 30.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 241' ' ' LEU . 56.5 m -126.27 140.39 52.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.142 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.444 ' N ' HG22 ' A' ' 240' ' ' THR . 25.2 mt -129.27 131.46 47.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.611 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -87.65 145.95 25.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 85.6 t -137.22 130.3 44.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -121.96 177.98 16.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.49 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.412 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 66.53 46.51 76.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.44 HD21 ' CD1' ' A' ' 255' ' ' LEU . 52.1 mt -77.12 -59.69 2.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.382 . . . . 0.0 110.906 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.87 148.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -42.18 -25.91 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.843 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.8 p -61.57 -45.96 91.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.112 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.466 ' CD1' ' CD2' ' A' ' 305' ' ' LEU . 53.7 mt -97.3 148.77 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.138 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 31.0 p -128.48 -176.47 3.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -66.83 -59.56 3.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.9 m -42.11 -55.33 3.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -41.95 -47.17 4.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.44 ' CD1' HD21 ' A' ' 246' ' ' LEU . 19.5 mt -72.34 -53.76 11.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.956 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -42.08 -45.85 4.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -75.87 -42.65 48.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.567 ' CE1' HD11 ' A' ' 298' ' ' LEU . 37.7 t-80 -56.62 -33.95 66.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.46 ' CE2' HG13 ' A' ' 279' ' ' ILE . 67.5 m-85 -94.19 -44.04 8.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.446 ' CA ' HD13 ' A' ' 265' ' ' ILE . 1.9 t80 -39.94 -36.73 0.49 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 14.4 pt20 -51.63 -46.88 63.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.932 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.567 ' CD2' ' HB3' ' A' ' 290' ' ' ALA . 67.4 m-85 -57.99 -45.94 86.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -176.33 -157.54 17.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.48 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -80.72 131.24 35.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.446 HD13 ' CA ' ' A' ' 260' ' ' TYR . 62.5 mt -97.56 112.41 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.127 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -57.86 -50.18 74.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 3.7 t -163.6 168.56 19.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 82.2 mt -145.73 111.52 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.144 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 88.8 m -102.21 101.81 12.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.17 114.64 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.076 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 11.1 t -101.71 100.06 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -60.07 -44.22 94.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . 0.449 ' HG2' ' N ' ' A' ' 274' ' ' GLN . 1.6 ptm180 -52.99 -32.95 49.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.829 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.449 ' N ' ' HG2' ' A' ' 273' ' ' ARG . 61.8 mm-40 -112.42 15.12 20.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 274' ' ' GLN . 46.9 mm-40 34.66 52.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.407 ' C ' HD12 ' A' ' 246' ' ' LEU . 9.5 p -142.24 174.18 10.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -152.72 135.53 15.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.108 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 27.1 m-85 -101.62 109.44 21.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . 0.46 HG13 ' CE2' ' A' ' 259' ' ' PHE . 3.5 mm -93.75 121.0 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -109.79 139.08 45.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -117.38 144.64 44.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.15 78.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 284' ' ' ARG . 31.1 p -125.14 118.73 26.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' A' ' 283' ' ' THR . 15.7 tpt180 -37.94 -32.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 283' ' ' THR . 5.2 tt0 -40.35 -67.91 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -56.36 -39.43 72.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -53.49 -62.23 1.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -49.63 -49.62 46.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.412 HG12 ' CE1' ' A' ' 262' ' ' PHE . 16.8 t -52.82 -64.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.567 ' HB3' ' CD2' ' A' ' 262' ' ' PHE . . . -53.27 -41.5 65.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . 0.448 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -51.34 -54.76 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.439 ' O ' ' NZ ' ' A' ' 297' ' ' LYS . 12.9 tm-20 -67.65 -26.71 66.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.843 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.9 mttm -94.84 4.6 53.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 290' ' ' ALA . 78.9 p -116.47 -26.91 6.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.4 m-30 -58.73 104.86 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 1.7 m120 47.82 29.12 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.439 ' NZ ' ' O ' ' A' ' 292' ' ' GLU . 0.5 OUTLIER -127.86 -34.94 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.567 HD11 ' CE1' ' A' ' 258' ' ' HIS . 7.4 tp -67.81 97.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 304' ' ' ARG . 42.1 mt -114.76 98.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.42 146.76 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.127 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 45.78 47.24 11.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.54 33.4 11.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 11.2 ttt85 -133.96 101.5 5.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.792 0.329 . . . . 0.0 110.892 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.452 ' N ' HG22 ' A' ' 299' ' ' ILE . 14.8 ttm180 -43.3 145.72 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.466 ' CD2' ' CD1' ' A' ' 250' ' ' ILE . 23.4 mt -129.71 134.02 47.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.57 101.38 11.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 72.5 t -103.85 133.29 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.575 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.0 pttt -145.59 152.52 39.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -55.91 130.38 43.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 179.971 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 6.7 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.897 0.379 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.8 p -98.45 39.83 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 18.4 m -138.91 139.62 38.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 44.1 mt -126.33 153.71 44.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.581 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.3 OUTLIER -105.53 146.18 29.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.415 HG22 ' C ' ' A' ' 242' ' ' TYR . 93.5 t -142.49 122.3 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.127 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -115.15 173.18 14.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.494 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.72 56.53 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.524 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.466 ' CD1' HG11 ' A' ' 270' ' ' VAL . 57.4 mt -70.23 -62.37 1.41 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.868 0.365 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.47 155.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.473 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -47.44 -30.36 3.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.5 p -58.12 -43.03 87.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.466 HG21 ' N ' ' A' ' 251' ' ' THR . 61.3 mt -102.18 143.53 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.466 ' N ' HG21 ' A' ' 250' ' ' ILE . 30.4 p -121.26 -177.31 3.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.183 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -70.02 -52.25 25.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 92.2 m -48.9 -54.98 13.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.154 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -40.24 -44.94 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 258' ' ' HIS . 16.7 mt -75.25 -59.08 2.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 255' ' ' LEU . 20.3 ttm-85 -36.29 -42.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -78.12 -40.17 39.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.57 ' CE1' HD11 ' A' ' 298' ' ' LEU . 13.9 t60 -59.56 -37.53 78.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 261' ' ' GLN . 73.5 m-85 -90.03 -39.06 13.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.466 ' CA ' HD11 ' A' ' 265' ' ' ILE . 1.1 t80 -45.02 -21.31 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.926 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 259' ' ' PHE . 24.4 pt20 -69.32 -43.3 74.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.559 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 81.4 m-85 -61.31 -42.52 98.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 179.96 -167.19 36.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.466 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -71.56 130.11 40.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.913 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.466 HD11 ' CA ' ' A' ' 260' ' ' TYR . 60.3 mt -98.29 112.13 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.112 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.5 mtp85 -56.89 -49.36 75.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 t -165.6 168.98 15.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.176 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.407 ' CD1' ' HA ' ' A' ' 256' ' ' ARG . 85.9 mt -144.01 110.95 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.174 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.8 m -100.92 102.21 13.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.466 HG11 ' CD1' ' A' ' 246' ' ' LEU . 40.3 t -96.18 104.68 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 99.8 t -92.52 99.95 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -37.75 80.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -55.99 -35.55 66.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -106.42 4.13 28.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 47.25 48.02 16.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.946 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.69 178.63 7.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -155.26 139.55 16.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -111.33 109.95 20.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 2.8 mm -92.46 126.84 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 266' ' ' ARG . 8.5 tt0 -113.52 142.16 46.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -121.49 149.82 42.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.0 -32.71 71.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.102 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 284' ' ' ARG . 16.0 p -127.1 117.4 22.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 283' ' ' THR . 15.1 tpt180 -37.29 -32.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' THR . 3.5 tt0 -39.22 -68.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -55.5 -47.66 75.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -43.8 -54.05 5.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.138 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -56.46 -60.72 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.848 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 21.0 t -45.12 -56.34 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.559 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -58.09 -37.25 74.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.088 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -52.23 -65.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -56.13 -39.53 72.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.832 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.5 ' HD2' ' CZ ' ' A' ' 262' ' ' PHE . 20.8 mttp -76.86 1.06 18.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 3.2 m -118.03 -28.14 5.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -54.81 106.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 57.5 t30 42.27 25.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -123.83 -27.32 3.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.57 HD11 ' CE1' ' A' ' 258' ' ' HIS . 5.9 tp -70.32 100.5 1.74 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 22.4 mt -120.17 99.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.36 138.91 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 60.64 45.87 9.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.85 34.53 11.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -137.67 106.24 5.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 0.0 110.872 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 16.9 ttm105 -50.58 150.2 2.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.451 HD21 ' CD1' ' A' ' 250' ' ' ILE . 38.7 mt -135.43 137.64 42.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.959 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -90.38 113.36 25.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.467 HG11 ' N ' ' A' ' 308' ' ' LYS . 35.4 t -112.4 143.17 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.581 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 5.1 ptpp? -150.12 160.37 43.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -67.67 129.56 40.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.494 -179.997 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 48.9 mt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.93 0.395 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.5 p -98.51 30.01 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 40.1 m -128.88 136.3 50.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.5 mt -126.66 126.43 43.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.585 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -82.56 140.59 33.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.886 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.49 131.72 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.171 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.07 -174.9 16.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.43 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 56.2 54.79 33.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.402 HD11 ' C ' ' A' ' 276' ' ' CYS . 77.8 mt -87.4 -57.81 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.912 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.78 156.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.66 -24.63 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.847 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.8 p -62.13 -35.27 78.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.127 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.419 ' CD1' ' CD2' ' A' ' 305' ' ' LEU . 73.6 mt -107.24 142.32 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.8 p -117.74 -179.93 3.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.84 -54.26 24.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 89.3 m -48.56 -54.89 12.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.222 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -39.15 -45.96 1.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.0 mt -75.95 -49.55 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -45.35 -44.25 11.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -76.41 -44.37 36.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.519 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 39.5 t-80 -56.37 -33.82 66.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -94.12 -42.71 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . 0.46 ' CA ' HD13 ' A' ' 265' ' ' ILE . 1.8 t80 -41.14 -44.46 2.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.8 pt20 -44.5 -41.02 6.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.576 ' CD2' ' HB3' ' A' ' 290' ' ' ALA . 53.4 m-85 -60.8 -49.84 75.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -175.63 -160.95 24.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.454 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -75.36 121.93 22.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.865 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.46 HD13 ' CA ' ' A' ' 260' ' ' TYR . 87.0 mt -89.83 108.98 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.46 ' HG3' ' N ' ' A' ' 282' ' ' ALA . 9.2 mtt-85 -52.46 -52.49 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 13.7 t -162.23 170.9 18.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 75.3 mt -146.08 110.26 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.131 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 19.2 m -103.1 98.9 8.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.194 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.17 107.06 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 5.3 t -91.3 100.84 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -60.21 -45.43 93.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -19.22 21.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 275' ' ' GLN . 15.2 mt-30 -121.39 11.93 10.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 274' ' ' GLN . 92.9 mt-30 36.87 44.3 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.402 ' C ' HD11 ' A' ' 246' ' ' LEU . 28.4 p -133.59 175.07 9.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -156.73 131.94 9.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 42.9 m-85 -100.74 111.91 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 4.6 mm -94.85 114.71 31.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -102.52 144.84 30.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.64 148.09 49.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.46 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -68.91 -38.26 79.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.111 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 284' ' ' ARG . 25.1 p -125.24 119.22 27.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.168 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 283' ' ' THR . 16.9 tpt180 -35.89 -36.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.901 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 284' ' ' ARG . 13.0 tp60 -36.96 -63.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -60.4 -36.77 78.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.127 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.71 -62.09 2.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.055 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -47.44 -56.6 6.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 29.3 t -47.21 -62.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.576 ' HB3' ' CD2' ' A' ' 262' ' ' PHE . . . -54.04 -39.85 66.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -51.34 -64.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -54.99 -40.95 70.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -77.31 3.07 13.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.455 ' HB3' ' CG1' ' A' ' 307' ' ' VAL . 1.9 m -116.65 -31.72 5.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -48.32 98.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.854 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 43.96 30.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.69 -35.79 2.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.519 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 6.6 tp -66.45 97.75 0.44 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 54.1 mt -114.53 91.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 58.1 t -85.62 147.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.118 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 43.73 48.7 6.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 46.5 33.57 6.1 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.474 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -132.9 100.14 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.866 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 -43.84 139.3 2.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.43 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 29.6 mt -122.12 133.35 54.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -82.67 101.3 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 294' ' ' SER . 53.8 t -103.77 146.65 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 10.5 ptpt -156.96 169.73 24.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -80.79 125.47 30.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 -179.973 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 57.2 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.869 0.366 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.437 HG21 ' N ' ' A' ' 284' ' ' ARG . 30.3 p -93.92 38.11 1.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 24.9 m -131.38 144.28 51.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 28.6 mt -134.71 128.61 33.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.941 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.565 ' CE1' ' HE2' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -85.6 143.99 28.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.412 HG23 ' C ' ' A' ' 242' ' ' TYR . 66.0 t -140.5 106.67 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.115 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -102.17 178.18 26.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.495 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.488 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 71.94 41.43 55.12 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.464 HD11 ' N ' ' A' ' 276' ' ' CYS . 96.5 mt -70.08 -63.11 1.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.841 0.353 . . . . 0.0 110.926 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 249' ' ' THR . . . 71.77 143.45 0.38 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -40.1 -29.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 247' ' ' GLY . 34.5 p -61.59 -53.12 60.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . 0.46 ' CD1' HD23 ' A' ' 305' ' ' LEU . 59.2 mt -84.53 153.82 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 55.9 p -134.68 178.37 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.77 -59.57 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.4 m -44.02 -55.14 4.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.156 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -39.75 -47.01 2.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.9 mt -75.86 -52.88 9.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 50.1 ttp85 -42.06 -44.01 3.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -74.97 -46.86 32.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.542 ' CE1' HD12 ' A' ' 298' ' ' LEU . 8.8 t60 -52.63 -39.39 61.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 261' ' ' GLN . 76.7 m-85 -87.84 -45.16 10.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.826 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -39.84 -27.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 259' ' ' PHE . 23.6 pt20 -62.28 -46.25 89.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.572 ' CD2' ' HB3' ' A' ' 290' ' ' ALA . 60.8 m-85 -54.39 -50.27 67.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -172.6 -146.99 5.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.511 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -90.29 123.02 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 47.1 mt -91.01 113.76 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.144 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -56.6 -48.82 76.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 t -165.2 170.28 15.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.165 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 92.6 mt -144.79 110.93 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.118 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 39.2 m -103.14 98.86 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 90.1 t -90.34 110.07 21.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.436 HG13 ' NE2' ' A' ' 274' ' ' GLN . 38.6 t -95.57 100.01 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 275' ' ' GLN . 10.4 tt0 -60.01 -57.8 11.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -45.11 -22.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.436 ' NE2' HG13 ' A' ' 271' ' ' VAL . 43.2 mt-30 -109.12 -16.44 14.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.962 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 272' ' ' GLN . 34.3 mt-30 64.37 45.14 3.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' CYS . . . . . 0.464 ' N ' HD11 ' A' ' 246' ' ' LEU . 5.3 m -145.76 177.52 8.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -153.29 142.18 21.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 33.1 m-85 -106.63 107.16 18.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 7.3 mm -90.1 117.44 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -105.79 150.19 25.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -130.79 151.83 50.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -74.53 -32.97 62.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.116 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 284' ' ' ARG . 24.9 p -127.17 118.08 23.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.437 ' N ' HG21 ' A' ' 239' ' ' THR . 5.7 tpp85 -36.01 -38.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 284' ' ' ARG . 12.0 tt0 -35.9 -64.83 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.59 -45.73 84.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -52.0 -66.31 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -43.29 -52.39 5.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.571 HG13 ' CD1' ' A' ' 262' ' ' PHE . 46.3 t -52.72 -64.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.572 ' HB3' ' CD2' ' A' ' 262' ' ' PHE . . . -48.84 -43.1 38.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.067 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -46.18 -67.66 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -53.14 -44.48 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -70.7 -0.94 9.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.472 ' HB3' ' CG2' ' A' ' 307' ' ' VAL . 12.6 m -119.14 -24.26 6.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.869 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -53.95 103.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 43.51 26.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -124.92 -26.77 3.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.542 HD12 ' CE1' ' A' ' 258' ' ' HIS . 12.5 tp -68.03 98.26 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.947 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.55 96.64 4.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.159 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 85.7 t -103.69 145.37 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 55.56 40.48 31.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 51.53 32.05 30.41 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.52 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 19.4 ttt-85 -133.56 105.63 6.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.92 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -49.95 147.12 4.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.488 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 40.4 mt -132.29 145.76 51.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.954 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -98.01 106.84 19.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' A' ' 294' ' ' SER . 98.3 t -105.25 137.7 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.565 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 3.4 pttt -151.26 148.94 28.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.935 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.61 141.06 44.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 23.3 t -112.26 150.8 30.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.918 0.39 . . . . 0.0 110.866 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 83.6 p -65.34 -45.88 82.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.819 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.24 112.76 0.84 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.443 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 88.1 p -134.94 156.95 48.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 110.874 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 50.1 m -131.23 92.5 3.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.797 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.36 -162.95 0.63 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.496 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -109.98 42.25 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.883 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -114.8 100.4 8.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.428 ' O ' ' NH1' ' A' ' 284' ' ' ARG . 0.7 OUTLIER -93.36 -66.89 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 72.2 p -120.89 29.24 7.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.152 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 59.4 mt -83.1 126.08 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 82.0 p -102.36 -11.68 18.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 16.7 m -84.84 141.92 30.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.181 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.555 HD23 ' CE3' ' A' ' 309' ' ' TRP . 19.8 mt -130.85 124.41 31.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.555 ' CE1' ' HE2' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -81.53 141.32 33.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.929 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 99.8 t -136.28 116.98 18.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.08 177.3 19.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 68.78 37.79 84.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.481 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.402 HD12 ' C ' ' A' ' 276' ' ' CYS . 31.4 mt -75.9 -59.8 2.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.4 149.95 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.483 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -40.96 -36.87 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 24.1 p -51.89 -43.0 63.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.469 ' CD1' HD21 ' A' ' 305' ' ' LEU . 76.4 mt -97.12 143.07 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.12 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.0 p -121.6 -178.29 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.109 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.94 -56.67 7.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 90.0 m -43.98 -50.67 8.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.82 -37.62 14.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 18.9 mt -80.52 -52.36 7.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 41.4 ttt-85 -43.91 -42.89 6.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -76.53 -44.27 35.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.627 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 45.3 t-80 -57.39 -33.12 67.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.443 ' CE2' HG13 ' A' ' 279' ' ' ILE . 76.5 m-85 -94.47 -41.39 9.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.438 ' CA ' HD12 ' A' ' 265' ' ' ILE . 1.8 t80 -42.71 -36.12 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.966 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 17.6 pt20 -54.13 -40.97 67.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.577 ' CD2' ' CB ' ' A' ' 290' ' ' ALA . 47.0 m-85 -63.75 -45.91 87.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.854 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 173.98 178.01 43.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.529 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -47.69 144.55 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.347 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.438 HD12 ' CA ' ' A' ' 260' ' ' TYR . 90.7 mt -115.45 109.56 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -52.34 -50.45 62.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.5 t -167.53 168.74 12.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 90.1 mt -144.38 108.65 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 54.7 m -103.14 99.08 8.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 43.1 t -91.93 110.81 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.434 ' CG1' ' HG2' ' A' ' 273' ' ' ARG . 51.2 t -94.53 99.96 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -60.09 -43.24 95.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.434 ' HG2' ' CG1' ' A' ' 271' ' ' VAL . 6.8 ptm180 -55.09 -26.54 38.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.454 ' O ' ' C ' ' A' ' 275' ' ' GLN . 73.7 mt-30 -117.29 17.75 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 274' ' ' GLN . 66.7 mt-30 34.25 43.94 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.402 ' C ' HD12 ' A' ' 246' ' ' LEU . 26.0 p -136.69 173.08 12.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -156.74 138.93 14.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -105.38 114.87 29.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.443 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.5 mm -98.06 118.03 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.162 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -104.42 140.4 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -119.43 146.38 45.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.34 -34.21 74.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 284' ' ' ARG . 29.5 p -127.68 118.18 23.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.171 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' A' ' 236' ' ' LYS . 13.6 tpt180 -36.72 -36.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 284' ' ' ARG . 6.1 tp60 -36.85 -65.69 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -59.11 -35.29 73.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.084 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.82 -57.39 12.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -52.33 -59.31 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 42.9 t -44.41 -61.61 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.577 ' CB ' ' CD2' ' A' ' 262' ' ' PHE . . . -57.42 -38.39 74.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.52 -69.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -54.08 -43.43 70.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -70.94 -3.72 20.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.448 ' HB3' ' CG2' ' A' ' 307' ' ' VAL . 33.2 m -112.3 -29.95 7.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -47.86 97.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.835 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 52.7 t30 45.17 25.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -120.57 -25.68 5.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.627 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 6.2 tp -72.53 99.83 2.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 25.5 mt -113.39 96.68 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.109 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.435 HG21 ' CD2' ' A' ' 258' ' ' HIS . 67.7 t -100.72 138.36 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 58.13 49.88 10.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.78 34.18 5.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 245' ' ' GLY . 16.1 ttt-85 -138.81 105.13 5.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 0.0 110.881 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -51.68 149.33 4.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.469 HD21 ' CD1' ' A' ' 250' ' ' ILE . 42.0 mt -133.52 134.93 44.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.77 102.2 14.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.448 ' CG2' ' HB3' ' A' ' 294' ' ' SER . 70.6 t -99.99 136.54 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.555 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 6.2 pttt -146.5 147.55 31.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . 0.555 ' CE3' HD23 ' A' ' 241' ' ' LEU . 64.9 m95 -55.29 142.71 30.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -93.09 -135.37 7.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.478 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 67.4 mmt-85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.857 0.361 . . . . 0.0 110.906 -179.83 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 6.4 m -103.7 -43.96 5.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 110.87 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 46.7 p 38.6 41.9 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -74.29 -131.31 0.22 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.482 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.2 t 54.88 41.45 31.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.895 0.379 . . . . 0.0 110.848 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 63.6 m -94.43 162.54 13.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 164.51 -110.38 0.42 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.452 ' C ' ' CD ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -155.92 168.06 28.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 0.0 110.865 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -130.12 117.63 20.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 238' ' ' ILE . 0.0 OUTLIER -63.03 89.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 36.8 p 38.44 31.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.11 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.425 ' CD1' ' O ' ' A' ' 311' ' ' ARG . 60.0 mt -72.44 96.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.147 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.414 HG23 ' N ' ' A' ' 284' ' ' ARG . 57.3 p -90.39 26.75 1.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.2 m -123.16 141.03 52.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.47 HD22 ' CB ' ' A' ' 291' ' ' ALA . 66.4 mt -124.1 139.88 53.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.555 ' CE1' ' CE ' ' A' ' 308' ' ' LYS . 0.6 OUTLIER -99.1 146.31 26.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 74.1 t -140.04 135.01 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -125.73 168.33 17.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 70.62 44.51 57.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.418 HD13 ' CA ' ' A' ' 276' ' ' CYS . 91.3 mt -80.29 -59.11 2.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.879 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.34 162.81 0.89 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.463 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -49.53 -38.39 30.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 35.6 p -50.63 -45.05 57.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.142 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.466 HG23 ' N ' ' A' ' 251' ' ' THR . 67.3 mt -95.44 143.95 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.466 ' N ' HG23 ' A' ' 250' ' ' ILE . 26.8 p -122.31 -175.23 3.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.454 ' CB ' HG22 ' A' ' 270' ' ' VAL . 37.6 tt0 -71.18 -57.18 4.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.6 m -45.33 -47.18 13.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.16 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -44.7 -50.67 9.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.0 -44.74 62.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.433 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 22.3 ttp180 -49.95 -46.05 51.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -75.7 -40.56 55.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.651 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 51.1 t-80 -61.06 -32.78 72.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.502 ' CD2' HG12 ' A' ' 279' ' ' ILE . 52.8 m-85 -94.32 -39.0 10.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -46.67 -38.02 9.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.439 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.2 pt20 -52.45 -38.22 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.562 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 79.0 m-85 -64.71 -43.97 91.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -178.97 -152.75 10.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.532 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -82.84 136.5 34.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 0.0 110.851 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.462 HG22 ' CG1' ' A' ' 268' ' ' ILE . 88.9 mt -105.35 112.95 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 -60.36 -48.98 79.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.4 t -165.13 159.02 17.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.16 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.462 ' CG1' HG22 ' A' ' 265' ' ' ILE . 59.5 mt -139.41 108.3 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 30.5 m -101.5 100.41 10.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.454 HG22 ' CB ' ' A' ' 252' ' ' GLU . 83.7 t -93.67 103.35 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 12.2 t -86.19 99.54 8.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -60.76 -48.26 82.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.48 -11.02 2.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 275' ' ' GLN . 19.8 mm-40 -126.6 14.41 7.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.953 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 274' ' ' GLN . 71.4 mt-30 33.04 51.09 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.418 ' CA ' HD13 ' A' ' 246' ' ' LEU . 14.2 p -148.8 165.27 31.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.95 148.09 29.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 56.7 m-85 -118.05 108.74 15.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.568 HG23 ' CE2' ' A' ' 281' ' ' PHE . 5.0 mp -93.02 121.67 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -105.38 148.54 27.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.568 ' CE2' HG23 ' A' ' 279' ' ' ILE . 98.9 m-85 -127.44 139.29 52.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.9 77.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.078 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 284' ' ' ARG . 32.7 p -126.71 118.03 23.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.165 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 283' ' ' THR . 9.5 tpt180 -36.13 -35.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 284' ' ' ARG . 46.4 tp60 -36.58 -68.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -54.7 -48.44 72.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -46.88 -59.56 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -50.18 -54.12 23.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.947 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 16.5 t -50.79 -60.13 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.115 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.562 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -56.51 -36.53 69.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.065 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.47 ' CB ' HD22 ' A' ' 241' ' ' LEU . . . -54.66 -53.66 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -68.88 -28.65 66.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -92.03 5.41 50.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 65.7 p -119.08 -32.06 4.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.461 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.4 m-30 -55.1 109.42 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 41.05 33.88 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -130.96 -38.43 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.89 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.651 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 8.4 tp -65.48 100.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 58.4 mt -117.64 93.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.435 HG13 ' ND2' ' A' ' 301' ' ' ASN . 53.9 t -97.86 140.39 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.435 ' ND2' HG13 ' A' ' 300' ' ' VAL . 69.5 m-80 58.43 42.34 21.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.93 34.12 10.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.491 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -134.19 99.38 4.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.349 . . . . 0.0 110.831 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -44.17 148.47 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 43.4 mt -132.77 135.07 45.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.6 98.18 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 308' ' ' LYS . 49.7 t -100.89 140.17 20.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.555 ' CE ' ' CE1' ' A' ' 242' ' ' TYR . 9.6 pttt -147.86 150.65 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . 0.436 ' CE3' HD23 ' A' ' 241' ' ' LEU . 29.8 m95 -52.21 134.83 33.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 311' ' ' ARG . . . -59.36 -119.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.482 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 310' ' ' GLY . 9.3 tpp180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.815 0.341 . . . . 0.0 110.889 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 50.4 m -105.69 -59.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.353 . . . . 0.0 110.842 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.7 m -109.11 135.11 50.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -126.47 84.4 0.34 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.51 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 35.4 p -137.81 117.11 12.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 110.833 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 4.7 m -150.53 130.47 13.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -134.86 -145.18 5.15 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.523 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -122.76 87.55 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 110.901 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.458 ' CB ' HD13 ' A' ' 238' ' ' ILE . 21.1 t0 -113.36 100.33 8.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -117.11 -65.57 1.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 40.2 p -118.98 39.4 3.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.458 HD13 ' CB ' ' A' ' 235' ' ' ASP . 85.2 mt -70.84 110.39 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.3 p -95.16 29.71 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.165 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.1 m -127.55 142.73 51.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.152 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.503 HD21 ' CD2' ' A' ' 309' ' ' TRP . 32.1 mt -134.16 124.63 26.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.93 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.603 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -82.89 143.11 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.98 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.4 t -135.79 127.66 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.104 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.91 176.3 16.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 72.15 37.25 59.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.508 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.447 HD11 ' CB ' ' A' ' 277' ' ' ALA . 93.4 mt -81.52 -57.43 3.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.28 162.03 0.16 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.463 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -35.43 29.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 110.872 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.7 p -51.64 -48.35 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.481 ' CD1' HD22 ' A' ' 305' ' ' LEU . 68.6 mt -95.03 142.8 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 30.9 p -115.57 -175.62 2.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -70.18 -56.7 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 98.4 m -44.96 -50.36 10.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.13 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.54 -41.1 4.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.7 mt -81.23 -55.12 4.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.406 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 19.2 ttm180 -39.72 -38.67 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -75.55 -44.07 45.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.867 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.57 ' CD2' HD12 ' A' ' 298' ' ' LEU . 30.5 t60 -58.82 -35.09 72.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.553 ' HA ' ' CD2' ' A' ' 262' ' ' PHE . 93.1 m-85 -91.48 -39.01 12.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.406 ' CB ' ' O ' ' A' ' 256' ' ' ARG . 1.1 t80 -44.35 -28.97 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.414 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 23.8 pt20 -64.48 -42.83 95.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.566 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 29.7 m-85 -59.5 -48.73 80.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 175.15 178.8 45.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.52 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -48.43 141.17 7.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 70.5 mt -111.26 110.77 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.152 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 280' ' ' GLN . 37.9 mtt-85 -52.79 -53.18 51.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.5 t -165.72 168.73 15.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 77.2 mt -142.81 111.96 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 50.0 m -104.06 98.91 8.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 65.4 t -90.99 105.43 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.159 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 14.9 t -91.12 100.73 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . 0.426 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 16.4 pt20 -59.69 -44.88 93.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.426 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 0.8 OUTLIER -56.47 -19.05 13.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 275' ' ' GLN . 8.7 mm-40 -122.95 14.23 9.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 274' ' ' GLN . 52.9 mt-30 34.37 46.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.965 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.41 ' C ' HD11 ' A' ' 246' ' ' LEU . 27.7 p -137.15 175.16 9.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . 0.447 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -155.2 132.15 10.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.541 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 35.3 m-85 -99.62 111.49 23.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.416 HG23 ' CZ ' ' A' ' 281' ' ' PHE . 4.9 mm -93.9 115.88 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.099 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 266' ' ' ARG . 40.1 tt0 -105.6 139.0 40.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.416 ' CZ ' HG23 ' A' ' 279' ' ' ILE . 95.6 m-85 -119.24 153.27 35.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.403 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -75.65 -34.47 60.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.105 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 284' ' ' ARG . 30.6 p -125.54 116.44 21.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 283' ' ' THR . 12.6 tpt180 -36.9 -34.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -38.48 -61.42 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.32 97.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -52.79 -59.98 3.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -48.13 -55.74 9.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 60.0 t -49.48 -61.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.566 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -52.87 -41.2 64.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.81 -52.72 59.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.63 -24.94 63.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.888 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -97.79 5.63 48.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 290' ' ' ALA . 81.5 p -117.8 -24.34 7.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 297' ' ' LYS . 2.8 m-85 -61.99 112.73 2.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 5.2 t30 40.51 25.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 295' ' ' PHE . 35.9 tttp -123.65 -36.69 2.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.57 HD12 ' CD2' ' A' ' 258' ' ' HIS . 14.9 tp -61.82 96.52 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 62.9 mt -120.47 95.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.423 ' CG2' HD11 ' A' ' 298' ' ' LEU . 61.1 t -103.67 134.19 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.18 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 57.5 54.88 6.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 41.8 33.07 1.02 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.0 ttm-85 -130.39 99.3 4.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.823 0.344 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -56.18 135.31 53.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.499 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 58.3 mt -120.23 135.66 54.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -91.95 99.05 11.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.441 ' CG2' HD23 ' A' ' 298' ' ' LEU . 79.5 t -94.58 136.74 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.499 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 1.0 OUTLIER -145.54 145.57 31.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . 0.503 ' CD2' HD21 ' A' ' 241' ' ' LEU . 61.6 m95 -54.56 141.06 32.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -88.62 -130.98 3.77 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.539 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 110.812 -179.87 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 92.1 p -66.98 83.5 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.886 0.374 . . . . 0.0 110.813 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 99.1 p -122.45 94.48 4.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.825 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -110.35 168.99 13.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.479 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.0 m -113.97 97.39 6.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 90.7 p -115.6 175.17 5.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.92 115.35 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.44 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.5 90.31 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.9 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.62 102.87 6.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.445 ' O ' ' NH1' ' A' ' 284' ' ' ARG . 27.6 mtmm -112.53 -66.25 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 37.7 p -120.28 34.08 5.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.123 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 78.1 mt -73.53 115.14 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.125 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.8 p -102.11 31.0 4.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 28.2 m -131.89 148.31 52.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 31.1 mt -132.91 156.01 48.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.562 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.4 OUTLIER -109.75 147.74 32.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.415 HG23 ' C ' ' A' ' 242' ' ' TYR . 90.4 t -141.1 120.72 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.03 168.78 12.67 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.494 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.484 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 73.81 44.31 31.78 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.503 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.419 HD13 ' CB ' ' A' ' 277' ' ' ALA . 52.4 mt -77.52 -60.41 2.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.931 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.28 156.45 0.17 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.492 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -49.39 -29.27 6.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.39 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.1 p -59.19 -43.84 92.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.146 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 60.4 mt -96.87 143.49 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 29.5 p -124.9 173.94 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -58.38 -59.64 5.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 88.7 m -41.22 -56.68 2.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -42.62 -42.73 3.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 33.4 mt -77.46 -57.26 3.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -39.0 -43.97 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -75.99 -38.04 57.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.87 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.561 ' CE1' HD13 ' A' ' 298' ' ' LEU . 45.0 t-80 -60.11 -35.13 74.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.839 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -94.15 -43.41 8.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.845 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.418 ' CA ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -39.93 -36.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.919 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 29.4 pt20 -52.55 -46.2 66.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.926 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 290' ' ' ALA . 62.7 m-85 -56.18 -48.84 75.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.39 -143.29 4.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.463 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -93.6 128.64 39.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 110.855 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.418 HD11 ' CA ' ' A' ' 260' ' ' TYR . 57.6 mt -93.73 114.98 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 280' ' ' GLN . 9.9 mtt180 -60.62 -49.21 78.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.6 t -162.56 168.06 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.166 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 87.9 mt -146.07 110.66 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.4 m -104.37 99.88 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.415 HG11 ' CD1' ' A' ' 246' ' ' LEU . 85.7 t -92.5 107.65 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 14.8 t -91.97 100.76 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -58.67 -48.53 80.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -55.78 -26.65 47.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 275' ' ' GLN . 19.2 mm100 -110.6 11.3 22.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.44 ' C ' ' O ' ' A' ' 274' ' ' GLN . 80.5 mt-30 35.15 47.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 16.7 p -140.5 177.53 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . 0.419 ' CB ' HD13 ' A' ' 246' ' ' LEU . . . -156.84 137.23 12.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.076 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -106.13 111.07 23.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 6.1 mm -94.27 127.68 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 266' ' ' ARG . 9.1 tt0 -114.66 145.1 42.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.933 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.31 147.37 48.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.94 -37.04 78.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.141 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 284' ' ' ARG . 24.4 p -125.12 121.28 33.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.445 ' NH1' ' O ' ' A' ' 236' ' ' LYS . 12.0 tpt180 -37.88 -35.69 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 284' ' ' ARG . 1.4 tm0? -36.8 -67.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.23 79.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.084 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -50.51 -58.51 5.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.085 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -51.63 -62.43 1.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.504 HG12 ' CE1' ' A' ' 262' ' ' PHE . 37.7 t -41.95 -56.44 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -57.33 -41.45 80.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -49.68 -65.97 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.082 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.25 -39.88 70.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -78.44 1.63 21.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.442 ' HB3' ' CG1' ' A' ' 307' ' ' VAL . 3.6 m -117.15 -26.67 6.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -57.0 103.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 42.13 27.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -124.24 -26.15 4.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.561 HD13 ' CE1' ' A' ' 258' ' ' HIS . 5.4 tp -72.88 97.82 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.92 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 32.0 mt -115.58 92.33 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 258' ' ' HIS . 19.9 t -95.39 146.94 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 51.59 46.52 26.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.12 30.05 5.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -133.07 103.66 6.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 110.898 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -47.72 144.38 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.484 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 47.4 mt -129.93 137.24 50.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -89.29 111.75 22.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 308' ' ' LYS . 45.6 t -111.39 145.09 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.562 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 6.0 ptpp? -149.54 163.68 37.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -69.75 124.35 23.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.64 -133.82 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.454 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 0.0 110.861 -179.833 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 85.6 p -115.85 150.91 36.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.793 0.33 . . . . 0.0 110.891 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.9 m -104.66 42.25 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 77.5 49.18 7.47 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.513 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.7 t -164.32 143.23 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 0.0 110.868 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 58.2 m -120.46 119.32 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -61.83 157.17 35.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.461 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.38 43.08 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 0.0 110.866 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.432 ' HA ' ' CD1' ' A' ' 238' ' ' ILE . 7.4 p-10 -88.89 112.75 23.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.797 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 237' ' ' THR . 6.1 mtmp? -101.67 103.39 14.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 236' ' ' LYS . 30.1 p 37.51 36.8 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.144 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 235' ' ' ASP . 67.6 mt -73.95 118.68 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.0 p -102.88 34.06 3.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.165 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 24.0 m -136.15 141.66 44.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.456 HD12 ' CA ' ' A' ' 291' ' ' ALA . 42.0 mt -128.81 125.9 38.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.577 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -80.44 150.07 29.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 97.6 t -138.57 137.4 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.114 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.68 -179.02 15.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 60.45 44.33 97.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.423 HD11 ' C ' ' A' ' 276' ' ' CYS . 21.8 mt -77.52 -60.27 2.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 110.905 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 62.97 150.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.492 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -42.1 -31.47 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.9 p -55.69 -42.3 75.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.447 ' CD1' HD22 ' A' ' 305' ' ' LEU . 69.2 mt -99.39 151.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.122 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 40.4 p -131.69 177.5 7.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.142 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -57.03 11.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.1 m -44.61 -55.5 5.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -43.74 -44.32 6.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.56 -48.51 32.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -46.09 -45.67 16.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -77.03 -37.7 54.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.567 ' CD2' HG23 ' A' ' 300' ' ' VAL . 46.6 t-80 -60.68 -35.01 75.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.845 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.47 ' CE2' HG13 ' A' ' 279' ' ' ILE . 69.7 m-85 -94.15 -41.11 9.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.898 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -41.97 -38.77 1.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.471 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 22.9 pt20 -48.53 -41.7 30.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.57 ' CE1' HG11 ' A' ' 289' ' ' VAL . 71.5 m-85 -63.34 -45.08 92.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 179.22 -154.92 14.73 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.476 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -78.74 144.8 34.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.794 0.33 . . . . 0.0 110.918 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.42 HG23 ' CG1' ' A' ' 268' ' ' ILE . 46.2 mt -110.55 119.27 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.43 ' NE ' ' HA ' ' A' ' 282' ' ' ALA . 49.1 mtt180 -65.11 -52.2 56.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 4.0 t -164.35 149.7 10.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.42 ' CG1' HG23 ' A' ' 265' ' ' ILE . 76.2 mt -128.68 110.26 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 21.8 m -102.98 98.91 8.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.133 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.419 HG13 ' CD1' ' A' ' 246' ' ' LEU . 45.3 t -92.69 107.58 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 22.1 t -93.87 100.53 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . 0.442 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 14.7 pt20 -60.09 -42.66 95.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.442 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 4.1 ptm180 -59.19 -17.68 29.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 275' ' ' GLN . 46.2 mt-30 -123.38 15.52 9.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.856 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 274' ' ' GLN . 40.7 mt-30 33.63 47.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.423 ' C ' HD11 ' A' ' 246' ' ' LEU . 25.8 p -140.8 170.35 15.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -153.75 134.62 13.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 26.9 m-85 -101.83 108.43 19.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.47 HG13 ' CE2' ' A' ' 259' ' ' PHE . 6.0 mm -93.17 112.17 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.145 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -102.78 143.52 32.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.547 ' CD2' ' HB1' ' A' ' 286' ' ' ALA . 79.5 m-85 -121.03 156.65 31.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.43 ' HA ' ' NE ' ' A' ' 266' ' ' ARG . . . -77.26 -37.24 53.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 284' ' ' ARG . 23.9 p -124.06 119.53 29.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.454 ' NE ' ' HG3' ' A' ' 288' ' ' GLU . 14.4 tpt180 -36.0 -40.09 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 284' ' ' ARG . 30.8 tp60 -34.68 -63.15 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.93 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . 0.547 ' HB1' ' CD2' ' A' ' 281' ' ' PHE . . . -59.69 -41.65 91.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.074 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.11 -61.3 2.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.454 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 13.6 mt-10 -48.45 -57.3 6.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.57 HG11 ' CE1' ' A' ' 262' ' ' PHE . 57.6 t -45.58 -63.77 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.569 ' HB1' ' CD2' ' A' ' 262' ' ' PHE . . . -54.96 -35.33 64.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.136 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.489 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -54.55 -49.09 71.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.34 -25.53 59.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -92.41 5.73 49.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.429 ' OG ' ' CG1' ' A' ' 307' ' ' VAL . 54.6 p -115.79 -35.72 4.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.839 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.3 m-85 -50.35 109.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 40.07 34.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -133.71 -33.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.468 HD12 ' CE1' ' A' ' 258' ' ' HIS . 10.1 tp -67.62 98.3 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.419 HG23 ' N ' ' A' ' 304' ' ' ARG . 40.4 mt -118.35 93.34 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.117 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.567 HG23 ' CD2' ' A' ' 258' ' ' HIS . 47.1 t -91.67 136.8 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.083 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 56.15 46.26 21.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.854 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 49.38 29.67 10.99 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -130.41 100.95 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.419 ' N ' HG23 ' A' ' 299' ' ' ILE . 22.6 ttp180 -44.69 144.75 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.501 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 52.2 mt -129.19 135.84 49.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -86.4 105.99 17.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.429 ' CG1' ' OG ' ' A' ' 294' ' ' SER . 55.5 t -105.87 144.87 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.577 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 15.9 ptpt -150.47 171.28 17.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -82.85 119.63 24.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.71 -133.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 110.843 -179.851 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 29.8 p -97.38 100.19 11.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.0 m -92.58 91.51 7.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 58.79 -136.38 51.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.494 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 80.6 p -166.88 108.99 0.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.882 0.372 . . . . 0.0 110.865 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 66.7 m -138.91 162.75 34.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -109.5 108.55 2.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -162.77 173.13 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.902 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 46.94 54.62 8.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -84.6 -47.45 10.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 28.4 p -132.03 23.47 4.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 13.8 mt -78.83 102.39 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.444 HG21 ' N ' ' A' ' 284' ' ' ARG . 44.0 p -95.35 35.39 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.1 m -133.02 141.16 48.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.0 mt -126.32 159.04 34.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.57 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.4 OUTLIER -111.58 147.59 35.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 95.5 t -140.42 120.63 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.17 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 -178.83 20.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.462 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.47 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 58.65 50.29 68.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.41 HD11 ' C ' ' A' ' 276' ' ' CYS . 62.2 mt -86.16 -57.34 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.862 0.363 . . . . 0.0 110.963 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.53 163.71 0.54 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.452 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -52.6 -32.65 42.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.951 0.405 . . . . 0.0 110.891 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.7 p -54.89 -44.78 74.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.467 ' CD1' HD22 ' A' ' 305' ' ' LEU . 86.6 mt -97.87 142.18 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.203 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.434 ' N ' HG21 ' A' ' 250' ' ' ILE . 37.4 p -124.18 -178.64 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -65.12 -59.68 3.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 87.3 m -42.05 -55.73 3.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.188 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.56 -45.27 6.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 14.5 mt -72.17 -47.2 52.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.405 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 24.1 ttp180 -46.31 -45.19 17.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -76.09 -38.21 57.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.606 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 52.4 t-80 -60.23 -35.4 75.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.567 ' CE2' HG13 ' A' ' 279' ' ' ILE . 62.9 m-85 -94.22 -42.3 9.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.434 ' CA ' HD12 ' A' ' 265' ' ' ILE . 1.7 t80 -39.92 -35.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 20.3 pt20 -56.26 -44.38 79.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 290' ' ' ALA . 41.3 m-85 -55.22 -51.03 67.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.51 -141.89 3.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.43 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -93.15 125.5 37.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 110.901 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.434 HD12 ' CA ' ' A' ' 260' ' ' TYR . 48.7 mt -93.51 121.53 44.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.471 ' NE ' ' HA ' ' A' ' 282' ' ' ALA . 43.0 mtt-85 -68.25 -47.94 66.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.4 t -171.14 153.0 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.138 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 256' ' ' ARG . 83.6 mt -127.86 116.42 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 24.4 m -109.37 99.04 8.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 85.6 t -93.52 121.21 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 90.3 t -108.7 100.17 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.091 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -57.07 -42.12 80.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 20.2 ttt-85 -50.13 -38.26 38.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -108.35 8.72 27.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.867 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 42.82 52.52 5.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.41 ' C ' HD11 ' A' ' 246' ' ' LEU . 18.6 p -142.91 177.13 8.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -160.17 136.94 9.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -102.36 115.8 31.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.567 HG13 ' CE2' ' A' ' 259' ' ' PHE . 9.3 mm -95.94 113.2 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.172 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -101.04 147.9 25.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.514 ' CD2' ' HB1' ' A' ' 286' ' ' ALA . 96.4 m-85 -129.97 151.6 50.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.873 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.471 ' HA ' ' NE ' ' A' ' 266' ' ' ARG . . . -72.4 -41.27 66.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 29.7 p -120.34 122.78 41.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.119 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.444 ' N ' HG21 ' A' ' 239' ' ' THR . 17.7 tpt180 -38.29 -39.62 0.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.881 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -37.48 -59.3 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . 0.514 ' HB1' ' CD2' ' A' ' 281' ' ' PHE . . . -59.74 -41.43 90.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.044 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.8 -53.5 57.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -53.77 -57.5 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 86.1 t -46.03 -63.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.526 ' HB3' ' CE2' ' A' ' 262' ' ' PHE . . . -53.02 -47.21 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -45.21 -67.17 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.095 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.8 -35.28 68.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -85.72 5.14 33.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 290' ' ' ALA . 4.7 m -119.07 -26.19 6.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 297' ' ' LYS . 2.9 m-85 -56.08 110.0 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 40.18 26.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 295' ' ' PHE . 19.1 tttm -124.91 -30.12 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.606 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 9.1 tp -67.53 100.56 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 50.1 mt -116.99 97.13 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.561 HG22 ' CD2' ' A' ' 258' ' ' HIS . 42.4 t -96.24 139.79 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.202 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.416 ' N ' HG13 ' A' ' 300' ' ' VAL . 74.7 m-20 52.36 47.74 24.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.65 27.56 6.21 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.46 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.1 ttt85 -127.44 101.52 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 110.821 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 45.3 ttp85 -43.83 146.82 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.47 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 45.3 mt -134.84 134.31 40.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -89.11 109.25 20.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 308' ' ' LYS . 81.7 t -106.63 142.96 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.159 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.57 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 13.3 ptpt -148.12 163.25 37.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -71.09 124.55 24.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -76.86 -145.82 2.03 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.451 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.862 -179.821 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 6.7 t -87.6 80.88 7.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.354 . . . . 0.0 110.885 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.8 m -108.48 153.13 23.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.889 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 69.78 163.54 4.0 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.483 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 87.3 p -81.63 150.24 28.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.869 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.6 t -112.42 128.17 56.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 66.29 159.39 0.72 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -109.38 82.93 1.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -57.72 116.77 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -118.25 -53.81 2.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 35.1 p -127.79 24.19 6.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.178 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 55.3 mt -74.52 106.11 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.1 p -97.57 36.19 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.172 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 18.0 m -133.84 151.28 51.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 35.5 mt -137.12 134.95 36.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.57 ' HB2' ' CE1' ' A' ' 278' ' ' PHE . 0.2 OUTLIER -97.3 150.36 21.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.461 HG11 ' N ' ' A' ' 244' ' ' GLY . 59.1 t -142.26 139.85 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.461 ' N ' HG11 ' A' ' 243' ' ' VAL . . . -130.51 164.55 22.96 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.445 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 74.97 43.84 25.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.434 HD11 ' C ' ' A' ' 276' ' ' CYS . 94.3 mt -74.11 -61.74 1.75 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.884 0.373 . . . . 0.0 110.918 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.42 151.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.464 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -42.78 -34.43 0.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.888 0.375 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.6 p -57.08 -42.83 81.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.156 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.469 ' CD1' HD22 ' A' ' 305' ' ' LEU . 55.9 mt -94.88 143.59 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.447 ' N ' HG21 ' A' ' 250' ' ' ILE . 33.1 p -126.98 -176.81 3.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.159 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -65.89 -59.88 3.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.997 0.427 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.2 m -43.36 -50.89 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -40.89 -50.62 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.85 -53.49 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -41.07 -42.95 2.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -75.5 -46.43 32.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.567 ' CE1' HD12 ' A' ' 298' ' ' LEU . 52.3 t60 -54.71 -36.31 64.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -90.47 -44.42 9.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -40.08 -35.67 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.446 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 26.8 pt20 -54.54 -46.19 73.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.57 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 52.8 m-85 -56.01 -50.01 72.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -177.12 -154.99 12.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.473 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -75.64 141.73 42.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 71.1 mt -110.58 112.43 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.137 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -57.66 -50.15 74.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 10.5 t -164.03 168.15 19.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.154 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 77.3 mt -145.12 106.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 57.1 m -97.61 98.84 10.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 88.5 t -93.93 109.12 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.466 ' CG1' ' HG2' ' A' ' 273' ' ' ARG . 15.9 t -97.0 99.65 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -60.67 -46.39 90.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.466 ' HG2' ' CG1' ' A' ' 271' ' ' VAL . 25.4 ptt180 -55.46 -19.83 10.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.47 ' O ' ' C ' ' A' ' 275' ' ' GLN . 65.1 mm-40 -121.19 15.88 11.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 274' ' ' GLN . 29.1 mt-30 32.26 50.45 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.434 ' C ' HD11 ' A' ' 246' ' ' LEU . 25.9 p -145.92 167.15 23.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.854 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.95 156.52 42.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 56.4 m-85 -126.32 108.07 10.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.571 HG21 ' CE1' ' A' ' 281' ' ' PHE . 4.7 mp -93.69 120.93 43.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.111 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -107.82 146.66 31.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.571 ' CE1' HG21 ' A' ' 279' ' ' ILE . 87.9 m-85 -124.31 147.1 48.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.65 70.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.137 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 284' ' ' ARG . 39.4 p -129.12 118.05 21.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 283' ' ' THR . 16.2 tpt180 -36.31 -34.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 283' ' ' THR . 20.8 tp60 -37.94 -68.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.6 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.138 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -52.12 -60.69 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -46.88 -59.41 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 39.4 t -46.5 -60.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.57 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -55.08 -32.23 61.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.594 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -61.53 -46.04 91.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -72.76 -29.94 63.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 297' ' ' LYS . 18.5 mttt -87.0 -18.08 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 290' ' ' ALA . 78.8 p -92.72 -36.03 13.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.3 m-85 -54.08 109.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 1.8 m120 41.51 29.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 293' ' ' LYS . 9.6 mmmt -126.93 -37.69 2.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.567 HD12 ' CE1' ' A' ' 258' ' ' HIS . 12.7 tp -63.4 98.03 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.52 94.43 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.427 ' CG2' HD13 ' A' ' 298' ' ' LEU . 59.9 t -102.21 146.33 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.163 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.407 ' ND2' HG11 ' A' ' 300' ' ' VAL . 63.0 m-80 54.47 41.02 32.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.63 33.41 12.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.447 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 22.7 ttt-85 -134.25 97.65 3.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.308 . . . . 0.0 110.863 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -43.72 144.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.469 HD22 ' CD1' ' A' ' 250' ' ' ILE . 48.9 mt -128.81 136.23 50.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -85.7 103.64 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.47 139.45 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.178 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.562 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 2.9 pttt -150.25 147.34 27.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.95 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -53.14 148.94 7.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -99.98 -137.53 9.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.488 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.844 -179.818 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 92.6 p -77.0 138.52 39.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 110.86 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 92.6 p -126.13 -50.98 1.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -71.85 -52.28 12.44 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.6 t -51.74 149.14 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.854 0.359 . . . . 0.0 110.839 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 67.1 m 62.05 44.6 7.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.885 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -96.67 -144.61 17.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.463 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -91.96 161.7 14.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 0.0 110.898 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.3 113.54 4.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -93.98 92.62 7.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 74.7 p 39.0 38.1 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.162 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.407 HD13 ' C ' ' A' ' 311' ' ' ARG . 82.3 mt -70.24 114.42 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.436 HG23 ' N ' ' A' ' 284' ' ' ARG . 51.2 p -98.67 27.02 5.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 21.7 m -125.58 139.51 53.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 35.5 mt -131.1 123.97 29.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.963 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.593 ' CE1' ' HE2' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -81.65 154.89 25.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.928 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.405 ' N ' ' CG ' ' A' ' 242' ' ' TYR . 75.1 t -139.76 134.83 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -123.04 -179.66 15.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 57.95 43.78 94.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.438 ' CD1' ' HB1' ' A' ' 277' ' ' ALA . 75.6 mt -83.81 -57.32 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 110.871 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.46 164.45 0.28 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.495 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -54.83 -31.19 59.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 110.828 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.409 ' OG1' ' NE ' ' A' ' 303' ' ' ARG . 23.2 p -56.83 -34.25 67.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 251' ' ' THR . 58.3 mt -104.78 138.83 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.123 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.465 ' N ' HG22 ' A' ' 250' ' ' ILE . 46.1 p -111.84 179.95 3.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -69.29 -52.04 31.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.8 m -50.06 -51.31 43.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.149 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -41.81 -42.16 2.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.9 mt -80.21 -50.24 10.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 -45.06 -41.55 7.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -76.92 -43.67 34.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.567 ' CE1' HD11 ' A' ' 298' ' ' LEU . 50.1 t-80 -58.69 -32.76 69.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -94.0 -38.85 10.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -46.35 -40.67 12.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.405 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.4 pt20 -48.61 -38.69 21.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.951 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 88.7 m-85 -65.86 -43.03 89.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 178.5 -153.73 13.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.506 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -80.87 141.24 34.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.794 0.331 . . . . 0.0 110.88 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 62.6 mt -110.32 111.28 35.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 280' ' ' GLN . 26.9 mtt-85 -53.91 -49.65 68.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 13.8 t -167.44 169.02 12.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 76.8 mt -144.95 111.25 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.3 m -105.31 98.94 8.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 82.0 t -91.69 107.4 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 95.1 t -92.81 99.97 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . 0.416 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 5.1 pt20 -59.75 -32.74 70.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.936 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.416 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 9.3 tpp85 -59.63 -38.47 81.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 275' ' ' GLN . 12.6 mt-30 -110.71 19.7 18.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 274' ' ' GLN . 60.0 mt-30 34.25 53.14 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.421 ' C ' HD11 ' A' ' 246' ' ' LEU . 31.1 p -143.56 165.7 26.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . 0.438 ' HB1' ' CD1' ' A' ' 246' ' ' LEU . . . -146.0 133.77 21.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.089 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 17.6 m-85 -99.31 108.19 20.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.873 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 3.8 mm -93.01 116.14 33.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 266' ' ' ARG . 34.9 tt0 -106.64 136.33 46.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.449 ' CD2' ' HB2' ' A' ' 286' ' ' ALA . 94.4 m-85 -113.72 153.16 29.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -77.63 -33.74 53.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.079 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 284' ' ' ARG . 34.4 p -128.75 118.72 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.129 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.468 ' NE ' ' HG3' ' A' ' 288' ' ' GLU . 15.4 tpt180 -35.99 -40.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 284' ' ' ARG . 0.7 OUTLIER -34.59 -62.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . 0.449 ' HB2' ' CD2' ' A' ' 281' ' ' PHE . . . -60.54 -42.29 96.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.086 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.25 -63.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.468 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 7.9 mt-10 -45.59 -54.3 7.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 39.2 t -50.7 -67.69 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.566 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -53.36 -29.41 34.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.065 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -55.11 -53.08 60.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -72.59 -26.45 61.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -90.25 5.23 47.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 89.8 p -117.13 -39.0 3.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 297' ' ' LYS . 3.1 m-85 -46.37 107.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 2.0 t30 40.12 27.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.876 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 295' ' ' PHE . 8.5 tmtt? -122.65 -32.85 3.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.567 HD11 ' CE1' ' A' ' 258' ' ' HIS . 8.1 tp -69.91 100.96 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.932 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 65.1 mt -120.11 93.1 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.506 HG21 ' CD2' ' A' ' 258' ' ' HIS . 60.1 t -96.33 142.35 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.121 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 50.96 55.03 10.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 40.54 33.13 0.53 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . 0.409 ' NE ' ' OG1' ' A' ' 249' ' ' THR . 31.0 ttm-85 -132.12 103.23 6.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.921 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 46.5 ttp85 -54.07 144.88 18.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.5 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 23.6 mt -130.06 132.15 46.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -87.45 102.73 14.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 95.8 t -100.86 136.42 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.593 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -146.89 145.88 29.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -52.82 133.92 37.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -87.4 -134.77 4.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.407 ' C ' HD13 ' A' ' 238' ' ' ILE . 28.1 ttp180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.77 0.319 . . . . 0.0 110.884 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 80.5 p -74.25 -52.52 12.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.909 0.385 . . . . 0.0 110.86 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 32.8 t -140.19 137.34 34.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -114.58 -147.45 9.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.6 t -116.67 139.8 50.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.907 0.384 . . . . 0.0 110.829 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 30.3 t -128.32 119.07 24.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.835 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -143.5 178.53 21.59 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.46 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -72.54 107.11 4.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.328 . . . . 0.0 110.924 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.457 ' CB ' HD12 ' A' ' 238' ' ' ILE . 6.3 m-20 -122.49 53.28 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.443 ' O ' ' NH1' ' A' ' 284' ' ' ARG . 0.0 OUTLIER -122.52 -33.68 3.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.89 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.436 ' N ' ' HD3' ' A' ' 236' ' ' LYS . 0.8 OUTLIER -106.82 29.15 7.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.158 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.457 HD12 ' CB ' ' A' ' 235' ' ' ASP . 75.5 mt -67.26 110.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.9 p -99.65 29.38 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.421 HG21 ' N ' ' A' ' 241' ' ' LEU . 23.1 m -124.9 152.21 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.156 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.421 ' N ' HG21 ' A' ' 240' ' ' THR . 31.5 mt -137.01 127.05 25.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.964 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.574 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -88.9 145.43 25.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 84.3 t -139.07 133.87 40.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -122.59 167.95 14.99 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.547 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.92 42.49 44.97 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.425 HD13 ' C ' ' A' ' 276' ' ' CYS . 29.7 mt -77.7 -60.03 2.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.847 0.356 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.57 159.0 0.72 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.451 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -48.36 -32.97 8.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 79.4 p -55.92 -46.39 78.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.413 ' CD1' HD21 ' A' ' 305' ' ' LEU . 77.2 mt -93.1 150.51 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.059 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.6 p -132.8 -179.89 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -66.13 -58.19 5.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 79.4 m -44.11 -51.01 8.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.185 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -44.49 -48.13 10.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 13.8 mt -74.78 -45.16 45.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.929 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 50.1 ttt180 -49.09 -42.94 40.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -78.76 -43.39 25.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.535 ' CE1' HD11 ' A' ' 298' ' ' LEU . 64.9 t-80 -57.9 -33.83 69.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -94.38 -40.02 10.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.459 ' CA ' HD12 ' A' ' 265' ' ' ILE . 1.5 t80 -42.4 -36.56 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.467 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 16.3 pt20 -51.89 -41.07 61.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 290' ' ' ALA . 63.7 m-85 -60.88 -49.23 78.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -178.95 -163.45 30.06 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -69.74 130.51 42.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 0.0 110.883 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.459 HD12 ' CA ' ' A' ' 260' ' ' TYR . 79.1 mt -99.98 109.66 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 282' ' ' ALA . 22.7 mtt-85 -51.39 -53.07 40.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.0 t -164.07 165.41 22.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 98.3 mt -139.65 105.57 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.092 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.2 m -98.06 99.98 11.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.127 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 66.7 t -93.59 106.02 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.472 ' CG1' ' HG2' ' A' ' 273' ' ' ARG . 4.4 t -91.15 99.67 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -60.79 -47.76 84.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.472 ' HG2' ' CG1' ' A' ' 271' ' ' VAL . 6.0 ptm180 -55.18 -20.1 9.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.475 ' O ' ' C ' ' A' ' 275' ' ' GLN . 28.2 mm-40 -121.28 15.74 11.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 274' ' ' GLN . 31.6 mt-30 32.25 50.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.425 ' C ' HD13 ' A' ' 246' ' ' LEU . 22.6 p -142.51 168.24 20.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.28 153.41 38.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 53.5 m-85 -124.65 108.96 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.435 HG23 ' CE1' ' A' ' 281' ' ' PHE . 4.5 mp -94.72 120.7 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.126 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 266' ' ' ARG . 53.0 tt0 -109.49 147.47 32.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.513 ' CD2' ' HB3' ' A' ' 286' ' ' ALA . 87.8 m-85 -126.95 139.86 52.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.866 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.475 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -59.7 -36.29 76.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 284' ' ' ARG . 38.3 p -123.1 116.66 23.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.443 ' NH1' ' O ' ' A' ' 236' ' ' LYS . 14.5 tpt180 -36.0 -37.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 284' ' ' ARG . 0.9 OUTLIER -35.65 -63.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . 0.513 ' HB3' ' CD2' ' A' ' 281' ' ' PHE . . . -58.41 -39.89 80.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.083 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.07 -45.84 79.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.122 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -62.94 -54.04 44.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.437 HG13 ' CE1' ' A' ' 262' ' ' PHE . 49.0 t -50.42 -58.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -57.47 -45.26 85.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.079 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -41.61 -67.82 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.046 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.58 -40.85 69.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -76.94 1.84 16.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 290' ' ' ALA . 3.3 m -118.41 -25.0 6.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -57.13 104.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 15.3 m120 41.46 30.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -126.8 -32.83 2.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.535 HD11 ' CE1' ' A' ' 258' ' ' HIS . 5.0 tp -65.96 96.4 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 56.0 mt -114.7 95.58 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.82 142.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 57.9 41.4 24.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 49.86 33.19 19.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -134.93 104.4 5.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 110.889 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -49.96 145.06 5.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.413 HD21 ' CD1' ' A' ' 250' ' ' ILE . 27.1 mt -129.64 133.39 47.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.44 98.73 10.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 93.8 t -96.45 145.01 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.195 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.531 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 0.6 OUTLIER -158.42 145.39 17.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -52.32 148.97 5.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -97.37 -136.43 9.11 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 120.787 0.327 . . . . 0.0 110.879 -179.839 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 15.2 m -98.81 90.62 4.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.896 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.3 t -107.76 161.59 14.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 148.55 89.68 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 12.9 t -175.0 134.31 0.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.896 0.379 . . . . 0.0 110.826 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 42.8 t -154.78 158.96 40.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -160.79 44.75 0.41 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.458 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -62.05 -42.05 98.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.367 . . . . 0.0 110.856 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -57.4 109.12 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -102.26 -69.48 0.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 82.0 p -119.48 30.28 7.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.146 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.526 ' N ' HH11 ' A' ' 284' ' ' ARG . 69.3 mt -78.24 114.68 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.107 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.459 HG22 ' N ' ' A' ' 284' ' ' ARG . 46.2 p -98.75 38.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 14.2 m -133.4 143.14 48.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.117 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.426 HD23 ' CB ' ' A' ' 291' ' ' ALA . 22.7 mt -133.28 122.18 23.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.914 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.606 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -79.84 143.65 34.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.955 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.2 t -133.36 131.4 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.134 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -121.58 176.8 16.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 64.15 44.33 95.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.547 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.418 HD13 ' CB ' ' A' ' 277' ' ' ALA . 92.7 mt -86.78 -56.32 3.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.828 0.347 . . . . 0.0 110.95 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.5 155.58 0.37 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.555 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -46.59 -34.25 4.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.847 0.356 . . . . 0.0 110.858 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.8 p -53.83 -56.71 15.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 251' ' ' THR . 76.3 mt -75.41 140.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.439 ' N ' HG22 ' A' ' 250' ' ' ILE . 32.9 p -117.15 179.64 3.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.109 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.74 -55.72 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 92.8 m -45.35 -47.22 13.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.41 -38.42 28.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 30.4 mt -83.82 -50.0 8.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 49.7 ttm-85 -46.65 -41.74 15.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.884 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -76.55 -43.2 40.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.561 ' CE1' HD13 ' A' ' 298' ' ' LEU . 56.7 t-80 -58.64 -33.8 70.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -94.19 -40.4 10.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.428 ' CB ' ' O ' ' A' ' 256' ' ' ARG . 1.5 t80 -42.01 -36.52 1.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.472 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.2 pt20 -51.98 -42.06 62.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 290' ' ' ALA . 63.1 m-85 -59.77 -49.93 75.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -175.23 -145.12 5.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -88.53 129.42 35.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.346 . . . . 0.0 110.918 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 65.3 mt -96.55 110.59 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.7 mtp85 -54.98 -54.55 41.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 11.9 t -162.14 166.49 25.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.153 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 87.1 mt -142.67 110.91 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 87.8 m -104.18 98.87 8.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.47 111.1 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.491 ' CG1' ' HG2' ' A' ' 273' ' ' ARG . 3.8 t -95.85 101.83 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -60.68 -47.13 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.491 ' HG2' ' CG1' ' A' ' 271' ' ' VAL . 4.7 ptm180 -53.18 -30.29 36.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 275' ' ' GLN . 55.7 mm-40 -112.76 13.64 19.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 274' ' ' GLN . 46.1 mt-30 34.91 53.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.417 ' C ' HD13 ' A' ' 246' ' ' LEU . 11.4 p -143.57 172.01 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . 0.418 ' CB ' HD13 ' A' ' 246' ' ' LEU . . . -152.77 132.1 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 18.4 m-85 -98.91 109.99 22.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 6.1 mm -94.14 116.29 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 266' ' ' ARG . 17.7 tt0 -105.86 141.71 36.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.407 ' C ' ' HG3' ' A' ' 266' ' ' ARG . 97.5 m-85 -119.56 151.95 37.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.16 77.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.087 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 33.8 p -126.08 126.17 43.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.131 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.526 HH11 ' N ' ' A' ' 238' ' ' ILE . 9.7 tpt180 -40.3 -32.19 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -40.99 -65.76 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.959 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.3 77.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.084 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.46 -58.06 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.101 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -48.82 -57.05 7.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.948 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.5 HG13 ' CE1' ' A' ' 262' ' ' PHE . 23.7 t -51.15 -54.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.57 ' HB3' ' CD2' ' A' ' 262' ' ' PHE . . . -57.06 -39.56 75.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.426 ' CB ' HD23 ' A' ' 241' ' ' LEU . . . -52.91 -66.38 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -53.42 -43.2 67.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -75.25 2.51 10.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.469 ' HB3' ' CG1' ' A' ' 307' ' ' VAL . 3.4 m -116.37 -30.9 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -52.43 95.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.1 m120 48.1 29.37 1.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 53.2 tttt -126.05 -31.01 2.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.561 HD13 ' CE1' ' A' ' 258' ' ' HIS . 5.4 tp -69.47 101.34 1.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 53.3 mt -118.72 94.4 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' A' ' 258' ' ' HIS . 53.5 t -93.53 133.36 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 57.31 54.32 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 41.84 32.11 0.89 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . 0.423 ' HD2' ' CD1' ' A' ' 250' ' ' ILE . 26.9 ttm-85 -130.57 102.08 5.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.779 0.323 . . . . 0.0 110.86 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -49.2 146.7 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.5 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 29.3 mt -134.03 133.62 41.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -87.98 101.91 14.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.469 ' CG1' ' HB3' ' A' ' 294' ' ' SER . 92.9 t -97.62 145.61 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.578 ' CE ' ' CE1' ' A' ' 242' ' ' TYR . 4.8 pttt -156.45 144.6 19.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.886 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -53.12 145.51 13.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -88.47 -153.09 26.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 18.0 mmm-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.783 0.325 . . . . 0.0 110.886 -179.86 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 69.2 m -74.63 149.5 39.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.389 . . . . 0.0 110.814 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 13.0 t -132.83 90.24 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 123.56 -177.07 16.72 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.464 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 2.3 m -149.14 117.53 6.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.876 0.37 . . . . 0.0 110.835 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 28.5 m -116.15 102.11 9.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.828 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 174.22 -71.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.452 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -43.63 117.13 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.368 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.421 ' CB ' HD12 ' A' ' 238' ' ' ILE . 4.9 p30 -148.98 116.71 6.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -81.78 92.35 6.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.4 p 43.21 33.92 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.136 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.421 HD12 ' CB ' ' A' ' 235' ' ' ASP . 66.6 mt -72.56 114.39 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.0 p -102.19 29.81 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.195 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 15.5 m -128.44 143.12 50.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 31.8 mt -131.96 124.69 29.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.509 ' CD1' ' HG3' ' A' ' 308' ' ' LYS . 0.3 OUTLIER -82.09 149.75 27.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.407 HG22 ' C ' ' A' ' 242' ' ' TYR . 66.8 t -140.28 129.32 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.124 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.69 173.75 14.93 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 65.68 51.45 47.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.517 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.459 ' CD1' HG13 ' A' ' 270' ' ' VAL . 79.3 mt -77.12 -61.58 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.12 145.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.476 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -40.13 -31.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.382 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 34.4 p -56.36 -45.9 80.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 61.8 mt -97.27 141.6 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 16.6 p -123.9 -177.5 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -66.46 -55.97 13.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 7.9 m -43.56 -59.14 2.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.464 ' HA ' ' ND2' ' A' ' 257' ' ' ASN . 18.7 m-20 -40.14 -59.28 1.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 14.9 mt -57.51 -52.12 66.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 41.8 ttt85 -48.87 -38.58 22.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . 0.523 ' C ' ' OD1' ' A' ' 257' ' ' ASN . 0.4 OUTLIER -77.97 -40.47 39.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.648 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 58.2 t-80 -61.57 -33.08 73.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.488 ' CE2' HG13 ' A' ' 279' ' ' ILE . 72.5 m-85 -94.31 -40.39 9.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.468 ' CA ' HD11 ' A' ' 265' ' ' ILE . 1.4 t80 -41.99 -35.48 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.937 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 26.2 pt20 -55.17 -50.2 69.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.568 ' CD1' HG12 ' A' ' 289' ' ' VAL . 56.9 m-85 -53.1 -50.16 65.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.837 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -172.72 -155.09 10.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.488 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -83.35 127.95 34.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.468 HD11 ' CA ' ' A' ' 260' ' ' TYR . 45.1 mt -93.61 114.19 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 280' ' ' GLN . 16.0 mtt180 -57.74 -50.61 72.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.5 t -165.45 170.96 13.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.124 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 86.8 mt -145.43 116.12 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 55.2 m -107.16 100.04 9.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.459 HG13 ' CD1' ' A' ' 246' ' ' LEU . 93.0 t -93.47 107.1 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.158 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 44.1 t -92.73 100.01 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.195 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -59.68 -38.76 82.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 -64.33 -10.22 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -130.44 6.0 4.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 41.81 45.11 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 14.1 p -137.24 166.62 23.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -146.21 135.68 23.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 26.2 m-85 -104.18 108.5 19.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.488 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.8 mm -91.72 119.87 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.17 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 266' ' ' ARG . 42.2 tt0 -107.77 141.92 38.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.475 ' CD1' ' HB1' ' A' ' 286' ' ' ALA . 97.2 m-85 -121.08 148.21 44.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.437 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -70.54 -37.36 74.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.096 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 284' ' ' ARG . 17.4 p -126.06 121.49 33.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 285' ' ' GLN . 12.6 tpt180 -36.93 -40.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 284' ' ' ARG . 36.4 tp60 -34.46 -63.9 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . 0.475 ' HB1' ' CD1' ' A' ' 281' ' ' PHE . . . -57.57 -44.88 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -50.78 -57.47 8.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.133 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -49.95 -65.04 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.568 HG12 ' CD1' ' A' ' 262' ' ' PHE . 59.7 t -39.08 -59.74 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.563 ' HB3' ' CD2' ' A' ' 262' ' ' PHE . . . -58.95 -37.69 77.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.101 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.585 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -49.9 -54.56 18.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -69.17 -28.59 66.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -90.3 4.98 49.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 58.2 p -117.37 -30.1 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 5.0 m-30 -55.57 105.76 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 40.67 29.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -124.4 -35.81 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.648 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 11.1 tp -67.04 93.33 0.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 42.5 mt -113.47 91.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 41.3 t -92.29 146.32 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 50.87 46.98 25.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.16 31.3 6.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -133.16 104.0 6.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 12.6 ttm-85 -50.11 148.64 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 21.9 mt -131.45 132.52 44.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.21 99.75 11.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.446 HG11 ' N ' ' A' ' 308' ' ' LYS . 72.9 t -101.92 140.37 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.509 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 11.7 pttt -149.17 149.07 30.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -52.77 136.3 33.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.913 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -82.79 -124.06 0.85 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.5 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 0.0 110.867 -179.873 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 32.8 t -64.52 151.63 43.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.922 0.392 . . . . 0.0 110.847 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.3 p -49.28 -43.86 43.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.88 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.8 95.77 2.28 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.488 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 84.1 p -103.0 116.3 32.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.907 0.384 . . . . 0.0 110.859 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 23.0 t -165.41 148.7 8.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.859 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 145.52 147.15 4.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.449 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -100.0 69.23 1.52 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 110.899 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.3 113.17 25.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -124.46 -56.48 1.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 78.8 p -126.68 26.15 6.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.161 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 34.0 mt -76.07 107.95 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.132 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 284' ' ' ARG . 30.2 p -99.2 36.27 1.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 30.1 m -137.18 138.46 40.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 22.0 mt -125.28 156.94 37.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.564 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.3 OUTLIER -109.7 149.29 29.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 91.4 t -141.95 119.19 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.32 -175.04 20.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.534 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 55.69 45.82 84.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.509 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.406 HD11 ' C ' ' A' ' 276' ' ' CYS . 44.7 mt -78.62 -59.13 2.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 0.0 110.943 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 62.72 153.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.507 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -42.12 -37.93 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.86 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 43.3 p -49.4 -44.43 45.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.443 ' CD1' ' CD2' ' A' ' 305' ' ' LEU . 65.3 mt -97.17 146.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.138 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.7 p -126.23 -178.78 4.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -66.39 -57.28 7.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.8 m -47.15 -54.36 10.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -40.81 -45.77 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 9.1 mt -74.07 -45.64 48.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -48.8 -46.03 41.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -76.25 -38.69 55.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.565 ' CD2' HG21 ' A' ' 300' ' ' VAL . 43.4 t-80 -61.07 -34.56 75.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.498 ' CE2' HG13 ' A' ' 279' ' ' ILE . 58.4 m-85 -94.34 -39.67 10.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.863 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -43.48 -38.93 3.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.957 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.474 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 29.0 pt20 -50.28 -43.55 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 85.1 m-85 -60.54 -47.8 84.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -177.69 -167.01 35.21 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -69.03 127.22 32.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.343 . . . . 0.0 110.873 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 84.3 mt -95.72 110.67 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.4 mtp180 -54.01 -51.5 63.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.8 t -164.71 169.47 16.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.194 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 88.6 mt -145.87 114.29 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.18 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 85.3 m -109.18 99.02 8.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 96.2 t -92.65 111.01 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.2 101.4 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . 0.418 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 5.2 pt20 -59.23 -40.61 86.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.418 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 6.6 ptp85 -62.16 -21.55 65.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 275' ' ' GLN . 74.0 mt-30 -117.31 14.27 14.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.94 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 274' ' ' GLN . 71.3 mt-30 34.38 43.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.406 ' C ' HD11 ' A' ' 246' ' ' LEU . 21.7 p -141.04 173.51 11.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -157.36 140.28 15.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -105.12 121.86 44.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.498 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.1 mm -102.32 117.03 47.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.186 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 266' ' ' ARG . 16.3 tt0 -105.17 140.3 38.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.405 ' C ' ' HG3' ' A' ' 266' ' ' ARG . 97.5 m-85 -120.72 148.3 44.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.884 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.428 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -70.23 -34.01 72.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 284' ' ' ARG . 22.4 p -125.82 116.6 21.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.178 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.466 ' N ' HG22 ' A' ' 239' ' ' THR . 16.7 tpt180 -36.14 -39.3 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 284' ' ' ARG . 0.6 OUTLIER -33.56 -64.42 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.02 -46.68 82.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.097 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -50.5 -53.26 31.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.428 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 6.2 mt-10 -55.24 -48.87 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 42.1 t -57.88 -59.96 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.566 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -56.12 -33.97 65.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.16 -67.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.42 -39.71 73.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -75.08 1.59 12.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.472 ' HB3' ' CB ' ' A' ' 307' ' ' VAL . 3.4 m -115.81 -33.38 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.2 102.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 9.0 m120 44.23 31.72 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -129.83 -31.14 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.455 HD23 ' CG2' ' A' ' 307' ' ' VAL . 6.6 tp -70.06 103.69 2.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 27.0 mt -119.74 96.76 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.565 HG21 ' CD2' ' A' ' 258' ' ' HIS . 31.1 t -96.28 138.31 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.097 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 56.95 47.19 18.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.15 29.64 6.95 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.496 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 18.0 ttt85 -130.49 103.85 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.859 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -48.23 137.67 10.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.443 ' CD2' ' CD1' ' A' ' 250' ' ' ILE . 26.3 mt -124.19 133.55 53.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -87.54 107.24 18.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.472 ' CB ' ' HB3' ' A' ' 294' ' ' SER . 53.4 t -105.13 143.46 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.564 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -146.15 165.15 29.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -74.25 122.12 22.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.24 -151.89 0.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 14.3 ttp-105 . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.89 -179.883 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.441 -0.264 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 59.5 p -53.94 115.66 2.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.888 0.375 . . . . 0.0 110.821 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 43.7 m -56.67 126.8 28.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.817 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -142.73 -41.85 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 4.3 t -103.66 88.16 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.83 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 2.6 m -88.35 128.5 35.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.894 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -161.86 90.26 0.11 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.454 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -43.26 126.99 4.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.86 0.362 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -91.03 101.85 14.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.0 pttt -115.25 101.7 9.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 66.6 p 36.44 44.82 0.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 14.3 mt -85.57 98.43 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.153 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.433 HG21 ' N ' ' A' ' 284' ' ' ARG . 51.0 p -90.95 23.47 3.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 26.4 m -121.14 141.76 50.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.155 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 26.7 mt -128.59 146.86 50.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.585 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -102.6 143.41 32.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 93.3 t -136.83 114.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.127 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -100.97 179.27 28.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.523 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.467 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 61.92 51.88 54.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.445 ' CD1' ' C ' ' A' ' 276' ' ' CYS . 88.0 mt -81.46 -59.65 2.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.11 149.97 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.459 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.9 -29.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.92 0.39 . . . . 0.0 110.842 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 23.8 p -57.94 -41.81 83.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 79.2 mt -99.13 146.16 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 40.6 p -127.04 -176.41 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.152 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -71.51 -56.23 6.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 96.0 m -45.01 -48.86 11.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -49.53 -50.91 39.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.7 mt -67.32 -43.55 81.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -51.49 -45.01 62.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -78.69 -33.02 47.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.57 ' CE1' HD11 ' A' ' 298' ' ' LEU . 38.2 t-80 -65.75 -34.87 79.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.436 ' CE2' HG13 ' A' ' 279' ' ' ILE . 60.4 m-85 -94.08 -37.58 11.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.473 ' CA ' HD11 ' A' ' 265' ' ' ILE . 1.3 t80 -44.77 -26.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.461 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 11.4 pt20 -63.96 -41.74 97.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.887 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.639 ' CD2' ' CB ' ' A' ' 290' ' ' ALA . 56.8 m-85 -62.21 -39.08 91.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 174.71 -154.35 18.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.491 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -79.0 141.69 37.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.87 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.473 HD11 ' CA ' ' A' ' 260' ' ' TYR . 70.9 mt -112.28 111.88 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 280' ' ' GLN . 20.5 mtt180 -59.97 -49.14 78.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.7 t -165.11 171.25 14.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.16 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 94.4 mt -144.4 106.96 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 26.4 m -96.61 100.66 12.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.136 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 94.6 t -94.79 109.54 22.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.082 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.44 99.91 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -40.62 89.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -50.35 -39.02 45.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -108.65 10.49 26.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 42.71 52.12 5.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.445 ' C ' ' CD1' ' A' ' 246' ' ' LEU . 25.7 p -140.58 168.66 19.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.29 130.23 15.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.126 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -100.14 109.56 21.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.436 HG13 ' CE2' ' A' ' 259' ' ' PHE . 2.9 mm -92.66 123.04 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.094 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 266' ' ' ARG . 38.6 tt0 -108.3 141.05 40.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -120.96 144.67 48.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.856 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.91 -37.09 78.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 284' ' ' ARG . 22.8 p -120.75 117.18 26.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.098 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.433 ' N ' HG21 ' A' ' 239' ' ' THR . 13.7 tpt180 -37.21 -38.83 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 284' ' ' ARG . 12.7 tp60 -37.79 -67.39 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -52.86 -43.15 65.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -52.44 -57.74 8.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -50.45 -63.15 1.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 28.8 t -41.21 -66.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.639 ' CB ' ' CD2' ' A' ' 262' ' ' PHE . . . -50.29 -46.4 55.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -47.26 -67.71 0.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -55.41 -38.76 69.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -84.28 6.07 24.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 290' ' ' ALA . 16.9 m -118.57 -13.22 9.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 297' ' ' LYS . 3.8 m-30 -71.27 113.92 8.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 41.9 25.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 295' ' ' PHE . 3.0 ttmm -126.21 -31.88 2.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.57 HD11 ' CE1' ' A' ' 258' ' ' HIS . 5.3 tp -71.62 101.4 2.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 304' ' ' ARG . 39.3 mt -115.88 95.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 32.8 t -90.36 136.61 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 53.74 51.19 15.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.61 28.84 2.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 18.2 ttt-85 -129.14 98.22 4.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 110.852 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.406 ' N ' HG22 ' A' ' 299' ' ' ILE . 32.2 ttp85 -42.25 145.9 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.467 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 49.7 mt -130.59 135.97 48.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -89.55 99.47 12.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 75.2 t -95.72 142.39 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.075 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 11.9 ptpt -145.77 171.94 14.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -85.06 122.02 28.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.25 -133.8 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.469 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.8 tpp85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 110.849 -179.837 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 2.7 t -157.0 154.42 29.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 110.89 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.5 m -94.7 -46.3 6.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 142.6 84.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.487 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 82.6 p -55.95 -44.04 78.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 110.87 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 24.8 t -60.4 163.56 5.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 169.86 -173.98 44.03 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.488 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -95.59 111.86 23.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.359 . . . . 0.0 110.948 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -115.53 119.62 36.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 237' ' ' THR . 22.8 mmmt -83.48 99.33 10.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.479 ' N ' HH21 ' A' ' 284' ' ' ARG . 72.6 p 35.84 40.64 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.168 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 65.4 mt -77.01 117.71 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.131 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 284' ' ' ARG . 29.1 p -108.41 26.59 10.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 18.3 m -117.75 140.98 48.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.16 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 30.6 mt -128.49 133.24 48.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.603 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -97.92 140.72 31.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 89.5 t -135.5 127.31 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.51 174.89 16.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.436 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 70.66 42.29 62.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.483 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.418 ' CD1' HG12 ' A' ' 270' ' ' VAL . 24.3 mt -70.64 -62.9 1.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.826 0.346 . . . . 0.0 110.919 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.71 158.98 0.75 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.443 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -56.65 -15.58 4.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.8 p -74.26 -32.49 62.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.469 ' CD1' HD23 ' A' ' 305' ' ' LEU . 68.6 mt -108.97 145.26 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 12.4 p -128.56 177.19 7.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.151 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -59.55 -61.25 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 94.6 m -38.66 -56.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -40.31 -56.03 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.9 mt -65.42 -48.86 71.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.437 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 44.0 ttt180 -45.92 -43.13 13.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -79.46 -41.21 28.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.649 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 59.6 t-80 -57.91 -33.66 69.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 279' ' ' ILE . 60.1 m-85 -94.22 -42.8 8.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -42.29 -36.06 1.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.8 pt20 -54.3 -41.28 68.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.959 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 86.3 m-85 -64.84 -42.86 94.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 176.36 -172.22 45.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -61.47 142.27 57.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 110.922 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 70.6 mt -111.93 111.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -55.02 -50.25 69.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.8 t -168.85 162.24 11.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 256' ' ' ARG . 79.7 mt -138.4 108.46 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 92.4 m -99.63 100.34 11.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.418 HG12 ' CD1' ' A' ' 246' ' ' LEU . 76.8 t -92.62 103.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 82.6 t -86.4 99.88 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -60.25 -31.68 70.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -59.23 -38.08 79.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 275' ' ' GLN . 77.0 mt-30 -112.52 21.66 15.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.943 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.456 ' HA ' ' NE2' ' A' ' 275' ' ' GLN . 14.5 mm100 33.73 50.82 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.418 ' C ' HD11 ' A' ' 246' ' ' LEU . 29.3 p -140.62 167.9 21.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -146.14 146.8 31.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.559 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 33.7 m-85 -115.21 107.72 15.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.571 HG12 ' CD2' ' A' ' 259' ' ' PHE . 3.9 mp -90.86 121.03 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.144 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -106.94 142.95 35.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.564 ' CD2' ' HB2' ' A' ' 286' ' ' ALA . 96.9 m-85 -122.75 142.03 51.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.43 74.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.046 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 36.8 p -131.81 123.88 28.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.134 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.479 HH21 ' N ' ' A' ' 237' ' ' THR . 6.0 tpp85 -39.0 -33.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -37.97 -65.9 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . 0.564 ' HB2' ' CD2' ' A' ' 281' ' ' PHE . . . -58.23 -53.83 53.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -41.59 -63.45 0.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.096 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -46.3 -64.31 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.869 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 18.6 t -40.25 -62.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.564 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -57.02 -33.98 67.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.119 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.59 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -53.86 -60.71 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.131 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -63.79 -36.53 84.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.436 ' HD2' ' CE2' ' A' ' 262' ' ' PHE . 17.7 mttm -75.97 -8.49 57.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 29.6 m -114.18 -9.82 12.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.8 m-30 -65.4 105.71 1.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.835 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 21.1 m120 43.36 27.79 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -127.68 -28.61 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.649 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 4.7 tp -67.8 97.37 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.961 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 38.4 mt -116.13 94.53 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 49.8 t -95.85 145.2 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 50.93 50.03 19.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.9 34.18 5.47 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.534 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -136.9 108.92 7.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 110.883 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -56.84 143.69 36.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.469 HD23 ' CD1' ' A' ' 250' ' ' ILE . 43.0 mt -126.78 137.95 53.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.74 98.89 11.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.44 ' CG2' HD21 ' A' ' 298' ' ' LEU . 79.0 t -93.22 138.65 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.528 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.3 ptpt -151.56 141.52 22.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -50.7 135.19 23.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -72.25 -119.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.841 0.353 . . . . 0.0 110.88 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 93.9 p -50.59 131.24 25.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.0 110.834 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 22.0 p -45.84 -22.37 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.917 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -105.44 45.83 1.25 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.535 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 36.4 t -108.26 80.81 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.884 0.373 . . . . 0.0 110.91 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 233' ' ' GLY . 55.6 p -170.0 158.92 7.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.882 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 232' ' ' SER . . . -36.61 148.94 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.45 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -97.57 80.7 2.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.84 0.352 . . . . 0.0 110.869 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.44 109.64 2.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -115.92 -62.68 1.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 21.1 p -122.35 35.73 4.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 58.5 mt -75.33 110.2 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 284' ' ' ARG . 39.0 p -99.61 32.2 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 241' ' ' LEU . 9.4 m -130.22 149.37 51.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.406 ' N ' HG22 ' A' ' 240' ' ' THR . 28.8 mt -132.3 156.85 45.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.585 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.3 OUTLIER -108.36 146.18 33.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.43 HG21 ' C ' ' A' ' 242' ' ' TYR . 58.2 t -140.77 113.84 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.098 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -107.0 -177.42 22.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.453 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 57.7 47.33 89.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.477 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.428 ' CD1' ' C ' ' A' ' 276' ' ' CYS . 95.4 mt -83.22 -57.82 3.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 110.915 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.26 158.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.477 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -47.02 -33.95 5.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.912 0.387 . . . . 0.0 110.857 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.9 p -52.75 -44.38 66.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.88 143.52 12.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 42.7 p -121.83 -176.65 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -70.1 -57.09 5.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.5 m -44.55 -50.1 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.124 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -46.99 -42.67 18.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 21.1 mt -77.34 -48.92 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.403 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 28.0 ttm180 -46.46 -44.44 17.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -76.3 -40.11 52.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.487 ' CE1' HD12 ' A' ' 298' ' ' LEU . 51.3 t-80 -60.19 -34.45 73.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.837 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -94.22 -40.68 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 256' ' ' ARG . 1.6 t80 -42.05 -34.82 0.77 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.468 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.0 pt20 -54.16 -43.2 70.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.934 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.571 ' CZ ' ' HA ' ' A' ' 290' ' ' ALA . 60.8 m-85 -57.68 -50.93 71.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.62 -150.1 7.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -85.13 122.61 29.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 0.0 110.848 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 77.2 mt -90.71 116.88 32.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -63.11 -51.67 65.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.3 t -165.13 161.59 19.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 76.7 mt -137.71 109.72 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 60.7 m -100.45 99.58 10.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.148 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 93.4 t -91.13 115.11 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.163 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 5.0 t -97.18 102.04 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -60.23 -49.49 77.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -54.03 -30.14 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 275' ' ' GLN . 16.6 mt-30 -108.33 13.79 25.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 274' ' ' GLN . 43.6 mt-30 34.32 47.26 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.428 ' C ' ' CD1' ' A' ' 246' ' ' LEU . 20.7 p -142.2 177.54 8.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . 0.418 ' CB ' HD12 ' A' ' 246' ' ' LEU . . . -159.59 140.2 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -107.06 119.5 39.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 3.8 mm -98.51 118.63 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.15 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -104.47 141.23 36.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 286' ' ' ALA . 97.5 m-85 -122.88 150.52 42.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -71.2 -41.84 69.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 33.1 p -118.99 122.5 42.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.12 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.427 ' N ' HG23 ' A' ' 239' ' ' THR . 17.0 tpt180 -38.44 -35.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -39.55 -65.86 0.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . 0.472 ' HB3' ' CD1' ' A' ' 281' ' ' PHE . . . -53.67 -48.94 68.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -47.49 -63.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -43.42 -64.1 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.449 HG11 ' CE1' ' A' ' 262' ' ' PHE . 41.5 t -42.51 -58.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -54.6 -39.55 67.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -52.22 -65.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -54.7 -39.52 68.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -80.41 2.42 25.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.453 ' HB3' ' CG1' ' A' ' 307' ' ' VAL . 24.0 m -117.36 -26.58 6.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -58.19 102.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.0 m120 43.69 32.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -129.74 -31.09 2.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.487 HD12 ' CE1' ' A' ' 258' ' ' HIS . 4.9 tp -68.65 98.53 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 304' ' ' ARG . 28.4 mt -113.72 94.47 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.2 t -92.07 139.36 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 53.71 47.35 23.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.885 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.31 27.02 5.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 -126.92 97.63 5.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.772 0.32 . . . . 0.0 110.907 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.469 ' N ' HG23 ' A' ' 299' ' ' ILE . 34.3 ttm-85 -42.41 139.76 1.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 29.2 mt -126.7 138.09 53.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -87.99 113.66 23.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 308' ' ' LYS . 47.0 t -113.79 143.63 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 18.7 pttt -152.65 161.26 42.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -67.68 123.53 20.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -72.23 -157.5 3.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.797 0.332 . . . . 0.0 110.892 -179.856 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 97.5 p -88.28 42.26 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.382 . . . . 0.0 110.844 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 77.5 p -102.95 130.78 50.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.868 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 179.74 -165.37 33.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.497 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 88.3 p -105.7 -45.8 4.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.844 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 89.0 p -79.43 101.33 8.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -117.85 -151.33 9.21 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -134.29 63.63 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.897 0.379 . . . . 0.0 110.894 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.437 ' HA ' ' CD1' ' A' ' 238' ' ' ILE . 10.3 p-10 -134.02 105.14 6.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -118.48 -63.68 1.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 41.1 p -120.78 37.17 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 235' ' ' ASP . 79.9 mt -74.84 118.75 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.135 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.1 p -102.41 35.14 2.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 17.2 m -138.72 143.2 38.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.5 mt -129.11 141.72 51.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.564 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -104.64 137.02 43.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.06 131.62 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.156 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.59 158.23 15.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 82.84 37.87 12.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.434 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.41 HD11 ' C ' ' A' ' 276' ' ' CYS . 63.6 mt -63.62 -66.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.417 ' HA3' ' NH1' ' A' ' 303' ' ' ARG . . . 66.01 148.32 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.5 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.0 -37.88 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 0.0 110.845 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 50.9 p -52.9 -46.58 68.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.151 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.477 ' CD1' ' CD2' ' A' ' 305' ' ' LEU . 53.0 mt -94.24 143.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.115 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.2 p -129.31 177.31 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.15 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.503 ' OE1' ' CG2' ' A' ' 270' ' ' VAL . 3.7 tp10 -60.35 -61.14 2.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.1 m -41.43 -52.61 3.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.134 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.51 -51.5 5.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.0 mt -70.03 -45.26 67.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.94 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -48.88 -47.27 43.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -76.59 -38.93 54.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.559 ' CE1' HD13 ' A' ' 298' ' ' LEU . 34.6 t-80 -60.44 -34.24 73.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.573 ' CD2' HG12 ' A' ' 279' ' ' ILE . 51.3 m-85 -94.87 -41.34 9.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.838 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.418 ' CA ' HD13 ' A' ' 265' ' ' ILE . 2.0 t80 -41.8 -38.17 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 27.4 pt20 -52.32 -41.71 63.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.562 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 70.2 m-85 -63.25 -48.29 78.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 177.13 174.29 43.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.545 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -45.81 147.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.456 HG21 ' CG1' ' A' ' 268' ' ' ILE . 65.8 mt -117.03 112.35 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.8 mtp180 -55.19 -50.98 67.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.1 t -167.03 158.84 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.456 ' CG1' HG21 ' A' ' 265' ' ' ILE . 21.0 mt -136.2 110.31 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.07 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 91.2 m -105.14 126.33 51.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.503 ' CG2' ' OE1' ' A' ' 252' ' ' GLU . 25.5 t -109.8 123.48 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 22.8 t -106.75 99.93 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.144 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -59.89 -50.0 75.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 9.4 ptt85 -53.79 -24.83 16.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.457 ' O ' ' C ' ' A' ' 275' ' ' GLN . 17.8 mt-30 -116.68 10.98 14.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 274' ' ' GLN . 66.8 mt-30 33.34 53.79 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.41 ' C ' HD11 ' A' ' 246' ' ' LEU . 26.9 p -142.86 172.21 13.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -146.3 151.2 37.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.065 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 49.6 m-85 -121.47 108.24 13.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.573 HG12 ' CD2' ' A' ' 259' ' ' PHE . 4.5 mp -94.24 118.52 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.126 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 266' ' ' ARG . 7.9 tt0 -105.91 142.52 35.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.548 ' CD2' ' HB1' ' A' ' 286' ' ' ALA . 87.7 m-85 -121.49 149.95 42.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.39 91.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.069 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 284' ' ' ARG . 35.8 p -125.81 125.34 42.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.15 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.461 ' O ' ' C ' ' A' ' 285' ' ' GLN . 4.9 tpt180 -35.97 -39.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.843 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 284' ' ' ARG . 36.2 tp60 -32.87 -65.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.94 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . 0.548 ' HB1' ' CD2' ' A' ' 281' ' ' PHE . . . -56.56 -43.56 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.061 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.08 -60.88 2.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.102 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -47.58 -53.35 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 45.5 t -53.17 -54.87 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.157 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.562 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -60.39 -32.79 71.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.448 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -56.41 -50.99 70.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -70.87 -26.86 63.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.464 ' HD2' ' CE2' ' A' ' 262' ' ' PHE . 20.5 mttt -92.51 -1.34 57.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 290' ' ' ALA . 61.3 p -112.29 -32.14 6.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 2.9 m-85 -53.73 106.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 29.5 t30 40.84 34.0 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -131.02 -33.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.559 HD13 ' CE1' ' A' ' 258' ' ' HIS . 4.3 tp -66.9 98.17 0.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 53.8 mt -113.53 96.29 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.84 141.89 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 53.82 43.88 30.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 50.79 32.94 26.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.461 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . 0.417 ' NH1' ' HA3' ' A' ' 247' ' ' GLY . 30.4 ttt180 -135.0 108.31 7.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.873 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -51.42 146.37 7.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.477 ' CD2' ' CD1' ' A' ' 250' ' ' ILE . 31.1 mt -132.45 135.15 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.97 97.92 9.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.459 ' CG2' HD22 ' A' ' 298' ' ' LEU . 39.1 t -94.89 141.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.526 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.5 ptpt -153.47 145.27 23.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -50.9 143.98 9.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.922 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -93.41 -132.7 6.36 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.444 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 43.7 ttt85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 110.869 -179.85 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 11.6 t -57.36 108.04 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 110.872 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 99.9 p -83.37 99.65 10.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.87 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -52.73 106.19 0.36 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.447 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 3.8 m -58.46 125.47 23.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.372 . . . . 0.0 110.866 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 51.8 p -127.26 97.34 4.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -161.39 -161.19 11.46 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.455 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -86.43 155.75 20.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 0.0 110.878 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.71 93.37 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 237' ' ' THR . 2.7 mmmp? -55.17 94.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 236' ' ' LYS . 0.2 OUTLIER 31.9 46.74 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 52.2 mt -78.91 98.25 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 37.3 p -86.34 30.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 241' ' ' LEU . 56.5 m -126.27 140.39 52.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.142 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.444 ' N ' HG22 ' A' ' 240' ' ' THR . 25.2 mt -129.27 131.46 47.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.611 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -87.65 145.95 25.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 85.6 t -137.22 130.3 44.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -121.96 177.98 16.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.49 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.412 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 66.53 46.51 76.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.44 HD21 ' CD1' ' A' ' 255' ' ' LEU . 52.1 mt -77.12 -59.69 2.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.382 . . . . 0.0 110.906 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.87 148.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -42.18 -25.91 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.843 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.8 p -61.57 -45.96 91.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.112 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.466 ' CD1' ' CD2' ' A' ' 305' ' ' LEU . 53.7 mt -97.3 148.77 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.138 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 31.0 p -128.48 -176.47 3.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -66.83 -59.56 3.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.9 m -42.11 -55.33 3.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -41.95 -47.17 4.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.44 ' CD1' HD21 ' A' ' 246' ' ' LEU . 19.5 mt -72.34 -53.76 11.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.956 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -42.08 -45.85 4.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -75.87 -42.65 48.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.567 ' CE1' HD11 ' A' ' 298' ' ' LEU . 37.7 t-80 -56.62 -33.95 66.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.46 ' CE2' HG13 ' A' ' 279' ' ' ILE . 67.5 m-85 -94.19 -44.04 8.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.446 ' CA ' HD13 ' A' ' 265' ' ' ILE . 1.9 t80 -39.94 -36.73 0.49 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 14.4 pt20 -51.63 -46.88 63.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.932 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.567 ' CD2' ' HB3' ' A' ' 290' ' ' ALA . 67.4 m-85 -57.99 -45.94 86.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -176.33 -157.54 17.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.48 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -80.72 131.24 35.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.446 HD13 ' CA ' ' A' ' 260' ' ' TYR . 62.5 mt -97.56 112.41 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.127 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -57.86 -50.18 74.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 3.7 t -163.6 168.56 19.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 82.2 mt -145.73 111.52 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.144 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 88.8 m -102.21 101.81 12.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.17 114.64 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.076 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 11.1 t -101.71 100.06 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -60.07 -44.22 94.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.449 ' HG2' ' N ' ' A' ' 274' ' ' GLN . 1.6 ptm180 -52.99 -32.95 49.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.829 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.449 ' N ' ' HG2' ' A' ' 273' ' ' ARG . 61.8 mm-40 -112.42 15.12 20.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 274' ' ' GLN . 46.9 mm-40 34.66 52.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.407 ' C ' HD12 ' A' ' 246' ' ' LEU . 9.5 p -142.24 174.18 10.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -152.72 135.53 15.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.108 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 27.1 m-85 -101.62 109.44 21.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . 0.46 HG13 ' CE2' ' A' ' 259' ' ' PHE . 3.5 mm -93.75 121.0 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -109.79 139.08 45.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -117.38 144.64 44.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.15 78.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 284' ' ' ARG . 31.1 p -125.14 118.73 26.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' A' ' 283' ' ' THR . 15.7 tpt180 -37.94 -32.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 283' ' ' THR . 5.2 tt0 -40.35 -67.91 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -56.36 -39.43 72.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -53.49 -62.23 1.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -49.63 -49.62 46.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.412 HG12 ' CE1' ' A' ' 262' ' ' PHE . 16.8 t -52.82 -64.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.567 ' HB3' ' CD2' ' A' ' 262' ' ' PHE . . . -53.27 -41.5 65.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . 0.448 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -51.34 -54.76 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.439 ' O ' ' NZ ' ' A' ' 297' ' ' LYS . 12.9 tm-20 -67.65 -26.71 66.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.843 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.9 mttm -94.84 4.6 53.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.456 ' N ' ' O ' ' A' ' 290' ' ' ALA . 78.9 p -116.47 -26.91 6.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.4 m-30 -58.73 104.86 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 1.7 m120 47.82 29.12 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.439 ' NZ ' ' O ' ' A' ' 292' ' ' GLU . 0.5 OUTLIER -127.86 -34.94 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.567 HD11 ' CE1' ' A' ' 258' ' ' HIS . 7.4 tp -67.81 97.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 304' ' ' ARG . 42.1 mt -114.76 98.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.42 146.76 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.127 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 45.78 47.24 11.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.54 33.4 11.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 11.2 ttt85 -133.96 101.5 5.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.792 0.329 . . . . 0.0 110.892 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.452 ' N ' HG22 ' A' ' 299' ' ' ILE . 14.8 ttm180 -43.3 145.72 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.466 ' CD2' ' CD1' ' A' ' 250' ' ' ILE . 23.4 mt -129.71 134.02 47.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.57 101.38 11.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 72.5 t -103.85 133.29 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.575 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.0 pttt -145.59 152.52 39.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -55.91 130.38 43.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -58.84 -117.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.789 0.328 . . . . 0.0 110.907 -179.856 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 79.9 p -101.01 152.53 20.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 0.0 110.841 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.4 t -162.81 147.28 11.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 79.46 98.14 0.28 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.501 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 58.4 m -97.9 90.46 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.833 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 76.6 p -75.72 -52.05 11.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.803 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 64.49 86.01 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.514 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 235' ' ' ASP . 4.7 mm-40 -99.09 162.95 12.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.362 . . . . 0.0 110.867 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.468 ' HA ' ' CD1' ' A' ' 238' ' ' ILE . 2.9 p30 34.71 45.81 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 237' ' ' THR . 32.5 mtmt -73.32 101.03 3.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 236' ' ' LYS . 28.6 p 34.43 39.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.146 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 235' ' ' ASP . 6.7 mt -65.17 105.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.142 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.8 p -98.45 39.83 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 18.4 m -138.91 139.62 38.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 44.1 mt -126.33 153.71 44.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.581 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.3 OUTLIER -105.53 146.18 29.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.415 HG22 ' C ' ' A' ' 242' ' ' TYR . 93.5 t -142.49 122.3 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.127 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -115.15 173.18 14.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.494 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.72 56.53 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.524 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.466 ' CD1' HG11 ' A' ' 270' ' ' VAL . 57.4 mt -70.23 -62.37 1.41 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.868 0.365 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.47 155.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.473 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -47.44 -30.36 3.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.5 p -58.12 -43.03 87.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.466 HG21 ' N ' ' A' ' 251' ' ' THR . 61.3 mt -102.18 143.53 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.466 ' N ' HG21 ' A' ' 250' ' ' ILE . 30.4 p -121.26 -177.31 3.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.183 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -70.02 -52.25 25.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 92.2 m -48.9 -54.98 13.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.154 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -40.24 -44.94 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 258' ' ' HIS . 16.7 mt -75.25 -59.08 2.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 255' ' ' LEU . 20.3 ttm-85 -36.29 -42.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -78.12 -40.17 39.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.57 ' CE1' HD11 ' A' ' 298' ' ' LEU . 13.9 t60 -59.56 -37.53 78.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 261' ' ' GLN . 73.5 m-85 -90.03 -39.06 13.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.466 ' CA ' HD11 ' A' ' 265' ' ' ILE . 1.1 t80 -45.02 -21.31 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.926 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 259' ' ' PHE . 24.4 pt20 -69.32 -43.3 74.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.559 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 81.4 m-85 -61.31 -42.52 98.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 179.96 -167.19 36.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.466 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -71.56 130.11 40.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.913 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.466 HD11 ' CA ' ' A' ' 260' ' ' TYR . 60.3 mt -98.29 112.13 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.112 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.5 mtp85 -56.89 -49.36 75.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 t -165.6 168.98 15.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.176 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.407 ' CD1' ' HA ' ' A' ' 256' ' ' ARG . 85.9 mt -144.01 110.95 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.174 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.8 m -100.92 102.21 13.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.466 HG11 ' CD1' ' A' ' 246' ' ' LEU . 40.3 t -96.18 104.68 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 99.8 t -92.52 99.95 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -37.75 80.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -55.99 -35.55 66.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -106.42 4.13 28.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 47.25 48.02 16.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.946 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.69 178.63 7.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -155.26 139.55 16.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -111.33 109.95 20.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 2.8 mm -92.46 126.84 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 266' ' ' ARG . 8.5 tt0 -113.52 142.16 46.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -121.49 149.82 42.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.0 -32.71 71.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.102 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 284' ' ' ARG . 16.0 p -127.1 117.4 22.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 283' ' ' THR . 15.1 tpt180 -37.29 -32.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' THR . 3.5 tt0 -39.22 -68.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -55.5 -47.66 75.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -43.8 -54.05 5.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.138 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -56.46 -60.72 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.848 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 21.0 t -45.12 -56.34 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.559 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -58.09 -37.25 74.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.088 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -52.23 -65.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -56.13 -39.53 72.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.832 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.5 ' HD2' ' CZ ' ' A' ' 262' ' ' PHE . 20.8 mttp -76.86 1.06 18.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 3.2 m -118.03 -28.14 5.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -54.81 106.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 57.5 t30 42.27 25.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -123.83 -27.32 3.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.57 HD11 ' CE1' ' A' ' 258' ' ' HIS . 5.9 tp -70.32 100.5 1.74 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 22.4 mt -120.17 99.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.36 138.91 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 60.64 45.87 9.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.85 34.53 11.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -137.67 106.24 5.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 0.0 110.872 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 16.9 ttm105 -50.58 150.2 2.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.451 HD21 ' CD1' ' A' ' 250' ' ' ILE . 38.7 mt -135.43 137.64 42.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.959 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -90.38 113.36 25.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.467 HG11 ' N ' ' A' ' 308' ' ' LYS . 35.4 t -112.4 143.17 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.581 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 5.1 ptpp? -150.12 160.37 43.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -67.67 129.56 40.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -79.55 -158.42 14.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.494 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.799 0.333 . . . . 0.0 110.909 -179.884 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 228' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 227' ' ' GLY . 63.1 m -36.97 -46.16 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.892 0.377 . . . . 0.0 110.843 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.5 t -144.53 148.61 34.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -167.29 171.57 42.02 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 26.3 t -80.13 -43.98 20.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.921 0.391 . . . . 0.0 110.86 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 74.8 m -62.05 139.63 58.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.872 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -173.19 -104.09 0.17 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.464 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -92.69 83.94 4.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 110.884 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.04 96.8 9.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.91 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.463 ' HD3' ' N ' ' A' ' 237' ' ' THR . 0.0 OUTLIER -132.69 -36.13 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.463 ' N ' ' HD3' ' A' ' 236' ' ' LYS . 17.0 p -134.43 27.62 3.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.164 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . 0.409 HD12 ' C ' ' A' ' 311' ' ' ARG . 48.9 mt -81.78 107.74 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.156 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.5 p -98.51 30.01 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 40.1 m -128.88 136.3 50.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.5 mt -126.66 126.43 43.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.585 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -82.56 140.59 33.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.886 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.49 131.72 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.171 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.07 -174.9 16.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.43 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 56.2 54.79 33.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.402 HD11 ' C ' ' A' ' 276' ' ' CYS . 77.8 mt -87.4 -57.81 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.912 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.78 156.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.66 -24.63 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.847 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.8 p -62.13 -35.27 78.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.127 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.419 ' CD1' ' CD2' ' A' ' 305' ' ' LEU . 73.6 mt -107.24 142.32 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.8 p -117.74 -179.93 3.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.84 -54.26 24.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 89.3 m -48.56 -54.89 12.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.222 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -39.15 -45.96 1.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.0 mt -75.95 -49.55 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -45.35 -44.25 11.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -76.41 -44.37 36.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.519 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 39.5 t-80 -56.37 -33.82 66.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -94.12 -42.71 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . 0.46 ' CA ' HD13 ' A' ' 265' ' ' ILE . 1.8 t80 -41.14 -44.46 2.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.8 pt20 -44.5 -41.02 6.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.576 ' CD2' ' HB3' ' A' ' 290' ' ' ALA . 53.4 m-85 -60.8 -49.84 75.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -175.63 -160.95 24.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.454 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -75.36 121.93 22.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.865 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.46 HD13 ' CA ' ' A' ' 260' ' ' TYR . 87.0 mt -89.83 108.98 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.46 ' HG3' ' N ' ' A' ' 282' ' ' ALA . 9.2 mtt-85 -52.46 -52.49 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 13.7 t -162.23 170.9 18.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 75.3 mt -146.08 110.26 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.131 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 19.2 m -103.1 98.9 8.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.194 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.17 107.06 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 5.3 t -91.3 100.84 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -60.21 -45.43 93.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -19.22 21.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 275' ' ' GLN . 15.2 mt-30 -121.39 11.93 10.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 274' ' ' GLN . 92.9 mt-30 36.87 44.3 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.402 ' C ' HD11 ' A' ' 246' ' ' LEU . 28.4 p -133.59 175.07 9.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -156.73 131.94 9.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.418 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 42.9 m-85 -100.74 111.91 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 4.6 mm -94.85 114.71 31.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -102.52 144.84 30.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.64 148.09 49.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.46 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -68.91 -38.26 79.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.111 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 284' ' ' ARG . 25.1 p -125.24 119.22 27.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.168 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 283' ' ' THR . 16.9 tpt180 -35.89 -36.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.901 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 284' ' ' ARG . 13.0 tp60 -36.96 -63.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -60.4 -36.77 78.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.127 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.71 -62.09 2.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.055 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -47.44 -56.6 6.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 29.3 t -47.21 -62.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.576 ' HB3' ' CD2' ' A' ' 262' ' ' PHE . . . -54.04 -39.85 66.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -51.34 -64.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -54.99 -40.95 70.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -77.31 3.07 13.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.455 ' HB3' ' CG1' ' A' ' 307' ' ' VAL . 1.9 m -116.65 -31.72 5.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -48.32 98.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.854 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 43.96 30.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.69 -35.79 2.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.519 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 6.6 tp -66.45 97.75 0.44 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 54.1 mt -114.53 91.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 58.1 t -85.62 147.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.118 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 43.73 48.7 6.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 46.5 33.57 6.1 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.474 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -132.9 100.14 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.866 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 20.3 ttm-85 -43.84 139.3 2.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.43 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 29.6 mt -122.12 133.35 54.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -82.67 101.3 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 294' ' ' SER . 53.8 t -103.77 146.65 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 10.5 ptpt -156.96 169.73 24.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -80.79 125.47 30.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 311' ' ' ARG . . . -59.29 -120.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 310' ' ' GLY . 56.6 mtm180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.84 0.353 . . . . 0.0 110.901 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 23.8 t -101.41 99.68 10.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 0.0 110.891 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 65.7 m -76.27 -49.96 15.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.876 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.45 -153.91 17.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.488 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 89.0 p -159.47 116.11 2.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 110.836 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 10.7 t -66.1 134.51 52.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.818 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 65.77 179.83 9.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.511 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -143.14 170.33 15.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.859 0.361 . . . . 0.0 110.875 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.91 107.61 7.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 237' ' ' THR . 62.2 mmtt -79.06 89.1 4.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 236' ' ' LYS . 73.0 p 37.62 40.37 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.097 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 57.2 mt -70.25 96.5 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.118 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.437 HG21 ' N ' ' A' ' 284' ' ' ARG . 30.3 p -93.92 38.11 1.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 24.9 m -131.38 144.28 51.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 28.6 mt -134.71 128.61 33.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.941 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.565 ' CE1' ' HE2' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -85.6 143.99 28.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.412 HG23 ' C ' ' A' ' 242' ' ' TYR . 66.0 t -140.5 106.67 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.115 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -102.17 178.18 26.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.495 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.488 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 71.94 41.43 55.12 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.464 HD11 ' N ' ' A' ' 276' ' ' CYS . 96.5 mt -70.08 -63.11 1.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.841 0.353 . . . . 0.0 110.926 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 249' ' ' THR . . . 71.77 143.45 0.38 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -40.1 -29.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 247' ' ' GLY . 34.5 p -61.59 -53.12 60.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . 0.46 ' CD1' HD23 ' A' ' 305' ' ' LEU . 59.2 mt -84.53 153.82 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 55.9 p -134.68 178.37 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.77 -59.57 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.4 m -44.02 -55.14 4.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.156 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -39.75 -47.01 2.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.9 mt -75.86 -52.88 9.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 50.1 ttp85 -42.06 -44.01 3.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -74.97 -46.86 32.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.542 ' CE1' HD12 ' A' ' 298' ' ' LEU . 8.8 t60 -52.63 -39.39 61.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 261' ' ' GLN . 76.7 m-85 -87.84 -45.16 10.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.826 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -39.84 -27.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 259' ' ' PHE . 23.6 pt20 -62.28 -46.25 89.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.572 ' CD2' ' HB3' ' A' ' 290' ' ' ALA . 60.8 m-85 -54.39 -50.27 67.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -172.6 -146.99 5.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.511 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -90.29 123.02 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 47.1 mt -91.01 113.76 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.144 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -56.6 -48.82 76.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 t -165.2 170.28 15.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.165 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 92.6 mt -144.79 110.93 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.118 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 39.2 m -103.14 98.86 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 90.1 t -90.34 110.07 21.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.436 HG13 ' NE2' ' A' ' 274' ' ' GLN . 38.6 t -95.57 100.01 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 275' ' ' GLN . 10.4 tt0 -60.01 -57.8 11.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -45.11 -22.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.436 ' NE2' HG13 ' A' ' 271' ' ' VAL . 43.2 mt-30 -109.12 -16.44 14.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.962 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 272' ' ' GLN . 34.3 mt-30 64.37 45.14 3.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' CYS . . . . . 0.464 ' N ' HD11 ' A' ' 246' ' ' LEU . 5.3 m -145.76 177.52 8.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -153.29 142.18 21.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 33.1 m-85 -106.63 107.16 18.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 7.3 mm -90.1 117.44 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -105.79 150.19 25.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -130.79 151.83 50.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -74.53 -32.97 62.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.116 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 284' ' ' ARG . 24.9 p -127.17 118.08 23.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.437 ' N ' HG21 ' A' ' 239' ' ' THR . 5.7 tpp85 -36.01 -38.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 284' ' ' ARG . 12.0 tt0 -35.9 -64.83 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.59 -45.73 84.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -52.0 -66.31 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -43.29 -52.39 5.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.571 HG13 ' CD1' ' A' ' 262' ' ' PHE . 46.3 t -52.72 -64.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.572 ' HB3' ' CD2' ' A' ' 262' ' ' PHE . . . -48.84 -43.1 38.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.067 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -46.18 -67.66 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -53.14 -44.48 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -70.7 -0.94 9.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.472 ' HB3' ' CG2' ' A' ' 307' ' ' VAL . 12.6 m -119.14 -24.26 6.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.869 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -53.95 103.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 43.51 26.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -124.92 -26.77 3.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.542 HD12 ' CE1' ' A' ' 258' ' ' HIS . 12.5 tp -68.03 98.26 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.947 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.55 96.64 4.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.159 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 85.7 t -103.69 145.37 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 55.56 40.48 31.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 51.53 32.05 30.41 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.52 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 19.4 ttt-85 -133.56 105.63 6.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.92 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 -49.95 147.12 4.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.488 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 40.4 mt -132.29 145.76 51.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.954 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -98.01 106.84 19.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' A' ' 294' ' ' SER . 98.3 t -105.25 137.7 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.565 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 3.4 pttt -151.26 148.94 28.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.935 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.61 141.06 44.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -80.23 -124.45 0.54 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 26.6 ttt-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.332 . . . . 0.0 110.86 -179.824 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.863 0.363 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.419 HG22 ' HA ' ' A' ' 284' ' ' ARG . 82.0 p -102.36 -11.68 18.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 16.7 m -84.84 141.92 30.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.181 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.8 mt -130.85 124.41 31.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.579 ' CE1' ' HE2' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -81.53 141.32 33.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.929 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.86 HG22 HG22 ' A' ' 307' ' ' VAL . 99.8 t -136.28 116.98 18.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.08 177.3 19.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 68.78 37.79 84.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.481 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.495 HD11 ' CB ' ' A' ' 277' ' ' ALA . 31.4 mt -75.9 -59.8 2.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.4 149.95 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.483 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -40.96 -36.87 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 24.1 p -51.89 -43.0 63.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.578 ' CD1' HD21 ' A' ' 305' ' ' LEU . 76.4 mt -97.12 143.07 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.12 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.0 p -121.6 -178.29 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.109 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.94 -56.67 7.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 90.0 m -43.98 -50.67 8.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.82 -37.62 14.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 18.9 mt -80.52 -52.36 7.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 41.4 ttt-85 -43.91 -42.89 6.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -76.53 -44.27 35.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.427 ' NE2' ' CD1' ' A' ' 298' ' ' LEU . 4.8 t60 -57.39 -33.12 67.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.444 ' CE2' HG13 ' A' ' 279' ' ' ILE . 76.5 m-85 -94.47 -41.39 9.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.534 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -42.71 -36.12 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.966 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 17.6 pt20 -54.13 -40.97 67.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.901 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 47.0 m-85 -63.75 -45.91 87.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.854 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 173.98 178.01 43.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.529 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -47.69 144.55 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.347 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.534 HD11 ' N ' ' A' ' 260' ' ' TYR . 90.7 mt -115.45 109.56 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -52.34 -50.45 62.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.5 t -167.53 168.74 12.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.458 HD11 HD13 ' A' ' 265' ' ' ILE . 90.1 mt -144.38 108.65 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 54.7 m -103.14 99.08 8.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 43.1 t -91.93 110.81 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.461 ' CG1' ' HG2' ' A' ' 273' ' ' ARG . 51.2 t -94.53 99.96 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -60.09 -43.24 95.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.461 ' HG2' ' CG1' ' A' ' 271' ' ' VAL . 6.8 ptm180 -55.09 -26.54 38.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.454 ' O ' ' C ' ' A' ' 275' ' ' GLN . 73.7 mt-30 -117.29 17.75 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 274' ' ' GLN . 66.7 mt-30 34.25 43.94 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 26.0 p -136.69 173.08 12.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.495 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -156.74 138.93 14.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -105.38 114.87 29.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.444 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.5 mm -98.06 118.03 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.162 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -104.42 140.4 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -119.43 146.38 45.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.34 -34.21 74.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 284' ' ' ARG . 29.5 p -127.68 118.18 23.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.171 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.431 ' O ' ' HB3' ' A' ' 287' ' ' ALA . 13.6 tpt180 -36.72 -36.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 284' ' ' ARG . 6.1 tp60 -36.85 -65.69 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -59.11 -35.29 73.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.084 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 284' ' ' ARG . . . -57.82 -57.39 12.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 13.7 mt-10 -52.33 -59.31 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 42.9 t -44.41 -61.61 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.901 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -57.42 -38.39 74.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -49.52 -69.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.108 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -54.08 -43.43 70.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -70.94 -3.72 20.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.673 ' HB3' HG21 ' A' ' 307' ' ' VAL . 33.2 m -112.3 -29.95 7.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -47.86 97.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.835 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 52.7 t30 45.17 25.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -120.57 -25.68 5.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.427 ' CD1' ' NE2' ' A' ' 258' ' ' HIS . 6.2 tp -72.53 99.83 2.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 304' ' ' ARG . 25.5 mt -113.39 96.68 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.109 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 67.7 t -100.72 138.36 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 58.13 49.88 10.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.78 34.18 5.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 245' ' ' GLY . 16.1 ttt-85 -138.81 105.13 5.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 0.0 110.881 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.604 ' O ' HD23 ' A' ' 305' ' ' LEU . 2.0 ttt85 -51.68 149.33 4.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 304' ' ' ARG . 42.0 mt -133.52 134.93 44.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.77 102.2 14.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.86 HG22 HG22 ' A' ' 243' ' ' VAL . 70.6 t -99.99 136.54 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.579 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 6.2 pttt -146.5 147.55 31.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -55.29 142.71 30.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.478 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 60.0 mt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.923 0.392 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 284' ' ' ARG . 57.3 p -90.39 26.75 1.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.2 m -123.16 141.03 52.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.588 HD21 ' HB2' ' A' ' 291' ' ' ALA . 66.4 mt -124.1 139.88 53.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.717 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.6 OUTLIER -99.1 146.31 26.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 307' ' ' VAL . 74.1 t -140.04 135.01 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -125.73 168.33 17.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 70.62 44.51 57.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 250' ' ' ILE . 91.3 mt -80.29 -59.11 2.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.879 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.34 162.81 0.89 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.463 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -49.53 -38.39 30.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 35.6 p -50.63 -45.05 57.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.142 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.696 ' CD1' HD21 ' A' ' 305' ' ' LEU . 67.3 mt -95.44 143.95 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 26.8 p -122.31 -175.23 3.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.477 ' HA ' HG21 ' A' ' 270' ' ' VAL . 37.6 tt0 -71.18 -57.18 4.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.6 m -45.33 -47.18 13.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.16 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -44.7 -50.67 9.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.0 -44.74 62.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.435 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 22.3 ttp180 -49.95 -46.05 51.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -75.7 -40.56 55.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.651 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 51.1 t-80 -61.06 -32.78 72.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.495 ' CD2' HG12 ' A' ' 279' ' ' ILE . 52.8 m-85 -94.32 -39.0 10.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.484 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -46.67 -38.02 9.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.2 pt20 -52.45 -38.22 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.56 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 79.0 m-85 -64.71 -43.97 91.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -178.97 -152.75 10.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.532 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -82.84 136.5 34.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 0.0 110.851 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.743 HD13 HD11 ' A' ' 268' ' ' ILE . 88.9 mt -105.35 112.95 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 282' ' ' ALA . 27.8 mtt180 -60.36 -48.98 79.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.4 t -165.13 159.02 17.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.16 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.743 HD11 HD13 ' A' ' 265' ' ' ILE . 59.5 mt -139.41 108.3 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 30.5 m -101.5 100.41 10.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 252' ' ' GLU . 83.7 t -93.67 103.35 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.403 HG12 ' HG2' ' A' ' 273' ' ' ARG . 12.2 t -86.19 99.54 8.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -60.76 -48.26 82.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.403 ' HG2' HG12 ' A' ' 271' ' ' VAL . 0.0 OUTLIER -58.48 -11.02 2.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 275' ' ' GLN . 19.8 mm-40 -126.6 14.41 7.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.953 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 274' ' ' GLN . 71.4 mt-30 33.04 51.09 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 14.2 p -148.8 165.27 31.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.467 ' CB ' HG22 ' A' ' 270' ' ' VAL . . . -148.95 148.09 29.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 56.7 m-85 -118.05 108.74 15.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.495 HG12 ' CD2' ' A' ' 259' ' ' PHE . 5.0 mp -93.02 121.67 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -105.38 148.54 27.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.429 ' HE2' HD12 ' A' ' 241' ' ' LEU . 98.9 m-85 -127.44 139.29 52.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.401 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -62.04 -34.9 77.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.078 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 284' ' ' ARG . 32.7 p -126.71 118.03 23.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.165 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.436 ' HA ' HG22 ' A' ' 239' ' ' THR . 9.5 tpt180 -36.13 -35.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.635 ' O ' HG23 ' A' ' 289' ' ' VAL . 46.4 tp60 -36.58 -68.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -54.7 -48.44 72.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -46.88 -59.56 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 5.6 mt-10 -50.18 -54.12 23.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.947 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 285' ' ' GLN . 16.5 t -50.79 -60.13 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.115 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.56 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -56.51 -36.53 69.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.065 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.588 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -54.66 -53.66 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -68.88 -28.65 66.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -92.03 5.41 50.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 65.7 p -119.08 -32.06 4.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.461 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.4 m-30 -55.1 109.42 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 41.05 33.88 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -130.96 -38.43 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.89 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.651 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 8.4 tp -65.48 100.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 58.4 mt -117.64 93.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.402 HG12 ' OD1' ' A' ' 301' ' ' ASN . 53.9 t -97.86 140.39 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.402 ' OD1' HG12 ' A' ' 300' ' ' VAL . 29.6 m120 58.43 42.34 21.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.93 34.12 10.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.491 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -134.19 99.38 4.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.349 . . . . 0.0 110.831 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.498 ' O ' HD23 ' A' ' 305' ' ' LEU . 6.9 ttm180 -44.17 148.47 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.696 HD21 ' CD1' ' A' ' 250' ' ' ILE . 43.4 mt -132.77 135.07 45.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.6 98.18 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 243' ' ' VAL . 49.7 t -100.89 140.17 20.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.555 ' CE ' ' CE1' ' A' ' 242' ' ' TYR . 9.6 pttt -147.86 150.65 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -52.21 134.83 33.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.482 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.558 HG22 ' H ' ' A' ' 240' ' ' THR . 85.2 mt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.943 0.401 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.3 p -95.16 29.71 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.165 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.558 ' H ' HG22 ' A' ' 238' ' ' ILE . 20.1 m -127.55 142.73 51.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.152 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 291' ' ' ALA . 32.1 mt -134.16 124.63 26.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.93 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.603 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -82.89 143.11 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.98 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 1.082 HG22 HG22 ' A' ' 307' ' ' VAL . 98.4 t -135.79 127.66 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.91 176.3 16.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 72.15 37.25 59.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.508 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.546 HD11 ' CB ' ' A' ' 277' ' ' ALA . 93.4 mt -81.52 -57.43 3.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.28 162.03 0.16 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.463 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -35.43 29.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 110.872 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.7 p -51.64 -48.35 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.494 ' CD1' HD21 ' A' ' 305' ' ' LEU . 68.6 mt -95.03 142.8 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 30.9 p -115.57 -175.62 2.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.598 ' HB2' HG21 ' A' ' 270' ' ' VAL . 18.8 tt0 -70.18 -56.7 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 98.4 m -44.96 -50.36 10.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.13 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.54 -41.1 4.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.7 mt -81.23 -55.12 4.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.406 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 19.2 ttm180 -39.72 -38.67 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -75.55 -44.07 45.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.867 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.743 ' NE2' HD13 ' A' ' 298' ' ' LEU . 30.5 t60 -58.82 -35.09 72.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.565 ' HA ' ' CD2' ' A' ' 262' ' ' PHE . 93.1 m-85 -91.48 -39.01 12.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.49 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.1 t80 -44.35 -28.97 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.432 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 23.8 pt20 -64.48 -42.83 95.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.703 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 29.7 m-85 -59.5 -48.73 80.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 175.15 178.8 45.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.52 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -48.43 141.17 7.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.49 HD11 ' N ' ' A' ' 260' ' ' TYR . 70.5 mt -111.26 110.77 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.152 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 280' ' ' GLN . 37.9 mtt-85 -52.79 -53.18 51.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.5 t -165.72 168.73 15.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 77.2 mt -142.81 111.96 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 50.0 m -104.06 98.91 8.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.598 HG21 ' HB2' ' A' ' 252' ' ' GLU . 65.4 t -90.99 105.43 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.159 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 14.9 t -91.12 100.73 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' GLN . . . . . 0.437 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 16.4 pt20 -59.69 -44.88 93.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.437 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 0.8 OUTLIER -56.47 -19.05 13.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 275' ' ' GLN . 10.0 mm100 -122.95 14.23 9.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 274' ' ' GLN . 52.9 mt-30 34.37 46.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.965 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 27.7 p -137.15 175.16 9.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.546 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -155.2 132.15 10.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 35.3 m-85 -99.62 111.49 23.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 4.9 mm -93.9 115.88 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.099 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 266' ' ' ARG . 40.1 tt0 -105.6 139.0 40.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.41 ' C ' ' HG3' ' A' ' 266' ' ' ARG . 95.6 m-85 -119.24 153.27 35.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.414 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -75.65 -34.47 60.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.105 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 284' ' ' ARG . 30.6 p -125.54 116.44 21.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 283' ' ' THR . 12.6 tpt180 -36.9 -34.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.414 ' O ' HG23 ' A' ' 289' ' ' VAL . 44.1 tp60 -38.48 -61.42 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.32 97.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -52.79 -59.98 3.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -48.13 -55.74 9.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.607 HG12 ' HE3' ' A' ' 293' ' ' LYS . 60.0 t -49.48 -61.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.703 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -52.87 -41.2 64.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.491 ' HB2' HD11 ' A' ' 241' ' ' LEU . . . -53.81 -52.72 59.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.63 -24.94 63.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.888 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.607 ' HE3' HG12 ' A' ' 289' ' ' VAL . 34.1 mtmt -97.79 5.63 48.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.724 ' HB2' HG21 ' A' ' 307' ' ' VAL . 81.5 p -117.8 -24.34 7.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 297' ' ' LYS . 2.8 m-85 -61.99 112.73 2.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 5.2 t30 40.51 25.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 295' ' ' PHE . 35.9 tttp -123.65 -36.69 2.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.743 HD13 ' NE2' ' A' ' 258' ' ' HIS . 14.9 tp -61.82 96.52 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 62.9 mt -120.47 95.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.67 134.19 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.18 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 57.5 54.88 6.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 41.8 33.07 1.02 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.0 ttm-85 -130.39 99.3 4.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.823 0.344 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -56.18 135.31 53.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.499 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 58.3 mt -120.23 135.66 54.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -91.95 99.05 11.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 1.082 HG22 HG22 ' A' ' 243' ' ' VAL . 79.5 t -94.58 136.74 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.522 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 1.0 OUTLIER -145.54 145.57 31.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 309' ' ' TRP . . . . . 0.468 ' HA ' HD23 ' A' ' 241' ' ' LEU . 61.6 m95 -54.56 141.06 32.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.539 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 240' ' ' THR . 78.1 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.859 0.361 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.8 p -102.11 31.0 4.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.533 ' H ' HG22 ' A' ' 238' ' ' ILE . 28.2 m -131.89 148.31 52.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 31.1 mt -132.91 156.01 48.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.56 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.4 OUTLIER -109.75 147.74 32.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.896 HG22 HG22 ' A' ' 307' ' ' VAL . 90.4 t -141.1 120.72 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.03 168.78 12.67 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.494 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.518 ' O ' HD22 ' A' ' 305' ' ' LEU . . . 73.81 44.31 31.78 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.503 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.668 HD11 ' HB2' ' A' ' 277' ' ' ALA . 52.4 mt -77.52 -60.41 2.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.931 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.28 156.45 0.17 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.492 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -49.39 -29.27 6.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.39 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.1 p -59.19 -43.84 92.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.146 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.573 ' CD1' HD21 ' A' ' 305' ' ' LEU . 60.4 mt -96.87 143.49 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 29.5 p -124.9 173.94 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -58.38 -59.64 5.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 88.7 m -41.22 -56.68 2.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -42.62 -42.73 3.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.463 HD11 HD22 ' A' ' 246' ' ' LEU . 33.4 mt -77.46 -57.26 3.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -39.0 -43.97 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -75.99 -38.04 57.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.87 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.431 ' O ' ' NE2' ' A' ' 261' ' ' GLN . 4.9 t60 -60.11 -35.13 74.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.839 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -94.15 -43.41 8.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.845 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.566 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -39.93 -36.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.919 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 29.4 pt20 -52.55 -46.2 66.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.926 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.591 ' CE1' HG12 ' A' ' 289' ' ' VAL . 62.7 m-85 -56.18 -48.84 75.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.39 -143.29 4.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.463 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -93.6 128.64 39.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 110.855 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.566 HD11 ' N ' ' A' ' 260' ' ' TYR . 57.6 mt -93.73 114.98 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 280' ' ' GLN . 9.9 mtt180 -60.62 -49.21 78.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.6 t -162.56 168.06 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.166 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.471 HD11 HG21 ' A' ' 265' ' ' ILE . 87.9 mt -146.07 110.66 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.4 m -104.37 99.88 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.438 HG13 ' CD1' ' A' ' 246' ' ' LEU . 85.7 t -92.5 107.65 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 14.8 t -91.97 100.76 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.67 -48.53 80.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -55.78 -26.65 47.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 275' ' ' GLN . 19.2 mm100 -110.6 11.3 22.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.44 ' C ' ' O ' ' A' ' 274' ' ' GLN . 80.5 mt-30 35.15 47.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 16.7 p -140.5 177.53 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.668 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -156.84 137.23 12.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.076 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -106.13 111.07 23.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 268' ' ' ILE . 6.1 mm -94.27 127.68 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 266' ' ' ARG . 9.1 tt0 -114.66 145.1 42.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.933 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.31 147.37 48.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.403 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -68.94 -37.04 78.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.141 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 284' ' ' ARG . 24.4 p -125.12 121.28 33.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.433 ' O ' ' HB3' ' A' ' 287' ' ' ALA . 12.0 tpt180 -37.88 -35.69 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 284' ' ' ARG . 1.4 tm0? -36.8 -67.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.23 79.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.084 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 284' ' ' ARG . . . -50.51 -58.51 5.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.085 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.446 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 11.5 mt-10 -51.63 -62.43 1.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.591 HG12 ' CE1' ' A' ' 262' ' ' PHE . 37.7 t -41.95 -56.44 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.58 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -57.33 -41.45 80.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -49.68 -65.97 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.082 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.25 -39.88 70.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -78.44 1.63 21.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.732 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.6 m -117.15 -26.67 6.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -57.0 103.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 42.13 27.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -124.24 -26.15 4.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 5.4 tp -72.88 97.82 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.92 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 304' ' ' ARG . 32.0 mt -115.58 92.33 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 19.9 t -95.39 146.94 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 5.8 m120 51.59 46.52 26.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.12 30.05 5.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -133.07 103.66 6.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 110.898 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.506 ' O ' HD23 ' A' ' 305' ' ' LEU . 4.7 ttm180 -47.72 144.38 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 250' ' ' ILE . 47.4 mt -129.93 137.24 50.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -89.29 111.75 22.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.896 HG22 HG22 ' A' ' 243' ' ' VAL . 45.6 t -111.39 145.09 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.56 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 6.0 ptpp? -149.54 163.68 37.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -69.75 124.35 23.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.454 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.565 HG22 ' H ' ' A' ' 240' ' ' THR . 67.6 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.934 0.397 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.0 p -102.88 34.06 3.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.165 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.565 ' H ' HG22 ' A' ' 238' ' ' ILE . 24.0 m -136.15 141.66 44.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.409 HD11 ' O ' ' A' ' 287' ' ' ALA . 42.0 mt -128.81 125.9 38.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.576 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -80.44 150.07 29.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.854 HG22 HG22 ' A' ' 307' ' ' VAL . 97.6 t -138.57 137.4 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.114 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.68 -179.02 15.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 60.45 44.33 97.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 277' ' ' ALA . 21.8 mt -77.52 -60.27 2.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 110.905 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 62.97 150.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.492 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -42.1 -31.47 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.9 p -55.69 -42.3 75.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.697 ' CD1' HD21 ' A' ' 305' ' ' LEU . 69.2 mt -99.39 151.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.122 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 40.4 p -131.69 177.5 7.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.142 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -57.03 11.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.1 m -44.61 -55.5 5.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -43.74 -44.32 6.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.56 -48.51 32.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -46.09 -45.67 16.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -77.03 -37.7 54.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -60.68 -35.01 75.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.845 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.474 ' CE2' HG13 ' A' ' 279' ' ' ILE . 69.7 m-85 -94.15 -41.11 9.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.898 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -41.97 -38.77 1.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 22.9 pt20 -48.53 -41.7 30.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.606 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 71.5 m-85 -63.34 -45.08 92.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 179.22 -154.92 14.73 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.476 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -78.74 144.8 34.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.794 0.33 . . . . 0.0 110.918 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.637 HD13 HD11 ' A' ' 268' ' ' ILE . 46.2 mt -110.55 119.27 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.438 ' NE ' ' HA ' ' A' ' 282' ' ' ALA . 49.1 mtt180 -65.11 -52.2 56.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 4.0 t -164.35 149.7 10.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.637 HD11 HD13 ' A' ' 265' ' ' ILE . 76.2 mt -128.68 110.26 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 21.8 m -102.98 98.91 8.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.133 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 246' ' ' LEU . 45.3 t -92.69 107.58 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.457 HG12 ' HG3' ' A' ' 273' ' ' ARG . 22.1 t -93.87 100.53 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 14.7 pt20 -60.09 -42.66 95.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.457 ' HG3' HG12 ' A' ' 271' ' ' VAL . 4.1 ptm180 -59.19 -17.68 29.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 275' ' ' GLN . 46.2 mt-30 -123.38 15.52 9.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.856 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 274' ' ' GLN . 40.7 mt-30 33.63 47.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 25.8 p -140.8 170.35 15.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -153.75 134.62 13.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 26.9 m-85 -101.83 108.43 19.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.598 HD13 HG23 ' A' ' 268' ' ' ILE . 6.0 mm -93.17 112.17 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.145 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -102.78 143.52 32.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -121.03 156.65 31.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.438 ' HA ' ' NE ' ' A' ' 266' ' ' ARG . . . -77.26 -37.24 53.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 284' ' ' ARG . 23.9 p -124.06 119.53 29.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.476 ' NE ' ' HG3' ' A' ' 288' ' ' GLU . 14.4 tpt180 -36.0 -40.09 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.557 ' O ' HG23 ' A' ' 289' ' ' VAL . 30.8 tp60 -34.68 -63.15 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.93 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -59.69 -41.65 91.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.074 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.426 ' HB3' ' HD2' ' A' ' 284' ' ' ARG . . . -55.11 -61.3 2.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.101 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 13.6 mt-10 -48.45 -57.3 6.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.563 HG12 ' CE1' ' A' ' 262' ' ' PHE . 57.6 t -45.58 -63.77 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.606 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -54.96 -35.33 64.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.136 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -54.55 -49.09 71.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.34 -25.53 59.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -92.41 5.73 49.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.773 ' OG ' HG11 ' A' ' 307' ' ' VAL . 54.6 p -115.79 -35.72 4.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.839 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.3 m-85 -50.35 109.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 40.07 34.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -133.71 -33.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.443 ' HG ' HD12 ' A' ' 305' ' ' LEU . 10.1 tp -67.62 98.3 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 304' ' ' ARG . 40.4 mt -118.35 93.34 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.117 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 47.1 t -91.67 136.8 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.083 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 56.15 46.26 21.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.854 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 49.38 29.67 10.99 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -130.41 100.95 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.437 ' N ' HG23 ' A' ' 299' ' ' ILE . 22.6 ttp180 -44.69 144.75 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.697 HD21 ' CD1' ' A' ' 250' ' ' ILE . 52.2 mt -129.19 135.84 49.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -86.4 105.99 17.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.854 HG22 HG22 ' A' ' 243' ' ' VAL . 55.5 t -105.87 144.87 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.576 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 15.9 ptpt -150.47 171.28 17.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -82.85 119.63 24.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 13.8 mt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.886 0.374 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 44.0 p -95.35 35.39 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.1 m -133.02 141.16 48.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.0 mt -126.32 159.04 34.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.679 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.4 OUTLIER -111.58 147.59 35.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 307' ' ' VAL . 95.5 t -140.42 120.63 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.17 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 -178.83 20.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.462 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.47 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 58.65 50.29 68.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 277' ' ' ALA . 62.2 mt -86.16 -57.34 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.862 0.363 . . . . 0.0 110.963 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.53 163.71 0.54 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.452 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -52.6 -32.65 42.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.951 0.405 . . . . 0.0 110.891 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.7 p -54.89 -44.78 74.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.484 ' CD1' HD21 ' A' ' 305' ' ' LEU . 86.6 mt -97.87 142.18 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.203 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 37.4 p -124.18 -178.64 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -65.12 -59.68 3.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 87.3 m -42.05 -55.73 3.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.188 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.56 -45.27 6.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 14.5 mt -72.17 -47.2 52.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.407 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 24.1 ttp180 -46.31 -45.19 17.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -76.09 -38.21 57.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.49 ' O ' ' NE2' ' A' ' 261' ' ' GLN . 5.7 t60 -60.23 -35.4 75.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.564 ' CE2' HG13 ' A' ' 279' ' ' ILE . 62.9 m-85 -94.22 -42.3 9.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.663 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.7 t80 -39.92 -35.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 20.3 pt20 -56.26 -44.38 79.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.748 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 41.3 m-85 -55.22 -51.03 67.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.51 -141.89 3.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.43 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -93.15 125.5 37.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 110.901 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.663 HD11 ' N ' ' A' ' 260' ' ' TYR . 48.7 mt -93.51 121.53 44.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.481 ' NE ' ' HA ' ' A' ' 282' ' ' ALA . 43.0 mtt-85 -68.25 -47.94 66.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.4 t -171.14 153.0 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.138 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.407 ' CD1' ' HA ' ' A' ' 256' ' ' ARG . 83.6 mt -127.86 116.42 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 24.4 m -109.37 99.04 8.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.651 HG22 ' CB ' ' A' ' 277' ' ' ALA . 85.6 t -93.52 121.21 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 274' ' ' GLN . 90.3 t -108.7 100.17 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.091 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -57.07 -42.12 80.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 20.2 ttt-85 -50.13 -38.26 38.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.542 ' H ' HG12 ' A' ' 271' ' ' VAL . 63.3 mt-30 -108.35 8.72 27.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.867 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 42.82 52.52 5.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 18.6 p -142.91 177.13 8.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.651 ' CB ' HG22 ' A' ' 270' ' ' VAL . . . -160.17 136.94 9.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.043 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -102.36 115.8 31.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.564 HG13 ' CE2' ' A' ' 259' ' ' PHE . 9.3 mm -95.94 113.2 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.172 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -101.04 147.9 25.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -129.97 151.6 50.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.481 ' HA ' ' NE ' ' A' ' 266' ' ' ARG . . . -72.4 -41.27 66.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 29.7 p -120.34 122.78 41.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.119 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.532 ' HD2' ' HB3' ' A' ' 287' ' ' ALA . 17.7 tpt180 -38.29 -39.62 0.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.881 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -37.48 -59.3 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -59.74 -41.43 90.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.044 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.532 ' HB3' ' HD2' ' A' ' 284' ' ' ARG . . . -56.8 -53.5 57.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -53.77 -57.5 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 285' ' ' GLN . 86.1 t -46.03 -63.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.748 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -53.02 -47.21 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -45.21 -67.17 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.095 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.8 -35.28 68.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.402 ' HE2' HG12 ' A' ' 289' ' ' VAL . 9.6 mtmm -85.72 5.14 33.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.575 ' HB3' HG21 ' A' ' 307' ' ' VAL . 4.7 m -119.07 -26.19 6.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 297' ' ' LYS . 2.9 m-85 -56.08 110.0 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 40.18 26.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 295' ' ' PHE . 19.1 tttm -124.91 -30.12 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.459 ' HG ' HD12 ' A' ' 305' ' ' LEU . 9.1 tp -67.53 100.56 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 50.1 mt -116.99 97.13 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.4 HG22 ' ND1' ' A' ' 258' ' ' HIS . 42.4 t -96.24 139.79 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.202 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 52.36 47.74 24.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.65 27.56 6.21 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.46 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.1 ttt85 -127.44 101.52 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 110.821 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.6 ' O ' HD23 ' A' ' 305' ' ' LEU . 45.3 ttp85 -43.83 146.82 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 304' ' ' ARG . 45.3 mt -134.84 134.31 40.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -89.11 109.25 20.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 242' ' ' TYR . 81.7 t -106.63 142.96 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.159 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.568 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 13.3 ptpt -148.12 163.25 37.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -71.09 124.55 24.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.451 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 55.3 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.921 0.391 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.1 p -97.57 36.19 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.172 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 18.0 m -133.84 151.28 51.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 291' ' ' ALA . 35.5 mt -137.12 134.95 36.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.585 ' CD1' ' HG3' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -97.3 150.36 21.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.607 HG22 HG22 ' A' ' 307' ' ' VAL . 59.1 t -142.26 139.85 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -130.51 164.55 22.96 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.445 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 74.97 43.84 25.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 250' ' ' ILE . 94.3 mt -74.11 -61.74 1.75 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.884 0.373 . . . . 0.0 110.918 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.42 151.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.464 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -42.78 -34.43 0.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.888 0.375 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.6 p -57.08 -42.83 81.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.156 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.76 ' CD1' HD21 ' A' ' 305' ' ' LEU . 55.9 mt -94.88 143.59 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.1 p -126.98 -176.81 3.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.159 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -65.89 -59.88 3.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.997 0.427 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.2 m -43.36 -50.89 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -40.89 -50.62 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.488 HD11 ' CD2' ' A' ' 246' ' ' LEU . 17.3 mt -73.85 -53.49 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 260' ' ' TYR . 67.0 ttt180 -41.07 -42.95 2.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -75.5 -46.43 32.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.765 ' CD2' HD13 ' A' ' 298' ' ' LEU . 52.3 t60 -54.71 -36.31 64.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -90.47 -44.42 9.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.5 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.3 t80 -40.08 -35.67 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.463 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 26.8 pt20 -54.54 -46.19 73.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.764 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 52.8 m-85 -56.01 -50.01 72.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -177.12 -154.99 12.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.473 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -75.64 141.73 42.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 260' ' ' TYR . 71.1 mt -110.58 112.43 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.137 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -57.66 -50.15 74.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 10.5 t -164.03 168.15 19.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.154 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.448 HD11 HG21 ' A' ' 265' ' ' ILE . 77.3 mt -145.12 106.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 57.1 m -97.61 98.84 10.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 88.5 t -93.93 109.12 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.521 HG12 ' HG2' ' A' ' 273' ' ' ARG . 15.9 t -97.0 99.65 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -60.67 -46.39 90.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.521 ' HG2' HG12 ' A' ' 271' ' ' VAL . 25.4 ptt180 -55.46 -19.83 10.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.47 ' O ' ' C ' ' A' ' 275' ' ' GLN . 65.1 mm-40 -121.19 15.88 11.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 274' ' ' GLN . 29.1 mt-30 32.26 50.45 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 25.9 p -145.92 167.15 23.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.854 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.95 156.52 42.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 56.4 m-85 -126.32 108.07 10.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.466 HG22 ' CE1' ' A' ' 281' ' ' PHE . 4.7 mp -93.69 120.93 43.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.111 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -107.82 146.66 31.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.482 ' HE1' HD12 ' A' ' 241' ' ' LEU . 87.9 m-85 -124.31 147.1 48.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.65 70.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.137 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 284' ' ' ARG . 39.4 p -129.12 118.05 21.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 283' ' ' THR . 16.2 tpt180 -36.31 -34.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 283' ' ' THR . 20.8 tp60 -37.94 -68.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.6 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.138 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -52.12 -60.69 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 6.4 mt-10 -46.88 -59.41 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 39.4 t -46.5 -60.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.764 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -55.08 -32.23 61.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.594 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -61.53 -46.04 91.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -72.76 -29.94 63.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 297' ' ' LYS . 18.5 mttt -87.0 -18.08 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.646 ' CB ' HG11 ' A' ' 307' ' ' VAL . 78.8 p -92.72 -36.03 13.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.3 m-85 -54.08 109.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 1.8 m120 41.51 29.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 293' ' ' LYS . 9.6 mmmt -126.93 -37.69 2.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.765 HD13 ' CD2' ' A' ' 258' ' ' HIS . 12.7 tp -63.4 98.03 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.52 94.43 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.21 146.33 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.163 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 22.0 m120 54.47 41.02 32.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.63 33.41 12.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.447 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 22.7 ttt-85 -134.25 97.65 3.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.308 . . . . 0.0 110.863 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -43.72 144.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.76 HD21 ' CD1' ' A' ' 250' ' ' ILE . 48.9 mt -128.81 136.23 50.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -85.7 103.64 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.646 HG11 ' CB ' ' A' ' 294' ' ' SER . 94.6 t -102.47 139.45 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.178 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.585 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 2.9 pttt -150.25 147.34 27.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.95 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -53.14 148.94 7.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.488 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 240' ' ' THR . 82.3 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.914 0.388 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.411 HG22 ' CA ' ' A' ' 284' ' ' ARG . 51.2 p -98.67 27.02 5.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.582 ' H ' HG22 ' A' ' 238' ' ' ILE . 21.7 m -125.58 139.51 53.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 35.5 mt -131.1 123.97 29.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.963 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.652 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.2 OUTLIER -81.65 154.89 25.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.928 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.841 HG22 HG22 ' A' ' 307' ' ' VAL . 75.1 t -139.76 134.83 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -123.04 -179.66 15.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 57.95 43.78 94.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.523 ' HA ' HD12 ' A' ' 250' ' ' ILE . 75.6 mt -83.81 -57.32 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 110.871 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.46 164.45 0.28 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.495 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -54.83 -31.19 59.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 110.828 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.409 ' OG1' ' NE ' ' A' ' 303' ' ' ARG . 23.2 p -56.83 -34.25 67.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.79 ' CD1' HD21 ' A' ' 305' ' ' LEU . 58.3 mt -104.78 138.83 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.123 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 46.1 p -111.84 179.95 3.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -69.29 -52.04 31.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.8 m -50.06 -51.31 43.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.149 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -41.81 -42.16 2.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.9 mt -80.21 -50.24 10.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 -45.06 -41.55 7.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -76.92 -43.67 34.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.505 ' CD2' HD13 ' A' ' 298' ' ' LEU . 6.0 t60 -58.69 -32.76 69.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.461 ' CZ ' HD22 ' A' ' 298' ' ' LEU . 61.7 m-85 -94.0 -38.85 10.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.475 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.4 t80 -46.35 -40.67 12.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.4 pt20 -48.61 -38.69 21.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.951 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 88.7 m-85 -65.86 -43.03 89.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 178.5 -153.73 13.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.506 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -80.87 141.24 34.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.794 0.331 . . . . 0.0 110.88 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.475 HD11 ' N ' ' A' ' 260' ' ' TYR . 62.6 mt -110.32 111.28 35.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 280' ' ' GLN . 26.9 mtt-85 -53.91 -49.65 68.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 13.8 t -167.44 169.02 12.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.423 HG23 HD13 ' A' ' 279' ' ' ILE . 76.8 mt -144.95 111.25 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.3 m -105.31 98.94 8.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.484 HG22 ' CB ' ' A' ' 277' ' ' ALA . 82.0 t -91.69 107.4 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 274' ' ' GLN . 95.1 t -92.81 99.97 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' GLN . . . . . 0.42 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 5.1 pt20 -59.75 -32.74 70.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.936 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.42 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 9.3 tpp85 -59.63 -38.47 81.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.672 ' H ' HG12 ' A' ' 271' ' ' VAL . 12.6 mt-30 -110.71 19.7 18.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 274' ' ' GLN . 60.0 mt-30 34.25 53.14 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 31.1 p -143.56 165.7 26.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.511 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -146.0 133.77 21.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.089 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.424 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 17.6 m-85 -99.31 108.19 20.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.873 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.423 HD13 HG23 ' A' ' 268' ' ' ILE . 3.8 mm -93.01 116.14 33.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 266' ' ' ARG . 34.9 tt0 -106.64 136.33 46.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -113.72 153.16 29.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -77.63 -33.74 53.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.079 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 284' ' ' ARG . 34.4 p -128.75 118.72 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.129 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.493 ' NE ' ' HG3' ' A' ' 288' ' ' GLU . 15.4 tpt180 -35.99 -40.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.722 ' O ' HG23 ' A' ' 289' ' ' VAL . 0.7 OUTLIER -34.59 -62.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -60.54 -42.29 96.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.086 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.25 -63.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.603 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 7.9 mt-10 -45.59 -54.3 7.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 285' ' ' GLN . 39.2 t -50.7 -67.69 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.564 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -53.36 -29.41 34.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.065 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -55.11 -53.08 60.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -72.59 -26.45 61.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -90.25 5.23 47.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.549 ' HB2' HG21 ' A' ' 307' ' ' VAL . 89.8 p -117.13 -39.0 3.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 297' ' ' LYS . 3.1 m-85 -46.37 107.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 2.0 t30 40.12 27.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.876 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 295' ' ' PHE . 8.5 tmtt? -122.65 -32.85 3.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.505 HD13 ' CD2' ' A' ' 258' ' ' HIS . 8.1 tp -69.91 100.96 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.932 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 65.1 mt -120.11 93.1 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 60.1 t -96.33 142.35 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.121 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 30.9 m120 50.96 55.03 10.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 40.54 33.13 0.53 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ARG . . . . . 0.409 ' NE ' ' OG1' ' A' ' 249' ' ' THR . 31.0 ttm-85 -132.12 103.23 6.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.921 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.57 ' O ' HD23 ' A' ' 305' ' ' LEU . 46.5 ttp85 -54.07 144.88 18.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.79 HD21 ' CD1' ' A' ' 250' ' ' ILE . 23.6 mt -130.06 132.15 46.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -87.45 102.73 14.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.841 HG22 HG22 ' A' ' 243' ' ' VAL . 95.8 t -100.86 136.42 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.605 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -146.89 145.88 29.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -52.82 133.92 37.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.53 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 240' ' ' THR . 75.5 mt . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.884 0.373 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.9 p -99.65 29.38 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.467 ' H ' HG22 ' A' ' 238' ' ' ILE . 23.1 m -124.9 152.21 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.156 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 31.5 mt -137.01 127.05 25.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.964 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.574 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -88.9 145.43 25.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 307' ' ' VAL . 84.3 t -139.07 133.87 40.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -122.59 167.95 14.99 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.547 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.92 42.49 44.97 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 277' ' ' ALA . 29.7 mt -77.7 -60.03 2.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.847 0.356 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.57 159.0 0.72 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.451 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -48.36 -32.97 8.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 79.4 p -55.92 -46.39 78.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.645 ' CD1' HD21 ' A' ' 305' ' ' LEU . 77.2 mt -93.1 150.51 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.059 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.6 p -132.8 -179.89 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.633 ' HB2' HG21 ' A' ' 270' ' ' VAL . 25.3 tt0 -66.13 -58.19 5.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 79.4 m -44.11 -51.01 8.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.185 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -44.49 -48.13 10.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 13.8 mt -74.78 -45.16 45.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.929 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 50.1 ttt180 -49.09 -42.94 40.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -78.76 -43.39 25.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.551 ' CE1' HD12 ' A' ' 298' ' ' LEU . 64.9 t-80 -57.9 -33.83 69.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -94.38 -40.02 10.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.565 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.5 t80 -42.4 -36.56 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.479 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 16.3 pt20 -51.89 -41.07 61.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.736 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 63.7 m-85 -60.88 -49.23 78.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -178.95 -163.45 30.06 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -69.74 130.51 42.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 0.0 110.883 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.565 HD11 ' N ' ' A' ' 260' ' ' TYR . 79.1 mt -99.98 109.66 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.486 ' HG3' ' N ' ' A' ' 282' ' ' ALA . 22.7 mtt-85 -51.39 -53.07 40.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.0 t -164.07 165.41 22.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 98.3 mt -139.65 105.57 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.092 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.2 m -98.06 99.98 11.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.127 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.633 HG21 ' HB2' ' A' ' 252' ' ' GLU . 66.7 t -93.59 106.02 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.784 HG12 ' HG2' ' A' ' 273' ' ' ARG . 4.4 t -91.15 99.67 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -60.79 -47.76 84.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.784 ' HG2' HG12 ' A' ' 271' ' ' VAL . 6.0 ptm180 -55.18 -20.1 9.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.475 ' O ' ' C ' ' A' ' 275' ' ' GLN . 28.2 mm-40 -121.28 15.74 11.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 274' ' ' GLN . 31.6 mt-30 32.25 50.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 22.6 p -142.51 168.24 20.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -148.28 153.41 38.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 53.5 m-85 -124.65 108.96 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.564 HG22 ' CE1' ' A' ' 281' ' ' PHE . 4.5 mp -94.72 120.7 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.126 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 266' ' ' ARG . 53.0 tt0 -109.49 147.47 32.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.564 ' CE1' HG22 ' A' ' 279' ' ' ILE . 87.8 m-85 -126.95 139.86 52.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.866 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.486 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -59.7 -36.29 76.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 284' ' ' ARG . 38.3 p -123.1 116.66 23.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 285' ' ' GLN . 14.5 tpt180 -36.0 -37.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 284' ' ' ARG . 0.9 OUTLIER -35.65 -63.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.89 80.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.083 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.07 -45.84 79.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.122 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -62.94 -54.04 44.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.489 HG12 ' CE1' ' A' ' 262' ' ' PHE . 49.0 t -50.42 -58.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.736 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -57.47 -45.26 85.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.079 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -41.61 -67.82 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.046 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.58 -40.85 69.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -76.94 1.84 16.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.709 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.3 m -118.41 -25.0 6.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -57.13 104.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 15.3 m120 41.46 30.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -126.8 -32.83 2.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.551 HD12 ' CE1' ' A' ' 258' ' ' HIS . 5.0 tp -65.96 96.4 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 56.0 mt -114.7 95.58 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.82 142.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 18.8 m120 57.9 41.4 24.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 49.86 33.19 19.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -134.93 104.4 5.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 110.889 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.402 ' O ' HD23 ' A' ' 305' ' ' LEU . 17.4 ttm180 -49.96 145.06 5.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.645 HD21 ' CD1' ' A' ' 250' ' ' ILE . 27.1 mt -129.64 133.39 47.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -85.44 98.73 10.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 243' ' ' VAL . 93.8 t -96.45 145.01 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.195 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.556 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 0.6 OUTLIER -158.42 145.39 17.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -52.32 148.97 5.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.537 ' N ' HH11 ' A' ' 284' ' ' ARG . 69.3 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.886 0.375 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.402 HG22 ' CA ' ' A' ' 284' ' ' ARG . 46.2 p -98.75 38.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.501 ' H ' HG22 ' A' ' 238' ' ' ILE . 14.2 m -133.4 143.14 48.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.117 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 22.7 mt -133.28 122.18 23.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.914 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.606 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -79.84 143.65 34.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.955 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.768 HG22 HG22 ' A' ' 307' ' ' VAL . 88.2 t -133.36 131.4 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.134 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -121.58 176.8 16.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 64.15 44.33 95.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.547 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.692 ' HA ' HD12 ' A' ' 250' ' ' ILE . 92.7 mt -86.78 -56.32 3.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.828 0.347 . . . . 0.0 110.95 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.5 155.58 0.37 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.555 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -46.59 -34.25 4.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.847 0.356 . . . . 0.0 110.858 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.8 p -53.83 -56.71 15.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.693 ' CD1' HD21 ' A' ' 305' ' ' LEU . 76.3 mt -75.41 140.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 32.9 p -117.15 179.64 3.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.109 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.74 -55.72 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 92.8 m -45.35 -47.22 13.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.459 ' HB3' HG11 ' A' ' 300' ' ' VAL . 0.7 OUTLIER -49.41 -38.42 28.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 30.4 mt -83.82 -50.0 8.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 49.7 ttm-85 -46.65 -41.74 15.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.884 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -76.55 -43.2 40.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.617 ' CE1' HD12 ' A' ' 298' ' ' LEU . 56.7 t-80 -58.64 -33.8 70.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -94.19 -40.4 10.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.547 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.5 t80 -42.01 -36.52 1.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.2 pt20 -51.98 -42.06 62.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.579 ' CE1' HG12 ' A' ' 289' ' ' VAL . 63.1 m-85 -59.77 -49.93 75.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -175.23 -145.12 5.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -88.53 129.42 35.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.346 . . . . 0.0 110.918 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.547 HD11 ' N ' ' A' ' 260' ' ' TYR . 65.3 mt -96.55 110.59 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.7 mtp85 -54.98 -54.55 41.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 11.9 t -162.14 166.49 25.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.153 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.494 HG23 HD13 ' A' ' 279' ' ' ILE . 87.1 mt -142.67 110.91 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 87.8 m -104.18 98.87 8.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.47 111.1 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.683 HG12 ' HG2' ' A' ' 273' ' ' ARG . 3.8 t -95.85 101.83 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -60.68 -47.13 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.683 ' HG2' HG12 ' A' ' 271' ' ' VAL . 4.7 ptm180 -53.18 -30.29 36.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 275' ' ' GLN . 55.7 mm-40 -112.76 13.64 19.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 274' ' ' GLN . 46.1 mt-30 34.91 53.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 11.4 p -143.57 172.01 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.515 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -152.77 132.1 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 18.4 m-85 -98.91 109.99 22.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.494 HD13 HG23 ' A' ' 268' ' ' ILE . 6.1 mm -94.14 116.29 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.149 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 266' ' ' ARG . 17.7 tt0 -105.86 141.71 36.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.413 ' C ' ' HG3' ' A' ' 266' ' ' ARG . 97.5 m-85 -119.56 151.95 37.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.16 77.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.087 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 33.8 p -126.08 126.17 43.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.131 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.537 HH11 ' N ' ' A' ' 238' ' ' ILE . 9.7 tpt180 -40.3 -32.19 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -40.99 -65.76 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.959 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.3 77.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.084 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.46 -58.06 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.101 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -48.82 -57.05 7.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.948 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.579 HG12 ' CE1' ' A' ' 262' ' ' PHE . 23.7 t -51.15 -54.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -57.06 -39.56 75.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -52.91 -66.38 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -53.42 -43.2 67.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -75.25 2.51 10.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.65 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.4 m -116.37 -30.9 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -52.43 95.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.1 m120 48.1 29.37 1.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 53.2 tttt -126.05 -31.01 2.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.617 HD12 ' CE1' ' A' ' 258' ' ' HIS . 5.4 tp -69.47 101.34 1.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 53.3 mt -118.72 94.4 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.465 HG22 ' CD2' ' A' ' 258' ' ' HIS . 53.5 t -93.53 133.36 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ASN . . . . . 0.426 ' ND2' HG12 ' A' ' 300' ' ' VAL . 78.1 m-20 57.31 54.32 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 41.84 32.11 0.89 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ARG . . . . . 0.501 ' HD2' HD11 ' A' ' 250' ' ' ILE . 26.9 ttm-85 -130.57 102.08 5.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.779 0.323 . . . . 0.0 110.86 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.563 ' O ' HD23 ' A' ' 305' ' ' LEU . 11.3 ttp180 -49.2 146.7 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.693 HD21 ' CD1' ' A' ' 250' ' ' ILE . 29.3 mt -134.03 133.62 41.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -87.98 101.91 14.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.768 HG22 HG22 ' A' ' 243' ' ' VAL . 92.9 t -97.62 145.61 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.591 ' HE3' ' CE1' ' A' ' 242' ' ' TYR . 4.8 pttt -156.45 144.6 19.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.886 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -53.12 145.51 13.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 240' ' ' THR . 66.6 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.903 0.382 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.0 p -102.19 29.81 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.195 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.517 ' H ' HG22 ' A' ' 238' ' ' ILE . 15.5 m -128.44 143.12 50.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 31.8 mt -131.96 124.69 29.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.6 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.3 OUTLIER -82.09 149.75 27.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.848 HG22 HG22 ' A' ' 307' ' ' VAL . 66.8 t -140.28 129.32 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.124 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.69 173.75 14.93 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 65.68 51.45 47.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.517 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.568 HD11 ' C ' ' A' ' 276' ' ' CYS . 79.3 mt -77.12 -61.58 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.12 145.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.476 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -40.13 -31.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.382 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 34.4 p -56.36 -45.9 80.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.626 ' CD1' HD21 ' A' ' 305' ' ' LEU . 61.8 mt -97.27 141.6 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 16.6 p -123.9 -177.5 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -66.46 -55.97 13.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 7.9 m -43.56 -59.14 2.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.476 ' HA ' ' ND2' ' A' ' 257' ' ' ASN . 18.7 m-20 -40.14 -59.28 1.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.432 HD11 HD22 ' A' ' 246' ' ' LEU . 14.9 mt -57.51 -52.12 66.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 41.8 ttt85 -48.87 -38.58 22.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ASN . . . . . 0.523 ' C ' ' OD1' ' A' ' 257' ' ' ASN . 0.4 OUTLIER -77.97 -40.47 39.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.648 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 58.2 t-80 -61.57 -33.08 73.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.49 ' CE2' HG13 ' A' ' 279' ' ' ILE . 72.5 m-85 -94.31 -40.39 9.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.629 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.4 t80 -41.99 -35.48 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.937 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 26.2 pt20 -55.17 -50.2 69.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.76 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 56.9 m-85 -53.1 -50.16 65.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.837 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -172.72 -155.09 10.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.488 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -83.35 127.95 34.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.629 HD11 ' N ' ' A' ' 260' ' ' TYR . 45.1 mt -93.61 114.19 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 280' ' ' GLN . 16.0 mtt180 -57.74 -50.61 72.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.5 t -165.45 170.96 13.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.124 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 86.8 mt -145.43 116.12 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 55.2 m -107.16 100.04 9.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.553 HG13 ' CD1' ' A' ' 246' ' ' LEU . 93.0 t -93.47 107.1 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.158 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 44.1 t -92.73 100.01 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.195 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -59.68 -38.76 82.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 -64.33 -10.22 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -130.44 6.0 4.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 41.81 45.11 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.568 ' C ' HD11 ' A' ' 246' ' ' LEU . 14.1 p -137.24 166.62 23.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -146.21 135.68 23.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 26.2 m-85 -104.18 108.5 19.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.49 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.8 mm -91.72 119.87 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.17 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 266' ' ' ARG . 42.2 tt0 -107.77 141.92 38.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.08 148.21 44.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.45 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -70.54 -37.36 74.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.096 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 284' ' ' ARG . 17.4 p -126.06 121.49 33.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.513 ' HD2' ' HB3' ' A' ' 287' ' ' ALA . 12.6 tpt180 -36.93 -40.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 284' ' ' ARG . 36.4 tp60 -34.46 -63.9 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.57 -44.88 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.513 ' HB3' ' HD2' ' A' ' 284' ' ' ARG . . . -50.78 -57.47 8.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.133 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 19.9 mt-10 -49.95 -65.04 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.498 HG12 ' CE1' ' A' ' 262' ' ' PHE . 59.7 t -39.08 -59.74 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.76 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -58.95 -37.69 77.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.101 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.585 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -49.9 -54.56 18.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -69.17 -28.59 66.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -90.3 4.98 49.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 58.2 p -117.37 -30.1 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 5.0 m-30 -55.57 105.76 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 40.67 29.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -124.4 -35.81 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.648 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 11.1 tp -67.04 93.33 0.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 304' ' ' ARG . 42.5 mt -113.47 91.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 41.3 t -92.29 146.32 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 m120 50.87 46.98 25.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.16 31.3 6.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -133.16 104.0 6.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.518 ' O ' HD23 ' A' ' 305' ' ' LEU . 12.6 ttm-85 -50.11 148.64 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.626 HD21 ' CD1' ' A' ' 250' ' ' ILE . 21.9 mt -131.45 132.52 44.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.21 99.75 11.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.848 HG22 HG22 ' A' ' 243' ' ' VAL . 72.9 t -101.92 140.37 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.532 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 11.7 pttt -149.17 149.07 30.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -52.77 136.3 33.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.913 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.5 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 34.0 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.882 0.373 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.448 HG22 ' CA ' ' A' ' 284' ' ' ARG . 30.2 p -99.2 36.27 1.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 30.1 m -137.18 138.46 40.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 22.0 mt -125.28 156.94 37.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.562 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.3 OUTLIER -109.7 149.29 29.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.913 HG22 HG22 ' A' ' 307' ' ' VAL . 91.4 t -141.95 119.19 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.32 -175.04 20.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.534 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 55.69 45.82 84.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.509 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.479 ' HA ' HD12 ' A' ' 250' ' ' ILE . 44.7 mt -78.62 -59.13 2.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 0.0 110.943 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 62.72 153.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.507 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -42.12 -37.93 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.86 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 43.3 p -49.4 -44.43 45.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.835 ' CD1' HD21 ' A' ' 305' ' ' LEU . 65.3 mt -97.17 146.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.138 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.7 p -126.23 -178.78 4.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' A' ' 270' ' ' VAL . 1.2 tm-20 -66.39 -57.28 7.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.8 m -47.15 -54.36 10.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -40.81 -45.77 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 9.1 mt -74.07 -45.64 48.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -48.8 -46.03 41.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -76.25 -38.69 55.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -61.07 -34.56 75.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.499 ' CE2' HG13 ' A' ' 279' ' ' ILE . 58.4 m-85 -94.34 -39.67 10.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.863 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.677 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.7 t80 -43.48 -38.93 3.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.957 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 29.0 pt20 -50.28 -43.55 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 85.1 m-85 -60.54 -47.8 84.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -177.69 -167.01 35.21 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -69.03 127.22 32.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.343 . . . . 0.0 110.873 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.677 HD11 ' N ' ' A' ' 260' ' ' TYR . 84.3 mt -95.72 110.67 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.128 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.4 mtp180 -54.01 -51.5 63.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.8 t -164.71 169.47 16.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.194 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.463 HD11 HG21 ' A' ' 265' ' ' ILE . 88.6 mt -145.87 114.29 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.18 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 85.3 m -109.18 99.02 8.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.619 HG22 ' CB ' ' A' ' 277' ' ' ALA . 96.2 t -92.65 111.01 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.404 ' CG1' ' HG2' ' A' ' 273' ' ' ARG . 38.5 t -94.2 101.4 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' GLN . . . . . 0.422 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 5.2 pt20 -59.23 -40.61 86.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.422 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 6.6 ptp85 -62.16 -21.55 65.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 275' ' ' GLN . 74.0 mt-30 -117.31 14.27 14.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.94 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 274' ' ' GLN . 71.3 mt-30 34.38 43.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 21.7 p -141.04 173.51 11.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.619 ' CB ' HG22 ' A' ' 270' ' ' VAL . . . -157.36 140.28 15.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -105.12 121.86 44.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.499 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.1 mm -102.32 117.03 47.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.186 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 266' ' ' ARG . 16.3 tt0 -105.17 140.3 38.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.411 ' C ' ' HG3' ' A' ' 266' ' ' ARG . 97.5 m-85 -120.72 148.3 44.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.884 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.444 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -70.23 -34.01 72.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 284' ' ' ARG . 22.4 p -125.82 116.6 21.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.178 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.631 ' HD2' ' HB3' ' A' ' 287' ' ' ALA . 16.7 tpt180 -36.14 -39.3 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.508 ' O ' HG23 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -33.56 -64.42 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.02 -46.68 82.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.097 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.631 ' HB3' ' HD2' ' A' ' 284' ' ' ARG . . . -50.5 -53.26 31.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.453 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 6.2 mt-10 -55.24 -48.87 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 285' ' ' GLN . 42.1 t -57.88 -59.96 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.564 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -56.12 -33.97 65.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.16 -67.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.42 -39.71 73.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -75.08 1.59 12.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.604 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.4 m -115.81 -33.38 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.2 102.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 44.23 31.72 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -129.83 -31.14 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.446 ' HG ' HD12 ' A' ' 305' ' ' LEU . 6.6 tp -70.06 103.69 2.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 304' ' ' ARG . 27.0 mt -119.74 96.76 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 31.1 t -96.28 138.31 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.097 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 56.95 47.19 18.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.15 29.64 6.95 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.496 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 18.0 ttt85 -130.49 103.85 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.859 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.464 ' N ' HG23 ' A' ' 299' ' ' ILE . 13.7 ttm180 -48.23 137.67 10.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.835 HD21 ' CD1' ' A' ' 250' ' ' ILE . 26.3 mt -124.19 133.55 53.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -87.54 107.24 18.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.913 HG22 HG22 ' A' ' 243' ' ' VAL . 53.4 t -105.13 143.46 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.562 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -146.15 165.15 29.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -74.25 122.12 22.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 179.99 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 14.3 mt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.899 0.38 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 284' ' ' ARG . 51.0 p -90.95 23.47 3.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 26.4 m -121.14 141.76 50.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.155 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 291' ' ' ALA . 26.7 mt -128.59 146.86 50.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.586 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -102.6 143.41 32.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.905 HG22 HG22 ' A' ' 307' ' ' VAL . 93.3 t -136.83 114.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -100.97 179.27 28.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.523 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.467 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 61.92 51.88 54.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.677 HD11 ' C ' ' A' ' 276' ' ' CYS . 88.0 mt -81.46 -59.65 2.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.11 149.97 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.459 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.9 -29.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.92 0.39 . . . . 0.0 110.842 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 23.8 p -57.94 -41.81 83.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.647 ' CD1' HD21 ' A' ' 305' ' ' LEU . 79.2 mt -99.13 146.16 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 40.6 p -127.04 -176.41 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.152 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.432 ' HB2' HG21 ' A' ' 270' ' ' VAL . 48.6 tt0 -71.51 -56.23 6.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 96.0 m -45.01 -48.86 11.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -49.53 -50.91 39.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.7 mt -67.32 -43.55 81.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -51.49 -45.01 62.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -78.69 -33.02 47.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -65.75 -34.87 79.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.435 ' CE2' HG13 ' A' ' 279' ' ' ILE . 60.4 m-85 -94.08 -37.58 11.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.601 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.3 t80 -44.77 -26.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.476 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 11.4 pt20 -63.96 -41.74 97.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.887 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.878 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 56.8 m-85 -62.21 -39.08 91.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 286' ' ' ALA . . . 174.71 -154.35 18.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.491 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -79.0 141.69 37.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.87 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.601 HD11 ' N ' ' A' ' 260' ' ' TYR . 70.9 mt -112.28 111.88 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 280' ' ' GLN . 20.5 mtt180 -59.97 -49.14 78.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.7 t -165.11 171.25 14.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.16 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 94.4 mt -144.4 106.96 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 26.4 m -96.61 100.66 12.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.136 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.432 HG21 ' HB2' ' A' ' 252' ' ' GLU . 94.6 t -94.79 109.54 22.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.082 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 274' ' ' GLN . 60.9 t -99.44 99.91 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -40.62 89.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -50.35 -39.02 45.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.524 ' H ' HG12 ' A' ' 271' ' ' VAL . 26.1 mt-30 -108.65 10.49 26.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 42.71 52.12 5.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.677 ' C ' HD11 ' A' ' 246' ' ' LEU . 25.7 p -140.58 168.66 19.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.29 130.23 15.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.126 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -100.14 109.56 21.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.435 HG13 ' CE2' ' A' ' 259' ' ' PHE . 2.9 mm -92.66 123.04 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.094 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 266' ' ' ARG . 38.6 tt0 -108.3 141.05 40.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -120.96 144.67 48.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.856 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.91 -37.09 78.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 284' ' ' ARG . 22.8 p -120.75 117.18 26.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.098 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.518 ' HA ' HG22 ' A' ' 239' ' ' THR . 13.7 tpt180 -37.21 -38.83 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 284' ' ' ARG . 12.7 tp60 -37.79 -67.39 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' ALA . . . . . 0.477 ' HB2' ' HA3' ' A' ' 263' ' ' GLY . . . -52.86 -43.15 65.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 284' ' ' ARG . . . -52.44 -57.74 8.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 18.7 mt-10 -50.45 -63.15 1.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.415 HG12 ' HE3' ' A' ' 293' ' ' LYS . 28.8 t -41.21 -66.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.878 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -50.29 -46.4 55.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.457 ' HB2' HD11 ' A' ' 241' ' ' LEU . . . -47.26 -67.71 0.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -55.41 -38.76 69.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.415 ' HE3' HG12 ' A' ' 289' ' ' VAL . 14.5 mtmt -84.28 6.07 24.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.554 ' HB3' HG21 ' A' ' 307' ' ' VAL . 16.9 m -118.57 -13.22 9.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 297' ' ' LYS . 3.8 m-30 -71.27 113.92 8.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ASN . . . . . 0.405 ' HA ' ' NH1' ' A' ' 304' ' ' ARG . 1.2 m-20 41.9 25.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.877 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 295' ' ' PHE . 3.0 ttmm -126.21 -31.88 2.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 5.3 tp -71.62 101.4 2.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 304' ' ' ARG . 39.3 mt -115.88 95.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 32.8 t -90.36 136.61 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 17.9 m120 53.74 51.19 15.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.61 28.84 2.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 18.2 ttt-85 -129.14 98.22 4.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 110.852 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.526 ' N ' HG23 ' A' ' 299' ' ' ILE . 32.2 ttp85 -42.25 145.9 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.647 HD21 ' CD1' ' A' ' 250' ' ' ILE . 49.7 mt -130.59 135.97 48.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -89.55 99.47 12.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.905 HG22 HG22 ' A' ' 243' ' ' VAL . 75.2 t -95.72 142.39 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.075 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.586 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 11.9 ptpt -145.77 171.94 14.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -85.06 122.02 28.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.469 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 240' ' ' THR . 65.4 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.96 0.41 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 29.1 p -108.41 26.59 10.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.473 ' H ' HG22 ' A' ' 238' ' ' ILE . 18.3 m -117.75 140.98 48.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.16 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 30.6 mt -128.49 133.24 48.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.603 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -97.92 140.72 31.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.969 HG22 HG22 ' A' ' 307' ' ' VAL . 89.5 t -135.5 127.31 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.51 174.89 16.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.436 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 70.66 42.29 62.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.483 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.575 ' CD1' HG13 ' A' ' 270' ' ' VAL . 24.3 mt -70.64 -62.9 1.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.826 0.346 . . . . 0.0 110.919 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.71 158.98 0.75 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.443 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -56.65 -15.58 4.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.8 p -74.26 -32.49 62.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.588 HD13 HD11 ' A' ' 305' ' ' LEU . 68.6 mt -108.97 145.26 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 12.4 p -128.56 177.19 7.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.151 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -59.55 -61.25 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 94.6 m -38.66 -56.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -40.31 -56.03 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.9 mt -65.42 -48.86 71.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.44 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 44.0 ttt180 -45.92 -43.13 13.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -79.46 -41.21 28.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.649 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 59.6 t-80 -57.91 -33.66 69.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.564 ' CD2' HG12 ' A' ' 279' ' ' ILE . 60.1 m-85 -94.22 -42.8 8.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.601 ' N ' HD11 ' A' ' 265' ' ' ILE . 2.0 t80 -42.29 -36.06 1.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.464 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.8 pt20 -54.3 -41.28 68.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.959 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 86.3 m-85 -64.84 -42.86 94.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 176.36 -172.22 45.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -61.47 142.27 57.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 110.922 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.601 HD11 ' N ' ' A' ' 260' ' ' TYR . 70.6 mt -111.93 111.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -55.02 -50.25 69.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.8 t -168.85 162.24 11.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.474 HD11 HD13 ' A' ' 265' ' ' ILE . 79.7 mt -138.4 108.46 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 92.4 m -99.63 100.34 11.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.575 HG13 ' CD1' ' A' ' 246' ' ' LEU . 76.8 t -92.62 103.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 274' ' ' GLN . 82.6 t -86.4 99.88 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' GLN . . . . . 0.475 ' O ' ' NE2' ' A' ' 275' ' ' GLN . 6.0 pt20 -60.25 -31.68 70.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -59.23 -38.08 79.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.695 ' H ' HG12 ' A' ' 271' ' ' VAL . 77.0 mt-30 -112.52 21.66 15.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.943 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 272' ' ' GLN . 65.2 mm-40 33.73 50.82 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 29.3 p -140.62 167.9 21.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.441 ' HB2' HG22 ' A' ' 270' ' ' VAL . . . -146.14 146.8 31.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.571 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 33.7 m-85 -115.21 107.72 15.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.598 HG22 ' CE1' ' A' ' 281' ' ' PHE . 3.9 mp -90.86 121.03 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.144 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -106.94 142.95 35.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.598 ' CE1' HG22 ' A' ' 279' ' ' ILE . 96.9 m-85 -122.75 142.03 51.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.43 74.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.046 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 36.8 p -131.81 123.88 28.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.134 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 6.0 tpp85 -39.0 -33.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.676 ' O ' HG23 ' A' ' 289' ' ' VAL . 21.6 tp60 -37.97 -65.9 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -58.23 -53.83 53.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -41.59 -63.45 0.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.096 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.585 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 4.7 mm-40 -46.3 -64.31 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.869 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 285' ' ' GLN . 18.6 t -40.25 -62.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.561 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -57.02 -33.98 67.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.119 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.59 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -53.86 -60.71 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.131 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -63.79 -36.53 84.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.425 ' HD2' ' CE2' ' A' ' 262' ' ' PHE . 17.7 mttm -75.97 -8.49 57.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.822 ' HB3' HG21 ' A' ' 307' ' ' VAL . 29.6 m -114.18 -9.82 12.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.8 m-30 -65.4 105.71 1.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.835 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 21.1 m120 43.36 27.79 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -127.68 -28.61 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.649 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 4.7 tp -67.8 97.37 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.961 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.419 HG23 ' N ' ' A' ' 304' ' ' ARG . 38.4 mt -116.13 94.53 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 49.8 t -95.85 145.2 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 14.5 m120 50.93 50.03 19.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.9 34.18 5.47 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.534 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -136.9 108.92 7.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 110.883 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.523 ' O ' HD23 ' A' ' 305' ' ' LEU . 24.5 ttm180 -56.84 143.69 36.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.588 HD11 HD13 ' A' ' 250' ' ' ILE . 43.0 mt -126.78 137.95 53.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.74 98.89 11.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.969 HG22 HG22 ' A' ' 243' ' ' VAL . 79.0 t -93.22 138.65 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.549 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.3 ptpt -151.56 141.52 22.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -50.7 135.19 23.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.464 HG22 ' H ' ' A' ' 240' ' ' THR . 58.5 mt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.944 0.402 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 284' ' ' ARG . 39.0 p -99.61 32.2 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.464 ' H ' HG22 ' A' ' 238' ' ' ILE . 9.4 m -130.22 149.37 51.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 291' ' ' ALA . 28.8 mt -132.3 156.85 45.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.817 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.3 OUTLIER -108.36 146.18 33.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 58.2 t -140.77 113.84 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.098 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -107.0 -177.42 22.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.519 ' O ' HD22 ' A' ' 305' ' ' LEU . . . 57.7 47.33 89.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.477 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.449 HD11 ' CB ' ' A' ' 277' ' ' ALA . 95.4 mt -83.22 -57.82 3.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 110.915 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.26 158.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.477 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -47.02 -33.95 5.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.912 0.387 . . . . 0.0 110.857 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.9 p -52.75 -44.38 66.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.774 ' CD1' HD21 ' A' ' 305' ' ' LEU . 70.4 mt -97.88 143.52 12.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 42.7 p -121.83 -176.65 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -70.1 -57.09 5.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.5 m -44.55 -50.1 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.124 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -46.99 -42.67 18.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 21.1 mt -77.34 -48.92 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.403 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 28.0 ttm180 -46.46 -44.44 17.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -76.3 -40.11 52.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.523 ' CE1' HD12 ' A' ' 298' ' ' LEU . 51.3 t-80 -60.19 -34.45 73.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.837 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -94.22 -40.68 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.668 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.6 t80 -42.05 -34.82 0.77 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.484 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.0 pt20 -54.16 -43.2 70.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.934 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.577 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 60.8 m-85 -57.68 -50.93 71.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.62 -150.1 7.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -85.13 122.61 29.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 0.0 110.848 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.668 HD11 ' N ' ' A' ' 260' ' ' TYR . 77.2 mt -90.71 116.88 32.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -63.11 -51.67 65.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.3 t -165.13 161.59 19.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.615 HG23 HD13 ' A' ' 279' ' ' ILE . 76.7 mt -137.71 109.72 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 60.7 m -100.45 99.58 10.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.148 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.495 HG22 ' CB ' ' A' ' 277' ' ' ALA . 93.4 t -91.13 115.11 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.163 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.544 HG12 ' HG2' ' A' ' 273' ' ' ARG . 5.0 t -97.18 102.04 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -60.23 -49.49 77.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.544 ' HG2' HG12 ' A' ' 271' ' ' VAL . 5.0 ptm180 -54.03 -30.14 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 275' ' ' GLN . 16.6 mt-30 -108.33 13.79 25.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 274' ' ' GLN . 43.6 mt-30 34.32 47.26 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.428 ' C ' ' CD1' ' A' ' 246' ' ' LEU . 20.7 p -142.2 177.54 8.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.495 ' CB ' HG22 ' A' ' 270' ' ' VAL . . . -159.59 140.2 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -107.06 119.5 39.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.615 HD13 HG23 ' A' ' 268' ' ' ILE . 3.8 mm -98.51 118.63 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.15 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -104.47 141.23 36.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -122.88 150.52 42.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -71.2 -41.84 69.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 33.1 p -118.99 122.5 42.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.12 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.412 ' HA ' HG22 ' A' ' 239' ' ' THR . 17.0 tpt180 -38.44 -35.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -39.55 -65.86 0.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -53.67 -48.94 68.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -47.49 -63.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 5.7 mt-10 -43.42 -64.1 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.518 HG12 ' CE1' ' A' ' 262' ' ' PHE . 41.5 t -42.51 -58.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.577 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -54.6 -39.55 67.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.513 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -52.22 -65.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -54.7 -39.52 68.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -80.41 2.42 25.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.781 ' HB3' HG11 ' A' ' 307' ' ' VAL . 24.0 m -117.36 -26.58 6.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -58.19 102.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.0 m120 43.69 32.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -129.74 -31.09 2.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.523 HD12 ' CE1' ' A' ' 258' ' ' HIS . 4.9 tp -68.65 98.53 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 304' ' ' ARG . 28.4 mt -113.72 94.47 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.433 ' HB ' HD11 ' A' ' 305' ' ' LEU . 59.2 t -92.07 139.36 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 53.71 47.35 23.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.885 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.31 27.02 5.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 -126.92 97.63 5.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.772 0.32 . . . . 0.0 110.907 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.486 ' N ' HG23 ' A' ' 299' ' ' ILE . 34.3 ttm-85 -42.41 139.76 1.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.774 HD21 ' CD1' ' A' ' 250' ' ' ILE . 29.2 mt -126.7 138.09 53.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -87.99 113.66 23.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.817 HG13 ' O ' ' A' ' 242' ' ' TYR . 47.0 t -113.79 143.63 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.59 ' HE2' ' CD1' ' A' ' 242' ' ' TYR . 18.7 pttt -152.65 161.26 42.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -67.68 123.53 20.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.974 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 240' ' ' THR . 79.9 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.978 0.418 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.1 p -102.41 35.14 2.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.577 ' H ' HG22 ' A' ' 238' ' ' ILE . 17.2 m -138.72 143.2 38.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.5 mt -129.11 141.72 51.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.564 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -104.64 137.02 43.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.06 131.62 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.156 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.59 158.23 15.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 82.84 37.87 12.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.434 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.546 HD11 ' C ' ' A' ' 276' ' ' CYS . 63.6 mt -63.62 -66.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.425 ' HA3' ' NH1' ' A' ' 303' ' ' ARG . . . 66.01 148.32 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.5 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.0 -37.88 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 0.0 110.845 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 50.9 p -52.9 -46.58 68.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.151 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.893 ' CD1' HD21 ' A' ' 305' ' ' LEU . 53.0 mt -94.24 143.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.115 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.2 p -129.31 177.31 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.15 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.503 ' OE1' ' CG2' ' A' ' 270' ' ' VAL . 3.7 tp10 -60.35 -61.14 2.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.1 m -41.43 -52.61 3.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.134 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.51 -51.5 5.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.0 mt -70.03 -45.26 67.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.94 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -48.88 -47.27 43.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -76.59 -38.93 54.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.573 ' CE1' HD12 ' A' ' 298' ' ' LEU . 34.6 t-80 -60.44 -34.24 73.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.567 ' CD2' HG12 ' A' ' 279' ' ' ILE . 51.3 m-85 -94.87 -41.34 9.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.838 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.432 ' N ' HD11 ' A' ' 265' ' ' ILE . 2.0 t80 -41.8 -38.17 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 27.4 pt20 -52.32 -41.71 63.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 70.2 m-85 -63.25 -48.29 78.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 177.13 174.29 43.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.545 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -45.81 147.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.432 HD11 ' N ' ' A' ' 260' ' ' TYR . 65.8 mt -117.03 112.35 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.8 mtp180 -55.19 -50.98 67.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.1 t -167.03 158.84 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.485 HG22 ' OE2' ' A' ' 252' ' ' GLU . 21.0 mt -136.2 110.31 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.07 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 91.2 m -105.14 126.33 51.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.503 ' CG2' ' OE1' ' A' ' 252' ' ' GLU . 25.5 t -109.8 123.48 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.419 HG12 ' HG2' ' A' ' 273' ' ' ARG . 22.8 t -106.75 99.93 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.144 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -59.89 -50.0 75.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.419 ' HG2' HG12 ' A' ' 271' ' ' VAL . 9.4 ptt85 -53.79 -24.83 16.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.457 ' O ' ' C ' ' A' ' 275' ' ' GLN . 17.8 mt-30 -116.68 10.98 14.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 274' ' ' GLN . 66.8 mt-30 33.34 53.79 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.546 ' C ' HD11 ' A' ' 246' ' ' LEU . 26.9 p -142.86 172.21 13.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -146.3 151.2 37.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.065 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 49.6 m-85 -121.47 108.24 13.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.612 HG22 ' CE1' ' A' ' 281' ' ' PHE . 4.5 mp -94.24 118.52 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.126 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 266' ' ' ARG . 7.9 tt0 -105.91 142.52 35.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.612 ' CE1' HG22 ' A' ' 279' ' ' ILE . 87.7 m-85 -121.49 149.95 42.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.39 91.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.069 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 284' ' ' ARG . 35.8 p -125.81 125.34 42.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.15 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.461 ' O ' ' C ' ' A' ' 285' ' ' GLN . 4.9 tpt180 -35.97 -39.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.843 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.578 ' O ' HG23 ' A' ' 289' ' ' VAL . 36.2 tp60 -32.87 -65.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.94 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -56.56 -43.56 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.061 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.08 -60.88 2.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.102 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 8.4 mt-10 -47.58 -53.35 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 285' ' ' GLN . 45.5 t -53.17 -54.87 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.561 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -60.39 -32.79 71.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.448 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -56.41 -50.99 70.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -70.87 -26.86 63.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.466 ' HD2' ' CZ ' ' A' ' 262' ' ' PHE . 20.5 mttt -92.51 -1.34 57.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.705 ' HB2' HG11 ' A' ' 307' ' ' VAL . 61.3 p -112.29 -32.14 6.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 2.9 m-85 -53.73 106.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 29.5 t30 40.84 34.0 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -131.02 -33.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.573 HD12 ' CE1' ' A' ' 258' ' ' HIS . 4.3 tp -66.9 98.17 0.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 53.8 mt -113.53 96.29 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 258' ' ' HIS . 59.6 t -95.84 141.89 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 24.3 m120 53.82 43.88 30.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 50.79 32.94 26.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.461 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ARG . . . . . 0.425 ' NH1' ' HA3' ' A' ' 247' ' ' GLY . 30.4 ttt180 -135.0 108.31 7.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.873 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.524 ' O ' HD23 ' A' ' 305' ' ' LEU . 39.9 ttp180 -51.42 146.37 7.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.893 HD21 ' CD1' ' A' ' 250' ' ' ILE . 31.1 mt -132.45 135.15 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -83.97 97.92 9.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.705 HG11 ' HB2' ' A' ' 294' ' ' SER . 39.1 t -94.89 141.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.549 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.5 ptpt -153.47 145.27 23.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -50.9 143.98 9.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.922 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.444 -179.947 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 240' ' ' THR . 52.2 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.899 0.38 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 37.3 p -86.34 30.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.422 ' H ' HG22 ' A' ' 238' ' ' ILE . 56.5 m -126.27 140.39 52.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.142 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 291' ' ' ALA . 25.2 mt -129.27 131.46 47.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.611 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -87.65 145.95 25.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.744 HG22 HG22 ' A' ' 307' ' ' VAL . 85.6 t -137.22 130.3 44.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.131 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -121.96 177.98 16.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.49 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.412 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 66.53 46.51 76.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.465 ' CD2' HD11 ' A' ' 255' ' ' LEU . 52.1 mt -77.12 -59.69 2.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.382 . . . . 0.0 110.906 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.87 148.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -42.18 -25.91 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.843 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.8 p -61.57 -45.96 91.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.112 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.868 ' CD1' HD21 ' A' ' 305' ' ' LEU . 53.7 mt -97.3 148.77 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.138 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 31.0 p -128.48 -176.47 3.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.478 ' HB2' HG21 ' A' ' 270' ' ' VAL . 30.7 tt0 -66.83 -59.56 3.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.9 m -42.11 -55.33 3.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -41.95 -47.17 4.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.465 HD11 ' CD2' ' A' ' 246' ' ' LEU . 19.5 mt -72.34 -53.76 11.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.956 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -42.08 -45.85 4.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -75.87 -42.65 48.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.551 ' CE1' HD12 ' A' ' 298' ' ' LEU . 37.7 t-80 -56.62 -33.95 66.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.456 ' CE2' HG13 ' A' ' 279' ' ' ILE . 67.5 m-85 -94.19 -44.04 8.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.592 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.9 t80 -39.94 -36.73 0.49 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 14.4 pt20 -51.63 -46.88 63.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.932 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.478 ' CE1' HG12 ' A' ' 289' ' ' VAL . 67.4 m-85 -57.99 -45.94 86.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -176.33 -157.54 17.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.48 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -80.72 131.24 35.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.592 HD11 ' N ' ' A' ' 260' ' ' TYR . 62.5 mt -97.56 112.41 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.127 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -57.86 -50.18 74.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 3.7 t -163.6 168.56 19.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.439 HD11 HD13 ' A' ' 265' ' ' ILE . 82.2 mt -145.73 111.52 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.144 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 88.8 m -102.21 101.81 12.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 252' ' ' GLU . 60.5 t -91.17 114.64 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.076 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.544 HG12 ' HG2' ' A' ' 273' ' ' ARG . 11.1 t -101.71 100.06 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -60.07 -44.22 94.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.544 ' HG2' HG12 ' A' ' 271' ' ' VAL . 1.6 ptm180 -52.99 -32.95 49.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.829 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.465 ' N ' ' HG2' ' A' ' 273' ' ' ARG . 61.8 mm-40 -112.42 15.12 20.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 274' ' ' GLN . 46.9 mm-40 34.66 52.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 9.5 p -142.24 174.18 10.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -152.72 135.53 15.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.108 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 27.1 m-85 -101.62 109.44 21.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.456 HG13 ' CE2' ' A' ' 259' ' ' PHE . 3.5 mm -93.75 121.0 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -109.79 139.08 45.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -117.38 144.64 44.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.15 78.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 284' ' ' ARG . 31.1 p -125.14 118.73 26.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' A' ' 283' ' ' THR . 15.7 tpt180 -37.94 -32.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.705 ' O ' HG23 ' A' ' 289' ' ' VAL . 5.2 tt0 -40.35 -67.91 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -56.36 -39.43 72.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -53.49 -62.23 1.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -49.63 -49.62 46.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 285' ' ' GLN . 16.8 t -52.82 -64.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 294' ' ' SER . . . -53.27 -41.5 65.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.509 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -51.34 -54.76 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.438 ' O ' ' NZ ' ' A' ' 297' ' ' LYS . 12.9 tm-20 -67.65 -26.71 66.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.843 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.9 mttm -94.84 4.6 53.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.711 ' OG ' HG11 ' A' ' 307' ' ' VAL . 78.9 p -116.47 -26.91 6.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.4 m-30 -58.73 104.86 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 1.7 m120 47.82 29.12 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 292' ' ' GLU . 0.5 OUTLIER -127.86 -34.94 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.628 ' HG ' HD12 ' A' ' 305' ' ' LEU . 7.4 tp -67.81 97.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 304' ' ' ARG . 42.1 mt -114.76 98.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.42 146.76 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.127 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 23.7 m120 45.78 47.24 11.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.54 33.4 11.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 11.2 ttt85 -133.96 101.5 5.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.792 0.329 . . . . 0.0 110.892 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.467 ' N ' HG23 ' A' ' 299' ' ' ILE . 14.8 ttm180 -43.3 145.72 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.868 HD21 ' CD1' ' A' ' 250' ' ' ILE . 23.4 mt -129.71 134.02 47.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.57 101.38 11.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.744 HG22 HG22 ' A' ' 243' ' ' VAL . 72.5 t -103.85 133.29 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.599 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.0 pttt -145.59 152.52 39.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -55.91 130.38 43.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 179.971 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 6.7 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.897 0.379 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.8 p -98.45 39.83 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 18.4 m -138.91 139.62 38.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.403 HD11 ' O ' ' A' ' 287' ' ' ALA . 44.1 mt -126.33 153.71 44.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.83 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.3 OUTLIER -105.53 146.18 29.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 307' ' ' VAL . 93.5 t -142.49 122.3 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.127 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -115.15 173.18 14.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.494 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.72 56.53 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.524 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.601 HD11 ' HB2' ' A' ' 277' ' ' ALA . 57.4 mt -70.23 -62.37 1.41 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.868 0.365 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.47 155.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.473 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -47.44 -30.36 3.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.5 p -58.12 -43.03 87.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.546 ' CD1' HD21 ' A' ' 305' ' ' LEU . 61.3 mt -102.18 143.53 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 30.4 p -121.26 -177.31 3.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.183 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.592 ' HB2' HG21 ' A' ' 270' ' ' VAL . 63.4 tt0 -70.02 -52.25 25.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.899 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 92.2 m -48.9 -54.98 13.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.154 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -40.24 -44.94 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 258' ' ' HIS . 16.7 mt -75.25 -59.08 2.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 255' ' ' LEU . 20.3 ttm-85 -36.29 -42.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -78.12 -40.17 39.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.609 ' NE2' HD13 ' A' ' 298' ' ' LEU . 13.9 t60 -59.56 -37.53 78.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 261' ' ' GLN . 73.5 m-85 -90.03 -39.06 13.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.665 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.1 t80 -45.02 -21.31 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.926 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 259' ' ' PHE . 24.4 pt20 -69.32 -43.3 74.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 81.4 m-85 -61.31 -42.52 98.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 179.96 -167.19 36.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.466 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -71.56 130.11 40.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.913 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.665 HD11 ' N ' ' A' ' 260' ' ' TYR . 60.3 mt -98.29 112.13 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.112 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.5 mtp85 -56.89 -49.36 75.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 t -165.6 168.98 15.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.176 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.418 HD11 ' HA ' ' A' ' 256' ' ' ARG . 85.9 mt -144.01 110.95 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.174 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.8 m -100.92 102.21 13.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 252' ' ' GLU . 40.3 t -96.18 104.68 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 274' ' ' GLN . 99.8 t -92.52 99.95 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' GLN . . . . . 0.516 ' O ' ' NE2' ' A' ' 272' ' ' GLN . 0.9 OUTLIER -60.01 -37.75 80.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -55.99 -35.55 66.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.628 ' H ' HG12 ' A' ' 271' ' ' VAL . 69.8 mt-30 -106.42 4.13 28.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 47.25 48.02 16.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.946 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.453 ' C ' HD11 ' A' ' 246' ' ' LEU . 1.8 p -139.69 178.63 7.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.601 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -155.26 139.55 16.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -111.33 109.95 20.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 2.8 mm -92.46 126.84 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 266' ' ' ARG . 8.5 tt0 -113.52 142.16 46.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -121.49 149.82 42.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.0 -32.71 71.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.102 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 284' ' ' ARG . 16.0 p -127.1 117.4 22.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 283' ' ' THR . 15.1 tpt180 -37.29 -32.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' THR . 3.5 tt0 -39.22 -68.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -55.5 -47.66 75.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.403 ' O ' HD11 ' A' ' 241' ' ' LEU . . . -43.8 -54.05 5.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.138 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 7.2 mt-10 -56.46 -60.72 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.848 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 21.0 t -45.12 -56.34 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.561 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -58.09 -37.25 74.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.088 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -52.23 -65.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.102 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -56.13 -39.53 72.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.832 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.505 ' HD2' ' CZ ' ' A' ' 262' ' ' PHE . 20.8 mttp -76.86 1.06 18.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.581 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.2 m -118.03 -28.14 5.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -54.81 106.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 57.5 t30 42.27 25.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -123.83 -27.32 3.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.609 HD13 ' NE2' ' A' ' 258' ' ' HIS . 5.9 tp -70.32 100.5 1.74 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 304' ' ' ARG . 22.4 mt -120.17 99.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.36 138.91 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 60.64 45.87 9.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.85 34.53 11.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -137.67 106.24 5.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 0.0 110.872 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.77 ' O ' HD23 ' A' ' 305' ' ' LEU . 16.9 ttm105 -50.58 150.2 2.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.919 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.77 HD23 ' O ' ' A' ' 304' ' ' ARG . 38.7 mt -135.43 137.64 42.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.959 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -90.38 113.36 25.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.83 HG13 ' O ' ' A' ' 242' ' ' TYR . 35.4 t -112.4 143.17 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.584 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 5.1 ptpp? -150.12 160.37 43.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -67.67 129.56 40.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.494 -179.997 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 240' ' ' THR . 48.9 mt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.93 0.395 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.5 p -98.51 30.01 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 238' ' ' ILE . 40.1 m -128.88 136.3 50.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.5 mt -126.66 126.43 43.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.585 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -82.56 140.59 33.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.886 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.49 131.72 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.171 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.07 -174.9 16.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.465 ' O ' HD22 ' A' ' 305' ' ' LEU . . . 56.2 54.79 33.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.523 HD22 HD11 ' A' ' 255' ' ' LEU . 77.8 mt -87.4 -57.81 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.912 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.78 156.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.66 -24.63 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.847 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.8 p -62.13 -35.27 78.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.127 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.777 ' CD1' HD21 ' A' ' 305' ' ' LEU . 73.6 mt -107.24 142.32 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.8 p -117.74 -179.93 3.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.84 -54.26 24.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 89.3 m -48.56 -54.89 12.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.222 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -39.15 -45.96 1.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.523 HD11 HD22 ' A' ' 246' ' ' LEU . 15.0 mt -75.95 -49.55 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -45.35 -44.25 11.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.41 -44.37 36.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.519 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 39.5 t-80 -56.37 -33.82 66.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -94.12 -42.71 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.614 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -41.14 -44.46 2.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.479 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.8 pt20 -44.5 -41.02 6.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.703 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 53.4 m-85 -60.8 -49.84 75.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -175.63 -160.95 24.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.454 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -75.36 121.93 22.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.865 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.614 HD11 ' N ' ' A' ' 260' ' ' TYR . 87.0 mt -89.83 108.98 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 282' ' ' ALA . 9.2 mtt-85 -52.46 -52.49 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 13.7 t -162.23 170.9 18.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.419 HD11 HG21 ' A' ' 265' ' ' ILE . 75.3 mt -146.08 110.26 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.131 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 19.2 m -103.1 98.9 8.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.194 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.17 107.06 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.638 HG12 ' HG3' ' A' ' 273' ' ' ARG . 5.3 t -91.3 100.84 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -60.21 -45.43 93.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' ARG . . . . . 0.638 ' HG3' HG12 ' A' ' 271' ' ' VAL . 0.0 OUTLIER -57.39 -19.22 21.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 275' ' ' GLN . 15.2 mt-30 -121.39 11.93 10.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 274' ' ' GLN . 92.9 mt-30 36.87 44.3 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.486 ' C ' HD11 ' A' ' 246' ' ' LEU . 28.4 p -133.59 175.07 9.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -156.73 131.94 9.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 42.9 m-85 -100.74 111.91 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 4.6 mm -94.85 114.71 31.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -102.52 144.84 30.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.64 148.09 49.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.471 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -68.91 -38.26 79.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.111 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 284' ' ' ARG . 25.1 p -125.24 119.22 27.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.168 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 283' ' ' THR . 16.9 tpt180 -35.89 -36.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.901 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.61 ' O ' HG23 ' A' ' 289' ' ' VAL . 13.0 tp60 -36.96 -63.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -60.4 -36.77 78.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.127 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.71 -62.09 2.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.055 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 20.9 mt-10 -47.44 -56.6 6.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.888 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 285' ' ' GLN . 29.3 t -47.21 -62.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.703 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -54.04 -39.85 66.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -51.34 -64.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -54.99 -40.95 70.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -77.31 3.07 13.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.729 ' HB3' HG11 ' A' ' 307' ' ' VAL . 1.9 m -116.65 -31.72 5.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -48.32 98.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.854 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 43.96 30.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.69 -35.79 2.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.519 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 6.6 tp -66.45 97.75 0.44 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 304' ' ' ARG . 54.1 mt -114.53 91.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 58.1 t -85.62 147.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.118 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 21.4 m120 43.73 48.7 6.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 46.5 33.57 6.1 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.474 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -132.9 100.14 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.866 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.432 ' N ' HG23 ' A' ' 299' ' ' ILE . 20.3 ttm-85 -43.84 139.3 2.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.777 HD21 ' CD1' ' A' ' 250' ' ' ILE . 29.6 mt -122.12 133.35 54.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -82.67 101.3 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.729 HG11 ' HB3' ' A' ' 294' ' ' SER . 53.8 t -103.77 146.65 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 10.5 ptpt -156.96 169.73 24.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -80.79 125.47 30.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 -179.973 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 57.2 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.869 0.366 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 30.3 p -93.92 38.11 1.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 24.9 m -131.38 144.28 51.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 291' ' ' ALA . 28.6 mt -134.71 128.61 33.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.588 ' CE1' ' HE2' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -85.6 143.99 28.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 307' ' ' VAL . 66.0 t -140.5 106.67 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.115 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -102.17 178.18 26.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.495 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.488 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 71.94 41.43 55.12 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.606 ' CD2' HD11 ' A' ' 255' ' ' LEU . 96.5 mt -70.08 -63.11 1.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.841 0.353 . . . . 0.0 110.926 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 249' ' ' THR . . . 71.77 143.45 0.38 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -40.1 -29.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 247' ' ' GLY . 34.5 p -61.59 -53.12 60.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.646 ' CD1' HD21 ' A' ' 305' ' ' LEU . 59.2 mt -84.53 153.82 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.437 ' N ' HG22 ' A' ' 250' ' ' ILE . 55.9 p -134.68 178.37 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.488 ' HB2' HG21 ' A' ' 270' ' ' VAL . 30.9 tt0 -62.77 -59.57 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.4 m -44.02 -55.14 4.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.156 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -39.75 -47.01 2.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.606 HD11 ' CD2' ' A' ' 246' ' ' LEU . 12.9 mt -75.86 -52.88 9.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ARG . . . . . 0.406 ' O ' ' HB3' ' A' ' 260' ' ' TYR . 50.1 ttp85 -42.06 -44.01 3.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -74.97 -46.86 32.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.655 ' CE1' HD13 ' A' ' 298' ' ' LEU . 3.2 t-80 -52.63 -39.39 61.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 261' ' ' GLN . 76.7 m-85 -87.84 -45.16 10.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.826 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' TYR . . . . . 0.696 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.1 t80 -39.84 -27.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 259' ' ' PHE . 23.6 pt20 -62.28 -46.25 89.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.637 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 60.8 m-85 -54.39 -50.27 67.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -172.6 -146.99 5.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.511 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -90.29 123.02 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.696 HD11 ' N ' ' A' ' 260' ' ' TYR . 47.1 mt -91.01 113.76 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.144 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -56.6 -48.82 76.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 t -165.2 170.28 15.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.165 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.407 HG23 HD13 ' A' ' 279' ' ' ILE . 92.6 mt -144.79 110.93 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.118 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 39.2 m -103.14 98.86 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.493 HG13 ' CD1' ' A' ' 246' ' ' LEU . 90.1 t -90.34 110.07 21.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 275' ' ' GLN . 38.6 t -95.57 100.01 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 275' ' ' GLN . 10.4 tt0 -60.01 -57.8 11.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -45.11 -22.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -109.12 -16.44 14.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.962 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 272' ' ' GLN . 34.3 mt-30 64.37 45.14 3.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' CYS . . . . . 0.521 ' C ' HD11 ' A' ' 246' ' ' LEU . 5.3 m -145.76 177.52 8.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.426 ' HB2' HG22 ' A' ' 270' ' ' VAL . . . -153.29 142.18 21.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 33.1 m-85 -106.63 107.16 18.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ILE . . . . . 0.407 HD13 HG23 ' A' ' 268' ' ' ILE . 7.3 mm -90.1 117.44 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.179 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' GLN . . . . . 0.484 ' O ' HG23 ' A' ' 265' ' ' ILE . 9.8 tt0 -105.79 150.19 25.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -130.79 151.83 50.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -74.53 -32.97 62.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.116 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 284' ' ' ARG . 24.9 p -127.17 118.08 23.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 285' ' ' GLN . 5.7 tpp85 -36.01 -38.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.696 ' O ' HG23 ' A' ' 289' ' ' VAL . 12.0 tt0 -35.9 -64.83 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.59 -45.73 84.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' ALA . . . . . 0.4 ' O ' HD11 ' A' ' 241' ' ' LEU . . . -52.0 -66.31 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 12.7 mt-10 -43.29 -52.39 5.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 285' ' ' GLN . 46.3 t -52.72 -64.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.637 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -48.84 -43.1 38.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.067 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ALA . . . . . 0.56 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -46.18 -67.66 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -53.14 -44.48 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -70.7 -0.94 9.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.773 ' HB3' HG21 ' A' ' 307' ' ' VAL . 12.6 m -119.14 -24.26 6.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.869 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -53.95 103.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 43.51 26.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -124.92 -26.77 3.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.655 HD13 ' CE1' ' A' ' 258' ' ' HIS . 12.5 tp -68.03 98.26 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.947 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.55 96.64 4.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.159 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 85.7 t -103.69 145.37 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 13.9 m120 55.56 40.48 31.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 51.53 32.05 30.41 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.52 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 19.4 ttt-85 -133.56 105.63 6.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.92 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.528 ' O ' HD23 ' A' ' 305' ' ' LEU . 13.7 ttp180 -49.95 147.12 4.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.646 HD21 ' CD1' ' A' ' 250' ' ' ILE . 40.4 mt -132.29 145.76 51.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.954 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -98.01 106.84 19.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.773 HG21 ' HB3' ' A' ' 294' ' ' SER . 98.3 t -105.25 137.7 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.588 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 3.4 pttt -151.26 148.94 28.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.935 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.61 141.06 44.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 23.3 t -112.26 150.8 30.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.918 0.39 . . . . 0.0 110.866 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 83.6 p -65.34 -45.88 82.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.819 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.24 112.76 0.84 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.443 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 88.1 p -134.94 156.95 48.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 110.874 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 50.1 m -131.23 92.5 3.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.797 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.36 -162.95 0.63 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.496 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -109.98 42.25 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.883 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -114.8 100.4 8.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.428 ' O ' ' NH1' ' A' ' 284' ' ' ARG . 0.7 OUTLIER -93.36 -66.89 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 72.2 p -120.89 29.24 7.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.152 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 59.4 mt -83.1 126.08 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.419 HG22 ' HA ' ' A' ' 284' ' ' ARG . 82.0 p -102.36 -11.68 18.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 16.7 m -84.84 141.92 30.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.181 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.8 mt -130.85 124.41 31.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.579 ' CE1' ' HE2' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -81.53 141.32 33.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.929 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.86 HG22 HG22 ' A' ' 307' ' ' VAL . 99.8 t -136.28 116.98 18.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.08 177.3 19.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 68.78 37.79 84.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.481 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.495 HD11 ' CB ' ' A' ' 277' ' ' ALA . 31.4 mt -75.9 -59.8 2.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.4 149.95 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.483 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -40.96 -36.87 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 24.1 p -51.89 -43.0 63.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.578 ' CD1' HD21 ' A' ' 305' ' ' LEU . 76.4 mt -97.12 143.07 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.12 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.0 p -121.6 -178.29 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.109 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.94 -56.67 7.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 90.0 m -43.98 -50.67 8.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.82 -37.62 14.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 18.9 mt -80.52 -52.36 7.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 41.4 ttt-85 -43.91 -42.89 6.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -76.53 -44.27 35.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.427 ' NE2' ' CD1' ' A' ' 298' ' ' LEU . 4.8 t60 -57.39 -33.12 67.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.444 ' CE2' HG13 ' A' ' 279' ' ' ILE . 76.5 m-85 -94.47 -41.39 9.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.534 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -42.71 -36.12 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.966 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 17.6 pt20 -54.13 -40.97 67.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.901 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 47.0 m-85 -63.75 -45.91 87.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.854 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 173.98 178.01 43.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.529 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -47.69 144.55 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.347 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.534 HD11 ' N ' ' A' ' 260' ' ' TYR . 90.7 mt -115.45 109.56 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -52.34 -50.45 62.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.5 t -167.53 168.74 12.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.458 HD11 HD13 ' A' ' 265' ' ' ILE . 90.1 mt -144.38 108.65 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 54.7 m -103.14 99.08 8.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 43.1 t -91.93 110.81 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.461 ' CG1' ' HG2' ' A' ' 273' ' ' ARG . 51.2 t -94.53 99.96 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -60.09 -43.24 95.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.461 ' HG2' ' CG1' ' A' ' 271' ' ' VAL . 6.8 ptm180 -55.09 -26.54 38.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.454 ' O ' ' C ' ' A' ' 275' ' ' GLN . 73.7 mt-30 -117.29 17.75 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 274' ' ' GLN . 66.7 mt-30 34.25 43.94 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 26.0 p -136.69 173.08 12.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.495 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -156.74 138.93 14.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -105.38 114.87 29.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.444 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.5 mm -98.06 118.03 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.162 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -104.42 140.4 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -119.43 146.38 45.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.34 -34.21 74.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 284' ' ' ARG . 29.5 p -127.68 118.18 23.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.171 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.431 ' O ' ' HB3' ' A' ' 287' ' ' ALA . 13.6 tpt180 -36.72 -36.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 284' ' ' ARG . 6.1 tp60 -36.85 -65.69 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -59.11 -35.29 73.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.084 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 284' ' ' ARG . . . -57.82 -57.39 12.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 13.7 mt-10 -52.33 -59.31 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 42.9 t -44.41 -61.61 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.901 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -57.42 -38.39 74.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -49.52 -69.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.108 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -54.08 -43.43 70.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -70.94 -3.72 20.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.673 ' HB3' HG21 ' A' ' 307' ' ' VAL . 33.2 m -112.3 -29.95 7.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -47.86 97.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.835 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 52.7 t30 45.17 25.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -120.57 -25.68 5.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.427 ' CD1' ' NE2' ' A' ' 258' ' ' HIS . 6.2 tp -72.53 99.83 2.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 304' ' ' ARG . 25.5 mt -113.39 96.68 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.109 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 67.7 t -100.72 138.36 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 58.13 49.88 10.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.78 34.18 5.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 245' ' ' GLY . 16.1 ttt-85 -138.81 105.13 5.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 0.0 110.881 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.604 ' O ' HD23 ' A' ' 305' ' ' LEU . 2.0 ttt85 -51.68 149.33 4.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 304' ' ' ARG . 42.0 mt -133.52 134.93 44.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.77 102.2 14.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.86 HG22 HG22 ' A' ' 243' ' ' VAL . 70.6 t -99.99 136.54 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.579 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 6.2 pttt -146.5 147.55 31.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -55.29 142.71 30.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -93.09 -135.37 7.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.478 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 67.4 mmt-85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.857 0.361 . . . . 0.0 110.906 -179.83 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 6.4 m -103.7 -43.96 5.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 110.87 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 46.7 p 38.6 41.9 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -74.29 -131.31 0.22 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.482 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.2 t 54.88 41.45 31.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.895 0.379 . . . . 0.0 110.848 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 63.6 m -94.43 162.54 13.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 164.51 -110.38 0.42 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.452 ' C ' ' CD ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -155.92 168.06 28.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 0.0 110.865 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.44 ' HB3' HD12 ' A' ' 238' ' ' ILE . 9.6 m-20 -130.12 117.63 20.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 238' ' ' ILE . 0.0 OUTLIER -63.03 89.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 36.8 p 38.44 31.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.11 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.75 HD13 ' O ' ' A' ' 311' ' ' ARG . 60.0 mt -72.44 96.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.147 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 284' ' ' ARG . 57.3 p -90.39 26.75 1.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.2 m -123.16 141.03 52.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.588 HD21 ' HB2' ' A' ' 291' ' ' ALA . 66.4 mt -124.1 139.88 53.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.717 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.6 OUTLIER -99.1 146.31 26.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 307' ' ' VAL . 74.1 t -140.04 135.01 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -125.73 168.33 17.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 70.62 44.51 57.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 250' ' ' ILE . 91.3 mt -80.29 -59.11 2.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.879 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.34 162.81 0.89 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.463 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -49.53 -38.39 30.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 35.6 p -50.63 -45.05 57.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.142 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.696 ' CD1' HD21 ' A' ' 305' ' ' LEU . 67.3 mt -95.44 143.95 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 26.8 p -122.31 -175.23 3.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.477 ' HA ' HG21 ' A' ' 270' ' ' VAL . 37.6 tt0 -71.18 -57.18 4.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.6 m -45.33 -47.18 13.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.16 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -44.7 -50.67 9.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.0 -44.74 62.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.435 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 22.3 ttp180 -49.95 -46.05 51.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -75.7 -40.56 55.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.651 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 51.1 t-80 -61.06 -32.78 72.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.495 ' CD2' HG12 ' A' ' 279' ' ' ILE . 52.8 m-85 -94.32 -39.0 10.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.484 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -46.67 -38.02 9.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.2 pt20 -52.45 -38.22 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.56 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 79.0 m-85 -64.71 -43.97 91.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -178.97 -152.75 10.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.532 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -82.84 136.5 34.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 0.0 110.851 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.743 HD13 HD11 ' A' ' 268' ' ' ILE . 88.9 mt -105.35 112.95 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 282' ' ' ALA . 27.8 mtt180 -60.36 -48.98 79.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.4 t -165.13 159.02 17.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.16 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.743 HD11 HD13 ' A' ' 265' ' ' ILE . 59.5 mt -139.41 108.3 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 30.5 m -101.5 100.41 10.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 252' ' ' GLU . 83.7 t -93.67 103.35 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.403 HG12 ' HG2' ' A' ' 273' ' ' ARG . 12.2 t -86.19 99.54 8.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -60.76 -48.26 82.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.403 ' HG2' HG12 ' A' ' 271' ' ' VAL . 0.0 OUTLIER -58.48 -11.02 2.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 275' ' ' GLN . 19.8 mm-40 -126.6 14.41 7.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.953 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 274' ' ' GLN . 71.4 mt-30 33.04 51.09 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 14.2 p -148.8 165.27 31.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.467 ' CB ' HG22 ' A' ' 270' ' ' VAL . . . -148.95 148.09 29.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 56.7 m-85 -118.05 108.74 15.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.495 HG12 ' CD2' ' A' ' 259' ' ' PHE . 5.0 mp -93.02 121.67 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -105.38 148.54 27.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.429 ' HE2' HD12 ' A' ' 241' ' ' LEU . 98.9 m-85 -127.44 139.29 52.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.401 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -62.04 -34.9 77.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.078 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 284' ' ' ARG . 32.7 p -126.71 118.03 23.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.165 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.436 ' HA ' HG22 ' A' ' 239' ' ' THR . 9.5 tpt180 -36.13 -35.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.635 ' O ' HG23 ' A' ' 289' ' ' VAL . 46.4 tp60 -36.58 -68.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -54.7 -48.44 72.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -46.88 -59.56 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 5.6 mt-10 -50.18 -54.12 23.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.947 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 285' ' ' GLN . 16.5 t -50.79 -60.13 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.115 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.56 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -56.51 -36.53 69.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.065 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.588 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -54.66 -53.66 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -68.88 -28.65 66.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -92.03 5.41 50.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 65.7 p -119.08 -32.06 4.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.461 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.4 m-30 -55.1 109.42 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 41.05 33.88 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -130.96 -38.43 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.89 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.651 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 8.4 tp -65.48 100.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 58.4 mt -117.64 93.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.402 HG12 ' OD1' ' A' ' 301' ' ' ASN . 53.9 t -97.86 140.39 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.402 ' OD1' HG12 ' A' ' 300' ' ' VAL . 29.6 m120 58.43 42.34 21.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.93 34.12 10.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.491 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -134.19 99.38 4.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.349 . . . . 0.0 110.831 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.498 ' O ' HD23 ' A' ' 305' ' ' LEU . 6.9 ttm180 -44.17 148.47 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.696 HD21 ' CD1' ' A' ' 250' ' ' ILE . 43.4 mt -132.77 135.07 45.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.6 98.18 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 243' ' ' VAL . 49.7 t -100.89 140.17 20.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.555 ' CE ' ' CE1' ' A' ' 242' ' ' TYR . 9.6 pttt -147.86 150.65 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -52.21 134.83 33.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 311' ' ' ARG . . . -59.36 -119.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.482 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.75 ' O ' HD13 ' A' ' 238' ' ' ILE . 9.3 tpp180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.815 0.341 . . . . 0.0 110.889 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 50.4 m -105.69 -59.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.353 . . . . 0.0 110.842 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.7 m -109.11 135.11 50.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -126.47 84.4 0.34 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.51 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 35.4 p -137.81 117.11 12.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 110.833 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 4.7 m -150.53 130.47 13.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -134.86 -145.18 5.15 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.523 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -122.76 87.55 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 110.901 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.445 ' HA ' ' CD1' ' A' ' 238' ' ' ILE . 21.1 t0 -113.36 100.33 8.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -117.11 -65.57 1.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 40.2 p -118.98 39.4 3.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.558 HG22 ' H ' ' A' ' 240' ' ' THR . 85.2 mt -70.84 110.39 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.3 p -95.16 29.71 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.165 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.558 ' H ' HG22 ' A' ' 238' ' ' ILE . 20.1 m -127.55 142.73 51.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.152 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 291' ' ' ALA . 32.1 mt -134.16 124.63 26.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.93 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.603 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -82.89 143.11 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.98 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 1.082 HG22 HG22 ' A' ' 307' ' ' VAL . 98.4 t -135.79 127.66 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.91 176.3 16.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 72.15 37.25 59.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.508 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.546 HD11 ' CB ' ' A' ' 277' ' ' ALA . 93.4 mt -81.52 -57.43 3.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.28 162.03 0.16 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.463 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -35.43 29.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 110.872 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.7 p -51.64 -48.35 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.494 ' CD1' HD21 ' A' ' 305' ' ' LEU . 68.6 mt -95.03 142.8 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 30.9 p -115.57 -175.62 2.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.598 ' HB2' HG21 ' A' ' 270' ' ' VAL . 18.8 tt0 -70.18 -56.7 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 98.4 m -44.96 -50.36 10.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.13 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.54 -41.1 4.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.7 mt -81.23 -55.12 4.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.406 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 19.2 ttm180 -39.72 -38.67 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -75.55 -44.07 45.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.867 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.743 ' NE2' HD13 ' A' ' 298' ' ' LEU . 30.5 t60 -58.82 -35.09 72.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.565 ' HA ' ' CD2' ' A' ' 262' ' ' PHE . 93.1 m-85 -91.48 -39.01 12.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.49 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.1 t80 -44.35 -28.97 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.432 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 23.8 pt20 -64.48 -42.83 95.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.703 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 29.7 m-85 -59.5 -48.73 80.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 175.15 178.8 45.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.52 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -48.43 141.17 7.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.49 HD11 ' N ' ' A' ' 260' ' ' TYR . 70.5 mt -111.26 110.77 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.152 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 280' ' ' GLN . 37.9 mtt-85 -52.79 -53.18 51.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.5 t -165.72 168.73 15.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 77.2 mt -142.81 111.96 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 50.0 m -104.06 98.91 8.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.598 HG21 ' HB2' ' A' ' 252' ' ' GLU . 65.4 t -90.99 105.43 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.159 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 14.9 t -91.12 100.73 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLN . . . . . 0.437 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 16.4 pt20 -59.69 -44.88 93.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.437 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 0.8 OUTLIER -56.47 -19.05 13.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 275' ' ' GLN . 10.0 mm100 -122.95 14.23 9.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 274' ' ' GLN . 52.9 mt-30 34.37 46.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.965 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 27.7 p -137.15 175.16 9.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.546 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -155.2 132.15 10.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 35.3 m-85 -99.62 111.49 23.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 4.9 mm -93.9 115.88 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.099 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 266' ' ' ARG . 40.1 tt0 -105.6 139.0 40.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.41 ' C ' ' HG3' ' A' ' 266' ' ' ARG . 95.6 m-85 -119.24 153.27 35.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.414 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -75.65 -34.47 60.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.105 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 284' ' ' ARG . 30.6 p -125.54 116.44 21.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 283' ' ' THR . 12.6 tpt180 -36.9 -34.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.414 ' O ' HG23 ' A' ' 289' ' ' VAL . 44.1 tp60 -38.48 -61.42 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.32 97.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -52.79 -59.98 3.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -48.13 -55.74 9.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.607 HG12 ' HE3' ' A' ' 293' ' ' LYS . 60.0 t -49.48 -61.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.703 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -52.87 -41.2 64.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.491 ' HB2' HD11 ' A' ' 241' ' ' LEU . . . -53.81 -52.72 59.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.63 -24.94 63.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.888 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.607 ' HE3' HG12 ' A' ' 289' ' ' VAL . 34.1 mtmt -97.79 5.63 48.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.724 ' HB2' HG21 ' A' ' 307' ' ' VAL . 81.5 p -117.8 -24.34 7.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 297' ' ' LYS . 2.8 m-85 -61.99 112.73 2.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 5.2 t30 40.51 25.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 295' ' ' PHE . 35.9 tttp -123.65 -36.69 2.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.743 HD13 ' NE2' ' A' ' 258' ' ' HIS . 14.9 tp -61.82 96.52 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 62.9 mt -120.47 95.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.67 134.19 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.18 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 57.5 54.88 6.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 41.8 33.07 1.02 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.0 ttm-85 -130.39 99.3 4.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.823 0.344 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -56.18 135.31 53.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.499 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 58.3 mt -120.23 135.66 54.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -91.95 99.05 11.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 1.082 HG22 HG22 ' A' ' 243' ' ' VAL . 79.5 t -94.58 136.74 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.522 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 1.0 OUTLIER -145.54 145.57 31.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 309' ' ' TRP . . . . . 0.468 ' HA ' HD23 ' A' ' 241' ' ' LEU . 61.6 m95 -54.56 141.06 32.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -88.62 -130.98 3.77 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.539 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 110.812 -179.87 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 92.1 p -66.98 83.5 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.886 0.374 . . . . 0.0 110.813 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 99.1 p -122.45 94.48 4.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.825 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -110.35 168.99 13.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.479 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.0 m -113.97 97.39 6.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 90.7 p -115.6 175.17 5.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.92 115.35 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.44 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.5 90.31 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.9 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.62 102.87 6.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.445 ' O ' ' NH1' ' A' ' 284' ' ' ARG . 27.6 mtmm -112.53 -66.25 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 37.7 p -120.28 34.08 5.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.123 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 240' ' ' THR . 78.1 mt -73.53 115.14 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.125 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.8 p -102.11 31.0 4.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.533 ' H ' HG22 ' A' ' 238' ' ' ILE . 28.2 m -131.89 148.31 52.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 31.1 mt -132.91 156.01 48.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.56 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.4 OUTLIER -109.75 147.74 32.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.896 HG22 HG22 ' A' ' 307' ' ' VAL . 90.4 t -141.1 120.72 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.03 168.78 12.67 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.494 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.518 ' O ' HD22 ' A' ' 305' ' ' LEU . . . 73.81 44.31 31.78 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.503 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.668 HD11 ' HB2' ' A' ' 277' ' ' ALA . 52.4 mt -77.52 -60.41 2.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.931 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.28 156.45 0.17 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.492 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -49.39 -29.27 6.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.39 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.1 p -59.19 -43.84 92.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.146 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.573 ' CD1' HD21 ' A' ' 305' ' ' LEU . 60.4 mt -96.87 143.49 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 29.5 p -124.9 173.94 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -58.38 -59.64 5.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 88.7 m -41.22 -56.68 2.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -42.62 -42.73 3.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.463 HD11 HD22 ' A' ' 246' ' ' LEU . 33.4 mt -77.46 -57.26 3.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -39.0 -43.97 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -75.99 -38.04 57.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.87 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.431 ' O ' ' NE2' ' A' ' 261' ' ' GLN . 4.9 t60 -60.11 -35.13 74.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.839 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -94.15 -43.41 8.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.845 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.566 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -39.93 -36.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.919 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 29.4 pt20 -52.55 -46.2 66.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.926 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.591 ' CE1' HG12 ' A' ' 289' ' ' VAL . 62.7 m-85 -56.18 -48.84 75.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.39 -143.29 4.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.463 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -93.6 128.64 39.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 110.855 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.566 HD11 ' N ' ' A' ' 260' ' ' TYR . 57.6 mt -93.73 114.98 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 280' ' ' GLN . 9.9 mtt180 -60.62 -49.21 78.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.6 t -162.56 168.06 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.166 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.471 HD11 HG21 ' A' ' 265' ' ' ILE . 87.9 mt -146.07 110.66 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.4 m -104.37 99.88 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.438 HG13 ' CD1' ' A' ' 246' ' ' LEU . 85.7 t -92.5 107.65 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 14.8 t -91.97 100.76 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.67 -48.53 80.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -55.78 -26.65 47.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 275' ' ' GLN . 19.2 mm100 -110.6 11.3 22.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.44 ' C ' ' O ' ' A' ' 274' ' ' GLN . 80.5 mt-30 35.15 47.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 16.7 p -140.5 177.53 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.668 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -156.84 137.23 12.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.076 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -106.13 111.07 23.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 268' ' ' ILE . 6.1 mm -94.27 127.68 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 266' ' ' ARG . 9.1 tt0 -114.66 145.1 42.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.933 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.31 147.37 48.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.403 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -68.94 -37.04 78.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.141 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 284' ' ' ARG . 24.4 p -125.12 121.28 33.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.445 ' NH1' ' O ' ' A' ' 236' ' ' LYS . 12.0 tpt180 -37.88 -35.69 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 284' ' ' ARG . 1.4 tm0? -36.8 -67.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.23 79.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.084 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 284' ' ' ARG . . . -50.51 -58.51 5.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.085 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.446 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 11.5 mt-10 -51.63 -62.43 1.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.591 HG12 ' CE1' ' A' ' 262' ' ' PHE . 37.7 t -41.95 -56.44 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.58 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -57.33 -41.45 80.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -49.68 -65.97 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.082 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.25 -39.88 70.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -78.44 1.63 21.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.732 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.6 m -117.15 -26.67 6.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -57.0 103.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 42.13 27.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -124.24 -26.15 4.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 5.4 tp -72.88 97.82 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.92 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 304' ' ' ARG . 32.0 mt -115.58 92.33 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 19.9 t -95.39 146.94 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 5.8 m120 51.59 46.52 26.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.12 30.05 5.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -133.07 103.66 6.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 110.898 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.506 ' O ' HD23 ' A' ' 305' ' ' LEU . 4.7 ttm180 -47.72 144.38 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 250' ' ' ILE . 47.4 mt -129.93 137.24 50.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -89.29 111.75 22.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.896 HG22 HG22 ' A' ' 243' ' ' VAL . 45.6 t -111.39 145.09 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.56 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 6.0 ptpp? -149.54 163.68 37.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -69.75 124.35 23.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.64 -133.82 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.454 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 0.0 110.861 -179.833 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 85.6 p -115.85 150.91 36.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.793 0.33 . . . . 0.0 110.891 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.9 m -104.66 42.25 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 77.5 49.18 7.47 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.513 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.7 t -164.32 143.23 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 0.0 110.868 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 58.2 m -120.46 119.32 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -61.83 157.17 35.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.461 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.38 43.08 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 0.0 110.866 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.443 ' HA ' ' CD1' ' A' ' 238' ' ' ILE . 7.4 p-10 -88.89 112.75 23.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.797 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 237' ' ' THR . 6.1 mtmp? -101.67 103.39 14.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 236' ' ' LYS . 30.1 p 37.51 36.8 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.144 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.565 HG22 ' H ' ' A' ' 240' ' ' THR . 67.6 mt -73.95 118.68 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.0 p -102.88 34.06 3.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.165 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.565 ' H ' HG22 ' A' ' 238' ' ' ILE . 24.0 m -136.15 141.66 44.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.409 HD11 ' O ' ' A' ' 287' ' ' ALA . 42.0 mt -128.81 125.9 38.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.576 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -80.44 150.07 29.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.854 HG22 HG22 ' A' ' 307' ' ' VAL . 97.6 t -138.57 137.4 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.114 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.68 -179.02 15.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 60.45 44.33 97.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 277' ' ' ALA . 21.8 mt -77.52 -60.27 2.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 110.905 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 62.97 150.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.492 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -42.1 -31.47 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.9 p -55.69 -42.3 75.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.697 ' CD1' HD21 ' A' ' 305' ' ' LEU . 69.2 mt -99.39 151.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.122 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 40.4 p -131.69 177.5 7.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.142 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -57.03 11.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.1 m -44.61 -55.5 5.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -43.74 -44.32 6.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.56 -48.51 32.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -46.09 -45.67 16.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -77.03 -37.7 54.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -60.68 -35.01 75.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.845 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.474 ' CE2' HG13 ' A' ' 279' ' ' ILE . 69.7 m-85 -94.15 -41.11 9.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.898 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -41.97 -38.77 1.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 22.9 pt20 -48.53 -41.7 30.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.606 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 71.5 m-85 -63.34 -45.08 92.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 179.22 -154.92 14.73 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.476 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -78.74 144.8 34.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.794 0.33 . . . . 0.0 110.918 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.637 HD13 HD11 ' A' ' 268' ' ' ILE . 46.2 mt -110.55 119.27 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.438 ' NE ' ' HA ' ' A' ' 282' ' ' ALA . 49.1 mtt180 -65.11 -52.2 56.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 4.0 t -164.35 149.7 10.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.637 HD11 HD13 ' A' ' 265' ' ' ILE . 76.2 mt -128.68 110.26 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 21.8 m -102.98 98.91 8.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.133 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 246' ' ' LEU . 45.3 t -92.69 107.58 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.457 HG12 ' HG3' ' A' ' 273' ' ' ARG . 22.1 t -93.87 100.53 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 14.7 pt20 -60.09 -42.66 95.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.457 ' HG3' HG12 ' A' ' 271' ' ' VAL . 4.1 ptm180 -59.19 -17.68 29.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 275' ' ' GLN . 46.2 mt-30 -123.38 15.52 9.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.856 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 274' ' ' GLN . 40.7 mt-30 33.63 47.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 25.8 p -140.8 170.35 15.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -153.75 134.62 13.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 26.9 m-85 -101.83 108.43 19.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.598 HD13 HG23 ' A' ' 268' ' ' ILE . 6.0 mm -93.17 112.17 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.145 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -102.78 143.52 32.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -121.03 156.65 31.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.438 ' HA ' ' NE ' ' A' ' 266' ' ' ARG . . . -77.26 -37.24 53.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 284' ' ' ARG . 23.9 p -124.06 119.53 29.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.476 ' NE ' ' HG3' ' A' ' 288' ' ' GLU . 14.4 tpt180 -36.0 -40.09 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.557 ' O ' HG23 ' A' ' 289' ' ' VAL . 30.8 tp60 -34.68 -63.15 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.93 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -59.69 -41.65 91.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.074 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.426 ' HB3' ' HD2' ' A' ' 284' ' ' ARG . . . -55.11 -61.3 2.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.101 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 13.6 mt-10 -48.45 -57.3 6.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.563 HG12 ' CE1' ' A' ' 262' ' ' PHE . 57.6 t -45.58 -63.77 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.606 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -54.96 -35.33 64.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.136 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -54.55 -49.09 71.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.34 -25.53 59.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -92.41 5.73 49.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.773 ' OG ' HG11 ' A' ' 307' ' ' VAL . 54.6 p -115.79 -35.72 4.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.839 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.3 m-85 -50.35 109.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 40.07 34.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -133.71 -33.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.443 ' HG ' HD12 ' A' ' 305' ' ' LEU . 10.1 tp -67.62 98.3 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 304' ' ' ARG . 40.4 mt -118.35 93.34 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.117 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 47.1 t -91.67 136.8 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.083 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 56.15 46.26 21.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.854 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 49.38 29.67 10.99 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -130.41 100.95 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.437 ' N ' HG23 ' A' ' 299' ' ' ILE . 22.6 ttp180 -44.69 144.75 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.697 HD21 ' CD1' ' A' ' 250' ' ' ILE . 52.2 mt -129.19 135.84 49.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -86.4 105.99 17.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.854 HG22 HG22 ' A' ' 243' ' ' VAL . 55.5 t -105.87 144.87 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.576 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 15.9 ptpt -150.47 171.28 17.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -82.85 119.63 24.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.71 -133.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 110.843 -179.851 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 29.8 p -97.38 100.19 11.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.0 m -92.58 91.51 7.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 58.79 -136.38 51.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.494 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 80.6 p -166.88 108.99 0.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.882 0.372 . . . . 0.0 110.865 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 66.7 m -138.91 162.75 34.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -109.5 108.55 2.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -162.77 173.13 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.902 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 46.94 54.62 8.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -84.6 -47.45 10.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 28.4 p -132.03 23.47 4.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 13.8 mt -78.83 102.39 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 44.0 p -95.35 35.39 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.1 m -133.02 141.16 48.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.0 mt -126.32 159.04 34.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.679 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.4 OUTLIER -111.58 147.59 35.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 307' ' ' VAL . 95.5 t -140.42 120.63 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.17 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 -178.83 20.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.462 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.47 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 58.65 50.29 68.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 277' ' ' ALA . 62.2 mt -86.16 -57.34 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.862 0.363 . . . . 0.0 110.963 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.53 163.71 0.54 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.452 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -52.6 -32.65 42.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.951 0.405 . . . . 0.0 110.891 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.7 p -54.89 -44.78 74.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.484 ' CD1' HD21 ' A' ' 305' ' ' LEU . 86.6 mt -97.87 142.18 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.203 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 37.4 p -124.18 -178.64 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -65.12 -59.68 3.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 87.3 m -42.05 -55.73 3.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.188 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.56 -45.27 6.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 14.5 mt -72.17 -47.2 52.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.407 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 24.1 ttp180 -46.31 -45.19 17.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -76.09 -38.21 57.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.49 ' O ' ' NE2' ' A' ' 261' ' ' GLN . 5.7 t60 -60.23 -35.4 75.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.564 ' CE2' HG13 ' A' ' 279' ' ' ILE . 62.9 m-85 -94.22 -42.3 9.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.663 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.7 t80 -39.92 -35.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 20.3 pt20 -56.26 -44.38 79.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.748 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 41.3 m-85 -55.22 -51.03 67.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.51 -141.89 3.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.43 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -93.15 125.5 37.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 110.901 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.663 HD11 ' N ' ' A' ' 260' ' ' TYR . 48.7 mt -93.51 121.53 44.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.481 ' NE ' ' HA ' ' A' ' 282' ' ' ALA . 43.0 mtt-85 -68.25 -47.94 66.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.4 t -171.14 153.0 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.138 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.407 ' CD1' ' HA ' ' A' ' 256' ' ' ARG . 83.6 mt -127.86 116.42 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 24.4 m -109.37 99.04 8.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.651 HG22 ' CB ' ' A' ' 277' ' ' ALA . 85.6 t -93.52 121.21 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 274' ' ' GLN . 90.3 t -108.7 100.17 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.091 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -57.07 -42.12 80.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 20.2 ttt-85 -50.13 -38.26 38.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.542 ' H ' HG12 ' A' ' 271' ' ' VAL . 63.3 mt-30 -108.35 8.72 27.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.867 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 42.82 52.52 5.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 18.6 p -142.91 177.13 8.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.651 ' CB ' HG22 ' A' ' 270' ' ' VAL . . . -160.17 136.94 9.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.043 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -102.36 115.8 31.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.564 HG13 ' CE2' ' A' ' 259' ' ' PHE . 9.3 mm -95.94 113.2 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.172 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -101.04 147.9 25.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -129.97 151.6 50.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.481 ' HA ' ' NE ' ' A' ' 266' ' ' ARG . . . -72.4 -41.27 66.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 29.7 p -120.34 122.78 41.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.119 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.532 ' HD2' ' HB3' ' A' ' 287' ' ' ALA . 17.7 tpt180 -38.29 -39.62 0.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.881 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -37.48 -59.3 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -59.74 -41.43 90.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.044 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.532 ' HB3' ' HD2' ' A' ' 284' ' ' ARG . . . -56.8 -53.5 57.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -53.77 -57.5 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 285' ' ' GLN . 86.1 t -46.03 -63.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.748 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -53.02 -47.21 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -45.21 -67.17 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.095 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.8 -35.28 68.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.402 ' HE2' HG12 ' A' ' 289' ' ' VAL . 9.6 mtmm -85.72 5.14 33.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.575 ' HB3' HG21 ' A' ' 307' ' ' VAL . 4.7 m -119.07 -26.19 6.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 297' ' ' LYS . 2.9 m-85 -56.08 110.0 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 40.18 26.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 295' ' ' PHE . 19.1 tttm -124.91 -30.12 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.459 ' HG ' HD12 ' A' ' 305' ' ' LEU . 9.1 tp -67.53 100.56 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 50.1 mt -116.99 97.13 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.4 HG22 ' ND1' ' A' ' 258' ' ' HIS . 42.4 t -96.24 139.79 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.202 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 52.36 47.74 24.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.65 27.56 6.21 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.46 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.1 ttt85 -127.44 101.52 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 110.821 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.6 ' O ' HD23 ' A' ' 305' ' ' LEU . 45.3 ttp85 -43.83 146.82 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 304' ' ' ARG . 45.3 mt -134.84 134.31 40.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -89.11 109.25 20.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 242' ' ' TYR . 81.7 t -106.63 142.96 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.159 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.568 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 13.3 ptpt -148.12 163.25 37.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -71.09 124.55 24.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -76.86 -145.82 2.03 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.451 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.862 -179.821 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 6.7 t -87.6 80.88 7.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.354 . . . . 0.0 110.885 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.8 m -108.48 153.13 23.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.889 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 69.78 163.54 4.0 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.483 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 87.3 p -81.63 150.24 28.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.869 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.6 t -112.42 128.17 56.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 66.29 159.39 0.72 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -109.38 82.93 1.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -57.72 116.77 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -118.25 -53.81 2.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 35.1 p -127.79 24.19 6.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.178 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 55.3 mt -74.52 106.11 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.1 p -97.57 36.19 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.172 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 18.0 m -133.84 151.28 51.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 291' ' ' ALA . 35.5 mt -137.12 134.95 36.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.585 ' CD1' ' HG3' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -97.3 150.36 21.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.607 HG22 HG22 ' A' ' 307' ' ' VAL . 59.1 t -142.26 139.85 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -130.51 164.55 22.96 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.445 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 74.97 43.84 25.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 250' ' ' ILE . 94.3 mt -74.11 -61.74 1.75 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.884 0.373 . . . . 0.0 110.918 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.42 151.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.464 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -42.78 -34.43 0.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.888 0.375 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.6 p -57.08 -42.83 81.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.156 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.76 ' CD1' HD21 ' A' ' 305' ' ' LEU . 55.9 mt -94.88 143.59 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.1 p -126.98 -176.81 3.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.159 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -65.89 -59.88 3.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.997 0.427 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.2 m -43.36 -50.89 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -40.89 -50.62 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.488 HD11 ' CD2' ' A' ' 246' ' ' LEU . 17.3 mt -73.85 -53.49 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 260' ' ' TYR . 67.0 ttt180 -41.07 -42.95 2.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -75.5 -46.43 32.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.765 ' CD2' HD13 ' A' ' 298' ' ' LEU . 52.3 t60 -54.71 -36.31 64.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -90.47 -44.42 9.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.5 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.3 t80 -40.08 -35.67 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.463 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 26.8 pt20 -54.54 -46.19 73.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.764 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 52.8 m-85 -56.01 -50.01 72.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -177.12 -154.99 12.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.473 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -75.64 141.73 42.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 260' ' ' TYR . 71.1 mt -110.58 112.43 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.137 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -57.66 -50.15 74.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 10.5 t -164.03 168.15 19.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.154 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.448 HD11 HG21 ' A' ' 265' ' ' ILE . 77.3 mt -145.12 106.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 57.1 m -97.61 98.84 10.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 88.5 t -93.93 109.12 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.521 HG12 ' HG2' ' A' ' 273' ' ' ARG . 15.9 t -97.0 99.65 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -60.67 -46.39 90.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.521 ' HG2' HG12 ' A' ' 271' ' ' VAL . 25.4 ptt180 -55.46 -19.83 10.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.47 ' O ' ' C ' ' A' ' 275' ' ' GLN . 65.1 mm-40 -121.19 15.88 11.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 274' ' ' GLN . 29.1 mt-30 32.26 50.45 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 25.9 p -145.92 167.15 23.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.854 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.95 156.52 42.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 56.4 m-85 -126.32 108.07 10.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.466 HG22 ' CE1' ' A' ' 281' ' ' PHE . 4.7 mp -93.69 120.93 43.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.111 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -107.82 146.66 31.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.482 ' HE1' HD12 ' A' ' 241' ' ' LEU . 87.9 m-85 -124.31 147.1 48.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.65 70.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.137 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 284' ' ' ARG . 39.4 p -129.12 118.05 21.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 283' ' ' THR . 16.2 tpt180 -36.31 -34.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 283' ' ' THR . 20.8 tp60 -37.94 -68.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.6 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.138 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -52.12 -60.69 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 6.4 mt-10 -46.88 -59.41 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 39.4 t -46.5 -60.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.764 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -55.08 -32.23 61.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.594 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -61.53 -46.04 91.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -72.76 -29.94 63.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 297' ' ' LYS . 18.5 mttt -87.0 -18.08 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.646 ' CB ' HG11 ' A' ' 307' ' ' VAL . 78.8 p -92.72 -36.03 13.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.3 m-85 -54.08 109.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 1.8 m120 41.51 29.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 293' ' ' LYS . 9.6 mmmt -126.93 -37.69 2.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.765 HD13 ' CD2' ' A' ' 258' ' ' HIS . 12.7 tp -63.4 98.03 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.52 94.43 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.21 146.33 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.163 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 22.0 m120 54.47 41.02 32.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.63 33.41 12.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.447 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 22.7 ttt-85 -134.25 97.65 3.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.308 . . . . 0.0 110.863 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -43.72 144.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.76 HD21 ' CD1' ' A' ' 250' ' ' ILE . 48.9 mt -128.81 136.23 50.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -85.7 103.64 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.646 HG11 ' CB ' ' A' ' 294' ' ' SER . 94.6 t -102.47 139.45 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.178 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.585 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 2.9 pttt -150.25 147.34 27.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.95 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -53.14 148.94 7.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -99.98 -137.53 9.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.488 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.844 -179.818 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 92.6 p -77.0 138.52 39.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 110.86 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 92.6 p -126.13 -50.98 1.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -71.85 -52.28 12.44 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.6 t -51.74 149.14 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.854 0.359 . . . . 0.0 110.839 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 67.1 m 62.05 44.6 7.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.885 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -96.67 -144.61 17.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.463 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -91.96 161.7 14.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 0.0 110.898 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.3 113.54 4.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -93.98 92.62 7.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 74.7 p 39.0 38.1 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.162 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 240' ' ' THR . 82.3 mt -70.24 114.42 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.411 HG22 ' CA ' ' A' ' 284' ' ' ARG . 51.2 p -98.67 27.02 5.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.582 ' H ' HG22 ' A' ' 238' ' ' ILE . 21.7 m -125.58 139.51 53.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 35.5 mt -131.1 123.97 29.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.963 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.652 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.2 OUTLIER -81.65 154.89 25.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.928 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.841 HG22 HG22 ' A' ' 307' ' ' VAL . 75.1 t -139.76 134.83 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -123.04 -179.66 15.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 57.95 43.78 94.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.523 ' HA ' HD12 ' A' ' 250' ' ' ILE . 75.6 mt -83.81 -57.32 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 110.871 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.46 164.45 0.28 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.495 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -54.83 -31.19 59.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 110.828 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.409 ' OG1' ' NE ' ' A' ' 303' ' ' ARG . 23.2 p -56.83 -34.25 67.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.79 ' CD1' HD21 ' A' ' 305' ' ' LEU . 58.3 mt -104.78 138.83 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.123 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 46.1 p -111.84 179.95 3.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -69.29 -52.04 31.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.8 m -50.06 -51.31 43.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.149 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -41.81 -42.16 2.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.9 mt -80.21 -50.24 10.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 -45.06 -41.55 7.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -76.92 -43.67 34.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.505 ' CD2' HD13 ' A' ' 298' ' ' LEU . 6.0 t60 -58.69 -32.76 69.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.461 ' CZ ' HD22 ' A' ' 298' ' ' LEU . 61.7 m-85 -94.0 -38.85 10.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.475 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.4 t80 -46.35 -40.67 12.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.4 pt20 -48.61 -38.69 21.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.951 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 88.7 m-85 -65.86 -43.03 89.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 178.5 -153.73 13.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.506 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -80.87 141.24 34.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.794 0.331 . . . . 0.0 110.88 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.475 HD11 ' N ' ' A' ' 260' ' ' TYR . 62.6 mt -110.32 111.28 35.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 280' ' ' GLN . 26.9 mtt-85 -53.91 -49.65 68.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 13.8 t -167.44 169.02 12.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.423 HG23 HD13 ' A' ' 279' ' ' ILE . 76.8 mt -144.95 111.25 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.3 m -105.31 98.94 8.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.484 HG22 ' CB ' ' A' ' 277' ' ' ALA . 82.0 t -91.69 107.4 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 274' ' ' GLN . 95.1 t -92.81 99.97 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' GLN . . . . . 0.42 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 5.1 pt20 -59.75 -32.74 70.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.936 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.42 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 9.3 tpp85 -59.63 -38.47 81.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.672 ' H ' HG12 ' A' ' 271' ' ' VAL . 12.6 mt-30 -110.71 19.7 18.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 274' ' ' GLN . 60.0 mt-30 34.25 53.14 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 31.1 p -143.56 165.7 26.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.511 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -146.0 133.77 21.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.089 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.424 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 17.6 m-85 -99.31 108.19 20.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.873 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.423 HD13 HG23 ' A' ' 268' ' ' ILE . 3.8 mm -93.01 116.14 33.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 266' ' ' ARG . 34.9 tt0 -106.64 136.33 46.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -113.72 153.16 29.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -77.63 -33.74 53.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.079 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 284' ' ' ARG . 34.4 p -128.75 118.72 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.129 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.493 ' NE ' ' HG3' ' A' ' 288' ' ' GLU . 15.4 tpt180 -35.99 -40.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.722 ' O ' HG23 ' A' ' 289' ' ' VAL . 0.7 OUTLIER -34.59 -62.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -60.54 -42.29 96.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.086 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.25 -63.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.603 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 7.9 mt-10 -45.59 -54.3 7.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 285' ' ' GLN . 39.2 t -50.7 -67.69 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.564 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -53.36 -29.41 34.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.065 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -55.11 -53.08 60.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -72.59 -26.45 61.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -90.25 5.23 47.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.549 ' HB2' HG21 ' A' ' 307' ' ' VAL . 89.8 p -117.13 -39.0 3.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 297' ' ' LYS . 3.1 m-85 -46.37 107.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 2.0 t30 40.12 27.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.876 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 295' ' ' PHE . 8.5 tmtt? -122.65 -32.85 3.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.505 HD13 ' CD2' ' A' ' 258' ' ' HIS . 8.1 tp -69.91 100.96 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.932 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 65.1 mt -120.11 93.1 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 60.1 t -96.33 142.35 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.121 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 30.9 m120 50.96 55.03 10.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 40.54 33.13 0.53 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ARG . . . . . 0.409 ' NE ' ' OG1' ' A' ' 249' ' ' THR . 31.0 ttm-85 -132.12 103.23 6.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.921 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.57 ' O ' HD23 ' A' ' 305' ' ' LEU . 46.5 ttp85 -54.07 144.88 18.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.79 HD21 ' CD1' ' A' ' 250' ' ' ILE . 23.6 mt -130.06 132.15 46.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -87.45 102.73 14.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.841 HG22 HG22 ' A' ' 243' ' ' VAL . 95.8 t -100.86 136.42 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.605 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -146.89 145.88 29.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -52.82 133.92 37.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -87.4 -134.77 4.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.77 0.319 . . . . 0.0 110.884 -179.895 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 80.5 p -74.25 -52.52 12.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.909 0.385 . . . . 0.0 110.86 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 32.8 t -140.19 137.34 34.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -114.58 -147.45 9.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.6 t -116.67 139.8 50.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.907 0.384 . . . . 0.0 110.829 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 30.3 t -128.32 119.07 24.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.835 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -143.5 178.53 21.59 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.46 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -72.54 107.11 4.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.328 . . . . 0.0 110.924 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -122.49 53.28 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.565 ' HD3' HG23 ' A' ' 237' ' ' THR . 0.0 OUTLIER -122.52 -33.68 3.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.89 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.565 HG23 ' HD3' ' A' ' 236' ' ' LYS . 0.8 OUTLIER -106.82 29.15 7.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.158 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 311' ' ' ARG . 75.5 mt -67.26 110.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.9 p -99.65 29.38 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.467 ' H ' HG22 ' A' ' 238' ' ' ILE . 23.1 m -124.9 152.21 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.156 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 31.5 mt -137.01 127.05 25.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.964 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.574 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -88.9 145.43 25.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 307' ' ' VAL . 84.3 t -139.07 133.87 40.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -122.59 167.95 14.99 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.547 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.92 42.49 44.97 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 277' ' ' ALA . 29.7 mt -77.7 -60.03 2.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.847 0.356 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.57 159.0 0.72 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.451 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -48.36 -32.97 8.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 79.4 p -55.92 -46.39 78.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.645 ' CD1' HD21 ' A' ' 305' ' ' LEU . 77.2 mt -93.1 150.51 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.059 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.6 p -132.8 -179.89 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.633 ' HB2' HG21 ' A' ' 270' ' ' VAL . 25.3 tt0 -66.13 -58.19 5.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 79.4 m -44.11 -51.01 8.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.185 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -44.49 -48.13 10.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 13.8 mt -74.78 -45.16 45.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.929 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 50.1 ttt180 -49.09 -42.94 40.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -78.76 -43.39 25.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.551 ' CE1' HD12 ' A' ' 298' ' ' LEU . 64.9 t-80 -57.9 -33.83 69.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -94.38 -40.02 10.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.565 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.5 t80 -42.4 -36.56 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.479 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 16.3 pt20 -51.89 -41.07 61.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.736 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 63.7 m-85 -60.88 -49.23 78.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -178.95 -163.45 30.06 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -69.74 130.51 42.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 0.0 110.883 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.565 HD11 ' N ' ' A' ' 260' ' ' TYR . 79.1 mt -99.98 109.66 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.486 ' HG3' ' N ' ' A' ' 282' ' ' ALA . 22.7 mtt-85 -51.39 -53.07 40.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.0 t -164.07 165.41 22.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 98.3 mt -139.65 105.57 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.092 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.2 m -98.06 99.98 11.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.127 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.633 HG21 ' HB2' ' A' ' 252' ' ' GLU . 66.7 t -93.59 106.02 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.784 HG12 ' HG2' ' A' ' 273' ' ' ARG . 4.4 t -91.15 99.67 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -60.79 -47.76 84.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.784 ' HG2' HG12 ' A' ' 271' ' ' VAL . 6.0 ptm180 -55.18 -20.1 9.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.475 ' O ' ' C ' ' A' ' 275' ' ' GLN . 28.2 mm-40 -121.28 15.74 11.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 274' ' ' GLN . 31.6 mt-30 32.25 50.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 22.6 p -142.51 168.24 20.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -148.28 153.41 38.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 53.5 m-85 -124.65 108.96 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.564 HG22 ' CE1' ' A' ' 281' ' ' PHE . 4.5 mp -94.72 120.7 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.126 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 266' ' ' ARG . 53.0 tt0 -109.49 147.47 32.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.564 ' CE1' HG22 ' A' ' 279' ' ' ILE . 87.8 m-85 -126.95 139.86 52.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.866 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.486 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -59.7 -36.29 76.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 284' ' ' ARG . 38.3 p -123.1 116.66 23.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.443 ' NH1' ' O ' ' A' ' 236' ' ' LYS . 14.5 tpt180 -36.0 -37.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 284' ' ' ARG . 0.9 OUTLIER -35.65 -63.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.89 80.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.083 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.07 -45.84 79.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.122 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -62.94 -54.04 44.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.489 HG12 ' CE1' ' A' ' 262' ' ' PHE . 49.0 t -50.42 -58.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.736 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -57.47 -45.26 85.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.079 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -41.61 -67.82 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.046 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.58 -40.85 69.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -76.94 1.84 16.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.709 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.3 m -118.41 -25.0 6.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -57.13 104.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 15.3 m120 41.46 30.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -126.8 -32.83 2.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.551 HD12 ' CE1' ' A' ' 258' ' ' HIS . 5.0 tp -65.96 96.4 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 56.0 mt -114.7 95.58 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.82 142.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 18.8 m120 57.9 41.4 24.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 49.86 33.19 19.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -134.93 104.4 5.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 110.889 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.402 ' O ' HD23 ' A' ' 305' ' ' LEU . 17.4 ttm180 -49.96 145.06 5.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.645 HD21 ' CD1' ' A' ' 250' ' ' ILE . 27.1 mt -129.64 133.39 47.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -85.44 98.73 10.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 243' ' ' VAL . 93.8 t -96.45 145.01 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.195 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.556 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 0.6 OUTLIER -158.42 145.39 17.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -52.32 148.97 5.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -97.37 -136.43 9.11 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 238' ' ' ILE . 14.4 ttp180 . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 120.787 0.327 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 15.2 m -98.81 90.62 4.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.896 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.3 t -107.76 161.59 14.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 148.55 89.68 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 12.9 t -175.0 134.31 0.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.896 0.379 . . . . 0.0 110.826 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 42.8 t -154.78 158.96 40.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -160.79 44.75 0.41 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.458 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -62.05 -42.05 98.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.367 . . . . 0.0 110.856 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -57.4 109.12 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -102.26 -69.48 0.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 82.0 p -119.48 30.28 7.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.146 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.537 ' N ' HH11 ' A' ' 284' ' ' ARG . 69.3 mt -78.24 114.68 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.107 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.402 HG22 ' CA ' ' A' ' 284' ' ' ARG . 46.2 p -98.75 38.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.501 ' H ' HG22 ' A' ' 238' ' ' ILE . 14.2 m -133.4 143.14 48.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.117 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 22.7 mt -133.28 122.18 23.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.914 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.606 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -79.84 143.65 34.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.955 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.768 HG22 HG22 ' A' ' 307' ' ' VAL . 88.2 t -133.36 131.4 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.134 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -121.58 176.8 16.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 64.15 44.33 95.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.547 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.692 ' HA ' HD12 ' A' ' 250' ' ' ILE . 92.7 mt -86.78 -56.32 3.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.828 0.347 . . . . 0.0 110.95 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.5 155.58 0.37 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.555 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -46.59 -34.25 4.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.847 0.356 . . . . 0.0 110.858 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.8 p -53.83 -56.71 15.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.693 ' CD1' HD21 ' A' ' 305' ' ' LEU . 76.3 mt -75.41 140.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 32.9 p -117.15 179.64 3.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.109 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.74 -55.72 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 92.8 m -45.35 -47.22 13.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.459 ' HB3' HG11 ' A' ' 300' ' ' VAL . 0.7 OUTLIER -49.41 -38.42 28.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 30.4 mt -83.82 -50.0 8.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 49.7 ttm-85 -46.65 -41.74 15.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.884 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -76.55 -43.2 40.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.617 ' CE1' HD12 ' A' ' 298' ' ' LEU . 56.7 t-80 -58.64 -33.8 70.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -94.19 -40.4 10.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.547 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.5 t80 -42.01 -36.52 1.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.2 pt20 -51.98 -42.06 62.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.579 ' CE1' HG12 ' A' ' 289' ' ' VAL . 63.1 m-85 -59.77 -49.93 75.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -175.23 -145.12 5.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -88.53 129.42 35.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.346 . . . . 0.0 110.918 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.547 HD11 ' N ' ' A' ' 260' ' ' TYR . 65.3 mt -96.55 110.59 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.7 mtp85 -54.98 -54.55 41.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 11.9 t -162.14 166.49 25.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.153 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.494 HG23 HD13 ' A' ' 279' ' ' ILE . 87.1 mt -142.67 110.91 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 87.8 m -104.18 98.87 8.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.47 111.1 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.683 HG12 ' HG2' ' A' ' 273' ' ' ARG . 3.8 t -95.85 101.83 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -60.68 -47.13 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.683 ' HG2' HG12 ' A' ' 271' ' ' VAL . 4.7 ptm180 -53.18 -30.29 36.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 275' ' ' GLN . 55.7 mm-40 -112.76 13.64 19.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 274' ' ' GLN . 46.1 mt-30 34.91 53.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 11.4 p -143.57 172.01 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.515 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -152.77 132.1 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 18.4 m-85 -98.91 109.99 22.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.494 HD13 HG23 ' A' ' 268' ' ' ILE . 6.1 mm -94.14 116.29 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.149 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 266' ' ' ARG . 17.7 tt0 -105.86 141.71 36.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.413 ' C ' ' HG3' ' A' ' 266' ' ' ARG . 97.5 m-85 -119.56 151.95 37.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.16 77.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.087 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 33.8 p -126.08 126.17 43.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.131 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.537 HH11 ' N ' ' A' ' 238' ' ' ILE . 9.7 tpt180 -40.3 -32.19 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -40.99 -65.76 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.959 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.3 77.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.084 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.46 -58.06 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.101 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -48.82 -57.05 7.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.948 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.579 HG12 ' CE1' ' A' ' 262' ' ' PHE . 23.7 t -51.15 -54.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -57.06 -39.56 75.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -52.91 -66.38 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -53.42 -43.2 67.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -75.25 2.51 10.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.65 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.4 m -116.37 -30.9 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -52.43 95.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.1 m120 48.1 29.37 1.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 53.2 tttt -126.05 -31.01 2.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.617 HD12 ' CE1' ' A' ' 258' ' ' HIS . 5.4 tp -69.47 101.34 1.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 53.3 mt -118.72 94.4 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.465 HG22 ' CD2' ' A' ' 258' ' ' HIS . 53.5 t -93.53 133.36 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ASN . . . . . 0.426 ' ND2' HG12 ' A' ' 300' ' ' VAL . 78.1 m-20 57.31 54.32 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 41.84 32.11 0.89 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ARG . . . . . 0.501 ' HD2' HD11 ' A' ' 250' ' ' ILE . 26.9 ttm-85 -130.57 102.08 5.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.779 0.323 . . . . 0.0 110.86 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.563 ' O ' HD23 ' A' ' 305' ' ' LEU . 11.3 ttp180 -49.2 146.7 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.693 HD21 ' CD1' ' A' ' 250' ' ' ILE . 29.3 mt -134.03 133.62 41.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -87.98 101.91 14.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.768 HG22 HG22 ' A' ' 243' ' ' VAL . 92.9 t -97.62 145.61 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.591 ' HE3' ' CE1' ' A' ' 242' ' ' TYR . 4.8 pttt -156.45 144.6 19.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.886 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -53.12 145.51 13.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -88.47 -153.09 26.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 18.0 mmm-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.783 0.325 . . . . 0.0 110.886 -179.86 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 69.2 m -74.63 149.5 39.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.389 . . . . 0.0 110.814 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 13.0 t -132.83 90.24 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 123.56 -177.07 16.72 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.464 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 2.3 m -149.14 117.53 6.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.876 0.37 . . . . 0.0 110.835 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 28.5 m -116.15 102.11 9.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.828 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 174.22 -71.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.452 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -43.63 117.13 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.368 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.442 ' CB ' HD12 ' A' ' 238' ' ' ILE . 4.9 p30 -148.98 116.71 6.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -81.78 92.35 6.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.4 p 43.21 33.92 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.136 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 240' ' ' THR . 66.6 mt -72.56 114.39 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.0 p -102.19 29.81 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.195 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.517 ' H ' HG22 ' A' ' 238' ' ' ILE . 15.5 m -128.44 143.12 50.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 31.8 mt -131.96 124.69 29.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.6 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.3 OUTLIER -82.09 149.75 27.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.848 HG22 HG22 ' A' ' 307' ' ' VAL . 66.8 t -140.28 129.32 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.124 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.69 173.75 14.93 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 65.68 51.45 47.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.517 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.568 HD11 ' C ' ' A' ' 276' ' ' CYS . 79.3 mt -77.12 -61.58 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.12 145.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.476 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -40.13 -31.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.382 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 34.4 p -56.36 -45.9 80.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.626 ' CD1' HD21 ' A' ' 305' ' ' LEU . 61.8 mt -97.27 141.6 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 16.6 p -123.9 -177.5 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -66.46 -55.97 13.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 7.9 m -43.56 -59.14 2.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.476 ' HA ' ' ND2' ' A' ' 257' ' ' ASN . 18.7 m-20 -40.14 -59.28 1.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.432 HD11 HD22 ' A' ' 246' ' ' LEU . 14.9 mt -57.51 -52.12 66.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 41.8 ttt85 -48.87 -38.58 22.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ASN . . . . . 0.523 ' C ' ' OD1' ' A' ' 257' ' ' ASN . 0.4 OUTLIER -77.97 -40.47 39.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.648 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 58.2 t-80 -61.57 -33.08 73.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.49 ' CE2' HG13 ' A' ' 279' ' ' ILE . 72.5 m-85 -94.31 -40.39 9.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.629 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.4 t80 -41.99 -35.48 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.937 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 26.2 pt20 -55.17 -50.2 69.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.76 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 56.9 m-85 -53.1 -50.16 65.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.837 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -172.72 -155.09 10.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.488 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -83.35 127.95 34.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.629 HD11 ' N ' ' A' ' 260' ' ' TYR . 45.1 mt -93.61 114.19 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 280' ' ' GLN . 16.0 mtt180 -57.74 -50.61 72.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.5 t -165.45 170.96 13.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.124 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 86.8 mt -145.43 116.12 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 55.2 m -107.16 100.04 9.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.553 HG13 ' CD1' ' A' ' 246' ' ' LEU . 93.0 t -93.47 107.1 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.158 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 44.1 t -92.73 100.01 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.195 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -59.68 -38.76 82.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 -64.33 -10.22 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -130.44 6.0 4.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 41.81 45.11 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.568 ' C ' HD11 ' A' ' 246' ' ' LEU . 14.1 p -137.24 166.62 23.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -146.21 135.68 23.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 26.2 m-85 -104.18 108.5 19.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.49 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.8 mm -91.72 119.87 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.17 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 266' ' ' ARG . 42.2 tt0 -107.77 141.92 38.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.08 148.21 44.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.45 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -70.54 -37.36 74.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.096 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 284' ' ' ARG . 17.4 p -126.06 121.49 33.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.513 ' HD2' ' HB3' ' A' ' 287' ' ' ALA . 12.6 tpt180 -36.93 -40.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 284' ' ' ARG . 36.4 tp60 -34.46 -63.9 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.57 -44.88 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.513 ' HB3' ' HD2' ' A' ' 284' ' ' ARG . . . -50.78 -57.47 8.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.133 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 19.9 mt-10 -49.95 -65.04 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.498 HG12 ' CE1' ' A' ' 262' ' ' PHE . 59.7 t -39.08 -59.74 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.76 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -58.95 -37.69 77.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.101 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.585 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -49.9 -54.56 18.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -69.17 -28.59 66.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -90.3 4.98 49.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 58.2 p -117.37 -30.1 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 5.0 m-30 -55.57 105.76 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 40.67 29.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -124.4 -35.81 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.648 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 11.1 tp -67.04 93.33 0.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 304' ' ' ARG . 42.5 mt -113.47 91.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 41.3 t -92.29 146.32 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 m120 50.87 46.98 25.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.16 31.3 6.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -133.16 104.0 6.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.518 ' O ' HD23 ' A' ' 305' ' ' LEU . 12.6 ttm-85 -50.11 148.64 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.626 HD21 ' CD1' ' A' ' 250' ' ' ILE . 21.9 mt -131.45 132.52 44.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.21 99.75 11.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.848 HG22 HG22 ' A' ' 243' ' ' VAL . 72.9 t -101.92 140.37 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.532 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 11.7 pttt -149.17 149.07 30.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -52.77 136.3 33.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.913 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -82.79 -124.06 0.85 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.5 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.402 ' C ' HG23 ' A' ' 238' ' ' ILE . 50.1 ttt180 . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 0.0 110.867 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 32.8 t -64.52 151.63 43.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.922 0.392 . . . . 0.0 110.847 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.3 p -49.28 -43.86 43.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.88 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.8 95.77 2.28 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.488 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 84.1 p -103.0 116.3 32.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.907 0.384 . . . . 0.0 110.859 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 23.0 t -165.41 148.7 8.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.859 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 145.52 147.15 4.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.449 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -100.0 69.23 1.52 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 110.899 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.3 113.17 25.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -124.46 -56.48 1.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 78.8 p -126.68 26.15 6.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.161 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 34.0 mt -76.07 107.95 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.132 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.448 HG22 ' CA ' ' A' ' 284' ' ' ARG . 30.2 p -99.2 36.27 1.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 30.1 m -137.18 138.46 40.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 22.0 mt -125.28 156.94 37.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.562 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.3 OUTLIER -109.7 149.29 29.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.913 HG22 HG22 ' A' ' 307' ' ' VAL . 91.4 t -141.95 119.19 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.32 -175.04 20.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.534 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 55.69 45.82 84.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.509 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.479 ' HA ' HD12 ' A' ' 250' ' ' ILE . 44.7 mt -78.62 -59.13 2.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 0.0 110.943 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 62.72 153.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.507 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -42.12 -37.93 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.86 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 43.3 p -49.4 -44.43 45.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.835 ' CD1' HD21 ' A' ' 305' ' ' LEU . 65.3 mt -97.17 146.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.138 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.7 p -126.23 -178.78 4.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' A' ' 270' ' ' VAL . 1.2 tm-20 -66.39 -57.28 7.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.8 m -47.15 -54.36 10.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -40.81 -45.77 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 9.1 mt -74.07 -45.64 48.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -48.8 -46.03 41.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -76.25 -38.69 55.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -61.07 -34.56 75.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.499 ' CE2' HG13 ' A' ' 279' ' ' ILE . 58.4 m-85 -94.34 -39.67 10.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.863 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.677 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.7 t80 -43.48 -38.93 3.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.957 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 29.0 pt20 -50.28 -43.55 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 85.1 m-85 -60.54 -47.8 84.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -177.69 -167.01 35.21 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -69.03 127.22 32.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.343 . . . . 0.0 110.873 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.677 HD11 ' N ' ' A' ' 260' ' ' TYR . 84.3 mt -95.72 110.67 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.128 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.4 mtp180 -54.01 -51.5 63.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.8 t -164.71 169.47 16.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.194 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.463 HD11 HG21 ' A' ' 265' ' ' ILE . 88.6 mt -145.87 114.29 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.18 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 85.3 m -109.18 99.02 8.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.619 HG22 ' CB ' ' A' ' 277' ' ' ALA . 96.2 t -92.65 111.01 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.404 ' CG1' ' HG2' ' A' ' 273' ' ' ARG . 38.5 t -94.2 101.4 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' GLN . . . . . 0.422 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 5.2 pt20 -59.23 -40.61 86.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.422 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 6.6 ptp85 -62.16 -21.55 65.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 275' ' ' GLN . 74.0 mt-30 -117.31 14.27 14.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.94 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 274' ' ' GLN . 71.3 mt-30 34.38 43.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 21.7 p -141.04 173.51 11.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.619 ' CB ' HG22 ' A' ' 270' ' ' VAL . . . -157.36 140.28 15.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -105.12 121.86 44.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.499 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.1 mm -102.32 117.03 47.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.186 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 266' ' ' ARG . 16.3 tt0 -105.17 140.3 38.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.411 ' C ' ' HG3' ' A' ' 266' ' ' ARG . 97.5 m-85 -120.72 148.3 44.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.884 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.444 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -70.23 -34.01 72.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 284' ' ' ARG . 22.4 p -125.82 116.6 21.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.178 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.631 ' HD2' ' HB3' ' A' ' 287' ' ' ALA . 16.7 tpt180 -36.14 -39.3 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.508 ' O ' HG23 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -33.56 -64.42 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.02 -46.68 82.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.097 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.631 ' HB3' ' HD2' ' A' ' 284' ' ' ARG . . . -50.5 -53.26 31.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.453 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 6.2 mt-10 -55.24 -48.87 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 285' ' ' GLN . 42.1 t -57.88 -59.96 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.564 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -56.12 -33.97 65.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.16 -67.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.42 -39.71 73.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -75.08 1.59 12.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.604 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.4 m -115.81 -33.38 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.2 102.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 44.23 31.72 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -129.83 -31.14 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.446 ' HG ' HD12 ' A' ' 305' ' ' LEU . 6.6 tp -70.06 103.69 2.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 304' ' ' ARG . 27.0 mt -119.74 96.76 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 31.1 t -96.28 138.31 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.097 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 56.95 47.19 18.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.15 29.64 6.95 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.496 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 18.0 ttt85 -130.49 103.85 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.859 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.464 ' N ' HG23 ' A' ' 299' ' ' ILE . 13.7 ttm180 -48.23 137.67 10.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.835 HD21 ' CD1' ' A' ' 250' ' ' ILE . 26.3 mt -124.19 133.55 53.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -87.54 107.24 18.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.913 HG22 HG22 ' A' ' 243' ' ' VAL . 53.4 t -105.13 143.46 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.562 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -146.15 165.15 29.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -74.25 122.12 22.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.24 -151.89 0.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 14.3 ttp-105 . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.89 -179.883 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.441 -0.264 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 59.5 p -53.94 115.66 2.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.888 0.375 . . . . 0.0 110.821 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 43.7 m -56.67 126.8 28.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.817 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -142.73 -41.85 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 4.3 t -103.66 88.16 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.83 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 2.6 m -88.35 128.5 35.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.894 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -161.86 90.26 0.11 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.454 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -43.26 126.99 4.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.86 0.362 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -91.03 101.85 14.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.0 pttt -115.25 101.7 9.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 66.6 p 36.44 44.82 0.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 14.3 mt -85.57 98.43 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.153 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 284' ' ' ARG . 51.0 p -90.95 23.47 3.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 26.4 m -121.14 141.76 50.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.155 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 291' ' ' ALA . 26.7 mt -128.59 146.86 50.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.586 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -102.6 143.41 32.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.905 HG22 HG22 ' A' ' 307' ' ' VAL . 93.3 t -136.83 114.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -100.97 179.27 28.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.523 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.467 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 61.92 51.88 54.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.677 HD11 ' C ' ' A' ' 276' ' ' CYS . 88.0 mt -81.46 -59.65 2.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.11 149.97 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.459 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.9 -29.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.92 0.39 . . . . 0.0 110.842 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 23.8 p -57.94 -41.81 83.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.647 ' CD1' HD21 ' A' ' 305' ' ' LEU . 79.2 mt -99.13 146.16 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 40.6 p -127.04 -176.41 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.152 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.432 ' HB2' HG21 ' A' ' 270' ' ' VAL . 48.6 tt0 -71.51 -56.23 6.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 96.0 m -45.01 -48.86 11.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -49.53 -50.91 39.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.7 mt -67.32 -43.55 81.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -51.49 -45.01 62.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -78.69 -33.02 47.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -65.75 -34.87 79.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.435 ' CE2' HG13 ' A' ' 279' ' ' ILE . 60.4 m-85 -94.08 -37.58 11.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.601 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.3 t80 -44.77 -26.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.476 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 11.4 pt20 -63.96 -41.74 97.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.887 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.878 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 56.8 m-85 -62.21 -39.08 91.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 286' ' ' ALA . . . 174.71 -154.35 18.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.491 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -79.0 141.69 37.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.87 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.601 HD11 ' N ' ' A' ' 260' ' ' TYR . 70.9 mt -112.28 111.88 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 280' ' ' GLN . 20.5 mtt180 -59.97 -49.14 78.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.7 t -165.11 171.25 14.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.16 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 94.4 mt -144.4 106.96 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 26.4 m -96.61 100.66 12.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.136 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.432 HG21 ' HB2' ' A' ' 252' ' ' GLU . 94.6 t -94.79 109.54 22.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.082 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 274' ' ' GLN . 60.9 t -99.44 99.91 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -40.62 89.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -50.35 -39.02 45.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.524 ' H ' HG12 ' A' ' 271' ' ' VAL . 26.1 mt-30 -108.65 10.49 26.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 42.71 52.12 5.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.677 ' C ' HD11 ' A' ' 246' ' ' LEU . 25.7 p -140.58 168.66 19.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.29 130.23 15.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.126 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -100.14 109.56 21.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.435 HG13 ' CE2' ' A' ' 259' ' ' PHE . 2.9 mm -92.66 123.04 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.094 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 266' ' ' ARG . 38.6 tt0 -108.3 141.05 40.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -120.96 144.67 48.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.856 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.91 -37.09 78.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 284' ' ' ARG . 22.8 p -120.75 117.18 26.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.098 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.518 ' HA ' HG22 ' A' ' 239' ' ' THR . 13.7 tpt180 -37.21 -38.83 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 284' ' ' ARG . 12.7 tp60 -37.79 -67.39 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ALA . . . . . 0.477 ' HB2' ' HA3' ' A' ' 263' ' ' GLY . . . -52.86 -43.15 65.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 284' ' ' ARG . . . -52.44 -57.74 8.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 18.7 mt-10 -50.45 -63.15 1.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.415 HG12 ' HE3' ' A' ' 293' ' ' LYS . 28.8 t -41.21 -66.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.878 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -50.29 -46.4 55.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.457 ' HB2' HD11 ' A' ' 241' ' ' LEU . . . -47.26 -67.71 0.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -55.41 -38.76 69.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.415 ' HE3' HG12 ' A' ' 289' ' ' VAL . 14.5 mtmt -84.28 6.07 24.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.554 ' HB3' HG21 ' A' ' 307' ' ' VAL . 16.9 m -118.57 -13.22 9.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 297' ' ' LYS . 3.8 m-30 -71.27 113.92 8.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ASN . . . . . 0.405 ' HA ' ' NH1' ' A' ' 304' ' ' ARG . 1.2 m-20 41.9 25.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.877 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 295' ' ' PHE . 3.0 ttmm -126.21 -31.88 2.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 5.3 tp -71.62 101.4 2.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 304' ' ' ARG . 39.3 mt -115.88 95.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 32.8 t -90.36 136.61 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 17.9 m120 53.74 51.19 15.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.61 28.84 2.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 18.2 ttt-85 -129.14 98.22 4.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 110.852 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.526 ' N ' HG23 ' A' ' 299' ' ' ILE . 32.2 ttp85 -42.25 145.9 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.647 HD21 ' CD1' ' A' ' 250' ' ' ILE . 49.7 mt -130.59 135.97 48.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -89.55 99.47 12.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.905 HG22 HG22 ' A' ' 243' ' ' VAL . 75.2 t -95.72 142.39 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.075 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.586 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 11.9 ptpt -145.77 171.94 14.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -85.06 122.02 28.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.25 -133.8 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.469 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.8 tpp85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 110.849 -179.837 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 2.7 t -157.0 154.42 29.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 110.89 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.5 m -94.7 -46.3 6.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 142.6 84.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.487 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 82.6 p -55.95 -44.04 78.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 110.87 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 24.8 t -60.4 163.56 5.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 169.86 -173.98 44.03 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.488 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -95.59 111.86 23.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.359 . . . . 0.0 110.948 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.539 ' HB3' HD12 ' A' ' 238' ' ' ILE . 60.7 m-20 -115.53 119.62 36.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 237' ' ' THR . 22.8 mmmt -83.48 99.33 10.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.498 ' N ' HH21 ' A' ' 284' ' ' ARG . 72.6 p 35.84 40.64 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.168 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 235' ' ' ASP . 65.4 mt -77.01 117.71 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.131 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 29.1 p -108.41 26.59 10.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.473 ' H ' HG22 ' A' ' 238' ' ' ILE . 18.3 m -117.75 140.98 48.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.16 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 30.6 mt -128.49 133.24 48.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.603 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -97.92 140.72 31.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.969 HG22 HG22 ' A' ' 307' ' ' VAL . 89.5 t -135.5 127.31 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.51 174.89 16.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.436 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 70.66 42.29 62.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.483 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.575 ' CD1' HG13 ' A' ' 270' ' ' VAL . 24.3 mt -70.64 -62.9 1.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.826 0.346 . . . . 0.0 110.919 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.71 158.98 0.75 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.443 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -56.65 -15.58 4.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.8 p -74.26 -32.49 62.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.588 HD13 HD11 ' A' ' 305' ' ' LEU . 68.6 mt -108.97 145.26 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 12.4 p -128.56 177.19 7.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.151 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -59.55 -61.25 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 94.6 m -38.66 -56.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -40.31 -56.03 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.9 mt -65.42 -48.86 71.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.44 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 44.0 ttt180 -45.92 -43.13 13.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -79.46 -41.21 28.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.649 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 59.6 t-80 -57.91 -33.66 69.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.564 ' CD2' HG12 ' A' ' 279' ' ' ILE . 60.1 m-85 -94.22 -42.8 8.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.601 ' N ' HD11 ' A' ' 265' ' ' ILE . 2.0 t80 -42.29 -36.06 1.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.464 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.8 pt20 -54.3 -41.28 68.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.959 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 86.3 m-85 -64.84 -42.86 94.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 176.36 -172.22 45.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -61.47 142.27 57.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 110.922 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.601 HD11 ' N ' ' A' ' 260' ' ' TYR . 70.6 mt -111.93 111.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -55.02 -50.25 69.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.8 t -168.85 162.24 11.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.474 HD11 HD13 ' A' ' 265' ' ' ILE . 79.7 mt -138.4 108.46 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 92.4 m -99.63 100.34 11.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.575 HG13 ' CD1' ' A' ' 246' ' ' LEU . 76.8 t -92.62 103.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 274' ' ' GLN . 82.6 t -86.4 99.88 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' GLN . . . . . 0.475 ' O ' ' NE2' ' A' ' 275' ' ' GLN . 6.0 pt20 -60.25 -31.68 70.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -59.23 -38.08 79.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.695 ' H ' HG12 ' A' ' 271' ' ' VAL . 77.0 mt-30 -112.52 21.66 15.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.943 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 272' ' ' GLN . 65.2 mm-40 33.73 50.82 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 29.3 p -140.62 167.9 21.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.441 ' HB2' HG22 ' A' ' 270' ' ' VAL . . . -146.14 146.8 31.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.571 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 33.7 m-85 -115.21 107.72 15.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.598 HG22 ' CE1' ' A' ' 281' ' ' PHE . 3.9 mp -90.86 121.03 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.144 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -106.94 142.95 35.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.598 ' CE1' HG22 ' A' ' 279' ' ' ILE . 96.9 m-85 -122.75 142.03 51.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.43 74.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.046 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 36.8 p -131.81 123.88 28.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.134 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.498 HH21 ' N ' ' A' ' 237' ' ' THR . 6.0 tpp85 -39.0 -33.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.676 ' O ' HG23 ' A' ' 289' ' ' VAL . 21.6 tp60 -37.97 -65.9 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -58.23 -53.83 53.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -41.59 -63.45 0.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.096 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.585 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 4.7 mm-40 -46.3 -64.31 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.869 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 285' ' ' GLN . 18.6 t -40.25 -62.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.561 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -57.02 -33.98 67.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.119 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.59 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -53.86 -60.71 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.131 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -63.79 -36.53 84.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.425 ' HD2' ' CE2' ' A' ' 262' ' ' PHE . 17.7 mttm -75.97 -8.49 57.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.822 ' HB3' HG21 ' A' ' 307' ' ' VAL . 29.6 m -114.18 -9.82 12.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.8 m-30 -65.4 105.71 1.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.835 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 21.1 m120 43.36 27.79 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -127.68 -28.61 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.649 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 4.7 tp -67.8 97.37 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.961 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.419 HG23 ' N ' ' A' ' 304' ' ' ARG . 38.4 mt -116.13 94.53 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 49.8 t -95.85 145.2 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 14.5 m120 50.93 50.03 19.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.9 34.18 5.47 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.534 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -136.9 108.92 7.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 110.883 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.523 ' O ' HD23 ' A' ' 305' ' ' LEU . 24.5 ttm180 -56.84 143.69 36.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.588 HD11 HD13 ' A' ' 250' ' ' ILE . 43.0 mt -126.78 137.95 53.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.74 98.89 11.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.969 HG22 HG22 ' A' ' 243' ' ' VAL . 79.0 t -93.22 138.65 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.549 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.3 ptpt -151.56 141.52 22.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -50.7 135.19 23.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -72.25 -119.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.841 0.353 . . . . 0.0 110.88 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 93.9 p -50.59 131.24 25.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.0 110.834 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 22.0 p -45.84 -22.37 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.917 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -105.44 45.83 1.25 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.535 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 36.4 t -108.26 80.81 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.884 0.373 . . . . 0.0 110.91 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 233' ' ' GLY . 55.6 p -170.0 158.92 7.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.882 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 232' ' ' SER . . . -36.61 148.94 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.45 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -97.57 80.7 2.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.84 0.352 . . . . 0.0 110.869 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.44 109.64 2.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -115.92 -62.68 1.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 21.1 p -122.35 35.73 4.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.464 HG22 ' H ' ' A' ' 240' ' ' THR . 58.5 mt -75.33 110.2 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 284' ' ' ARG . 39.0 p -99.61 32.2 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.464 ' H ' HG22 ' A' ' 238' ' ' ILE . 9.4 m -130.22 149.37 51.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 291' ' ' ALA . 28.8 mt -132.3 156.85 45.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.817 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.3 OUTLIER -108.36 146.18 33.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 58.2 t -140.77 113.84 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.098 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -107.0 -177.42 22.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.519 ' O ' HD22 ' A' ' 305' ' ' LEU . . . 57.7 47.33 89.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.477 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.449 HD11 ' CB ' ' A' ' 277' ' ' ALA . 95.4 mt -83.22 -57.82 3.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 110.915 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.26 158.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.477 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -47.02 -33.95 5.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.912 0.387 . . . . 0.0 110.857 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.9 p -52.75 -44.38 66.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.774 ' CD1' HD21 ' A' ' 305' ' ' LEU . 70.4 mt -97.88 143.52 12.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 42.7 p -121.83 -176.65 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -70.1 -57.09 5.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.5 m -44.55 -50.1 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.124 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -46.99 -42.67 18.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 21.1 mt -77.34 -48.92 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.403 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 28.0 ttm180 -46.46 -44.44 17.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -76.3 -40.11 52.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.523 ' CE1' HD12 ' A' ' 298' ' ' LEU . 51.3 t-80 -60.19 -34.45 73.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.837 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -94.22 -40.68 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.668 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.6 t80 -42.05 -34.82 0.77 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.484 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.0 pt20 -54.16 -43.2 70.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.934 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.577 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 60.8 m-85 -57.68 -50.93 71.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.62 -150.1 7.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -85.13 122.61 29.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 0.0 110.848 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.668 HD11 ' N ' ' A' ' 260' ' ' TYR . 77.2 mt -90.71 116.88 32.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -63.11 -51.67 65.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.3 t -165.13 161.59 19.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.615 HG23 HD13 ' A' ' 279' ' ' ILE . 76.7 mt -137.71 109.72 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 60.7 m -100.45 99.58 10.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.148 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.495 HG22 ' CB ' ' A' ' 277' ' ' ALA . 93.4 t -91.13 115.11 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.163 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.544 HG12 ' HG2' ' A' ' 273' ' ' ARG . 5.0 t -97.18 102.04 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -60.23 -49.49 77.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.544 ' HG2' HG12 ' A' ' 271' ' ' VAL . 5.0 ptm180 -54.03 -30.14 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 275' ' ' GLN . 16.6 mt-30 -108.33 13.79 25.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 274' ' ' GLN . 43.6 mt-30 34.32 47.26 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.428 ' C ' ' CD1' ' A' ' 246' ' ' LEU . 20.7 p -142.2 177.54 8.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.495 ' CB ' HG22 ' A' ' 270' ' ' VAL . . . -159.59 140.2 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -107.06 119.5 39.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.615 HD13 HG23 ' A' ' 268' ' ' ILE . 3.8 mm -98.51 118.63 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.15 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -104.47 141.23 36.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -122.88 150.52 42.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -71.2 -41.84 69.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 33.1 p -118.99 122.5 42.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.12 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.412 ' HA ' HG22 ' A' ' 239' ' ' THR . 17.0 tpt180 -38.44 -35.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -39.55 -65.86 0.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -53.67 -48.94 68.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -47.49 -63.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 5.7 mt-10 -43.42 -64.1 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.518 HG12 ' CE1' ' A' ' 262' ' ' PHE . 41.5 t -42.51 -58.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.577 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -54.6 -39.55 67.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.513 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -52.22 -65.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -54.7 -39.52 68.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -80.41 2.42 25.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.781 ' HB3' HG11 ' A' ' 307' ' ' VAL . 24.0 m -117.36 -26.58 6.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -58.19 102.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.0 m120 43.69 32.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -129.74 -31.09 2.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.523 HD12 ' CE1' ' A' ' 258' ' ' HIS . 4.9 tp -68.65 98.53 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 304' ' ' ARG . 28.4 mt -113.72 94.47 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.433 ' HB ' HD11 ' A' ' 305' ' ' LEU . 59.2 t -92.07 139.36 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 53.71 47.35 23.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.885 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.31 27.02 5.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 -126.92 97.63 5.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.772 0.32 . . . . 0.0 110.907 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.486 ' N ' HG23 ' A' ' 299' ' ' ILE . 34.3 ttm-85 -42.41 139.76 1.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.774 HD21 ' CD1' ' A' ' 250' ' ' ILE . 29.2 mt -126.7 138.09 53.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -87.99 113.66 23.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.817 HG13 ' O ' ' A' ' 242' ' ' TYR . 47.0 t -113.79 143.63 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.59 ' HE2' ' CD1' ' A' ' 242' ' ' TYR . 18.7 pttt -152.65 161.26 42.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -67.68 123.53 20.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -72.23 -157.5 3.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.797 0.332 . . . . 0.0 110.892 -179.856 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 97.5 p -88.28 42.26 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.382 . . . . 0.0 110.844 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 77.5 p -102.95 130.78 50.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.868 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 179.74 -165.37 33.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.497 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 88.3 p -105.7 -45.8 4.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.844 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 89.0 p -79.43 101.33 8.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -117.85 -151.33 9.21 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -134.29 63.63 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.897 0.379 . . . . 0.0 110.894 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.444 ' HA ' ' CD1' ' A' ' 238' ' ' ILE . 10.3 p-10 -134.02 105.14 6.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -118.48 -63.68 1.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 41.1 p -120.78 37.17 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 240' ' ' THR . 79.9 mt -74.84 118.75 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.135 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.1 p -102.41 35.14 2.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.577 ' H ' HG22 ' A' ' 238' ' ' ILE . 17.2 m -138.72 143.2 38.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.5 mt -129.11 141.72 51.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.564 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -104.64 137.02 43.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.06 131.62 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.156 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.59 158.23 15.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 82.84 37.87 12.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.434 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.546 HD11 ' C ' ' A' ' 276' ' ' CYS . 63.6 mt -63.62 -66.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.425 ' HA3' ' NH1' ' A' ' 303' ' ' ARG . . . 66.01 148.32 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.5 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.0 -37.88 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 0.0 110.845 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 50.9 p -52.9 -46.58 68.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.151 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.893 ' CD1' HD21 ' A' ' 305' ' ' LEU . 53.0 mt -94.24 143.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.115 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.2 p -129.31 177.31 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.15 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.503 ' OE1' ' CG2' ' A' ' 270' ' ' VAL . 3.7 tp10 -60.35 -61.14 2.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.1 m -41.43 -52.61 3.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.134 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.51 -51.5 5.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.0 mt -70.03 -45.26 67.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.94 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -48.88 -47.27 43.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -76.59 -38.93 54.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.573 ' CE1' HD12 ' A' ' 298' ' ' LEU . 34.6 t-80 -60.44 -34.24 73.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.567 ' CD2' HG12 ' A' ' 279' ' ' ILE . 51.3 m-85 -94.87 -41.34 9.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.838 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.432 ' N ' HD11 ' A' ' 265' ' ' ILE . 2.0 t80 -41.8 -38.17 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 27.4 pt20 -52.32 -41.71 63.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 70.2 m-85 -63.25 -48.29 78.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 177.13 174.29 43.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.545 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -45.81 147.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.432 HD11 ' N ' ' A' ' 260' ' ' TYR . 65.8 mt -117.03 112.35 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.8 mtp180 -55.19 -50.98 67.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.1 t -167.03 158.84 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.485 HG22 ' OE2' ' A' ' 252' ' ' GLU . 21.0 mt -136.2 110.31 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.07 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 91.2 m -105.14 126.33 51.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.503 ' CG2' ' OE1' ' A' ' 252' ' ' GLU . 25.5 t -109.8 123.48 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.419 HG12 ' HG2' ' A' ' 273' ' ' ARG . 22.8 t -106.75 99.93 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.144 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -59.89 -50.0 75.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.419 ' HG2' HG12 ' A' ' 271' ' ' VAL . 9.4 ptt85 -53.79 -24.83 16.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.457 ' O ' ' C ' ' A' ' 275' ' ' GLN . 17.8 mt-30 -116.68 10.98 14.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 274' ' ' GLN . 66.8 mt-30 33.34 53.79 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.546 ' C ' HD11 ' A' ' 246' ' ' LEU . 26.9 p -142.86 172.21 13.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -146.3 151.2 37.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.065 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 49.6 m-85 -121.47 108.24 13.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.612 HG22 ' CE1' ' A' ' 281' ' ' PHE . 4.5 mp -94.24 118.52 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.126 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 266' ' ' ARG . 7.9 tt0 -105.91 142.52 35.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.612 ' CE1' HG22 ' A' ' 279' ' ' ILE . 87.7 m-85 -121.49 149.95 42.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.39 91.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.069 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 284' ' ' ARG . 35.8 p -125.81 125.34 42.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.15 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.461 ' O ' ' C ' ' A' ' 285' ' ' GLN . 4.9 tpt180 -35.97 -39.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.843 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.578 ' O ' HG23 ' A' ' 289' ' ' VAL . 36.2 tp60 -32.87 -65.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.94 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -56.56 -43.56 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.061 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.08 -60.88 2.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.102 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 8.4 mt-10 -47.58 -53.35 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 285' ' ' GLN . 45.5 t -53.17 -54.87 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.561 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -60.39 -32.79 71.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.448 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -56.41 -50.99 70.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -70.87 -26.86 63.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.466 ' HD2' ' CZ ' ' A' ' 262' ' ' PHE . 20.5 mttt -92.51 -1.34 57.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.705 ' HB2' HG11 ' A' ' 307' ' ' VAL . 61.3 p -112.29 -32.14 6.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 2.9 m-85 -53.73 106.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 29.5 t30 40.84 34.0 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -131.02 -33.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.573 HD12 ' CE1' ' A' ' 258' ' ' HIS . 4.3 tp -66.9 98.17 0.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 53.8 mt -113.53 96.29 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 258' ' ' HIS . 59.6 t -95.84 141.89 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 24.3 m120 53.82 43.88 30.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 50.79 32.94 26.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.461 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ARG . . . . . 0.425 ' NH1' ' HA3' ' A' ' 247' ' ' GLY . 30.4 ttt180 -135.0 108.31 7.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.873 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.524 ' O ' HD23 ' A' ' 305' ' ' LEU . 39.9 ttp180 -51.42 146.37 7.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.893 HD21 ' CD1' ' A' ' 250' ' ' ILE . 31.1 mt -132.45 135.15 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -83.97 97.92 9.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.705 HG11 ' HB2' ' A' ' 294' ' ' SER . 39.1 t -94.89 141.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.549 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.5 ptpt -153.47 145.27 23.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -50.9 143.98 9.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.922 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -93.41 -132.7 6.36 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.444 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 43.7 ttt85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 110.869 -179.85 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 11.6 t -57.36 108.04 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 110.872 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 99.9 p -83.37 99.65 10.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.87 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -52.73 106.19 0.36 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.447 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 3.8 m -58.46 125.47 23.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.372 . . . . 0.0 110.866 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 51.8 p -127.26 97.34 4.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -161.39 -161.19 11.46 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.455 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -86.43 155.75 20.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 0.0 110.878 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.71 93.37 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 237' ' ' THR . 2.7 mmmp? -55.17 94.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 236' ' ' LYS . 0.2 OUTLIER 31.9 46.74 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 311' ' ' ARG . 52.2 mt -78.91 98.25 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 37.3 p -86.34 30.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.422 ' H ' HG22 ' A' ' 238' ' ' ILE . 56.5 m -126.27 140.39 52.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.142 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 291' ' ' ALA . 25.2 mt -129.27 131.46 47.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.611 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -87.65 145.95 25.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.744 HG22 HG22 ' A' ' 307' ' ' VAL . 85.6 t -137.22 130.3 44.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.131 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -121.96 177.98 16.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.49 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.412 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 66.53 46.51 76.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.465 ' CD2' HD11 ' A' ' 255' ' ' LEU . 52.1 mt -77.12 -59.69 2.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.382 . . . . 0.0 110.906 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.87 148.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -42.18 -25.91 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.843 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.8 p -61.57 -45.96 91.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.112 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.868 ' CD1' HD21 ' A' ' 305' ' ' LEU . 53.7 mt -97.3 148.77 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.138 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 31.0 p -128.48 -176.47 3.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.478 ' HB2' HG21 ' A' ' 270' ' ' VAL . 30.7 tt0 -66.83 -59.56 3.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.9 m -42.11 -55.33 3.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -41.95 -47.17 4.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.465 HD11 ' CD2' ' A' ' 246' ' ' LEU . 19.5 mt -72.34 -53.76 11.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.956 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -42.08 -45.85 4.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -75.87 -42.65 48.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.551 ' CE1' HD12 ' A' ' 298' ' ' LEU . 37.7 t-80 -56.62 -33.95 66.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.456 ' CE2' HG13 ' A' ' 279' ' ' ILE . 67.5 m-85 -94.19 -44.04 8.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.592 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.9 t80 -39.94 -36.73 0.49 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 14.4 pt20 -51.63 -46.88 63.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.932 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.478 ' CE1' HG12 ' A' ' 289' ' ' VAL . 67.4 m-85 -57.99 -45.94 86.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -176.33 -157.54 17.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.48 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -80.72 131.24 35.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.592 HD11 ' N ' ' A' ' 260' ' ' TYR . 62.5 mt -97.56 112.41 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.127 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -57.86 -50.18 74.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 3.7 t -163.6 168.56 19.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.439 HD11 HD13 ' A' ' 265' ' ' ILE . 82.2 mt -145.73 111.52 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.144 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 88.8 m -102.21 101.81 12.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 252' ' ' GLU . 60.5 t -91.17 114.64 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.076 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.544 HG12 ' HG2' ' A' ' 273' ' ' ARG . 11.1 t -101.71 100.06 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -60.07 -44.22 94.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.544 ' HG2' HG12 ' A' ' 271' ' ' VAL . 1.6 ptm180 -52.99 -32.95 49.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.829 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.465 ' N ' ' HG2' ' A' ' 273' ' ' ARG . 61.8 mm-40 -112.42 15.12 20.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 274' ' ' GLN . 46.9 mm-40 34.66 52.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 9.5 p -142.24 174.18 10.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -152.72 135.53 15.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.108 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 27.1 m-85 -101.62 109.44 21.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.456 HG13 ' CE2' ' A' ' 259' ' ' PHE . 3.5 mm -93.75 121.0 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -109.79 139.08 45.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -117.38 144.64 44.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.15 78.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 284' ' ' ARG . 31.1 p -125.14 118.73 26.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' A' ' 283' ' ' THR . 15.7 tpt180 -37.94 -32.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.705 ' O ' HG23 ' A' ' 289' ' ' VAL . 5.2 tt0 -40.35 -67.91 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -56.36 -39.43 72.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -53.49 -62.23 1.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -49.63 -49.62 46.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 285' ' ' GLN . 16.8 t -52.82 -64.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 294' ' ' SER . . . -53.27 -41.5 65.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.509 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -51.34 -54.76 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.438 ' O ' ' NZ ' ' A' ' 297' ' ' LYS . 12.9 tm-20 -67.65 -26.71 66.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.843 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.9 mttm -94.84 4.6 53.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.711 ' OG ' HG11 ' A' ' 307' ' ' VAL . 78.9 p -116.47 -26.91 6.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.4 m-30 -58.73 104.86 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 1.7 m120 47.82 29.12 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 292' ' ' GLU . 0.5 OUTLIER -127.86 -34.94 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.628 ' HG ' HD12 ' A' ' 305' ' ' LEU . 7.4 tp -67.81 97.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 304' ' ' ARG . 42.1 mt -114.76 98.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.42 146.76 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.127 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 23.7 m120 45.78 47.24 11.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.54 33.4 11.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 11.2 ttt85 -133.96 101.5 5.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.792 0.329 . . . . 0.0 110.892 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.467 ' N ' HG23 ' A' ' 299' ' ' ILE . 14.8 ttm180 -43.3 145.72 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.868 HD21 ' CD1' ' A' ' 250' ' ' ILE . 23.4 mt -129.71 134.02 47.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.57 101.38 11.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.744 HG22 HG22 ' A' ' 243' ' ' VAL . 72.5 t -103.85 133.29 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.599 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.0 pttt -145.59 152.52 39.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -55.91 130.38 43.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -58.84 -117.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.538 ' O ' HD13 ' A' ' 238' ' ' ILE . 79.1 mtt180 . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.789 0.328 . . . . 0.0 110.907 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 79.9 p -101.01 152.53 20.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 0.0 110.841 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.4 t -162.81 147.28 11.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 79.46 98.14 0.28 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.501 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 58.4 m -97.9 90.46 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.833 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 76.6 p -75.72 -52.05 11.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.803 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 64.49 86.01 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.514 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 235' ' ' ASP . 4.7 mm-40 -99.09 162.95 12.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.362 . . . . 0.0 110.867 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.478 ' HA ' ' CD1' ' A' ' 238' ' ' ILE . 2.9 p30 34.71 45.81 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 237' ' ' THR . 32.5 mtmt -73.32 101.03 3.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 236' ' ' LYS . 28.6 p 34.43 39.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.146 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.478 ' CD1' ' HA ' ' A' ' 235' ' ' ASP . 6.7 mt -65.17 105.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.142 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.8 p -98.45 39.83 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 18.4 m -138.91 139.62 38.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.403 HD11 ' O ' ' A' ' 287' ' ' ALA . 44.1 mt -126.33 153.71 44.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.83 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.3 OUTLIER -105.53 146.18 29.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 307' ' ' VAL . 93.5 t -142.49 122.3 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.127 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -115.15 173.18 14.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.494 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.72 56.53 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.524 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.601 HD11 ' HB2' ' A' ' 277' ' ' ALA . 57.4 mt -70.23 -62.37 1.41 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.868 0.365 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.47 155.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.473 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -47.44 -30.36 3.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.5 p -58.12 -43.03 87.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.546 ' CD1' HD21 ' A' ' 305' ' ' LEU . 61.3 mt -102.18 143.53 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 30.4 p -121.26 -177.31 3.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.183 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.592 ' HB2' HG21 ' A' ' 270' ' ' VAL . 63.4 tt0 -70.02 -52.25 25.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.899 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 92.2 m -48.9 -54.98 13.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.154 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -40.24 -44.94 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 258' ' ' HIS . 16.7 mt -75.25 -59.08 2.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 255' ' ' LEU . 20.3 ttm-85 -36.29 -42.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -78.12 -40.17 39.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.609 ' NE2' HD13 ' A' ' 298' ' ' LEU . 13.9 t60 -59.56 -37.53 78.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 261' ' ' GLN . 73.5 m-85 -90.03 -39.06 13.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.665 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.1 t80 -45.02 -21.31 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.926 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 259' ' ' PHE . 24.4 pt20 -69.32 -43.3 74.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 81.4 m-85 -61.31 -42.52 98.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 179.96 -167.19 36.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.466 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -71.56 130.11 40.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.913 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.665 HD11 ' N ' ' A' ' 260' ' ' TYR . 60.3 mt -98.29 112.13 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.112 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.5 mtp85 -56.89 -49.36 75.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 t -165.6 168.98 15.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.176 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.418 HD11 ' HA ' ' A' ' 256' ' ' ARG . 85.9 mt -144.01 110.95 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.174 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.8 m -100.92 102.21 13.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 252' ' ' GLU . 40.3 t -96.18 104.68 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 274' ' ' GLN . 99.8 t -92.52 99.95 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' GLN . . . . . 0.516 ' O ' ' NE2' ' A' ' 272' ' ' GLN . 0.9 OUTLIER -60.01 -37.75 80.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -55.99 -35.55 66.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.628 ' H ' HG12 ' A' ' 271' ' ' VAL . 69.8 mt-30 -106.42 4.13 28.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 47.25 48.02 16.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.946 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.453 ' C ' HD11 ' A' ' 246' ' ' LEU . 1.8 p -139.69 178.63 7.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.601 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -155.26 139.55 16.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -111.33 109.95 20.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 2.8 mm -92.46 126.84 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 266' ' ' ARG . 8.5 tt0 -113.52 142.16 46.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -121.49 149.82 42.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.0 -32.71 71.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.102 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 284' ' ' ARG . 16.0 p -127.1 117.4 22.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 283' ' ' THR . 15.1 tpt180 -37.29 -32.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' THR . 3.5 tt0 -39.22 -68.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -55.5 -47.66 75.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.403 ' O ' HD11 ' A' ' 241' ' ' LEU . . . -43.8 -54.05 5.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.138 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 7.2 mt-10 -56.46 -60.72 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.848 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 21.0 t -45.12 -56.34 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.561 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -58.09 -37.25 74.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.088 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -52.23 -65.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.102 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -56.13 -39.53 72.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.832 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.505 ' HD2' ' CZ ' ' A' ' 262' ' ' PHE . 20.8 mttp -76.86 1.06 18.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.581 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.2 m -118.03 -28.14 5.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -54.81 106.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 57.5 t30 42.27 25.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -123.83 -27.32 3.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.609 HD13 ' NE2' ' A' ' 258' ' ' HIS . 5.9 tp -70.32 100.5 1.74 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 304' ' ' ARG . 22.4 mt -120.17 99.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.36 138.91 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 60.64 45.87 9.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.85 34.53 11.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -137.67 106.24 5.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 0.0 110.872 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.77 ' O ' HD23 ' A' ' 305' ' ' LEU . 16.9 ttm105 -50.58 150.2 2.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.919 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.77 HD23 ' O ' ' A' ' 304' ' ' ARG . 38.7 mt -135.43 137.64 42.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.959 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -90.38 113.36 25.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.83 HG13 ' O ' ' A' ' 242' ' ' TYR . 35.4 t -112.4 143.17 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.584 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 5.1 ptpp? -150.12 160.37 43.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -67.67 129.56 40.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -79.55 -158.42 14.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.494 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.799 0.333 . . . . 0.0 110.909 -179.884 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 228' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 227' ' ' GLY . 63.1 m -36.97 -46.16 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.892 0.377 . . . . 0.0 110.843 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.5 t -144.53 148.61 34.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -167.29 171.57 42.02 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 26.3 t -80.13 -43.98 20.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.921 0.391 . . . . 0.0 110.86 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 74.8 m -62.05 139.63 58.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.872 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -173.19 -104.09 0.17 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.464 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -92.69 83.94 4.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 110.884 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.04 96.8 9.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.91 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.631 ' HD3' HG23 ' A' ' 237' ' ' THR . 0.0 OUTLIER -132.69 -36.13 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.631 HG23 ' HD3' ' A' ' 236' ' ' LYS . 17.0 p -134.43 27.62 3.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.164 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 240' ' ' THR . 48.9 mt -81.78 107.74 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.156 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.5 p -98.51 30.01 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 238' ' ' ILE . 40.1 m -128.88 136.3 50.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.5 mt -126.66 126.43 43.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.585 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -82.56 140.59 33.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.886 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.49 131.72 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.171 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.07 -174.9 16.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.465 ' O ' HD22 ' A' ' 305' ' ' LEU . . . 56.2 54.79 33.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.523 HD22 HD11 ' A' ' 255' ' ' LEU . 77.8 mt -87.4 -57.81 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.912 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.78 156.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.66 -24.63 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.847 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.8 p -62.13 -35.27 78.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.127 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.777 ' CD1' HD21 ' A' ' 305' ' ' LEU . 73.6 mt -107.24 142.32 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.8 p -117.74 -179.93 3.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.84 -54.26 24.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 89.3 m -48.56 -54.89 12.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.222 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -39.15 -45.96 1.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.523 HD11 HD22 ' A' ' 246' ' ' LEU . 15.0 mt -75.95 -49.55 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -45.35 -44.25 11.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.41 -44.37 36.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.519 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 39.5 t-80 -56.37 -33.82 66.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -94.12 -42.71 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.614 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -41.14 -44.46 2.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.479 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.8 pt20 -44.5 -41.02 6.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.703 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 53.4 m-85 -60.8 -49.84 75.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -175.63 -160.95 24.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.454 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -75.36 121.93 22.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.865 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.614 HD11 ' N ' ' A' ' 260' ' ' TYR . 87.0 mt -89.83 108.98 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 282' ' ' ALA . 9.2 mtt-85 -52.46 -52.49 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 13.7 t -162.23 170.9 18.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.419 HD11 HG21 ' A' ' 265' ' ' ILE . 75.3 mt -146.08 110.26 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.131 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 19.2 m -103.1 98.9 8.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.194 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.17 107.06 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.638 HG12 ' HG3' ' A' ' 273' ' ' ARG . 5.3 t -91.3 100.84 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -60.21 -45.43 93.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.638 ' HG3' HG12 ' A' ' 271' ' ' VAL . 0.0 OUTLIER -57.39 -19.22 21.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 275' ' ' GLN . 15.2 mt-30 -121.39 11.93 10.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 274' ' ' GLN . 92.9 mt-30 36.87 44.3 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.486 ' C ' HD11 ' A' ' 246' ' ' LEU . 28.4 p -133.59 175.07 9.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -156.73 131.94 9.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 42.9 m-85 -100.74 111.91 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 4.6 mm -94.85 114.71 31.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -102.52 144.84 30.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.64 148.09 49.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.471 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -68.91 -38.26 79.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.111 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 284' ' ' ARG . 25.1 p -125.24 119.22 27.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.168 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 283' ' ' THR . 16.9 tpt180 -35.89 -36.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.901 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.61 ' O ' HG23 ' A' ' 289' ' ' VAL . 13.0 tp60 -36.96 -63.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -60.4 -36.77 78.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.127 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.71 -62.09 2.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.055 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 20.9 mt-10 -47.44 -56.6 6.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.888 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 285' ' ' GLN . 29.3 t -47.21 -62.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.703 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -54.04 -39.85 66.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -51.34 -64.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -54.99 -40.95 70.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -77.31 3.07 13.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.729 ' HB3' HG11 ' A' ' 307' ' ' VAL . 1.9 m -116.65 -31.72 5.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -48.32 98.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.854 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 43.96 30.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.69 -35.79 2.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.519 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 6.6 tp -66.45 97.75 0.44 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 304' ' ' ARG . 54.1 mt -114.53 91.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 58.1 t -85.62 147.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.118 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 21.4 m120 43.73 48.7 6.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 46.5 33.57 6.1 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.474 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -132.9 100.14 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.866 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.432 ' N ' HG23 ' A' ' 299' ' ' ILE . 20.3 ttm-85 -43.84 139.3 2.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.777 HD21 ' CD1' ' A' ' 250' ' ' ILE . 29.6 mt -122.12 133.35 54.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -82.67 101.3 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.729 HG11 ' HB3' ' A' ' 294' ' ' SER . 53.8 t -103.77 146.65 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 10.5 ptpt -156.96 169.73 24.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -80.79 125.47 30.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 311' ' ' ARG . . . -59.29 -120.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 310' ' ' GLY . 56.6 mtm180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.84 0.353 . . . . 0.0 110.901 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 23.8 t -101.41 99.68 10.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 0.0 110.891 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 65.7 m -76.27 -49.96 15.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.876 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.45 -153.91 17.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.488 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 89.0 p -159.47 116.11 2.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 110.836 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 10.7 t -66.1 134.51 52.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.818 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 65.77 179.83 9.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.511 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -143.14 170.33 15.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.859 0.361 . . . . 0.0 110.875 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.91 107.61 7.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 237' ' ' THR . 62.2 mmtt -79.06 89.1 4.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 236' ' ' LYS . 73.0 p 37.62 40.37 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.097 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 57.2 mt -70.25 96.5 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.118 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 30.3 p -93.92 38.11 1.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 24.9 m -131.38 144.28 51.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 291' ' ' ALA . 28.6 mt -134.71 128.61 33.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.588 ' CE1' ' HE2' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -85.6 143.99 28.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 307' ' ' VAL . 66.0 t -140.5 106.67 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.115 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -102.17 178.18 26.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.495 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.488 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 71.94 41.43 55.12 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.606 ' CD2' HD11 ' A' ' 255' ' ' LEU . 96.5 mt -70.08 -63.11 1.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.841 0.353 . . . . 0.0 110.926 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 249' ' ' THR . . . 71.77 143.45 0.38 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -40.1 -29.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 247' ' ' GLY . 34.5 p -61.59 -53.12 60.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.646 ' CD1' HD21 ' A' ' 305' ' ' LEU . 59.2 mt -84.53 153.82 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.437 ' N ' HG22 ' A' ' 250' ' ' ILE . 55.9 p -134.68 178.37 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.488 ' HB2' HG21 ' A' ' 270' ' ' VAL . 30.9 tt0 -62.77 -59.57 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.4 m -44.02 -55.14 4.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.156 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -39.75 -47.01 2.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.606 HD11 ' CD2' ' A' ' 246' ' ' LEU . 12.9 mt -75.86 -52.88 9.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ARG . . . . . 0.406 ' O ' ' HB3' ' A' ' 260' ' ' TYR . 50.1 ttp85 -42.06 -44.01 3.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -74.97 -46.86 32.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.655 ' CE1' HD13 ' A' ' 298' ' ' LEU . 3.2 t-80 -52.63 -39.39 61.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 261' ' ' GLN . 76.7 m-85 -87.84 -45.16 10.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.826 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' TYR . . . . . 0.696 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.1 t80 -39.84 -27.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 259' ' ' PHE . 23.6 pt20 -62.28 -46.25 89.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.637 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 60.8 m-85 -54.39 -50.27 67.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -172.6 -146.99 5.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.511 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -90.29 123.02 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.696 HD11 ' N ' ' A' ' 260' ' ' TYR . 47.1 mt -91.01 113.76 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.144 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -56.6 -48.82 76.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 t -165.2 170.28 15.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.165 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.407 HG23 HD13 ' A' ' 279' ' ' ILE . 92.6 mt -144.79 110.93 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.118 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 39.2 m -103.14 98.86 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.493 HG13 ' CD1' ' A' ' 246' ' ' LEU . 90.1 t -90.34 110.07 21.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 275' ' ' GLN . 38.6 t -95.57 100.01 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 275' ' ' GLN . 10.4 tt0 -60.01 -57.8 11.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -45.11 -22.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -109.12 -16.44 14.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.962 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 272' ' ' GLN . 34.3 mt-30 64.37 45.14 3.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' CYS . . . . . 0.521 ' C ' HD11 ' A' ' 246' ' ' LEU . 5.3 m -145.76 177.52 8.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.426 ' HB2' HG22 ' A' ' 270' ' ' VAL . . . -153.29 142.18 21.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 33.1 m-85 -106.63 107.16 18.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ILE . . . . . 0.407 HD13 HG23 ' A' ' 268' ' ' ILE . 7.3 mm -90.1 117.44 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.179 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' GLN . . . . . 0.484 ' O ' HG23 ' A' ' 265' ' ' ILE . 9.8 tt0 -105.79 150.19 25.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -130.79 151.83 50.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -74.53 -32.97 62.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.116 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 284' ' ' ARG . 24.9 p -127.17 118.08 23.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 285' ' ' GLN . 5.7 tpp85 -36.01 -38.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.696 ' O ' HG23 ' A' ' 289' ' ' VAL . 12.0 tt0 -35.9 -64.83 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.59 -45.73 84.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ALA . . . . . 0.4 ' O ' HD11 ' A' ' 241' ' ' LEU . . . -52.0 -66.31 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 12.7 mt-10 -43.29 -52.39 5.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 285' ' ' GLN . 46.3 t -52.72 -64.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.637 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -48.84 -43.1 38.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.067 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ALA . . . . . 0.56 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -46.18 -67.66 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -53.14 -44.48 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -70.7 -0.94 9.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.773 ' HB3' HG21 ' A' ' 307' ' ' VAL . 12.6 m -119.14 -24.26 6.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.869 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -53.95 103.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 43.51 26.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -124.92 -26.77 3.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.655 HD13 ' CE1' ' A' ' 258' ' ' HIS . 12.5 tp -68.03 98.26 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.947 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.55 96.64 4.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.159 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 85.7 t -103.69 145.37 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 13.9 m120 55.56 40.48 31.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 51.53 32.05 30.41 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.52 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 19.4 ttt-85 -133.56 105.63 6.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.92 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.528 ' O ' HD23 ' A' ' 305' ' ' LEU . 13.7 ttp180 -49.95 147.12 4.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.646 HD21 ' CD1' ' A' ' 250' ' ' ILE . 40.4 mt -132.29 145.76 51.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.954 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -98.01 106.84 19.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.773 HG21 ' HB3' ' A' ' 294' ' ' SER . 98.3 t -105.25 137.7 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.588 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 3.4 pttt -151.26 148.94 28.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.935 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.61 141.06 44.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -80.23 -124.45 0.54 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 26.6 ttt-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.332 . . . . 0.0 110.86 -179.824 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.863 0.363 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.419 HG22 ' HA ' ' A' ' 284' ' ' ARG . 82.0 p -102.36 -11.68 18.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 16.7 m -84.84 141.92 30.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.181 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.8 mt -130.85 124.41 31.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.579 ' CE1' ' HE2' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -81.53 141.32 33.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.929 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.86 HG22 HG22 ' A' ' 307' ' ' VAL . 99.8 t -136.28 116.98 18.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.08 177.3 19.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 68.78 37.79 84.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.481 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.495 HD11 ' CB ' ' A' ' 277' ' ' ALA . 31.4 mt -75.9 -59.8 2.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.4 149.95 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.483 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -40.96 -36.87 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 24.1 p -51.89 -43.0 63.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.578 ' CD1' HD21 ' A' ' 305' ' ' LEU . 76.4 mt -97.12 143.07 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.12 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.0 p -121.6 -178.29 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.109 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.94 -56.67 7.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 90.0 m -43.98 -50.67 8.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.82 -37.62 14.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 18.9 mt -80.52 -52.36 7.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 41.4 ttt-85 -43.91 -42.89 6.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -76.53 -44.27 35.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.627 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 45.3 t-80 -57.39 -33.12 67.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.444 ' CE2' HG13 ' A' ' 279' ' ' ILE . 76.5 m-85 -94.47 -41.39 9.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.534 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -42.71 -36.12 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.966 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 17.6 pt20 -54.13 -40.97 67.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.901 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 47.0 m-85 -63.75 -45.91 87.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.854 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 173.98 178.01 43.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.529 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -47.69 144.55 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.347 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.534 HD11 ' N ' ' A' ' 260' ' ' TYR . 90.7 mt -115.45 109.56 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -52.34 -50.45 62.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.5 t -167.53 168.74 12.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.458 HD11 HD13 ' A' ' 265' ' ' ILE . 90.1 mt -144.38 108.65 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 54.7 m -103.14 99.08 8.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 43.1 t -91.93 110.81 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.461 ' CG1' ' HG2' ' A' ' 273' ' ' ARG . 51.2 t -94.53 99.96 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -60.09 -43.24 95.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.461 ' HG2' ' CG1' ' A' ' 271' ' ' VAL . 6.8 ptm180 -55.09 -26.54 38.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.454 ' O ' ' C ' ' A' ' 275' ' ' GLN . 73.7 mt-30 -117.29 17.75 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 274' ' ' GLN . 66.7 mt-30 34.25 43.94 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 26.0 p -136.69 173.08 12.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.495 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -156.74 138.93 14.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -105.38 114.87 29.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.444 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.5 mm -98.06 118.03 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.162 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -104.42 140.4 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -119.43 146.38 45.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.34 -34.21 74.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 284' ' ' ARG . 29.5 p -127.68 118.18 23.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.171 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.431 ' O ' ' HB3' ' A' ' 287' ' ' ALA . 13.6 tpt180 -36.72 -36.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 284' ' ' ARG . 6.1 tp60 -36.85 -65.69 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -59.11 -35.29 73.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.084 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 284' ' ' ARG . . . -57.82 -57.39 12.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 13.7 mt-10 -52.33 -59.31 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 42.9 t -44.41 -61.61 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.901 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -57.42 -38.39 74.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -49.52 -69.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.108 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -54.08 -43.43 70.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -70.94 -3.72 20.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.673 ' HB3' HG21 ' A' ' 307' ' ' VAL . 33.2 m -112.3 -29.95 7.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -47.86 97.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.835 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 52.7 t30 45.17 25.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -120.57 -25.68 5.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.627 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 6.2 tp -72.53 99.83 2.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 304' ' ' ARG . 25.5 mt -113.39 96.68 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.109 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 67.7 t -100.72 138.36 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 58.13 49.88 10.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.78 34.18 5.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 245' ' ' GLY . 16.1 ttt-85 -138.81 105.13 5.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 0.0 110.881 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.604 ' O ' HD23 ' A' ' 305' ' ' LEU . 2.0 ttt85 -51.68 149.33 4.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 304' ' ' ARG . 42.0 mt -133.52 134.93 44.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.77 102.2 14.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.86 HG22 HG22 ' A' ' 243' ' ' VAL . 70.6 t -99.99 136.54 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.579 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 6.2 pttt -146.5 147.55 31.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -55.29 142.71 30.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.478 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 60.0 mt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.923 0.392 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 284' ' ' ARG . 57.3 p -90.39 26.75 1.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.2 m -123.16 141.03 52.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.588 HD21 ' HB2' ' A' ' 291' ' ' ALA . 66.4 mt -124.1 139.88 53.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.717 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.6 OUTLIER -99.1 146.31 26.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 307' ' ' VAL . 74.1 t -140.04 135.01 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -125.73 168.33 17.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 70.62 44.51 57.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 250' ' ' ILE . 91.3 mt -80.29 -59.11 2.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.879 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.34 162.81 0.89 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.463 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -49.53 -38.39 30.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 35.6 p -50.63 -45.05 57.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.142 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.696 ' CD1' HD21 ' A' ' 305' ' ' LEU . 67.3 mt -95.44 143.95 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 26.8 p -122.31 -175.23 3.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.477 ' HA ' HG21 ' A' ' 270' ' ' VAL . 37.6 tt0 -71.18 -57.18 4.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.6 m -45.33 -47.18 13.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.16 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -44.7 -50.67 9.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.0 -44.74 62.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.435 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 22.3 ttp180 -49.95 -46.05 51.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -75.7 -40.56 55.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.651 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 51.1 t-80 -61.06 -32.78 72.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.495 ' CD2' HG12 ' A' ' 279' ' ' ILE . 52.8 m-85 -94.32 -39.0 10.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.484 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -46.67 -38.02 9.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.2 pt20 -52.45 -38.22 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.56 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 79.0 m-85 -64.71 -43.97 91.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -178.97 -152.75 10.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.532 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -82.84 136.5 34.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 0.0 110.851 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.743 HD13 HD11 ' A' ' 268' ' ' ILE . 88.9 mt -105.35 112.95 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 282' ' ' ALA . 27.8 mtt180 -60.36 -48.98 79.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.4 t -165.13 159.02 17.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.16 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.743 HD11 HD13 ' A' ' 265' ' ' ILE . 59.5 mt -139.41 108.3 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 30.5 m -101.5 100.41 10.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 252' ' ' GLU . 83.7 t -93.67 103.35 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.403 HG12 ' HG2' ' A' ' 273' ' ' ARG . 12.2 t -86.19 99.54 8.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -60.76 -48.26 82.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.403 ' HG2' HG12 ' A' ' 271' ' ' VAL . 0.0 OUTLIER -58.48 -11.02 2.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 275' ' ' GLN . 19.8 mm-40 -126.6 14.41 7.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.953 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 274' ' ' GLN . 71.4 mt-30 33.04 51.09 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 14.2 p -148.8 165.27 31.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.467 ' CB ' HG22 ' A' ' 270' ' ' VAL . . . -148.95 148.09 29.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 56.7 m-85 -118.05 108.74 15.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.495 HG12 ' CD2' ' A' ' 259' ' ' PHE . 5.0 mp -93.02 121.67 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -105.38 148.54 27.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.429 ' HE2' HD12 ' A' ' 241' ' ' LEU . 98.9 m-85 -127.44 139.29 52.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.401 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -62.04 -34.9 77.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.078 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 284' ' ' ARG . 32.7 p -126.71 118.03 23.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.165 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.436 ' HA ' HG22 ' A' ' 239' ' ' THR . 9.5 tpt180 -36.13 -35.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.635 ' O ' HG23 ' A' ' 289' ' ' VAL . 46.4 tp60 -36.58 -68.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -54.7 -48.44 72.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -46.88 -59.56 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 5.6 mt-10 -50.18 -54.12 23.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.947 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 285' ' ' GLN . 16.5 t -50.79 -60.13 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.115 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.56 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -56.51 -36.53 69.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.065 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.588 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -54.66 -53.66 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -68.88 -28.65 66.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -92.03 5.41 50.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 65.7 p -119.08 -32.06 4.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.461 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.4 m-30 -55.1 109.42 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 41.05 33.88 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -130.96 -38.43 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.89 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.651 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 8.4 tp -65.48 100.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 58.4 mt -117.64 93.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.546 HG12 ' ND2' ' A' ' 301' ' ' ASN . 53.9 t -97.86 140.39 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.546 ' ND2' HG12 ' A' ' 300' ' ' VAL . 69.5 m-80 58.43 42.34 21.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.93 34.12 10.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.491 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -134.19 99.38 4.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.349 . . . . 0.0 110.831 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.498 ' O ' HD23 ' A' ' 305' ' ' LEU . 6.9 ttm180 -44.17 148.47 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.696 HD21 ' CD1' ' A' ' 250' ' ' ILE . 43.4 mt -132.77 135.07 45.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.6 98.18 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 243' ' ' VAL . 49.7 t -100.89 140.17 20.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.555 ' CE ' ' CE1' ' A' ' 242' ' ' TYR . 9.6 pttt -147.86 150.65 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -52.21 134.83 33.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.482 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.558 HG22 ' H ' ' A' ' 240' ' ' THR . 85.2 mt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.943 0.401 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.3 p -95.16 29.71 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.165 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.558 ' H ' HG22 ' A' ' 238' ' ' ILE . 20.1 m -127.55 142.73 51.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.152 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 291' ' ' ALA . 32.1 mt -134.16 124.63 26.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.93 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.603 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -82.89 143.11 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.98 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 1.082 HG22 HG22 ' A' ' 307' ' ' VAL . 98.4 t -135.79 127.66 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.91 176.3 16.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 72.15 37.25 59.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.508 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.546 HD11 ' CB ' ' A' ' 277' ' ' ALA . 93.4 mt -81.52 -57.43 3.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.28 162.03 0.16 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.463 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -35.43 29.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 110.872 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.7 p -51.64 -48.35 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.494 ' CD1' HD21 ' A' ' 305' ' ' LEU . 68.6 mt -95.03 142.8 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 30.9 p -115.57 -175.62 2.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.598 ' HB2' HG21 ' A' ' 270' ' ' VAL . 18.8 tt0 -70.18 -56.7 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 98.4 m -44.96 -50.36 10.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.13 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.54 -41.1 4.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.7 mt -81.23 -55.12 4.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.406 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 19.2 ttm180 -39.72 -38.67 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -75.55 -44.07 45.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.867 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.743 ' NE2' HD13 ' A' ' 298' ' ' LEU . 30.5 t60 -58.82 -35.09 72.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.565 ' HA ' ' CD2' ' A' ' 262' ' ' PHE . 93.1 m-85 -91.48 -39.01 12.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.49 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.1 t80 -44.35 -28.97 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.432 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 23.8 pt20 -64.48 -42.83 95.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.703 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 29.7 m-85 -59.5 -48.73 80.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 175.15 178.8 45.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.52 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -48.43 141.17 7.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.49 HD11 ' N ' ' A' ' 260' ' ' TYR . 70.5 mt -111.26 110.77 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.152 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 280' ' ' GLN . 37.9 mtt-85 -52.79 -53.18 51.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.5 t -165.72 168.73 15.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 77.2 mt -142.81 111.96 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 50.0 m -104.06 98.91 8.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.598 HG21 ' HB2' ' A' ' 252' ' ' GLU . 65.4 t -90.99 105.43 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.159 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 14.9 t -91.12 100.73 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . 0.437 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 16.4 pt20 -59.69 -44.88 93.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.437 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 0.8 OUTLIER -56.47 -19.05 13.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 275' ' ' GLN . 8.7 mm-40 -122.95 14.23 9.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 274' ' ' GLN . 52.9 mt-30 34.37 46.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.965 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 27.7 p -137.15 175.16 9.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.546 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -155.2 132.15 10.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 35.3 m-85 -99.62 111.49 23.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 4.9 mm -93.9 115.88 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.099 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 266' ' ' ARG . 40.1 tt0 -105.6 139.0 40.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.41 ' C ' ' HG3' ' A' ' 266' ' ' ARG . 95.6 m-85 -119.24 153.27 35.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.414 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -75.65 -34.47 60.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.105 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 284' ' ' ARG . 30.6 p -125.54 116.44 21.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 283' ' ' THR . 12.6 tpt180 -36.9 -34.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.414 ' O ' HG23 ' A' ' 289' ' ' VAL . 44.1 tp60 -38.48 -61.42 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.32 97.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -52.79 -59.98 3.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -48.13 -55.74 9.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.607 HG12 ' HE3' ' A' ' 293' ' ' LYS . 60.0 t -49.48 -61.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.703 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -52.87 -41.2 64.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.491 ' HB2' HD11 ' A' ' 241' ' ' LEU . . . -53.81 -52.72 59.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.63 -24.94 63.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.888 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.607 ' HE3' HG12 ' A' ' 289' ' ' VAL . 34.1 mtmt -97.79 5.63 48.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.724 ' HB2' HG21 ' A' ' 307' ' ' VAL . 81.5 p -117.8 -24.34 7.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 297' ' ' LYS . 2.8 m-85 -61.99 112.73 2.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 5.2 t30 40.51 25.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 295' ' ' PHE . 35.9 tttp -123.65 -36.69 2.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.743 HD13 ' NE2' ' A' ' 258' ' ' HIS . 14.9 tp -61.82 96.52 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 62.9 mt -120.47 95.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.67 134.19 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.18 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 57.5 54.88 6.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 41.8 33.07 1.02 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.0 ttm-85 -130.39 99.3 4.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.823 0.344 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -56.18 135.31 53.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.499 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 58.3 mt -120.23 135.66 54.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -91.95 99.05 11.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 1.082 HG22 HG22 ' A' ' 243' ' ' VAL . 79.5 t -94.58 136.74 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.522 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 1.0 OUTLIER -145.54 145.57 31.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . 0.468 ' HA ' HD23 ' A' ' 241' ' ' LEU . 61.6 m95 -54.56 141.06 32.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.539 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 240' ' ' THR . 78.1 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.859 0.361 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.8 p -102.11 31.0 4.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.533 ' H ' HG22 ' A' ' 238' ' ' ILE . 28.2 m -131.89 148.31 52.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 31.1 mt -132.91 156.01 48.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.56 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.4 OUTLIER -109.75 147.74 32.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.896 HG22 HG22 ' A' ' 307' ' ' VAL . 90.4 t -141.1 120.72 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.03 168.78 12.67 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.494 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.518 ' O ' HD22 ' A' ' 305' ' ' LEU . . . 73.81 44.31 31.78 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.503 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.668 HD11 ' HB2' ' A' ' 277' ' ' ALA . 52.4 mt -77.52 -60.41 2.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.931 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.28 156.45 0.17 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.492 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -49.39 -29.27 6.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.39 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.1 p -59.19 -43.84 92.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.146 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.573 ' CD1' HD21 ' A' ' 305' ' ' LEU . 60.4 mt -96.87 143.49 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 29.5 p -124.9 173.94 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -58.38 -59.64 5.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 88.7 m -41.22 -56.68 2.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -42.62 -42.73 3.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.463 HD11 HD22 ' A' ' 246' ' ' LEU . 33.4 mt -77.46 -57.26 3.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -39.0 -43.97 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -75.99 -38.04 57.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.87 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.585 ' CE1' HD12 ' A' ' 298' ' ' LEU . 45.0 t-80 -60.11 -35.13 74.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.839 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -94.15 -43.41 8.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.845 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.566 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -39.93 -36.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.919 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 29.4 pt20 -52.55 -46.2 66.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.926 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.591 ' CE1' HG12 ' A' ' 289' ' ' VAL . 62.7 m-85 -56.18 -48.84 75.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.39 -143.29 4.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.463 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -93.6 128.64 39.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 110.855 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.566 HD11 ' N ' ' A' ' 260' ' ' TYR . 57.6 mt -93.73 114.98 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 280' ' ' GLN . 9.9 mtt180 -60.62 -49.21 78.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.6 t -162.56 168.06 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.166 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.471 HD11 HG21 ' A' ' 265' ' ' ILE . 87.9 mt -146.07 110.66 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.4 m -104.37 99.88 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.438 HG13 ' CD1' ' A' ' 246' ' ' LEU . 85.7 t -92.5 107.65 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 14.8 t -91.97 100.76 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -58.67 -48.53 80.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -55.78 -26.65 47.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 275' ' ' GLN . 19.2 mm100 -110.6 11.3 22.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.44 ' C ' ' O ' ' A' ' 274' ' ' GLN . 80.5 mt-30 35.15 47.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 16.7 p -140.5 177.53 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.668 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -156.84 137.23 12.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.076 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -106.13 111.07 23.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 268' ' ' ILE . 6.1 mm -94.27 127.68 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 266' ' ' ARG . 9.1 tt0 -114.66 145.1 42.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.933 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.31 147.37 48.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.403 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -68.94 -37.04 78.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.141 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 284' ' ' ARG . 24.4 p -125.12 121.28 33.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.433 ' O ' ' HB3' ' A' ' 287' ' ' ALA . 12.0 tpt180 -37.88 -35.69 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 284' ' ' ARG . 1.4 tm0? -36.8 -67.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.23 79.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.084 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 284' ' ' ARG . . . -50.51 -58.51 5.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.085 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.446 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 11.5 mt-10 -51.63 -62.43 1.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.591 HG12 ' CE1' ' A' ' 262' ' ' PHE . 37.7 t -41.95 -56.44 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.58 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -57.33 -41.45 80.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -49.68 -65.97 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.082 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.25 -39.88 70.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -78.44 1.63 21.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.732 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.6 m -117.15 -26.67 6.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -57.0 103.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 42.13 27.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -124.24 -26.15 4.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.585 HD12 ' CE1' ' A' ' 258' ' ' HIS . 5.4 tp -72.88 97.82 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.92 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 304' ' ' ARG . 32.0 mt -115.58 92.33 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 19.9 t -95.39 146.94 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 51.59 46.52 26.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.12 30.05 5.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -133.07 103.66 6.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 110.898 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.506 ' O ' HD23 ' A' ' 305' ' ' LEU . 4.7 ttm180 -47.72 144.38 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 250' ' ' ILE . 47.4 mt -129.93 137.24 50.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -89.29 111.75 22.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.896 HG22 HG22 ' A' ' 243' ' ' VAL . 45.6 t -111.39 145.09 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.56 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 6.0 ptpp? -149.54 163.68 37.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -69.75 124.35 23.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.454 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.565 HG22 ' H ' ' A' ' 240' ' ' THR . 67.6 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.934 0.397 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.0 p -102.88 34.06 3.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.165 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.565 ' H ' HG22 ' A' ' 238' ' ' ILE . 24.0 m -136.15 141.66 44.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.409 HD11 ' O ' ' A' ' 287' ' ' ALA . 42.0 mt -128.81 125.9 38.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.576 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -80.44 150.07 29.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.854 HG22 HG22 ' A' ' 307' ' ' VAL . 97.6 t -138.57 137.4 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.114 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.68 -179.02 15.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 60.45 44.33 97.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 277' ' ' ALA . 21.8 mt -77.52 -60.27 2.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 110.905 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 62.97 150.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.492 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -42.1 -31.47 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.9 p -55.69 -42.3 75.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.697 ' CD1' HD21 ' A' ' 305' ' ' LEU . 69.2 mt -99.39 151.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.122 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 40.4 p -131.69 177.5 7.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.142 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -57.03 11.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.1 m -44.61 -55.5 5.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -43.74 -44.32 6.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.56 -48.51 32.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -46.09 -45.67 16.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -77.03 -37.7 54.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.55 ' CD2' HG22 ' A' ' 300' ' ' VAL . 46.6 t-80 -60.68 -35.01 75.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.845 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.474 ' CE2' HG13 ' A' ' 279' ' ' ILE . 69.7 m-85 -94.15 -41.11 9.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.898 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -41.97 -38.77 1.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 22.9 pt20 -48.53 -41.7 30.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.606 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 71.5 m-85 -63.34 -45.08 92.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 179.22 -154.92 14.73 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.476 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -78.74 144.8 34.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.794 0.33 . . . . 0.0 110.918 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.637 HD13 HD11 ' A' ' 268' ' ' ILE . 46.2 mt -110.55 119.27 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.438 ' NE ' ' HA ' ' A' ' 282' ' ' ALA . 49.1 mtt180 -65.11 -52.2 56.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 4.0 t -164.35 149.7 10.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.637 HD11 HD13 ' A' ' 265' ' ' ILE . 76.2 mt -128.68 110.26 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 21.8 m -102.98 98.91 8.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.133 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 246' ' ' LEU . 45.3 t -92.69 107.58 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.457 HG12 ' HG3' ' A' ' 273' ' ' ARG . 22.1 t -93.87 100.53 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 14.7 pt20 -60.09 -42.66 95.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.457 ' HG3' HG12 ' A' ' 271' ' ' VAL . 4.1 ptm180 -59.19 -17.68 29.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 275' ' ' GLN . 46.2 mt-30 -123.38 15.52 9.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.856 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 274' ' ' GLN . 40.7 mt-30 33.63 47.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 25.8 p -140.8 170.35 15.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -153.75 134.62 13.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 26.9 m-85 -101.83 108.43 19.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.598 HD13 HG23 ' A' ' 268' ' ' ILE . 6.0 mm -93.17 112.17 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.145 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -102.78 143.52 32.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -121.03 156.65 31.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.438 ' HA ' ' NE ' ' A' ' 266' ' ' ARG . . . -77.26 -37.24 53.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 284' ' ' ARG . 23.9 p -124.06 119.53 29.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.476 ' NE ' ' HG3' ' A' ' 288' ' ' GLU . 14.4 tpt180 -36.0 -40.09 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.557 ' O ' HG23 ' A' ' 289' ' ' VAL . 30.8 tp60 -34.68 -63.15 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.93 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -59.69 -41.65 91.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.074 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.426 ' HB3' ' HD2' ' A' ' 284' ' ' ARG . . . -55.11 -61.3 2.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.101 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 13.6 mt-10 -48.45 -57.3 6.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.563 HG12 ' CE1' ' A' ' 262' ' ' PHE . 57.6 t -45.58 -63.77 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.606 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -54.96 -35.33 64.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.136 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -54.55 -49.09 71.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.34 -25.53 59.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -92.41 5.73 49.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.773 ' OG ' HG11 ' A' ' 307' ' ' VAL . 54.6 p -115.79 -35.72 4.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.839 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.3 m-85 -50.35 109.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 40.07 34.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -133.71 -33.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.463 HD12 ' CE1' ' A' ' 258' ' ' HIS . 10.1 tp -67.62 98.3 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 304' ' ' ARG . 40.4 mt -118.35 93.34 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.117 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.55 HG22 ' CD2' ' A' ' 258' ' ' HIS . 47.1 t -91.67 136.8 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.083 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 56.15 46.26 21.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.854 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 49.38 29.67 10.99 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -130.41 100.95 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.437 ' N ' HG23 ' A' ' 299' ' ' ILE . 22.6 ttp180 -44.69 144.75 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.697 HD21 ' CD1' ' A' ' 250' ' ' ILE . 52.2 mt -129.19 135.84 49.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -86.4 105.99 17.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.854 HG22 HG22 ' A' ' 243' ' ' VAL . 55.5 t -105.87 144.87 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.576 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 15.9 ptpt -150.47 171.28 17.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -82.85 119.63 24.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 13.8 mt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.886 0.374 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 44.0 p -95.35 35.39 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.1 m -133.02 141.16 48.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.0 mt -126.32 159.04 34.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.679 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.4 OUTLIER -111.58 147.59 35.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 307' ' ' VAL . 95.5 t -140.42 120.63 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.17 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 -178.83 20.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.462 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.47 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 58.65 50.29 68.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 277' ' ' ALA . 62.2 mt -86.16 -57.34 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.862 0.363 . . . . 0.0 110.963 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.53 163.71 0.54 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.452 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -52.6 -32.65 42.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.951 0.405 . . . . 0.0 110.891 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.7 p -54.89 -44.78 74.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.484 ' CD1' HD21 ' A' ' 305' ' ' LEU . 86.6 mt -97.87 142.18 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.203 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 37.4 p -124.18 -178.64 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -65.12 -59.68 3.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 87.3 m -42.05 -55.73 3.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.188 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.56 -45.27 6.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 14.5 mt -72.17 -47.2 52.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.407 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 24.1 ttp180 -46.31 -45.19 17.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -76.09 -38.21 57.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.607 ' CD2' HG22 ' A' ' 300' ' ' VAL . 52.4 t-80 -60.23 -35.4 75.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.564 ' CE2' HG13 ' A' ' 279' ' ' ILE . 62.9 m-85 -94.22 -42.3 9.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.663 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.7 t80 -39.92 -35.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 20.3 pt20 -56.26 -44.38 79.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.748 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 41.3 m-85 -55.22 -51.03 67.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.51 -141.89 3.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.43 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -93.15 125.5 37.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 110.901 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.663 HD11 ' N ' ' A' ' 260' ' ' TYR . 48.7 mt -93.51 121.53 44.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.481 ' NE ' ' HA ' ' A' ' 282' ' ' ALA . 43.0 mtt-85 -68.25 -47.94 66.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.4 t -171.14 153.0 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.138 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.407 ' CD1' ' HA ' ' A' ' 256' ' ' ARG . 83.6 mt -127.86 116.42 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 24.4 m -109.37 99.04 8.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.651 HG22 ' CB ' ' A' ' 277' ' ' ALA . 85.6 t -93.52 121.21 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 274' ' ' GLN . 90.3 t -108.7 100.17 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.091 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -57.07 -42.12 80.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 20.2 ttt-85 -50.13 -38.26 38.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.542 ' H ' HG12 ' A' ' 271' ' ' VAL . 63.3 mt-30 -108.35 8.72 27.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.867 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 42.82 52.52 5.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 18.6 p -142.91 177.13 8.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.651 ' CB ' HG22 ' A' ' 270' ' ' VAL . . . -160.17 136.94 9.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.043 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -102.36 115.8 31.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.564 HG13 ' CE2' ' A' ' 259' ' ' PHE . 9.3 mm -95.94 113.2 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.172 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -101.04 147.9 25.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -129.97 151.6 50.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.481 ' HA ' ' NE ' ' A' ' 266' ' ' ARG . . . -72.4 -41.27 66.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 29.7 p -120.34 122.78 41.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.119 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.532 ' HD2' ' HB3' ' A' ' 287' ' ' ALA . 17.7 tpt180 -38.29 -39.62 0.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.881 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -37.48 -59.3 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -59.74 -41.43 90.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.044 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.532 ' HB3' ' HD2' ' A' ' 284' ' ' ARG . . . -56.8 -53.5 57.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -53.77 -57.5 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 285' ' ' GLN . 86.1 t -46.03 -63.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.748 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -53.02 -47.21 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -45.21 -67.17 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.095 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.8 -35.28 68.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.402 ' HE2' HG12 ' A' ' 289' ' ' VAL . 9.6 mtmm -85.72 5.14 33.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.575 ' HB3' HG21 ' A' ' 307' ' ' VAL . 4.7 m -119.07 -26.19 6.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 297' ' ' LYS . 2.9 m-85 -56.08 110.0 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 40.18 26.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 295' ' ' PHE . 19.1 tttm -124.91 -30.12 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.606 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 9.1 tp -67.53 100.56 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 50.1 mt -116.99 97.13 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.607 HG22 ' CD2' ' A' ' 258' ' ' HIS . 42.4 t -96.24 139.79 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.202 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 52.36 47.74 24.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.65 27.56 6.21 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.46 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.1 ttt85 -127.44 101.52 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 110.821 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.6 ' O ' HD23 ' A' ' 305' ' ' LEU . 45.3 ttp85 -43.83 146.82 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 304' ' ' ARG . 45.3 mt -134.84 134.31 40.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -89.11 109.25 20.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 242' ' ' TYR . 81.7 t -106.63 142.96 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.159 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.568 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 13.3 ptpt -148.12 163.25 37.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -71.09 124.55 24.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.451 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 55.3 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.921 0.391 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.1 p -97.57 36.19 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.172 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 18.0 m -133.84 151.28 51.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 291' ' ' ALA . 35.5 mt -137.12 134.95 36.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.585 ' CD1' ' HG3' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -97.3 150.36 21.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.607 HG22 HG22 ' A' ' 307' ' ' VAL . 59.1 t -142.26 139.85 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -130.51 164.55 22.96 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.445 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 74.97 43.84 25.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 250' ' ' ILE . 94.3 mt -74.11 -61.74 1.75 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.884 0.373 . . . . 0.0 110.918 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.42 151.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.464 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -42.78 -34.43 0.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.888 0.375 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.6 p -57.08 -42.83 81.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.156 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.76 ' CD1' HD21 ' A' ' 305' ' ' LEU . 55.9 mt -94.88 143.59 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.1 p -126.98 -176.81 3.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.159 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -65.89 -59.88 3.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.997 0.427 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.2 m -43.36 -50.89 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -40.89 -50.62 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.488 HD11 ' CD2' ' A' ' 246' ' ' LEU . 17.3 mt -73.85 -53.49 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 260' ' ' TYR . 67.0 ttt180 -41.07 -42.95 2.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -75.5 -46.43 32.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.765 ' CD2' HD13 ' A' ' 298' ' ' LEU . 52.3 t60 -54.71 -36.31 64.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -90.47 -44.42 9.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.5 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.3 t80 -40.08 -35.67 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.463 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 26.8 pt20 -54.54 -46.19 73.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.764 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 52.8 m-85 -56.01 -50.01 72.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -177.12 -154.99 12.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.473 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -75.64 141.73 42.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 260' ' ' TYR . 71.1 mt -110.58 112.43 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.137 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -57.66 -50.15 74.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 10.5 t -164.03 168.15 19.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.154 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.448 HD11 HG21 ' A' ' 265' ' ' ILE . 77.3 mt -145.12 106.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 57.1 m -97.61 98.84 10.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 88.5 t -93.93 109.12 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.521 HG12 ' HG2' ' A' ' 273' ' ' ARG . 15.9 t -97.0 99.65 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -60.67 -46.39 90.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.521 ' HG2' HG12 ' A' ' 271' ' ' VAL . 25.4 ptt180 -55.46 -19.83 10.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.47 ' O ' ' C ' ' A' ' 275' ' ' GLN . 65.1 mm-40 -121.19 15.88 11.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 274' ' ' GLN . 29.1 mt-30 32.26 50.45 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 25.9 p -145.92 167.15 23.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.854 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.95 156.52 42.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 56.4 m-85 -126.32 108.07 10.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.466 HG22 ' CE1' ' A' ' 281' ' ' PHE . 4.7 mp -93.69 120.93 43.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.111 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -107.82 146.66 31.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.482 ' HE1' HD12 ' A' ' 241' ' ' LEU . 87.9 m-85 -124.31 147.1 48.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.65 70.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.137 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 284' ' ' ARG . 39.4 p -129.12 118.05 21.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 283' ' ' THR . 16.2 tpt180 -36.31 -34.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 283' ' ' THR . 20.8 tp60 -37.94 -68.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.6 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.138 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -52.12 -60.69 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 6.4 mt-10 -46.88 -59.41 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 39.4 t -46.5 -60.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.764 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -55.08 -32.23 61.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.594 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -61.53 -46.04 91.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -72.76 -29.94 63.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 297' ' ' LYS . 18.5 mttt -87.0 -18.08 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.646 ' CB ' HG11 ' A' ' 307' ' ' VAL . 78.8 p -92.72 -36.03 13.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.3 m-85 -54.08 109.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 1.8 m120 41.51 29.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 293' ' ' LYS . 9.6 mmmt -126.93 -37.69 2.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.765 HD13 ' CD2' ' A' ' 258' ' ' HIS . 12.7 tp -63.4 98.03 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.52 94.43 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.21 146.33 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.163 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 54.47 41.02 32.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.63 33.41 12.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.447 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 22.7 ttt-85 -134.25 97.65 3.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.308 . . . . 0.0 110.863 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -43.72 144.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.76 HD21 ' CD1' ' A' ' 250' ' ' ILE . 48.9 mt -128.81 136.23 50.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -85.7 103.64 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.646 HG11 ' CB ' ' A' ' 294' ' ' SER . 94.6 t -102.47 139.45 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.178 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.585 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 2.9 pttt -150.25 147.34 27.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.95 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -53.14 148.94 7.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.488 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 240' ' ' THR . 82.3 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.914 0.388 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.411 HG22 ' CA ' ' A' ' 284' ' ' ARG . 51.2 p -98.67 27.02 5.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.582 ' H ' HG22 ' A' ' 238' ' ' ILE . 21.7 m -125.58 139.51 53.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 35.5 mt -131.1 123.97 29.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.963 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.652 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.2 OUTLIER -81.65 154.89 25.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.928 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.841 HG22 HG22 ' A' ' 307' ' ' VAL . 75.1 t -139.76 134.83 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -123.04 -179.66 15.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 57.95 43.78 94.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.523 ' HA ' HD12 ' A' ' 250' ' ' ILE . 75.6 mt -83.81 -57.32 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 110.871 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.46 164.45 0.28 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.495 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -54.83 -31.19 59.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 110.828 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.409 ' OG1' ' NE ' ' A' ' 303' ' ' ARG . 23.2 p -56.83 -34.25 67.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.79 ' CD1' HD21 ' A' ' 305' ' ' LEU . 58.3 mt -104.78 138.83 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.123 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 46.1 p -111.84 179.95 3.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -69.29 -52.04 31.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.8 m -50.06 -51.31 43.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.149 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -41.81 -42.16 2.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.9 mt -80.21 -50.24 10.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 -45.06 -41.55 7.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -76.92 -43.67 34.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.502 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 50.1 t-80 -58.69 -32.76 69.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.461 ' CZ ' HD22 ' A' ' 298' ' ' LEU . 61.7 m-85 -94.0 -38.85 10.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.475 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.4 t80 -46.35 -40.67 12.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.4 pt20 -48.61 -38.69 21.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.951 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 88.7 m-85 -65.86 -43.03 89.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 178.5 -153.73 13.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.506 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -80.87 141.24 34.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.794 0.331 . . . . 0.0 110.88 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.475 HD11 ' N ' ' A' ' 260' ' ' TYR . 62.6 mt -110.32 111.28 35.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 280' ' ' GLN . 26.9 mtt-85 -53.91 -49.65 68.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 13.8 t -167.44 169.02 12.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.423 HG23 HD13 ' A' ' 279' ' ' ILE . 76.8 mt -144.95 111.25 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.3 m -105.31 98.94 8.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.484 HG22 ' CB ' ' A' ' 277' ' ' ALA . 82.0 t -91.69 107.4 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 274' ' ' GLN . 95.1 t -92.81 99.97 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . 0.42 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 5.1 pt20 -59.75 -32.74 70.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.936 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.42 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 9.3 tpp85 -59.63 -38.47 81.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.672 ' H ' HG12 ' A' ' 271' ' ' VAL . 12.6 mt-30 -110.71 19.7 18.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 274' ' ' GLN . 60.0 mt-30 34.25 53.14 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 31.1 p -143.56 165.7 26.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.511 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -146.0 133.77 21.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.089 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.424 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 17.6 m-85 -99.31 108.19 20.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.873 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.423 HD13 HG23 ' A' ' 268' ' ' ILE . 3.8 mm -93.01 116.14 33.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 266' ' ' ARG . 34.9 tt0 -106.64 136.33 46.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -113.72 153.16 29.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -77.63 -33.74 53.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.079 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 284' ' ' ARG . 34.4 p -128.75 118.72 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.129 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.493 ' NE ' ' HG3' ' A' ' 288' ' ' GLU . 15.4 tpt180 -35.99 -40.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.722 ' O ' HG23 ' A' ' 289' ' ' VAL . 0.7 OUTLIER -34.59 -62.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -60.54 -42.29 96.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.086 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.25 -63.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.603 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 7.9 mt-10 -45.59 -54.3 7.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 285' ' ' GLN . 39.2 t -50.7 -67.69 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.564 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -53.36 -29.41 34.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.065 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -55.11 -53.08 60.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -72.59 -26.45 61.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -90.25 5.23 47.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.549 ' HB2' HG21 ' A' ' 307' ' ' VAL . 89.8 p -117.13 -39.0 3.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 297' ' ' LYS . 3.1 m-85 -46.37 107.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 2.0 t30 40.12 27.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.876 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 295' ' ' PHE . 8.5 tmtt? -122.65 -32.85 3.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.502 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 8.1 tp -69.91 100.96 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.932 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 65.1 mt -120.11 93.1 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.498 HG22 ' CD2' ' A' ' 258' ' ' HIS . 60.1 t -96.33 142.35 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.121 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 50.96 55.03 10.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 40.54 33.13 0.53 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . 0.409 ' NE ' ' OG1' ' A' ' 249' ' ' THR . 31.0 ttm-85 -132.12 103.23 6.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.921 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.57 ' O ' HD23 ' A' ' 305' ' ' LEU . 46.5 ttp85 -54.07 144.88 18.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.79 HD21 ' CD1' ' A' ' 250' ' ' ILE . 23.6 mt -130.06 132.15 46.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -87.45 102.73 14.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.841 HG22 HG22 ' A' ' 243' ' ' VAL . 95.8 t -100.86 136.42 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.605 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -146.89 145.88 29.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -52.82 133.92 37.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.53 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.467 HG22 ' H ' ' A' ' 240' ' ' THR . 75.5 mt . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.884 0.373 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.9 p -99.65 29.38 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.467 ' H ' HG22 ' A' ' 238' ' ' ILE . 23.1 m -124.9 152.21 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.156 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 31.5 mt -137.01 127.05 25.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.964 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.574 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -88.9 145.43 25.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 307' ' ' VAL . 84.3 t -139.07 133.87 40.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -122.59 167.95 14.99 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.547 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.92 42.49 44.97 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 277' ' ' ALA . 29.7 mt -77.7 -60.03 2.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.847 0.356 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.57 159.0 0.72 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.451 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -48.36 -32.97 8.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 79.4 p -55.92 -46.39 78.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.645 ' CD1' HD21 ' A' ' 305' ' ' LEU . 77.2 mt -93.1 150.51 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.059 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.6 p -132.8 -179.89 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.633 ' HB2' HG21 ' A' ' 270' ' ' VAL . 25.3 tt0 -66.13 -58.19 5.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 79.4 m -44.11 -51.01 8.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.185 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -44.49 -48.13 10.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 13.8 mt -74.78 -45.16 45.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.929 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 50.1 ttt180 -49.09 -42.94 40.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -78.76 -43.39 25.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.551 ' CE1' HD12 ' A' ' 298' ' ' LEU . 64.9 t-80 -57.9 -33.83 69.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -94.38 -40.02 10.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.565 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.5 t80 -42.4 -36.56 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.479 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 16.3 pt20 -51.89 -41.07 61.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.736 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 63.7 m-85 -60.88 -49.23 78.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -178.95 -163.45 30.06 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -69.74 130.51 42.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 0.0 110.883 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.565 HD11 ' N ' ' A' ' 260' ' ' TYR . 79.1 mt -99.98 109.66 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.486 ' HG3' ' N ' ' A' ' 282' ' ' ALA . 22.7 mtt-85 -51.39 -53.07 40.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.0 t -164.07 165.41 22.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 98.3 mt -139.65 105.57 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.092 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.2 m -98.06 99.98 11.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.127 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.633 HG21 ' HB2' ' A' ' 252' ' ' GLU . 66.7 t -93.59 106.02 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.784 HG12 ' HG2' ' A' ' 273' ' ' ARG . 4.4 t -91.15 99.67 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -60.79 -47.76 84.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.784 ' HG2' HG12 ' A' ' 271' ' ' VAL . 6.0 ptm180 -55.18 -20.1 9.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.475 ' O ' ' C ' ' A' ' 275' ' ' GLN . 28.2 mm-40 -121.28 15.74 11.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 274' ' ' GLN . 31.6 mt-30 32.25 50.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 22.6 p -142.51 168.24 20.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -148.28 153.41 38.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 53.5 m-85 -124.65 108.96 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.564 HG22 ' CE1' ' A' ' 281' ' ' PHE . 4.5 mp -94.72 120.7 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.126 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 266' ' ' ARG . 53.0 tt0 -109.49 147.47 32.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.564 ' CE1' HG22 ' A' ' 279' ' ' ILE . 87.8 m-85 -126.95 139.86 52.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.866 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.486 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -59.7 -36.29 76.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 284' ' ' ARG . 38.3 p -123.1 116.66 23.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 285' ' ' GLN . 14.5 tpt180 -36.0 -37.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 284' ' ' ARG . 0.9 OUTLIER -35.65 -63.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.89 80.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.083 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.07 -45.84 79.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.122 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -62.94 -54.04 44.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.489 HG12 ' CE1' ' A' ' 262' ' ' PHE . 49.0 t -50.42 -58.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.736 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -57.47 -45.26 85.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.079 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -41.61 -67.82 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.046 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.58 -40.85 69.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -76.94 1.84 16.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.709 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.3 m -118.41 -25.0 6.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -57.13 104.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 15.3 m120 41.46 30.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -126.8 -32.83 2.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.551 HD12 ' CE1' ' A' ' 258' ' ' HIS . 5.0 tp -65.96 96.4 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 56.0 mt -114.7 95.58 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.82 142.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 57.9 41.4 24.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 49.86 33.19 19.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -134.93 104.4 5.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 110.889 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.402 ' O ' HD23 ' A' ' 305' ' ' LEU . 17.4 ttm180 -49.96 145.06 5.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.645 HD21 ' CD1' ' A' ' 250' ' ' ILE . 27.1 mt -129.64 133.39 47.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.44 98.73 10.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 243' ' ' VAL . 93.8 t -96.45 145.01 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.195 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.556 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 0.6 OUTLIER -158.42 145.39 17.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -52.32 148.97 5.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.537 ' N ' HH11 ' A' ' 284' ' ' ARG . 69.3 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.886 0.375 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.402 HG22 ' CA ' ' A' ' 284' ' ' ARG . 46.2 p -98.75 38.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.501 ' H ' HG22 ' A' ' 238' ' ' ILE . 14.2 m -133.4 143.14 48.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.117 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 22.7 mt -133.28 122.18 23.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.914 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.606 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -79.84 143.65 34.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.955 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.768 HG22 HG22 ' A' ' 307' ' ' VAL . 88.2 t -133.36 131.4 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.134 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -121.58 176.8 16.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 64.15 44.33 95.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.547 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.692 ' HA ' HD12 ' A' ' 250' ' ' ILE . 92.7 mt -86.78 -56.32 3.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.828 0.347 . . . . 0.0 110.95 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.5 155.58 0.37 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.555 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -46.59 -34.25 4.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.847 0.356 . . . . 0.0 110.858 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.8 p -53.83 -56.71 15.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.693 ' CD1' HD21 ' A' ' 305' ' ' LEU . 76.3 mt -75.41 140.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 32.9 p -117.15 179.64 3.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.109 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.74 -55.72 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 92.8 m -45.35 -47.22 13.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.459 ' HB3' HG11 ' A' ' 300' ' ' VAL . 0.7 OUTLIER -49.41 -38.42 28.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 30.4 mt -83.82 -50.0 8.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 49.7 ttm-85 -46.65 -41.74 15.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.884 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -76.55 -43.2 40.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.617 ' CE1' HD12 ' A' ' 298' ' ' LEU . 56.7 t-80 -58.64 -33.8 70.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -94.19 -40.4 10.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.547 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.5 t80 -42.01 -36.52 1.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.2 pt20 -51.98 -42.06 62.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.579 ' CE1' HG12 ' A' ' 289' ' ' VAL . 63.1 m-85 -59.77 -49.93 75.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -175.23 -145.12 5.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -88.53 129.42 35.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.346 . . . . 0.0 110.918 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.547 HD11 ' N ' ' A' ' 260' ' ' TYR . 65.3 mt -96.55 110.59 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.7 mtp85 -54.98 -54.55 41.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 11.9 t -162.14 166.49 25.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.153 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.494 HG23 HD13 ' A' ' 279' ' ' ILE . 87.1 mt -142.67 110.91 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 87.8 m -104.18 98.87 8.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.47 111.1 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.683 HG12 ' HG2' ' A' ' 273' ' ' ARG . 3.8 t -95.85 101.83 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -60.68 -47.13 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.683 ' HG2' HG12 ' A' ' 271' ' ' VAL . 4.7 ptm180 -53.18 -30.29 36.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 275' ' ' GLN . 55.7 mm-40 -112.76 13.64 19.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 274' ' ' GLN . 46.1 mt-30 34.91 53.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 11.4 p -143.57 172.01 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.515 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -152.77 132.1 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 18.4 m-85 -98.91 109.99 22.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.494 HD13 HG23 ' A' ' 268' ' ' ILE . 6.1 mm -94.14 116.29 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.149 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 266' ' ' ARG . 17.7 tt0 -105.86 141.71 36.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.413 ' C ' ' HG3' ' A' ' 266' ' ' ARG . 97.5 m-85 -119.56 151.95 37.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.16 77.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.087 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 33.8 p -126.08 126.17 43.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.131 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.537 HH11 ' N ' ' A' ' 238' ' ' ILE . 9.7 tpt180 -40.3 -32.19 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -40.99 -65.76 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.959 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.3 77.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.084 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.46 -58.06 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.101 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -48.82 -57.05 7.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.948 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.579 HG12 ' CE1' ' A' ' 262' ' ' PHE . 23.7 t -51.15 -54.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -57.06 -39.56 75.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -52.91 -66.38 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -53.42 -43.2 67.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -75.25 2.51 10.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.65 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.4 m -116.37 -30.9 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -52.43 95.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.1 m120 48.1 29.37 1.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 53.2 tttt -126.05 -31.01 2.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.617 HD12 ' CE1' ' A' ' 258' ' ' HIS . 5.4 tp -69.47 101.34 1.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 53.3 mt -118.72 94.4 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.465 HG22 ' CD2' ' A' ' 258' ' ' HIS . 53.5 t -93.53 133.36 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.426 ' ND2' HG12 ' A' ' 300' ' ' VAL . 78.1 m-20 57.31 54.32 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 41.84 32.11 0.89 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . 0.501 ' HD2' HD11 ' A' ' 250' ' ' ILE . 26.9 ttm-85 -130.57 102.08 5.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.779 0.323 . . . . 0.0 110.86 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.563 ' O ' HD23 ' A' ' 305' ' ' LEU . 11.3 ttp180 -49.2 146.7 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.693 HD21 ' CD1' ' A' ' 250' ' ' ILE . 29.3 mt -134.03 133.62 41.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -87.98 101.91 14.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.768 HG22 HG22 ' A' ' 243' ' ' VAL . 92.9 t -97.62 145.61 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.591 ' HE3' ' CE1' ' A' ' 242' ' ' TYR . 4.8 pttt -156.45 144.6 19.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.886 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -53.12 145.51 13.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 240' ' ' THR . 66.6 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.903 0.382 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.0 p -102.19 29.81 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.195 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.517 ' H ' HG22 ' A' ' 238' ' ' ILE . 15.5 m -128.44 143.12 50.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 31.8 mt -131.96 124.69 29.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.6 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.3 OUTLIER -82.09 149.75 27.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.848 HG22 HG22 ' A' ' 307' ' ' VAL . 66.8 t -140.28 129.32 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.124 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.69 173.75 14.93 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 65.68 51.45 47.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.517 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.568 HD11 ' C ' ' A' ' 276' ' ' CYS . 79.3 mt -77.12 -61.58 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.12 145.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.476 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -40.13 -31.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.382 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 34.4 p -56.36 -45.9 80.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.626 ' CD1' HD21 ' A' ' 305' ' ' LEU . 61.8 mt -97.27 141.6 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 16.6 p -123.9 -177.5 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -66.46 -55.97 13.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 7.9 m -43.56 -59.14 2.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.476 ' HA ' ' ND2' ' A' ' 257' ' ' ASN . 18.7 m-20 -40.14 -59.28 1.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.432 HD11 HD22 ' A' ' 246' ' ' LEU . 14.9 mt -57.51 -52.12 66.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 41.8 ttt85 -48.87 -38.58 22.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . 0.523 ' C ' ' OD1' ' A' ' 257' ' ' ASN . 0.4 OUTLIER -77.97 -40.47 39.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.648 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 58.2 t-80 -61.57 -33.08 73.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.49 ' CE2' HG13 ' A' ' 279' ' ' ILE . 72.5 m-85 -94.31 -40.39 9.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.629 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.4 t80 -41.99 -35.48 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.937 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 26.2 pt20 -55.17 -50.2 69.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.76 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 56.9 m-85 -53.1 -50.16 65.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.837 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -172.72 -155.09 10.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.488 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -83.35 127.95 34.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.629 HD11 ' N ' ' A' ' 260' ' ' TYR . 45.1 mt -93.61 114.19 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 280' ' ' GLN . 16.0 mtt180 -57.74 -50.61 72.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.5 t -165.45 170.96 13.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.124 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 86.8 mt -145.43 116.12 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 55.2 m -107.16 100.04 9.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.553 HG13 ' CD1' ' A' ' 246' ' ' LEU . 93.0 t -93.47 107.1 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.158 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 44.1 t -92.73 100.01 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.195 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -59.68 -38.76 82.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 -64.33 -10.22 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -130.44 6.0 4.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 41.81 45.11 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.568 ' C ' HD11 ' A' ' 246' ' ' LEU . 14.1 p -137.24 166.62 23.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -146.21 135.68 23.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 26.2 m-85 -104.18 108.5 19.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.49 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.8 mm -91.72 119.87 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.17 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 266' ' ' ARG . 42.2 tt0 -107.77 141.92 38.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.08 148.21 44.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.45 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -70.54 -37.36 74.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.096 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 284' ' ' ARG . 17.4 p -126.06 121.49 33.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.513 ' HD2' ' HB3' ' A' ' 287' ' ' ALA . 12.6 tpt180 -36.93 -40.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 284' ' ' ARG . 36.4 tp60 -34.46 -63.9 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.57 -44.88 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.513 ' HB3' ' HD2' ' A' ' 284' ' ' ARG . . . -50.78 -57.47 8.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.133 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 19.9 mt-10 -49.95 -65.04 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.498 HG12 ' CE1' ' A' ' 262' ' ' PHE . 59.7 t -39.08 -59.74 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.76 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -58.95 -37.69 77.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.101 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.585 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -49.9 -54.56 18.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -69.17 -28.59 66.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -90.3 4.98 49.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 58.2 p -117.37 -30.1 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 5.0 m-30 -55.57 105.76 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 40.67 29.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -124.4 -35.81 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.648 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 11.1 tp -67.04 93.33 0.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 304' ' ' ARG . 42.5 mt -113.47 91.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 41.3 t -92.29 146.32 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 50.87 46.98 25.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.16 31.3 6.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -133.16 104.0 6.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.518 ' O ' HD23 ' A' ' 305' ' ' LEU . 12.6 ttm-85 -50.11 148.64 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.626 HD21 ' CD1' ' A' ' 250' ' ' ILE . 21.9 mt -131.45 132.52 44.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.21 99.75 11.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.848 HG22 HG22 ' A' ' 243' ' ' VAL . 72.9 t -101.92 140.37 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.532 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 11.7 pttt -149.17 149.07 30.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -52.77 136.3 33.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.913 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.5 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 34.0 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.882 0.373 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.448 HG22 ' CA ' ' A' ' 284' ' ' ARG . 30.2 p -99.2 36.27 1.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 30.1 m -137.18 138.46 40.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 22.0 mt -125.28 156.94 37.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.562 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.3 OUTLIER -109.7 149.29 29.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.913 HG22 HG22 ' A' ' 307' ' ' VAL . 91.4 t -141.95 119.19 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.32 -175.04 20.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.534 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 55.69 45.82 84.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.509 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.479 ' HA ' HD12 ' A' ' 250' ' ' ILE . 44.7 mt -78.62 -59.13 2.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 0.0 110.943 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 62.72 153.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.507 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -42.12 -37.93 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.86 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 43.3 p -49.4 -44.43 45.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.835 ' CD1' HD21 ' A' ' 305' ' ' LEU . 65.3 mt -97.17 146.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.138 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.7 p -126.23 -178.78 4.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' A' ' 270' ' ' VAL . 1.2 tm-20 -66.39 -57.28 7.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.8 m -47.15 -54.36 10.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -40.81 -45.77 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 9.1 mt -74.07 -45.64 48.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -48.8 -46.03 41.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -76.25 -38.69 55.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.529 ' CD2' HG22 ' A' ' 300' ' ' VAL . 43.4 t-80 -61.07 -34.56 75.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.499 ' CE2' HG13 ' A' ' 279' ' ' ILE . 58.4 m-85 -94.34 -39.67 10.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.863 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.677 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.7 t80 -43.48 -38.93 3.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.957 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 29.0 pt20 -50.28 -43.55 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 85.1 m-85 -60.54 -47.8 84.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -177.69 -167.01 35.21 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -69.03 127.22 32.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.343 . . . . 0.0 110.873 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.677 HD11 ' N ' ' A' ' 260' ' ' TYR . 84.3 mt -95.72 110.67 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.128 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.4 mtp180 -54.01 -51.5 63.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.8 t -164.71 169.47 16.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.194 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.463 HD11 HG21 ' A' ' 265' ' ' ILE . 88.6 mt -145.87 114.29 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.18 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 85.3 m -109.18 99.02 8.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.619 HG22 ' CB ' ' A' ' 277' ' ' ALA . 96.2 t -92.65 111.01 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.404 ' CG1' ' HG2' ' A' ' 273' ' ' ARG . 38.5 t -94.2 101.4 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . 0.422 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 5.2 pt20 -59.23 -40.61 86.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.422 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 6.6 ptp85 -62.16 -21.55 65.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 275' ' ' GLN . 74.0 mt-30 -117.31 14.27 14.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.94 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 274' ' ' GLN . 71.3 mt-30 34.38 43.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 21.7 p -141.04 173.51 11.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.619 ' CB ' HG22 ' A' ' 270' ' ' VAL . . . -157.36 140.28 15.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -105.12 121.86 44.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.499 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.1 mm -102.32 117.03 47.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.186 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 266' ' ' ARG . 16.3 tt0 -105.17 140.3 38.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.411 ' C ' ' HG3' ' A' ' 266' ' ' ARG . 97.5 m-85 -120.72 148.3 44.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.884 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.444 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -70.23 -34.01 72.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 284' ' ' ARG . 22.4 p -125.82 116.6 21.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.178 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.631 ' HD2' ' HB3' ' A' ' 287' ' ' ALA . 16.7 tpt180 -36.14 -39.3 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.508 ' O ' HG23 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -33.56 -64.42 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.02 -46.68 82.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.097 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.631 ' HB3' ' HD2' ' A' ' 284' ' ' ARG . . . -50.5 -53.26 31.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.453 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 6.2 mt-10 -55.24 -48.87 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 285' ' ' GLN . 42.1 t -57.88 -59.96 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.564 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -56.12 -33.97 65.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.16 -67.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.42 -39.71 73.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -75.08 1.59 12.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.604 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.4 m -115.81 -33.38 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.2 102.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 9.0 m120 44.23 31.72 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -129.83 -31.14 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.475 HD12 ' CE1' ' A' ' 258' ' ' HIS . 6.6 tp -70.06 103.69 2.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 304' ' ' ARG . 27.0 mt -119.74 96.76 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.529 HG22 ' CD2' ' A' ' 258' ' ' HIS . 31.1 t -96.28 138.31 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.097 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 56.95 47.19 18.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.15 29.64 6.95 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.496 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 18.0 ttt85 -130.49 103.85 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.859 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.464 ' N ' HG23 ' A' ' 299' ' ' ILE . 13.7 ttm180 -48.23 137.67 10.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.835 HD21 ' CD1' ' A' ' 250' ' ' ILE . 26.3 mt -124.19 133.55 53.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -87.54 107.24 18.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.913 HG22 HG22 ' A' ' 243' ' ' VAL . 53.4 t -105.13 143.46 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.562 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -146.15 165.15 29.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -74.25 122.12 22.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 179.99 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 14.3 mt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.899 0.38 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 284' ' ' ARG . 51.0 p -90.95 23.47 3.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 26.4 m -121.14 141.76 50.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.155 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 291' ' ' ALA . 26.7 mt -128.59 146.86 50.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.586 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -102.6 143.41 32.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.905 HG22 HG22 ' A' ' 307' ' ' VAL . 93.3 t -136.83 114.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -100.97 179.27 28.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.523 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.467 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 61.92 51.88 54.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.677 HD11 ' C ' ' A' ' 276' ' ' CYS . 88.0 mt -81.46 -59.65 2.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.11 149.97 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.459 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.9 -29.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.92 0.39 . . . . 0.0 110.842 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 23.8 p -57.94 -41.81 83.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.647 ' CD1' HD21 ' A' ' 305' ' ' LEU . 79.2 mt -99.13 146.16 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 40.6 p -127.04 -176.41 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.152 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.432 ' HB2' HG21 ' A' ' 270' ' ' VAL . 48.6 tt0 -71.51 -56.23 6.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 96.0 m -45.01 -48.86 11.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -49.53 -50.91 39.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.7 mt -67.32 -43.55 81.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -51.49 -45.01 62.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -78.69 -33.02 47.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.563 ' CE1' HD12 ' A' ' 298' ' ' LEU . 38.2 t-80 -65.75 -34.87 79.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.435 ' CE2' HG13 ' A' ' 279' ' ' ILE . 60.4 m-85 -94.08 -37.58 11.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.601 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.3 t80 -44.77 -26.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.476 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 11.4 pt20 -63.96 -41.74 97.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.887 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.878 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 56.8 m-85 -62.21 -39.08 91.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 286' ' ' ALA . . . 174.71 -154.35 18.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.491 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -79.0 141.69 37.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.87 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.601 HD11 ' N ' ' A' ' 260' ' ' TYR . 70.9 mt -112.28 111.88 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 280' ' ' GLN . 20.5 mtt180 -59.97 -49.14 78.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.7 t -165.11 171.25 14.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.16 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 94.4 mt -144.4 106.96 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 26.4 m -96.61 100.66 12.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.136 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.432 HG21 ' HB2' ' A' ' 252' ' ' GLU . 94.6 t -94.79 109.54 22.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.082 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 274' ' ' GLN . 60.9 t -99.44 99.91 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -40.62 89.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -50.35 -39.02 45.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.524 ' H ' HG12 ' A' ' 271' ' ' VAL . 26.1 mt-30 -108.65 10.49 26.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 42.71 52.12 5.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.677 ' C ' HD11 ' A' ' 246' ' ' LEU . 25.7 p -140.58 168.66 19.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.29 130.23 15.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.126 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -100.14 109.56 21.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.435 HG13 ' CE2' ' A' ' 259' ' ' PHE . 2.9 mm -92.66 123.04 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.094 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 266' ' ' ARG . 38.6 tt0 -108.3 141.05 40.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -120.96 144.67 48.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.856 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.91 -37.09 78.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 284' ' ' ARG . 22.8 p -120.75 117.18 26.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.098 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.518 ' HA ' HG22 ' A' ' 239' ' ' THR . 13.7 tpt180 -37.21 -38.83 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 284' ' ' ARG . 12.7 tp60 -37.79 -67.39 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . 0.477 ' HB2' ' HA3' ' A' ' 263' ' ' GLY . . . -52.86 -43.15 65.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 284' ' ' ARG . . . -52.44 -57.74 8.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 18.7 mt-10 -50.45 -63.15 1.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.415 HG12 ' HE3' ' A' ' 293' ' ' LYS . 28.8 t -41.21 -66.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.878 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -50.29 -46.4 55.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.457 ' HB2' HD11 ' A' ' 241' ' ' LEU . . . -47.26 -67.71 0.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -55.41 -38.76 69.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.415 ' HE3' HG12 ' A' ' 289' ' ' VAL . 14.5 mtmt -84.28 6.07 24.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.554 ' HB3' HG21 ' A' ' 307' ' ' VAL . 16.9 m -118.57 -13.22 9.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 297' ' ' LYS . 3.8 m-30 -71.27 113.92 8.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . 0.405 ' HA ' ' NH1' ' A' ' 304' ' ' ARG . 1.2 m-20 41.9 25.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.877 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 295' ' ' PHE . 3.0 ttmm -126.21 -31.88 2.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.563 HD12 ' CE1' ' A' ' 258' ' ' HIS . 5.3 tp -71.62 101.4 2.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 304' ' ' ARG . 39.3 mt -115.88 95.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 32.8 t -90.36 136.61 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 53.74 51.19 15.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.61 28.84 2.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 18.2 ttt-85 -129.14 98.22 4.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 110.852 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.526 ' N ' HG23 ' A' ' 299' ' ' ILE . 32.2 ttp85 -42.25 145.9 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.647 HD21 ' CD1' ' A' ' 250' ' ' ILE . 49.7 mt -130.59 135.97 48.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -89.55 99.47 12.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.905 HG22 HG22 ' A' ' 243' ' ' VAL . 75.2 t -95.72 142.39 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.075 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.586 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 11.9 ptpt -145.77 171.94 14.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -85.06 122.02 28.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.469 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 240' ' ' THR . 65.4 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.96 0.41 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 29.1 p -108.41 26.59 10.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.473 ' H ' HG22 ' A' ' 238' ' ' ILE . 18.3 m -117.75 140.98 48.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.16 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 30.6 mt -128.49 133.24 48.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.603 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -97.92 140.72 31.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.969 HG22 HG22 ' A' ' 307' ' ' VAL . 89.5 t -135.5 127.31 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.51 174.89 16.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.436 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 70.66 42.29 62.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.483 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.575 ' CD1' HG13 ' A' ' 270' ' ' VAL . 24.3 mt -70.64 -62.9 1.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.826 0.346 . . . . 0.0 110.919 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.71 158.98 0.75 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.443 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -56.65 -15.58 4.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.8 p -74.26 -32.49 62.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.588 HD13 HD11 ' A' ' 305' ' ' LEU . 68.6 mt -108.97 145.26 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 12.4 p -128.56 177.19 7.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.151 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -59.55 -61.25 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 94.6 m -38.66 -56.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -40.31 -56.03 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.9 mt -65.42 -48.86 71.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.44 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 44.0 ttt180 -45.92 -43.13 13.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -79.46 -41.21 28.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.649 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 59.6 t-80 -57.91 -33.66 69.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.564 ' CD2' HG12 ' A' ' 279' ' ' ILE . 60.1 m-85 -94.22 -42.8 8.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.601 ' N ' HD11 ' A' ' 265' ' ' ILE . 2.0 t80 -42.29 -36.06 1.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.464 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.8 pt20 -54.3 -41.28 68.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.959 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 86.3 m-85 -64.84 -42.86 94.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 176.36 -172.22 45.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -61.47 142.27 57.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 110.922 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.601 HD11 ' N ' ' A' ' 260' ' ' TYR . 70.6 mt -111.93 111.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -55.02 -50.25 69.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.8 t -168.85 162.24 11.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.474 HD11 HD13 ' A' ' 265' ' ' ILE . 79.7 mt -138.4 108.46 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 92.4 m -99.63 100.34 11.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.575 HG13 ' CD1' ' A' ' 246' ' ' LEU . 76.8 t -92.62 103.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 274' ' ' GLN . 82.6 t -86.4 99.88 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -60.25 -31.68 70.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -59.23 -38.08 79.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.695 ' H ' HG12 ' A' ' 271' ' ' VAL . 77.0 mt-30 -112.52 21.66 15.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.943 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.459 ' HA ' ' NE2' ' A' ' 275' ' ' GLN . 14.5 mm100 33.73 50.82 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 29.3 p -140.62 167.9 21.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.441 ' HB2' HG22 ' A' ' 270' ' ' VAL . . . -146.14 146.8 31.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.571 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 33.7 m-85 -115.21 107.72 15.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.598 HG22 ' CE1' ' A' ' 281' ' ' PHE . 3.9 mp -90.86 121.03 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.144 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -106.94 142.95 35.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.598 ' CE1' HG22 ' A' ' 279' ' ' ILE . 96.9 m-85 -122.75 142.03 51.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.43 74.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.046 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 36.8 p -131.81 123.88 28.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.134 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 6.0 tpp85 -39.0 -33.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.676 ' O ' HG23 ' A' ' 289' ' ' VAL . 21.6 tp60 -37.97 -65.9 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -58.23 -53.83 53.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -41.59 -63.45 0.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.096 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.585 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 4.7 mm-40 -46.3 -64.31 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.869 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 285' ' ' GLN . 18.6 t -40.25 -62.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.561 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -57.02 -33.98 67.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.119 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.59 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -53.86 -60.71 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.131 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -63.79 -36.53 84.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.425 ' HD2' ' CE2' ' A' ' 262' ' ' PHE . 17.7 mttm -75.97 -8.49 57.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.822 ' HB3' HG21 ' A' ' 307' ' ' VAL . 29.6 m -114.18 -9.82 12.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.8 m-30 -65.4 105.71 1.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.835 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 21.1 m120 43.36 27.79 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -127.68 -28.61 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.649 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 4.7 tp -67.8 97.37 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.961 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.419 HG23 ' N ' ' A' ' 304' ' ' ARG . 38.4 mt -116.13 94.53 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 49.8 t -95.85 145.2 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 50.93 50.03 19.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.9 34.18 5.47 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.534 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -136.9 108.92 7.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 110.883 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.523 ' O ' HD23 ' A' ' 305' ' ' LEU . 24.5 ttm180 -56.84 143.69 36.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.588 HD11 HD13 ' A' ' 250' ' ' ILE . 43.0 mt -126.78 137.95 53.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.74 98.89 11.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.969 HG22 HG22 ' A' ' 243' ' ' VAL . 79.0 t -93.22 138.65 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.549 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.3 ptpt -151.56 141.52 22.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -50.7 135.19 23.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.464 HG22 ' H ' ' A' ' 240' ' ' THR . 58.5 mt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.944 0.402 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 284' ' ' ARG . 39.0 p -99.61 32.2 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.464 ' H ' HG22 ' A' ' 238' ' ' ILE . 9.4 m -130.22 149.37 51.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 291' ' ' ALA . 28.8 mt -132.3 156.85 45.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.817 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.3 OUTLIER -108.36 146.18 33.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 58.2 t -140.77 113.84 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.098 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -107.0 -177.42 22.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.519 ' O ' HD22 ' A' ' 305' ' ' LEU . . . 57.7 47.33 89.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.477 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.449 HD11 ' CB ' ' A' ' 277' ' ' ALA . 95.4 mt -83.22 -57.82 3.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 110.915 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.26 158.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.477 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -47.02 -33.95 5.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.912 0.387 . . . . 0.0 110.857 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.9 p -52.75 -44.38 66.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.774 ' CD1' HD21 ' A' ' 305' ' ' LEU . 70.4 mt -97.88 143.52 12.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 42.7 p -121.83 -176.65 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -70.1 -57.09 5.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.5 m -44.55 -50.1 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.124 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -46.99 -42.67 18.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 21.1 mt -77.34 -48.92 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.403 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 28.0 ttm180 -46.46 -44.44 17.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -76.3 -40.11 52.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.523 ' CE1' HD12 ' A' ' 298' ' ' LEU . 51.3 t-80 -60.19 -34.45 73.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.837 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -94.22 -40.68 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.668 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.6 t80 -42.05 -34.82 0.77 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.484 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.0 pt20 -54.16 -43.2 70.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.934 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.577 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 60.8 m-85 -57.68 -50.93 71.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.62 -150.1 7.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -85.13 122.61 29.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 0.0 110.848 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.668 HD11 ' N ' ' A' ' 260' ' ' TYR . 77.2 mt -90.71 116.88 32.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -63.11 -51.67 65.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.3 t -165.13 161.59 19.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.615 HG23 HD13 ' A' ' 279' ' ' ILE . 76.7 mt -137.71 109.72 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 60.7 m -100.45 99.58 10.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.148 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.495 HG22 ' CB ' ' A' ' 277' ' ' ALA . 93.4 t -91.13 115.11 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.163 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.544 HG12 ' HG2' ' A' ' 273' ' ' ARG . 5.0 t -97.18 102.04 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -60.23 -49.49 77.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.544 ' HG2' HG12 ' A' ' 271' ' ' VAL . 5.0 ptm180 -54.03 -30.14 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 275' ' ' GLN . 16.6 mt-30 -108.33 13.79 25.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 274' ' ' GLN . 43.6 mt-30 34.32 47.26 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.428 ' C ' ' CD1' ' A' ' 246' ' ' LEU . 20.7 p -142.2 177.54 8.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.495 ' CB ' HG22 ' A' ' 270' ' ' VAL . . . -159.59 140.2 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -107.06 119.5 39.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.615 HD13 HG23 ' A' ' 268' ' ' ILE . 3.8 mm -98.51 118.63 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.15 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -104.47 141.23 36.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -122.88 150.52 42.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -71.2 -41.84 69.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 33.1 p -118.99 122.5 42.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.12 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.412 ' HA ' HG22 ' A' ' 239' ' ' THR . 17.0 tpt180 -38.44 -35.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -39.55 -65.86 0.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -53.67 -48.94 68.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -47.49 -63.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 5.7 mt-10 -43.42 -64.1 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.518 HG12 ' CE1' ' A' ' 262' ' ' PHE . 41.5 t -42.51 -58.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.577 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -54.6 -39.55 67.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.513 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -52.22 -65.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -54.7 -39.52 68.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -80.41 2.42 25.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.781 ' HB3' HG11 ' A' ' 307' ' ' VAL . 24.0 m -117.36 -26.58 6.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -58.19 102.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.0 m120 43.69 32.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -129.74 -31.09 2.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.523 HD12 ' CE1' ' A' ' 258' ' ' HIS . 4.9 tp -68.65 98.53 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 304' ' ' ARG . 28.4 mt -113.72 94.47 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.433 ' HB ' HD11 ' A' ' 305' ' ' LEU . 59.2 t -92.07 139.36 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 53.71 47.35 23.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.885 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.31 27.02 5.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 -126.92 97.63 5.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.772 0.32 . . . . 0.0 110.907 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.486 ' N ' HG23 ' A' ' 299' ' ' ILE . 34.3 ttm-85 -42.41 139.76 1.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.774 HD21 ' CD1' ' A' ' 250' ' ' ILE . 29.2 mt -126.7 138.09 53.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -87.99 113.66 23.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.817 HG13 ' O ' ' A' ' 242' ' ' TYR . 47.0 t -113.79 143.63 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.59 ' HE2' ' CD1' ' A' ' 242' ' ' TYR . 18.7 pttt -152.65 161.26 42.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -67.68 123.53 20.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.974 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 240' ' ' THR . 79.9 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.978 0.418 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.1 p -102.41 35.14 2.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.577 ' H ' HG22 ' A' ' 238' ' ' ILE . 17.2 m -138.72 143.2 38.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.5 mt -129.11 141.72 51.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.564 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -104.64 137.02 43.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.06 131.62 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.156 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.59 158.23 15.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 82.84 37.87 12.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.434 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.546 HD11 ' C ' ' A' ' 276' ' ' CYS . 63.6 mt -63.62 -66.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.425 ' HA3' ' NH1' ' A' ' 303' ' ' ARG . . . 66.01 148.32 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.5 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.0 -37.88 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 0.0 110.845 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 50.9 p -52.9 -46.58 68.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.151 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.893 ' CD1' HD21 ' A' ' 305' ' ' LEU . 53.0 mt -94.24 143.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.115 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.2 p -129.31 177.31 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.15 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.503 ' OE1' ' CG2' ' A' ' 270' ' ' VAL . 3.7 tp10 -60.35 -61.14 2.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.1 m -41.43 -52.61 3.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.134 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.51 -51.5 5.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.0 mt -70.03 -45.26 67.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.94 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -48.88 -47.27 43.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -76.59 -38.93 54.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.573 ' CE1' HD12 ' A' ' 298' ' ' LEU . 34.6 t-80 -60.44 -34.24 73.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.567 ' CD2' HG12 ' A' ' 279' ' ' ILE . 51.3 m-85 -94.87 -41.34 9.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.838 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.432 ' N ' HD11 ' A' ' 265' ' ' ILE . 2.0 t80 -41.8 -38.17 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 27.4 pt20 -52.32 -41.71 63.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 70.2 m-85 -63.25 -48.29 78.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 177.13 174.29 43.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.545 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -45.81 147.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.432 HD11 ' N ' ' A' ' 260' ' ' TYR . 65.8 mt -117.03 112.35 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.8 mtp180 -55.19 -50.98 67.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.1 t -167.03 158.84 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.485 HG22 ' OE2' ' A' ' 252' ' ' GLU . 21.0 mt -136.2 110.31 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.07 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 91.2 m -105.14 126.33 51.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.503 ' CG2' ' OE1' ' A' ' 252' ' ' GLU . 25.5 t -109.8 123.48 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.419 HG12 ' HG2' ' A' ' 273' ' ' ARG . 22.8 t -106.75 99.93 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.144 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -59.89 -50.0 75.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.419 ' HG2' HG12 ' A' ' 271' ' ' VAL . 9.4 ptt85 -53.79 -24.83 16.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.457 ' O ' ' C ' ' A' ' 275' ' ' GLN . 17.8 mt-30 -116.68 10.98 14.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 274' ' ' GLN . 66.8 mt-30 33.34 53.79 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.546 ' C ' HD11 ' A' ' 246' ' ' LEU . 26.9 p -142.86 172.21 13.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -146.3 151.2 37.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.065 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 49.6 m-85 -121.47 108.24 13.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.612 HG22 ' CE1' ' A' ' 281' ' ' PHE . 4.5 mp -94.24 118.52 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.126 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 266' ' ' ARG . 7.9 tt0 -105.91 142.52 35.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.612 ' CE1' HG22 ' A' ' 279' ' ' ILE . 87.7 m-85 -121.49 149.95 42.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.39 91.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.069 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 284' ' ' ARG . 35.8 p -125.81 125.34 42.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.15 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.461 ' O ' ' C ' ' A' ' 285' ' ' GLN . 4.9 tpt180 -35.97 -39.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.843 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.578 ' O ' HG23 ' A' ' 289' ' ' VAL . 36.2 tp60 -32.87 -65.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.94 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -56.56 -43.56 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.061 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.08 -60.88 2.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.102 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 8.4 mt-10 -47.58 -53.35 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 285' ' ' GLN . 45.5 t -53.17 -54.87 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.561 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -60.39 -32.79 71.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.448 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -56.41 -50.99 70.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -70.87 -26.86 63.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.466 ' HD2' ' CZ ' ' A' ' 262' ' ' PHE . 20.5 mttt -92.51 -1.34 57.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.705 ' HB2' HG11 ' A' ' 307' ' ' VAL . 61.3 p -112.29 -32.14 6.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 2.9 m-85 -53.73 106.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 29.5 t30 40.84 34.0 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -131.02 -33.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.573 HD12 ' CE1' ' A' ' 258' ' ' HIS . 4.3 tp -66.9 98.17 0.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 53.8 mt -113.53 96.29 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.43 HG12 ' ND2' ' A' ' 301' ' ' ASN . 59.6 t -95.84 141.89 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.43 ' ND2' HG12 ' A' ' 300' ' ' VAL . 65.6 m-80 53.82 43.88 30.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 50.79 32.94 26.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.461 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . 0.425 ' NH1' ' HA3' ' A' ' 247' ' ' GLY . 30.4 ttt180 -135.0 108.31 7.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.873 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.524 ' O ' HD23 ' A' ' 305' ' ' LEU . 39.9 ttp180 -51.42 146.37 7.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.893 HD21 ' CD1' ' A' ' 250' ' ' ILE . 31.1 mt -132.45 135.15 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.97 97.92 9.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.705 HG11 ' HB2' ' A' ' 294' ' ' SER . 39.1 t -94.89 141.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.549 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.5 ptpt -153.47 145.27 23.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -50.9 143.98 9.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.922 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.444 -179.947 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 240' ' ' THR . 52.2 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.899 0.38 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 37.3 p -86.34 30.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.422 ' H ' HG22 ' A' ' 238' ' ' ILE . 56.5 m -126.27 140.39 52.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.142 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 291' ' ' ALA . 25.2 mt -129.27 131.46 47.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.611 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -87.65 145.95 25.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.744 HG22 HG22 ' A' ' 307' ' ' VAL . 85.6 t -137.22 130.3 44.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.131 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -121.96 177.98 16.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.49 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.412 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 66.53 46.51 76.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.465 ' CD2' HD11 ' A' ' 255' ' ' LEU . 52.1 mt -77.12 -59.69 2.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.382 . . . . 0.0 110.906 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.87 148.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -42.18 -25.91 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.843 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.8 p -61.57 -45.96 91.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.112 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.868 ' CD1' HD21 ' A' ' 305' ' ' LEU . 53.7 mt -97.3 148.77 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.138 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 31.0 p -128.48 -176.47 3.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.478 ' HB2' HG21 ' A' ' 270' ' ' VAL . 30.7 tt0 -66.83 -59.56 3.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.9 m -42.11 -55.33 3.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -41.95 -47.17 4.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.465 HD11 ' CD2' ' A' ' 246' ' ' LEU . 19.5 mt -72.34 -53.76 11.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.956 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -42.08 -45.85 4.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -75.87 -42.65 48.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.551 ' CE1' HD12 ' A' ' 298' ' ' LEU . 37.7 t-80 -56.62 -33.95 66.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.456 ' CE2' HG13 ' A' ' 279' ' ' ILE . 67.5 m-85 -94.19 -44.04 8.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.592 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.9 t80 -39.94 -36.73 0.49 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 14.4 pt20 -51.63 -46.88 63.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.932 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.478 ' CE1' HG12 ' A' ' 289' ' ' VAL . 67.4 m-85 -57.99 -45.94 86.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -176.33 -157.54 17.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.48 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -80.72 131.24 35.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.592 HD11 ' N ' ' A' ' 260' ' ' TYR . 62.5 mt -97.56 112.41 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.127 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -57.86 -50.18 74.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 3.7 t -163.6 168.56 19.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.439 HD11 HD13 ' A' ' 265' ' ' ILE . 82.2 mt -145.73 111.52 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.144 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 88.8 m -102.21 101.81 12.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 252' ' ' GLU . 60.5 t -91.17 114.64 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.076 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.544 HG12 ' HG2' ' A' ' 273' ' ' ARG . 11.1 t -101.71 100.06 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -60.07 -44.22 94.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.544 ' HG2' HG12 ' A' ' 271' ' ' VAL . 1.6 ptm180 -52.99 -32.95 49.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.829 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.465 ' N ' ' HG2' ' A' ' 273' ' ' ARG . 61.8 mm-40 -112.42 15.12 20.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 274' ' ' GLN . 46.9 mm-40 34.66 52.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 9.5 p -142.24 174.18 10.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -152.72 135.53 15.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.108 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 27.1 m-85 -101.62 109.44 21.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.456 HG13 ' CE2' ' A' ' 259' ' ' PHE . 3.5 mm -93.75 121.0 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -109.79 139.08 45.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -117.38 144.64 44.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.15 78.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 284' ' ' ARG . 31.1 p -125.14 118.73 26.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' A' ' 283' ' ' THR . 15.7 tpt180 -37.94 -32.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.705 ' O ' HG23 ' A' ' 289' ' ' VAL . 5.2 tt0 -40.35 -67.91 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -56.36 -39.43 72.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -53.49 -62.23 1.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -49.63 -49.62 46.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 285' ' ' GLN . 16.8 t -52.82 -64.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 294' ' ' SER . . . -53.27 -41.5 65.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.509 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -51.34 -54.76 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.438 ' O ' ' NZ ' ' A' ' 297' ' ' LYS . 12.9 tm-20 -67.65 -26.71 66.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.843 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.9 mttm -94.84 4.6 53.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.711 ' OG ' HG11 ' A' ' 307' ' ' VAL . 78.9 p -116.47 -26.91 6.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.4 m-30 -58.73 104.86 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 1.7 m120 47.82 29.12 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 292' ' ' GLU . 0.5 OUTLIER -127.86 -34.94 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.628 ' HG ' HD12 ' A' ' 305' ' ' LEU . 7.4 tp -67.81 97.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 304' ' ' ARG . 42.1 mt -114.76 98.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.42 146.76 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.127 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 45.78 47.24 11.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.54 33.4 11.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 11.2 ttt85 -133.96 101.5 5.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.792 0.329 . . . . 0.0 110.892 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.467 ' N ' HG23 ' A' ' 299' ' ' ILE . 14.8 ttm180 -43.3 145.72 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.868 HD21 ' CD1' ' A' ' 250' ' ' ILE . 23.4 mt -129.71 134.02 47.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.57 101.38 11.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.744 HG22 HG22 ' A' ' 243' ' ' VAL . 72.5 t -103.85 133.29 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.599 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.0 pttt -145.59 152.52 39.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -55.91 130.38 43.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 179.971 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 6.7 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.897 0.379 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.8 p -98.45 39.83 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 18.4 m -138.91 139.62 38.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.403 HD11 ' O ' ' A' ' 287' ' ' ALA . 44.1 mt -126.33 153.71 44.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.83 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.3 OUTLIER -105.53 146.18 29.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 307' ' ' VAL . 93.5 t -142.49 122.3 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.127 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -115.15 173.18 14.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.494 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.72 56.53 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.524 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.601 HD11 ' HB2' ' A' ' 277' ' ' ALA . 57.4 mt -70.23 -62.37 1.41 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.868 0.365 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.47 155.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.473 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -47.44 -30.36 3.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.5 p -58.12 -43.03 87.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.546 ' CD1' HD21 ' A' ' 305' ' ' LEU . 61.3 mt -102.18 143.53 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 30.4 p -121.26 -177.31 3.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.183 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.592 ' HB2' HG21 ' A' ' 270' ' ' VAL . 63.4 tt0 -70.02 -52.25 25.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.899 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 92.2 m -48.9 -54.98 13.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.154 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -40.24 -44.94 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 258' ' ' HIS . 16.7 mt -75.25 -59.08 2.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 255' ' ' LEU . 20.3 ttm-85 -36.29 -42.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -78.12 -40.17 39.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.609 ' NE2' HD13 ' A' ' 298' ' ' LEU . 13.9 t60 -59.56 -37.53 78.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 261' ' ' GLN . 73.5 m-85 -90.03 -39.06 13.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.665 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.1 t80 -45.02 -21.31 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.926 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 259' ' ' PHE . 24.4 pt20 -69.32 -43.3 74.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 81.4 m-85 -61.31 -42.52 98.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 179.96 -167.19 36.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.466 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -71.56 130.11 40.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.913 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.665 HD11 ' N ' ' A' ' 260' ' ' TYR . 60.3 mt -98.29 112.13 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.112 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.5 mtp85 -56.89 -49.36 75.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 t -165.6 168.98 15.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.176 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.418 HD11 ' HA ' ' A' ' 256' ' ' ARG . 85.9 mt -144.01 110.95 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.174 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.8 m -100.92 102.21 13.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 252' ' ' GLU . 40.3 t -96.18 104.68 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 274' ' ' GLN . 99.8 t -92.52 99.95 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -37.75 80.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -55.99 -35.55 66.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.628 ' H ' HG12 ' A' ' 271' ' ' VAL . 69.8 mt-30 -106.42 4.13 28.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 47.25 48.02 16.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.946 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.453 ' C ' HD11 ' A' ' 246' ' ' LEU . 1.8 p -139.69 178.63 7.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.601 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -155.26 139.55 16.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -111.33 109.95 20.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 2.8 mm -92.46 126.84 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 266' ' ' ARG . 8.5 tt0 -113.52 142.16 46.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -121.49 149.82 42.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.0 -32.71 71.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.102 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 284' ' ' ARG . 16.0 p -127.1 117.4 22.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 283' ' ' THR . 15.1 tpt180 -37.29 -32.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' THR . 3.5 tt0 -39.22 -68.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -55.5 -47.66 75.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.403 ' O ' HD11 ' A' ' 241' ' ' LEU . . . -43.8 -54.05 5.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.138 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 7.2 mt-10 -56.46 -60.72 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.848 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 21.0 t -45.12 -56.34 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.561 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -58.09 -37.25 74.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.088 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -52.23 -65.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.102 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -56.13 -39.53 72.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.832 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.505 ' HD2' ' CZ ' ' A' ' 262' ' ' PHE . 20.8 mttp -76.86 1.06 18.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.581 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.2 m -118.03 -28.14 5.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -54.81 106.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 57.5 t30 42.27 25.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -123.83 -27.32 3.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.609 HD13 ' NE2' ' A' ' 258' ' ' HIS . 5.9 tp -70.32 100.5 1.74 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 304' ' ' ARG . 22.4 mt -120.17 99.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.36 138.91 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 60.64 45.87 9.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.85 34.53 11.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -137.67 106.24 5.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 0.0 110.872 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.77 ' O ' HD23 ' A' ' 305' ' ' LEU . 16.9 ttm105 -50.58 150.2 2.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.919 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.77 HD23 ' O ' ' A' ' 304' ' ' ARG . 38.7 mt -135.43 137.64 42.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.959 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -90.38 113.36 25.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.83 HG13 ' O ' ' A' ' 242' ' ' TYR . 35.4 t -112.4 143.17 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.584 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 5.1 ptpp? -150.12 160.37 43.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -67.67 129.56 40.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.494 -179.997 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 240' ' ' THR . 48.9 mt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.93 0.395 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.5 p -98.51 30.01 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 238' ' ' ILE . 40.1 m -128.88 136.3 50.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.5 mt -126.66 126.43 43.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.585 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -82.56 140.59 33.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.886 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.49 131.72 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.171 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.07 -174.9 16.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.465 ' O ' HD22 ' A' ' 305' ' ' LEU . . . 56.2 54.79 33.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.523 HD22 HD11 ' A' ' 255' ' ' LEU . 77.8 mt -87.4 -57.81 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.912 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.78 156.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.66 -24.63 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.847 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.8 p -62.13 -35.27 78.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.127 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.777 ' CD1' HD21 ' A' ' 305' ' ' LEU . 73.6 mt -107.24 142.32 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.8 p -117.74 -179.93 3.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.84 -54.26 24.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 89.3 m -48.56 -54.89 12.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.222 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -39.15 -45.96 1.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.523 HD11 HD22 ' A' ' 246' ' ' LEU . 15.0 mt -75.95 -49.55 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -45.35 -44.25 11.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -76.41 -44.37 36.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.519 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 39.5 t-80 -56.37 -33.82 66.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -94.12 -42.71 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.614 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -41.14 -44.46 2.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.479 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.8 pt20 -44.5 -41.02 6.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.703 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 53.4 m-85 -60.8 -49.84 75.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -175.63 -160.95 24.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.454 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -75.36 121.93 22.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.865 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.614 HD11 ' N ' ' A' ' 260' ' ' TYR . 87.0 mt -89.83 108.98 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 282' ' ' ALA . 9.2 mtt-85 -52.46 -52.49 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 13.7 t -162.23 170.9 18.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.419 HD11 HG21 ' A' ' 265' ' ' ILE . 75.3 mt -146.08 110.26 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.131 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 19.2 m -103.1 98.9 8.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.194 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.17 107.06 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.638 HG12 ' HG3' ' A' ' 273' ' ' ARG . 5.3 t -91.3 100.84 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -60.21 -45.43 93.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . 0.638 ' HG3' HG12 ' A' ' 271' ' ' VAL . 0.0 OUTLIER -57.39 -19.22 21.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 275' ' ' GLN . 15.2 mt-30 -121.39 11.93 10.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 274' ' ' GLN . 92.9 mt-30 36.87 44.3 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.486 ' C ' HD11 ' A' ' 246' ' ' LEU . 28.4 p -133.59 175.07 9.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -156.73 131.94 9.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 42.9 m-85 -100.74 111.91 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 4.6 mm -94.85 114.71 31.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -102.52 144.84 30.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.64 148.09 49.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.471 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -68.91 -38.26 79.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.111 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 284' ' ' ARG . 25.1 p -125.24 119.22 27.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.168 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 283' ' ' THR . 16.9 tpt180 -35.89 -36.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.901 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.61 ' O ' HG23 ' A' ' 289' ' ' VAL . 13.0 tp60 -36.96 -63.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -60.4 -36.77 78.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.127 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.71 -62.09 2.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.055 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 20.9 mt-10 -47.44 -56.6 6.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.888 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 285' ' ' GLN . 29.3 t -47.21 -62.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.703 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -54.04 -39.85 66.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -51.34 -64.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -54.99 -40.95 70.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -77.31 3.07 13.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.729 ' HB3' HG11 ' A' ' 307' ' ' VAL . 1.9 m -116.65 -31.72 5.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -48.32 98.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.854 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 43.96 30.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.69 -35.79 2.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.519 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 6.6 tp -66.45 97.75 0.44 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 304' ' ' ARG . 54.1 mt -114.53 91.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 58.1 t -85.62 147.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.118 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 43.73 48.7 6.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 46.5 33.57 6.1 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.474 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -132.9 100.14 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.866 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.432 ' N ' HG23 ' A' ' 299' ' ' ILE . 20.3 ttm-85 -43.84 139.3 2.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.777 HD21 ' CD1' ' A' ' 250' ' ' ILE . 29.6 mt -122.12 133.35 54.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -82.67 101.3 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.729 HG11 ' HB3' ' A' ' 294' ' ' SER . 53.8 t -103.77 146.65 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 10.5 ptpt -156.96 169.73 24.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -80.79 125.47 30.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 -179.973 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 57.2 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.869 0.366 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 30.3 p -93.92 38.11 1.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 24.9 m -131.38 144.28 51.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 291' ' ' ALA . 28.6 mt -134.71 128.61 33.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.588 ' CE1' ' HE2' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -85.6 143.99 28.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 307' ' ' VAL . 66.0 t -140.5 106.67 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.115 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -102.17 178.18 26.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.495 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.488 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 71.94 41.43 55.12 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.606 ' CD2' HD11 ' A' ' 255' ' ' LEU . 96.5 mt -70.08 -63.11 1.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.841 0.353 . . . . 0.0 110.926 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 249' ' ' THR . . . 71.77 143.45 0.38 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -40.1 -29.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 247' ' ' GLY . 34.5 p -61.59 -53.12 60.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.646 ' CD1' HD21 ' A' ' 305' ' ' LEU . 59.2 mt -84.53 153.82 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.437 ' N ' HG22 ' A' ' 250' ' ' ILE . 55.9 p -134.68 178.37 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.488 ' HB2' HG21 ' A' ' 270' ' ' VAL . 30.9 tt0 -62.77 -59.57 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.4 m -44.02 -55.14 4.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.156 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -39.75 -47.01 2.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.606 HD11 ' CD2' ' A' ' 246' ' ' LEU . 12.9 mt -75.86 -52.88 9.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . 0.406 ' O ' ' HB3' ' A' ' 260' ' ' TYR . 50.1 ttp85 -42.06 -44.01 3.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -74.97 -46.86 32.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.47 ' NE2' HD13 ' A' ' 298' ' ' LEU . 8.8 t60 -52.63 -39.39 61.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 261' ' ' GLN . 76.7 m-85 -87.84 -45.16 10.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.826 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' TYR . . . . . 0.696 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.1 t80 -39.84 -27.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 259' ' ' PHE . 23.6 pt20 -62.28 -46.25 89.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.637 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 60.8 m-85 -54.39 -50.27 67.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -172.6 -146.99 5.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.511 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -90.29 123.02 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.696 HD11 ' N ' ' A' ' 260' ' ' TYR . 47.1 mt -91.01 113.76 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.144 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -56.6 -48.82 76.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 t -165.2 170.28 15.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.165 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.407 HG23 HD13 ' A' ' 279' ' ' ILE . 92.6 mt -144.79 110.93 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.118 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 39.2 m -103.14 98.86 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.493 HG13 ' CD1' ' A' ' 246' ' ' LEU . 90.1 t -90.34 110.07 21.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.489 HG11 ' NE2' ' A' ' 274' ' ' GLN . 38.6 t -95.57 100.01 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 275' ' ' GLN . 10.4 tt0 -60.01 -57.8 11.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -45.11 -22.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.489 ' NE2' HG11 ' A' ' 271' ' ' VAL . 43.2 mt-30 -109.12 -16.44 14.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.962 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 272' ' ' GLN . 34.3 mt-30 64.37 45.14 3.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' CYS . . . . . 0.521 ' C ' HD11 ' A' ' 246' ' ' LEU . 5.3 m -145.76 177.52 8.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.426 ' HB2' HG22 ' A' ' 270' ' ' VAL . . . -153.29 142.18 21.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 33.1 m-85 -106.63 107.16 18.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ILE . . . . . 0.407 HD13 HG23 ' A' ' 268' ' ' ILE . 7.3 mm -90.1 117.44 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.179 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' GLN . . . . . 0.484 ' O ' HG23 ' A' ' 265' ' ' ILE . 9.8 tt0 -105.79 150.19 25.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -130.79 151.83 50.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -74.53 -32.97 62.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.116 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 284' ' ' ARG . 24.9 p -127.17 118.08 23.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 285' ' ' GLN . 5.7 tpp85 -36.01 -38.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.696 ' O ' HG23 ' A' ' 289' ' ' VAL . 12.0 tt0 -35.9 -64.83 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.59 -45.73 84.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' ALA . . . . . 0.4 ' O ' HD11 ' A' ' 241' ' ' LEU . . . -52.0 -66.31 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 12.7 mt-10 -43.29 -52.39 5.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 285' ' ' GLN . 46.3 t -52.72 -64.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.637 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -48.84 -43.1 38.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.067 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . 0.56 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -46.18 -67.66 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -53.14 -44.48 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -70.7 -0.94 9.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.773 ' HB3' HG21 ' A' ' 307' ' ' VAL . 12.6 m -119.14 -24.26 6.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.869 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -53.95 103.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 43.51 26.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -124.92 -26.77 3.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.592 ' HG ' HD12 ' A' ' 305' ' ' LEU . 12.5 tp -68.03 98.26 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.947 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.55 96.64 4.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.159 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 85.7 t -103.69 145.37 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 55.56 40.48 31.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 51.53 32.05 30.41 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.52 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 19.4 ttt-85 -133.56 105.63 6.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.92 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.528 ' O ' HD23 ' A' ' 305' ' ' LEU . 13.7 ttp180 -49.95 147.12 4.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.646 HD21 ' CD1' ' A' ' 250' ' ' ILE . 40.4 mt -132.29 145.76 51.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.954 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -98.01 106.84 19.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.773 HG21 ' HB3' ' A' ' 294' ' ' SER . 98.3 t -105.25 137.7 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.588 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 3.4 pttt -151.26 148.94 28.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.935 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.61 141.06 44.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 23.3 t -112.26 150.8 30.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.918 0.39 . . . . 0.0 110.866 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 83.6 p -65.34 -45.88 82.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.819 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.24 112.76 0.84 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.443 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 88.1 p -134.94 156.95 48.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 110.874 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 50.1 m -131.23 92.5 3.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.797 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.36 -162.95 0.63 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.496 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -109.98 42.25 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.883 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -114.8 100.4 8.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.428 ' O ' ' NH1' ' A' ' 284' ' ' ARG . 0.7 OUTLIER -93.36 -66.89 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 72.2 p -120.89 29.24 7.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.152 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 59.4 mt -83.1 126.08 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.419 HG22 ' HA ' ' A' ' 284' ' ' ARG . 82.0 p -102.36 -11.68 18.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.119 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 16.7 m -84.84 141.92 30.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.181 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.8 mt -130.85 124.41 31.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.579 ' CE1' ' HE2' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -81.53 141.32 33.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.929 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.86 HG22 HG22 ' A' ' 307' ' ' VAL . 99.8 t -136.28 116.98 18.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.08 177.3 19.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.502 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 68.78 37.79 84.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.481 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.495 HD11 ' CB ' ' A' ' 277' ' ' ALA . 31.4 mt -75.9 -59.8 2.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.862 0.363 . . . . 0.0 110.872 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.4 149.95 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.483 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -40.96 -36.87 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 24.1 p -51.89 -43.0 63.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.578 ' CD1' HD21 ' A' ' 305' ' ' LEU . 76.4 mt -97.12 143.07 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.12 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.0 p -121.6 -178.29 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.109 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.94 -56.67 7.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 90.0 m -43.98 -50.67 8.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.82 -37.62 14.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 18.9 mt -80.52 -52.36 7.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 41.4 ttt-85 -43.91 -42.89 6.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -76.53 -44.27 35.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.627 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 45.3 t-80 -57.39 -33.12 67.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.444 ' CE2' HG13 ' A' ' 279' ' ' ILE . 76.5 m-85 -94.47 -41.39 9.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.534 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -42.71 -36.12 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.966 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 17.6 pt20 -54.13 -40.97 67.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.901 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 47.0 m-85 -63.75 -45.91 87.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.854 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 173.98 178.01 43.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.529 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -47.69 144.55 3.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.347 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.534 HD11 ' N ' ' A' ' 260' ' ' TYR . 90.7 mt -115.45 109.56 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -52.34 -50.45 62.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.5 t -167.53 168.74 12.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.458 HD11 HD13 ' A' ' 265' ' ' ILE . 90.1 mt -144.38 108.65 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 54.7 m -103.14 99.08 8.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 43.1 t -91.93 110.81 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.461 ' CG1' ' HG2' ' A' ' 273' ' ' ARG . 51.2 t -94.53 99.96 10.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -60.09 -43.24 95.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.461 ' HG2' ' CG1' ' A' ' 271' ' ' VAL . 6.8 ptm180 -55.09 -26.54 38.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.454 ' O ' ' C ' ' A' ' 275' ' ' GLN . 73.7 mt-30 -117.29 17.75 14.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 274' ' ' GLN . 66.7 mt-30 34.25 43.94 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.924 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 26.0 p -136.69 173.08 12.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.495 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -156.74 138.93 14.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -105.38 114.87 29.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.444 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.5 mm -98.06 118.03 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.162 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -104.42 140.4 37.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -119.43 146.38 45.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.34 -34.21 74.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 284' ' ' ARG . 29.5 p -127.68 118.18 23.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.171 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.431 ' O ' ' HB3' ' A' ' 287' ' ' ALA . 13.6 tpt180 -36.72 -36.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 284' ' ' ARG . 6.1 tp60 -36.85 -65.69 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -59.11 -35.29 73.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.084 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 284' ' ' ARG . . . -57.82 -57.39 12.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 13.7 mt-10 -52.33 -59.31 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 42.9 t -44.41 -61.61 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.901 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -57.42 -38.39 74.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -49.52 -69.64 0.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.108 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -54.08 -43.43 70.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -70.94 -3.72 20.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.673 ' HB3' HG21 ' A' ' 307' ' ' VAL . 33.2 m -112.3 -29.95 7.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -47.86 97.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.835 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 52.7 t30 45.17 25.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -120.57 -25.68 5.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.627 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 6.2 tp -72.53 99.83 2.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 304' ' ' ARG . 25.5 mt -113.39 96.68 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.109 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 67.7 t -100.72 138.36 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 58.13 49.88 10.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.78 34.18 5.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 245' ' ' GLY . 16.1 ttt-85 -138.81 105.13 5.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 0.0 110.881 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.604 ' O ' HD23 ' A' ' 305' ' ' LEU . 2.0 ttt85 -51.68 149.33 4.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 304' ' ' ARG . 42.0 mt -133.52 134.93 44.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.77 102.2 14.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.86 HG22 HG22 ' A' ' 243' ' ' VAL . 70.6 t -99.99 136.54 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.579 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 6.2 pttt -146.5 147.55 31.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -55.29 142.71 30.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -93.09 -135.37 7.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.478 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 67.4 mmt-85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.857 0.361 . . . . 0.0 110.906 -179.83 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 6.4 m -103.7 -43.96 5.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.919 0.39 . . . . 0.0 110.87 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 46.7 p 38.6 41.9 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -74.29 -131.31 0.22 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.482 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.2 t 54.88 41.45 31.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.895 0.379 . . . . 0.0 110.848 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 63.6 m -94.43 162.54 13.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 164.51 -110.38 0.42 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.452 ' C ' ' CD ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -155.92 168.06 28.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 0.0 110.865 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.44 ' HB3' HD12 ' A' ' 238' ' ' ILE . 9.6 m-20 -130.12 117.63 20.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 238' ' ' ILE . 0.0 OUTLIER -63.03 89.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 36.8 p 38.44 31.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.11 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.75 HD13 ' O ' ' A' ' 311' ' ' ARG . 60.0 mt -72.44 96.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.147 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 284' ' ' ARG . 57.3 p -90.39 26.75 1.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.2 m -123.16 141.03 52.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.588 HD21 ' HB2' ' A' ' 291' ' ' ALA . 66.4 mt -124.1 139.88 53.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.717 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.6 OUTLIER -99.1 146.31 26.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 307' ' ' VAL . 74.1 t -140.04 135.01 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -125.73 168.33 17.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.468 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 70.62 44.51 57.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 250' ' ' ILE . 91.3 mt -80.29 -59.11 2.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.833 0.349 . . . . 0.0 110.879 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.34 162.81 0.89 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.463 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -49.53 -38.39 30.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 35.6 p -50.63 -45.05 57.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.142 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.696 ' CD1' HD21 ' A' ' 305' ' ' LEU . 67.3 mt -95.44 143.95 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 26.8 p -122.31 -175.23 3.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.477 ' HA ' HG21 ' A' ' 270' ' ' VAL . 37.6 tt0 -71.18 -57.18 4.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.6 m -45.33 -47.18 13.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.16 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -44.7 -50.67 9.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.0 -44.74 62.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.435 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 22.3 ttp180 -49.95 -46.05 51.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -75.7 -40.56 55.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.651 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 51.1 t-80 -61.06 -32.78 72.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.495 ' CD2' HG12 ' A' ' 279' ' ' ILE . 52.8 m-85 -94.32 -39.0 10.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.484 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -46.67 -38.02 9.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.2 pt20 -52.45 -38.22 58.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.56 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 79.0 m-85 -64.71 -43.97 91.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -178.97 -152.75 10.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.532 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -82.84 136.5 34.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.348 . . . . 0.0 110.851 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.743 HD13 HD11 ' A' ' 268' ' ' ILE . 88.9 mt -105.35 112.95 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.15 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 282' ' ' ALA . 27.8 mtt180 -60.36 -48.98 79.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.4 t -165.13 159.02 17.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.16 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.743 HD11 HD13 ' A' ' 265' ' ' ILE . 59.5 mt -139.41 108.3 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 30.5 m -101.5 100.41 10.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.142 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 252' ' ' GLU . 83.7 t -93.67 103.35 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.121 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.403 HG12 ' HG2' ' A' ' 273' ' ' ARG . 12.2 t -86.19 99.54 8.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -60.76 -48.26 82.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.403 ' HG2' HG12 ' A' ' 271' ' ' VAL . 0.0 OUTLIER -58.48 -11.02 2.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.451 ' O ' ' C ' ' A' ' 275' ' ' GLN . 19.8 mm-40 -126.6 14.41 7.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.953 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 274' ' ' GLN . 71.4 mt-30 33.04 51.09 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 14.2 p -148.8 165.27 31.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.467 ' CB ' HG22 ' A' ' 270' ' ' VAL . . . -148.95 148.09 29.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 56.7 m-85 -118.05 108.74 15.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.495 HG12 ' CD2' ' A' ' 259' ' ' PHE . 5.0 mp -93.02 121.67 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -105.38 148.54 27.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.429 ' HE2' HD12 ' A' ' 241' ' ' LEU . 98.9 m-85 -127.44 139.29 52.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.401 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -62.04 -34.9 77.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.078 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 284' ' ' ARG . 32.7 p -126.71 118.03 23.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.165 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.436 ' HA ' HG22 ' A' ' 239' ' ' THR . 9.5 tpt180 -36.13 -35.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.635 ' O ' HG23 ' A' ' 289' ' ' VAL . 46.4 tp60 -36.58 -68.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -54.7 -48.44 72.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -46.88 -59.56 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 5.6 mt-10 -50.18 -54.12 23.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.947 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 285' ' ' GLN . 16.5 t -50.79 -60.13 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.115 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.56 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -56.51 -36.53 69.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.065 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.588 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -54.66 -53.66 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -68.88 -28.65 66.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -92.03 5.41 50.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 65.7 p -119.08 -32.06 4.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.461 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.4 m-30 -55.1 109.42 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 41.05 33.88 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -130.96 -38.43 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.89 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.651 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 8.4 tp -65.48 100.33 0.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 58.4 mt -117.64 93.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.175 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.546 HG12 ' ND2' ' A' ' 301' ' ' ASN . 53.9 t -97.86 140.39 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.546 ' ND2' HG12 ' A' ' 300' ' ' VAL . 69.5 m-80 58.43 42.34 21.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.93 34.12 10.96 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.491 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -134.19 99.38 4.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.349 . . . . 0.0 110.831 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.498 ' O ' HD23 ' A' ' 305' ' ' LEU . 6.9 ttm180 -44.17 148.47 0.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.696 HD21 ' CD1' ' A' ' 250' ' ' ILE . 43.4 mt -132.77 135.07 45.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.6 98.18 11.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 243' ' ' VAL . 49.7 t -100.89 140.17 20.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.555 ' CE ' ' CE1' ' A' ' 242' ' ' TYR . 9.6 pttt -147.86 150.65 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -52.21 134.83 33.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 311' ' ' ARG . . . -59.36 -119.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.482 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.75 ' O ' HD13 ' A' ' 238' ' ' ILE . 9.3 tpp180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.815 0.341 . . . . 0.0 110.889 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 50.4 m -105.69 -59.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.353 . . . . 0.0 110.842 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.7 m -109.11 135.11 50.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -126.47 84.4 0.34 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.51 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 35.4 p -137.81 117.11 12.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 110.833 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 4.7 m -150.53 130.47 13.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -134.86 -145.18 5.15 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.523 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -122.76 87.55 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 110.901 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.445 ' HA ' ' CD1' ' A' ' 238' ' ' ILE . 21.1 t0 -113.36 100.33 8.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -117.11 -65.57 1.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 40.2 p -118.98 39.4 3.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.558 HG22 ' H ' ' A' ' 240' ' ' THR . 85.2 mt -70.84 110.39 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.3 p -95.16 29.71 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.165 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.558 ' H ' HG22 ' A' ' 238' ' ' ILE . 20.1 m -127.55 142.73 51.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.152 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 291' ' ' ALA . 32.1 mt -134.16 124.63 26.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.93 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.603 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -82.89 143.11 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.98 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 1.082 HG22 HG22 ' A' ' 307' ' ' VAL . 98.4 t -135.79 127.66 45.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.91 176.3 16.09 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.514 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.499 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 72.15 37.25 59.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.508 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.546 HD11 ' CB ' ' A' ' 277' ' ' ALA . 93.4 mt -81.52 -57.43 3.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.28 162.03 0.16 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.463 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.51 -35.43 29.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 110.872 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.7 p -51.64 -48.35 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.494 ' CD1' HD21 ' A' ' 305' ' ' LEU . 68.6 mt -95.03 142.8 12.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.108 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 30.9 p -115.57 -175.62 2.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.598 ' HB2' HG21 ' A' ' 270' ' ' VAL . 18.8 tt0 -70.18 -56.7 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 98.4 m -44.96 -50.36 10.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.13 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -43.54 -41.1 4.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.7 mt -81.23 -55.12 4.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.406 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 19.2 ttm180 -39.72 -38.67 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -75.55 -44.07 45.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.867 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.743 ' NE2' HD13 ' A' ' 298' ' ' LEU . 30.5 t60 -58.82 -35.09 72.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.565 ' HA ' ' CD2' ' A' ' 262' ' ' PHE . 93.1 m-85 -91.48 -39.01 12.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.49 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.1 t80 -44.35 -28.97 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.432 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 23.8 pt20 -64.48 -42.83 95.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.703 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 29.7 m-85 -59.5 -48.73 80.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 175.15 178.8 45.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.52 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -48.43 141.17 7.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.839 0.352 . . . . 0.0 110.901 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.49 HD11 ' N ' ' A' ' 260' ' ' TYR . 70.5 mt -111.26 110.77 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.152 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 280' ' ' GLN . 37.9 mtt-85 -52.79 -53.18 51.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 7.5 t -165.72 168.73 15.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 77.2 mt -142.81 111.96 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 50.0 m -104.06 98.91 8.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.147 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.598 HG21 ' HB2' ' A' ' 252' ' ' GLU . 65.4 t -90.99 105.43 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.159 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 14.9 t -91.12 100.73 11.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.121 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . 0.437 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 16.4 pt20 -59.69 -44.88 93.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.437 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 0.8 OUTLIER -56.47 -19.05 13.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.849 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 275' ' ' GLN . 8.7 mm-40 -122.95 14.23 9.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 274' ' ' GLN . 52.9 mt-30 34.37 46.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.965 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 27.7 p -137.15 175.16 9.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.546 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -155.2 132.15 10.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 35.3 m-85 -99.62 111.49 23.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.868 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 4.9 mm -93.9 115.88 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.099 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 266' ' ' ARG . 40.1 tt0 -105.6 139.0 40.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.41 ' C ' ' HG3' ' A' ' 266' ' ' ARG . 95.6 m-85 -119.24 153.27 35.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.414 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -75.65 -34.47 60.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.105 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . 0.417 ' O ' ' C ' ' A' ' 284' ' ' ARG . 30.6 p -125.54 116.44 21.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 283' ' ' THR . 12.6 tpt180 -36.9 -34.54 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.414 ' O ' HG23 ' A' ' 289' ' ' VAL . 44.1 tp60 -38.48 -61.42 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.32 97.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.11 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -52.79 -59.98 3.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -48.13 -55.74 9.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.607 HG12 ' HE3' ' A' ' 293' ' ' LYS . 60.0 t -49.48 -61.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.159 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.703 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -52.87 -41.2 64.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.491 ' HB2' HD11 ' A' ' 241' ' ' LEU . . . -53.81 -52.72 59.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.63 -24.94 63.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.888 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.607 ' HE3' HG12 ' A' ' 289' ' ' VAL . 34.1 mtmt -97.79 5.63 48.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.724 ' HB2' HG21 ' A' ' 307' ' ' VAL . 81.5 p -117.8 -24.34 7.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.462 ' O ' ' N ' ' A' ' 297' ' ' LYS . 2.8 m-85 -61.99 112.73 2.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 5.2 t30 40.51 25.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 295' ' ' PHE . 35.9 tttp -123.65 -36.69 2.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.743 HD13 ' NE2' ' A' ' 258' ' ' HIS . 14.9 tp -61.82 96.52 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 62.9 mt -120.47 95.93 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.163 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.67 134.19 45.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.18 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 57.5 54.88 6.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 41.8 33.07 1.02 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.46 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.0 ttm-85 -130.39 99.3 4.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.823 0.344 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -56.18 135.31 53.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.499 ' CD2' ' O ' ' A' ' 245' ' ' GLY . 58.3 mt -120.23 135.66 54.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -91.95 99.05 11.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 1.082 HG22 HG22 ' A' ' 243' ' ' VAL . 79.5 t -94.58 136.74 24.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.114 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.522 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 1.0 OUTLIER -145.54 145.57 31.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . 0.468 ' HA ' HD23 ' A' ' 241' ' ' LEU . 61.6 m95 -54.56 141.06 32.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -88.62 -130.98 3.77 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.539 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 110.812 -179.87 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 92.1 p -66.98 83.5 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.886 0.374 . . . . 0.0 110.813 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 99.1 p -122.45 94.48 4.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.825 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -110.35 168.99 13.24 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.479 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 68.0 m -113.97 97.39 6.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 90.7 p -115.6 175.17 5.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.818 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.92 115.35 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.44 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.5 90.31 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.826 0.346 . . . . 0.0 110.9 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.62 102.87 6.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.445 ' O ' ' NH1' ' A' ' 284' ' ' ARG . 27.6 mtmm -112.53 -66.25 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 37.7 p -120.28 34.08 5.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.123 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 240' ' ' THR . 78.1 mt -73.53 115.14 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.125 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.8 p -102.11 31.0 4.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.533 ' H ' HG22 ' A' ' 238' ' ' ILE . 28.2 m -131.89 148.31 52.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.136 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 31.1 mt -132.91 156.01 48.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.56 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.4 OUTLIER -109.75 147.74 32.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.896 HG22 HG22 ' A' ' 307' ' ' VAL . 90.4 t -141.1 120.72 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.03 168.78 12.67 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.494 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.518 ' O ' HD22 ' A' ' 305' ' ' LEU . . . 73.81 44.31 31.78 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.503 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.668 HD11 ' HB2' ' A' ' 277' ' ' ALA . 52.4 mt -77.52 -60.41 2.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.931 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.28 156.45 0.17 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.492 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -49.39 -29.27 6.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.92 0.39 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.1 p -59.19 -43.84 92.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.146 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.573 ' CD1' HD21 ' A' ' 305' ' ' LEU . 60.4 mt -96.87 143.49 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 29.5 p -124.9 173.94 8.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -58.38 -59.64 5.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 88.7 m -41.22 -56.68 2.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -42.62 -42.73 3.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.463 HD11 HD22 ' A' ' 246' ' ' LEU . 33.4 mt -77.46 -57.26 3.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -39.0 -43.97 1.04 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -75.99 -38.04 57.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.87 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.585 ' CE1' HD12 ' A' ' 298' ' ' LEU . 45.0 t-80 -60.11 -35.13 74.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.839 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -94.15 -43.41 8.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.845 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.566 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -39.93 -36.19 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.919 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 29.4 pt20 -52.55 -46.2 66.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.926 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.591 ' CE1' HG12 ' A' ' 289' ' ' VAL . 62.7 m-85 -56.18 -48.84 75.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.39 -143.29 4.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.463 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -93.6 128.64 39.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 110.855 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.566 HD11 ' N ' ' A' ' 260' ' ' TYR . 57.6 mt -93.73 114.98 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 280' ' ' GLN . 9.9 mtt180 -60.62 -49.21 78.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.6 t -162.56 168.06 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.166 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.471 HD11 HG21 ' A' ' 265' ' ' ILE . 87.9 mt -146.07 110.66 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.4 m -104.37 99.88 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.195 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.438 HG13 ' CD1' ' A' ' 246' ' ' LEU . 85.7 t -92.5 107.65 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 14.8 t -91.97 100.76 11.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.109 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -58.67 -48.53 80.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -55.78 -26.65 47.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 275' ' ' GLN . 19.2 mm100 -110.6 11.3 22.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.44 ' C ' ' O ' ' A' ' 274' ' ' GLN . 80.5 mt-30 35.15 47.91 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 16.7 p -140.5 177.53 7.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.668 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -156.84 137.23 12.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.076 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -106.13 111.07 23.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 268' ' ' ILE . 6.1 mm -94.27 127.68 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 266' ' ' ARG . 9.1 tt0 -114.66 145.1 42.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.933 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.31 147.37 48.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.403 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -68.94 -37.04 78.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.141 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 284' ' ' ARG . 24.4 p -125.12 121.28 33.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.445 ' NH1' ' O ' ' A' ' 236' ' ' LYS . 12.0 tpt180 -37.88 -35.69 0.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 284' ' ' ARG . 1.4 tm0? -36.8 -67.49 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.23 79.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.084 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 284' ' ' ARG . . . -50.51 -58.51 5.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.085 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.446 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 11.5 mt-10 -51.63 -62.43 1.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.591 HG12 ' CE1' ' A' ' 262' ' ' PHE . 37.7 t -41.95 -56.44 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.58 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -57.33 -41.45 80.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -49.68 -65.97 0.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.082 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -55.25 -39.88 70.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -78.44 1.63 21.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.732 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.6 m -117.15 -26.67 6.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -57.0 103.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 42.13 27.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -124.24 -26.15 4.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.585 HD12 ' CE1' ' A' ' 258' ' ' HIS . 5.4 tp -72.88 97.82 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.92 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 304' ' ' ARG . 32.0 mt -115.58 92.33 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 19.9 t -95.39 146.94 6.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.143 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 51.59 46.52 26.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.12 30.05 5.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.501 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -133.07 103.66 6.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 110.898 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.506 ' O ' HD23 ' A' ' 305' ' ' LEU . 4.7 ttm180 -47.72 144.38 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.573 HD21 ' CD1' ' A' ' 250' ' ' ILE . 47.4 mt -129.93 137.24 50.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -89.29 111.75 22.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.896 HG22 HG22 ' A' ' 243' ' ' VAL . 45.6 t -111.39 145.09 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.56 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 6.0 ptpp? -149.54 163.68 37.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -69.75 124.35 23.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.64 -133.82 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.454 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 0.0 110.861 -179.833 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 85.6 p -115.85 150.91 36.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.793 0.33 . . . . 0.0 110.891 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.9 m -104.66 42.25 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 77.5 49.18 7.47 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.513 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 10.7 t -164.32 143.23 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 0.0 110.868 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 58.2 m -120.46 119.32 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -61.83 157.17 35.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.461 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.38 43.08 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 0.0 110.866 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.443 ' HA ' ' CD1' ' A' ' 238' ' ' ILE . 7.4 p-10 -88.89 112.75 23.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.797 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 237' ' ' THR . 6.1 mtmp? -101.67 103.39 14.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 236' ' ' LYS . 30.1 p 37.51 36.8 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.144 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.565 HG22 ' H ' ' A' ' 240' ' ' THR . 67.6 mt -73.95 118.68 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.0 p -102.88 34.06 3.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.165 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.565 ' H ' HG22 ' A' ' 238' ' ' ILE . 24.0 m -136.15 141.66 44.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.409 HD11 ' O ' ' A' ' 287' ' ' ALA . 42.0 mt -128.81 125.9 38.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.939 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.576 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -80.44 150.07 29.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.854 HG22 HG22 ' A' ' 307' ' ' VAL . 97.6 t -138.57 137.4 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.114 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.68 -179.02 15.6 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 60.45 44.33 97.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 277' ' ' ALA . 21.8 mt -77.52 -60.27 2.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 110.905 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 62.97 150.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.492 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -42.1 -31.47 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.879 0.371 . . . . 0.0 110.876 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.9 p -55.69 -42.3 75.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.697 ' CD1' HD21 ' A' ' 305' ' ' LEU . 69.2 mt -99.39 151.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.122 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 40.4 p -131.69 177.5 7.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.142 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -57.03 11.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.1 m -44.61 -55.5 5.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -43.74 -44.32 6.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.56 -48.51 32.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -46.09 -45.67 16.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -77.03 -37.7 54.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.55 ' CD2' HG22 ' A' ' 300' ' ' VAL . 46.6 t-80 -60.68 -35.01 75.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.845 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.474 ' CE2' HG13 ' A' ' 279' ' ' ILE . 69.7 m-85 -94.15 -41.11 9.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.898 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -41.97 -38.77 1.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.92 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 22.9 pt20 -48.53 -41.7 30.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.606 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 71.5 m-85 -63.34 -45.08 92.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 179.22 -154.92 14.73 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.476 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -78.74 144.8 34.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.794 0.33 . . . . 0.0 110.918 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.637 HD13 HD11 ' A' ' 268' ' ' ILE . 46.2 mt -110.55 119.27 59.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.438 ' NE ' ' HA ' ' A' ' 282' ' ' ALA . 49.1 mtt180 -65.11 -52.2 56.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 4.0 t -164.35 149.7 10.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.637 HD11 HD13 ' A' ' 265' ' ' ILE . 76.2 mt -128.68 110.26 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 21.8 m -102.98 98.91 8.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.133 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 246' ' ' LEU . 45.3 t -92.69 107.58 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.457 HG12 ' HG3' ' A' ' 273' ' ' ARG . 22.1 t -93.87 100.53 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 14.7 pt20 -60.09 -42.66 95.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.457 ' HG3' HG12 ' A' ' 271' ' ' VAL . 4.1 ptm180 -59.19 -17.68 29.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 275' ' ' GLN . 46.2 mt-30 -123.38 15.52 9.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.856 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 274' ' ' GLN . 40.7 mt-30 33.63 47.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 25.8 p -140.8 170.35 15.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -153.75 134.62 13.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 26.9 m-85 -101.83 108.43 19.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.598 HD13 HG23 ' A' ' 268' ' ' ILE . 6.0 mm -93.17 112.17 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.145 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -102.78 143.52 32.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -121.03 156.65 31.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.438 ' HA ' ' NE ' ' A' ' 266' ' ' ARG . . . -77.26 -37.24 53.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 284' ' ' ARG . 23.9 p -124.06 119.53 29.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.476 ' NE ' ' HG3' ' A' ' 288' ' ' GLU . 14.4 tpt180 -36.0 -40.09 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.557 ' O ' HG23 ' A' ' 289' ' ' VAL . 30.8 tp60 -34.68 -63.15 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.93 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -59.69 -41.65 91.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.074 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.426 ' HB3' ' HD2' ' A' ' 284' ' ' ARG . . . -55.11 -61.3 2.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.101 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 13.6 mt-10 -48.45 -57.3 6.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.563 HG12 ' CE1' ' A' ' 262' ' ' PHE . 57.6 t -45.58 -63.77 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.606 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -54.96 -35.33 64.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.136 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -54.55 -49.09 71.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.34 -25.53 59.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -92.41 5.73 49.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.773 ' OG ' HG11 ' A' ' 307' ' ' VAL . 54.6 p -115.79 -35.72 4.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.839 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.489 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.3 m-85 -50.35 109.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 40.07 34.81 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -133.71 -33.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.463 HD12 ' CE1' ' A' ' 258' ' ' HIS . 10.1 tp -67.62 98.3 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 304' ' ' ARG . 40.4 mt -118.35 93.34 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.117 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.55 HG22 ' CD2' ' A' ' 258' ' ' HIS . 47.1 t -91.67 136.8 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.083 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 56.15 46.26 21.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.854 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 49.38 29.67 10.99 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -130.41 100.95 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.437 ' N ' HG23 ' A' ' 299' ' ' ILE . 22.6 ttp180 -44.69 144.75 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.697 HD21 ' CD1' ' A' ' 250' ' ' ILE . 52.2 mt -129.19 135.84 49.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -86.4 105.99 17.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.854 HG22 HG22 ' A' ' 243' ' ' VAL . 55.5 t -105.87 144.87 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.576 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 15.9 ptpt -150.47 171.28 17.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -82.85 119.63 24.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.71 -133.65 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 110.843 -179.851 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 29.8 p -97.38 100.19 11.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.0 m -92.58 91.51 7.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 58.79 -136.38 51.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.494 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 80.6 p -166.88 108.99 0.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.882 0.372 . . . . 0.0 110.865 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 66.7 m -138.91 162.75 34.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -109.5 108.55 2.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -162.77 173.13 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.902 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 46.94 54.62 8.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -84.6 -47.45 10.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 28.4 p -132.03 23.47 4.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 13.8 mt -78.83 102.39 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 44.0 p -95.35 35.39 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.1 m -133.02 141.16 48.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 29.0 mt -126.32 159.04 34.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.679 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.4 OUTLIER -111.58 147.59 35.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 307' ' ' VAL . 95.5 t -140.42 120.63 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.17 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 -178.83 20.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.462 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.47 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 58.65 50.29 68.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 277' ' ' ALA . 62.2 mt -86.16 -57.34 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.862 0.363 . . . . 0.0 110.963 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.53 163.71 0.54 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.452 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -52.6 -32.65 42.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.951 0.405 . . . . 0.0 110.891 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.7 p -54.89 -44.78 74.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.484 ' CD1' HD21 ' A' ' 305' ' ' LEU . 86.6 mt -97.87 142.18 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.203 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 37.4 p -124.18 -178.64 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -65.12 -59.68 3.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 87.3 m -42.05 -55.73 3.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.188 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.56 -45.27 6.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 14.5 mt -72.17 -47.2 52.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.407 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 24.1 ttp180 -46.31 -45.19 17.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -76.09 -38.21 57.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.607 ' CD2' HG22 ' A' ' 300' ' ' VAL . 52.4 t-80 -60.23 -35.4 75.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.564 ' CE2' HG13 ' A' ' 279' ' ' ILE . 62.9 m-85 -94.22 -42.3 9.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.663 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.7 t80 -39.92 -35.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 20.3 pt20 -56.26 -44.38 79.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.855 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.748 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 41.3 m-85 -55.22 -51.03 67.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.51 -141.89 3.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.43 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -93.15 125.5 37.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.831 0.348 . . . . 0.0 110.901 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.663 HD11 ' N ' ' A' ' 260' ' ' TYR . 48.7 mt -93.51 121.53 44.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.156 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.481 ' NE ' ' HA ' ' A' ' 282' ' ' ALA . 43.0 mtt-85 -68.25 -47.94 66.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.908 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.4 t -171.14 153.0 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.138 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.407 ' CD1' ' HA ' ' A' ' 256' ' ' ARG . 83.6 mt -127.86 116.42 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 24.4 m -109.37 99.04 8.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.651 HG22 ' CB ' ' A' ' 277' ' ' ALA . 85.6 t -93.52 121.21 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 274' ' ' GLN . 90.3 t -108.7 100.17 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.091 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -57.07 -42.12 80.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 20.2 ttt-85 -50.13 -38.26 38.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.542 ' H ' HG12 ' A' ' 271' ' ' VAL . 63.3 mt-30 -108.35 8.72 27.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.867 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 42.82 52.52 5.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 18.6 p -142.91 177.13 8.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.651 ' CB ' HG22 ' A' ' 270' ' ' VAL . . . -160.17 136.94 9.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.043 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -102.36 115.8 31.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.564 HG13 ' CE2' ' A' ' 259' ' ' PHE . 9.3 mm -95.94 113.2 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.172 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -101.04 147.9 25.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -129.97 151.6 50.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.481 ' HA ' ' NE ' ' A' ' 266' ' ' ARG . . . -72.4 -41.27 66.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 29.7 p -120.34 122.78 41.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.119 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.532 ' HD2' ' HB3' ' A' ' 287' ' ' ALA . 17.7 tpt180 -38.29 -39.62 0.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.881 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 284' ' ' ARG . 0.8 OUTLIER -37.48 -59.3 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -59.74 -41.43 90.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.044 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.532 ' HB3' ' HD2' ' A' ' 284' ' ' ARG . . . -56.8 -53.5 57.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -53.77 -57.5 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 285' ' ' GLN . 86.1 t -46.03 -63.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.748 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -53.02 -47.21 68.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -45.21 -67.17 0.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.095 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.8 -35.28 68.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.402 ' HE2' HG12 ' A' ' 289' ' ' VAL . 9.6 mtmm -85.72 5.14 33.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.575 ' HB3' HG21 ' A' ' 307' ' ' VAL . 4.7 m -119.07 -26.19 6.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 297' ' ' LYS . 2.9 m-85 -56.08 110.0 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 40.18 26.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 295' ' ' PHE . 19.1 tttm -124.91 -30.12 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.606 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 9.1 tp -67.53 100.56 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 50.1 mt -116.99 97.13 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.138 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.607 HG22 ' CD2' ' A' ' 258' ' ' HIS . 42.4 t -96.24 139.79 18.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.202 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 52.36 47.74 24.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.65 27.56 6.21 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.46 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.1 ttt85 -127.44 101.52 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.0 110.821 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.6 ' O ' HD23 ' A' ' 305' ' ' LEU . 45.3 ttp85 -43.83 146.82 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 304' ' ' ARG . 45.3 mt -134.84 134.31 40.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -89.11 109.25 20.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 242' ' ' TYR . 81.7 t -106.63 142.96 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.159 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.568 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 13.3 ptpt -148.12 163.25 37.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -71.09 124.55 24.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -76.86 -145.82 2.03 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.451 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.862 -179.821 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 6.7 t -87.6 80.88 7.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.354 . . . . 0.0 110.885 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.8 m -108.48 153.13 23.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.889 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 69.78 163.54 4.0 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.483 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 87.3 p -81.63 150.24 28.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 110.869 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.6 t -112.42 128.17 56.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.857 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 66.29 159.39 0.72 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -109.38 82.93 1.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -57.72 116.77 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -118.25 -53.81 2.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 35.1 p -127.79 24.19 6.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.178 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 55.3 mt -74.52 106.11 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.1 p -97.57 36.19 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.172 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 18.0 m -133.84 151.28 51.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.136 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' A' ' 291' ' ' ALA . 35.5 mt -137.12 134.95 36.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.585 ' CD1' ' HG3' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -97.3 150.36 21.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.607 HG22 HG22 ' A' ' 307' ' ' VAL . 59.1 t -142.26 139.85 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -130.51 164.55 22.96 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.445 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 74.97 43.84 25.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 250' ' ' ILE . 94.3 mt -74.11 -61.74 1.75 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.884 0.373 . . . . 0.0 110.918 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.42 151.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.464 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -42.78 -34.43 0.93 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.888 0.375 . . . . 0.0 110.882 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.6 p -57.08 -42.83 81.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.156 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.76 ' CD1' HD21 ' A' ' 305' ' ' LEU . 55.9 mt -94.88 143.59 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.1 p -126.98 -176.81 3.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.159 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -65.89 -59.88 3.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.997 0.427 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.2 m -43.36 -50.89 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -40.89 -50.62 3.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.488 HD11 ' CD2' ' A' ' 246' ' ' LEU . 17.3 mt -73.85 -53.49 10.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 260' ' ' TYR . 67.0 ttt180 -41.07 -42.95 2.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -75.5 -46.43 32.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.765 ' CD2' HD13 ' A' ' 298' ' ' LEU . 52.3 t60 -54.71 -36.31 64.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -90.47 -44.42 9.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.5 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.3 t80 -40.08 -35.67 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.463 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 26.8 pt20 -54.54 -46.19 73.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.907 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.764 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 52.8 m-85 -56.01 -50.01 72.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -177.12 -154.99 12.67 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.473 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -75.64 141.73 42.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 260' ' ' TYR . 71.1 mt -110.58 112.43 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.137 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -57.66 -50.15 74.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 10.5 t -164.03 168.15 19.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.154 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.448 HD11 HG21 ' A' ' 265' ' ' ILE . 77.3 mt -145.12 106.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 57.1 m -97.61 98.84 10.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 88.5 t -93.93 109.12 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.521 HG12 ' HG2' ' A' ' 273' ' ' ARG . 15.9 t -97.0 99.65 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -60.67 -46.39 90.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.521 ' HG2' HG12 ' A' ' 271' ' ' VAL . 25.4 ptt180 -55.46 -19.83 10.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.47 ' O ' ' C ' ' A' ' 275' ' ' GLN . 65.1 mm-40 -121.19 15.88 11.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.47 ' C ' ' O ' ' A' ' 274' ' ' GLN . 29.1 mt-30 32.26 50.45 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 25.9 p -145.92 167.15 23.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.854 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.95 156.52 42.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 56.4 m-85 -126.32 108.07 10.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.466 HG22 ' CE1' ' A' ' 281' ' ' PHE . 4.7 mp -93.69 120.93 43.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.111 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -107.82 146.66 31.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.482 ' HE1' HD12 ' A' ' 241' ' ' LEU . 87.9 m-85 -124.31 147.1 48.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.65 70.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.137 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 284' ' ' ARG . 39.4 p -129.12 118.05 21.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 283' ' ' THR . 16.2 tpt180 -36.31 -34.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 283' ' ' THR . 20.8 tp60 -37.94 -68.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -56.27 -41.6 76.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.138 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -52.12 -60.69 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 6.4 mt-10 -46.88 -59.41 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 39.4 t -46.5 -60.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.12 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.764 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -55.08 -32.23 61.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.077 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.594 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -61.53 -46.04 91.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.115 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -72.76 -29.94 63.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 297' ' ' LYS . 18.5 mttt -87.0 -18.08 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.646 ' CB ' HG11 ' A' ' 307' ' ' VAL . 78.8 p -92.72 -36.03 13.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.3 m-85 -54.08 109.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 1.8 m120 41.51 29.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 293' ' ' LYS . 9.6 mmmt -126.93 -37.69 2.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.765 HD13 ' CD2' ' A' ' 258' ' ' HIS . 12.7 tp -63.4 98.03 0.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.52 94.43 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.21 146.33 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.163 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 54.47 41.02 32.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.63 33.41 12.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.447 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 22.7 ttt-85 -134.25 97.65 3.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.308 . . . . 0.0 110.863 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -43.72 144.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.76 HD21 ' CD1' ' A' ' 250' ' ' ILE . 48.9 mt -128.81 136.23 50.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -85.7 103.64 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.646 HG11 ' CB ' ' A' ' 294' ' ' SER . 94.6 t -102.47 139.45 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.178 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.585 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 2.9 pttt -150.25 147.34 27.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.95 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 31.7 m95 -53.14 148.94 7.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -99.98 -137.53 9.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.488 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.844 -179.818 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 92.6 p -77.0 138.52 39.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.85 0.357 . . . . 0.0 110.86 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 92.6 p -126.13 -50.98 1.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -71.85 -52.28 12.44 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 20.6 t -51.74 149.14 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.854 0.359 . . . . 0.0 110.839 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 67.1 m 62.05 44.6 7.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.885 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -96.67 -144.61 17.47 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.463 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -91.96 161.7 14.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 0.0 110.898 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.3 113.54 4.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -93.98 92.62 7.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 74.7 p 39.0 38.1 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.162 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 240' ' ' THR . 82.3 mt -70.24 114.42 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.411 HG22 ' CA ' ' A' ' 284' ' ' ARG . 51.2 p -98.67 27.02 5.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.582 ' H ' HG22 ' A' ' 238' ' ' ILE . 21.7 m -125.58 139.51 53.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 35.5 mt -131.1 123.97 29.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.963 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.652 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.2 OUTLIER -81.65 154.89 25.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.928 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.841 HG22 HG22 ' A' ' 307' ' ' VAL . 75.1 t -139.76 134.83 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -123.04 -179.66 15.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.509 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 57.95 43.78 94.77 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.523 ' HA ' HD12 ' A' ' 250' ' ' ILE . 75.6 mt -83.81 -57.32 3.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 0.0 110.871 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.46 164.45 0.28 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.495 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -54.83 -31.19 59.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.847 0.356 . . . . 0.0 110.828 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.409 ' OG1' ' NE ' ' A' ' 303' ' ' ARG . 23.2 p -56.83 -34.25 67.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.79 ' CD1' HD21 ' A' ' 305' ' ' LEU . 58.3 mt -104.78 138.83 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.123 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 46.1 p -111.84 179.95 3.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -69.29 -52.04 31.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 91.8 m -50.06 -51.31 43.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.149 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -41.81 -42.16 2.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.9 mt -80.21 -50.24 10.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 -45.06 -41.55 7.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -76.92 -43.67 34.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.502 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 50.1 t-80 -58.69 -32.76 69.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.461 ' CZ ' HD22 ' A' ' 298' ' ' LEU . 61.7 m-85 -94.0 -38.85 10.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.475 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.4 t80 -46.35 -40.67 12.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.4 pt20 -48.61 -38.69 21.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.951 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 88.7 m-85 -65.86 -43.03 89.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 178.5 -153.73 13.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.506 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -80.87 141.24 34.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.794 0.331 . . . . 0.0 110.88 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.475 HD11 ' N ' ' A' ' 260' ' ' TYR . 62.6 mt -110.32 111.28 35.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 280' ' ' GLN . 26.9 mtt-85 -53.91 -49.65 68.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 13.8 t -167.44 169.02 12.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.423 HG23 HD13 ' A' ' 279' ' ' ILE . 76.8 mt -144.95 111.25 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.3 m -105.31 98.94 8.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.484 HG22 ' CB ' ' A' ' 277' ' ' ALA . 82.0 t -91.69 107.4 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.672 HG12 ' H ' ' A' ' 274' ' ' GLN . 95.1 t -92.81 99.97 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . 0.42 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 5.1 pt20 -59.75 -32.74 70.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.936 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.42 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 9.3 tpp85 -59.63 -38.47 81.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.672 ' H ' HG12 ' A' ' 271' ' ' VAL . 12.6 mt-30 -110.71 19.7 18.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 274' ' ' GLN . 60.0 mt-30 34.25 53.14 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 31.1 p -143.56 165.7 26.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.511 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -146.0 133.77 21.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.089 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.424 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 17.6 m-85 -99.31 108.19 20.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.873 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.423 HD13 HG23 ' A' ' 268' ' ' ILE . 3.8 mm -93.01 116.14 33.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 266' ' ' ARG . 34.9 tt0 -106.64 136.33 46.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -113.72 153.16 29.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -77.63 -33.74 53.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.079 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 284' ' ' ARG . 34.4 p -128.75 118.72 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.129 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.493 ' NE ' ' HG3' ' A' ' 288' ' ' GLU . 15.4 tpt180 -35.99 -40.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.722 ' O ' HG23 ' A' ' 289' ' ' VAL . 0.7 OUTLIER -34.59 -62.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -60.54 -42.29 96.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.086 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.25 -63.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.603 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 7.9 mt-10 -45.59 -54.3 7.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 285' ' ' GLN . 39.2 t -50.7 -67.69 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.564 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -53.36 -29.41 34.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.065 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -55.11 -53.08 60.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -72.59 -26.45 61.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -90.25 5.23 47.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.549 ' HB2' HG21 ' A' ' 307' ' ' VAL . 89.8 p -117.13 -39.0 3.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 297' ' ' LYS . 3.1 m-85 -46.37 107.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.863 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 2.0 t30 40.12 27.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.876 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 295' ' ' PHE . 8.5 tmtt? -122.65 -32.85 3.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.502 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 8.1 tp -69.91 100.96 1.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.932 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 65.1 mt -120.11 93.1 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.498 HG22 ' CD2' ' A' ' 258' ' ' HIS . 60.1 t -96.33 142.35 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.121 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 50.96 55.03 10.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 40.54 33.13 0.53 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . 0.409 ' NE ' ' OG1' ' A' ' 249' ' ' THR . 31.0 ttm-85 -132.12 103.23 6.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.921 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.57 ' O ' HD23 ' A' ' 305' ' ' LEU . 46.5 ttp85 -54.07 144.88 18.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.79 HD21 ' CD1' ' A' ' 250' ' ' ILE . 23.6 mt -130.06 132.15 46.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -87.45 102.73 14.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.841 HG22 HG22 ' A' ' 243' ' ' VAL . 95.8 t -100.86 136.42 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.605 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -146.89 145.88 29.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -52.82 133.92 37.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -87.4 -134.77 4.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.77 0.319 . . . . 0.0 110.884 -179.895 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 80.5 p -74.25 -52.52 12.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.909 0.385 . . . . 0.0 110.86 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 32.8 t -140.19 137.34 34.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -114.58 -147.45 9.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.6 t -116.67 139.8 50.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.907 0.384 . . . . 0.0 110.829 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 30.3 t -128.32 119.07 24.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.835 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -143.5 178.53 21.59 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.46 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -72.54 107.11 4.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.79 0.328 . . . . 0.0 110.924 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -122.49 53.28 1.26 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.565 ' HD3' HG23 ' A' ' 237' ' ' THR . 0.0 OUTLIER -122.52 -33.68 3.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.89 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.565 HG23 ' HD3' ' A' ' 236' ' ' LYS . 0.8 OUTLIER -106.82 29.15 7.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.158 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 311' ' ' ARG . 75.5 mt -67.26 110.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.9 p -99.65 29.38 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.17 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.467 ' H ' HG22 ' A' ' 238' ' ' ILE . 23.1 m -124.9 152.21 44.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.156 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 31.5 mt -137.01 127.05 25.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.964 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.574 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -88.9 145.43 25.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 307' ' ' VAL . 84.3 t -139.07 133.87 40.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -122.59 167.95 14.99 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.547 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.92 42.49 44.97 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 277' ' ' ALA . 29.7 mt -77.7 -60.03 2.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.847 0.356 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.57 159.0 0.72 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.451 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -48.36 -32.97 8.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.904 0.383 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 79.4 p -55.92 -46.39 78.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.645 ' CD1' HD21 ' A' ' 305' ' ' LEU . 77.2 mt -93.1 150.51 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.059 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.6 p -132.8 -179.89 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.138 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.633 ' HB2' HG21 ' A' ' 270' ' ' VAL . 25.3 tt0 -66.13 -58.19 5.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 79.4 m -44.11 -51.01 8.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.185 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -44.49 -48.13 10.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 13.8 mt -74.78 -45.16 45.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.929 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 50.1 ttt180 -49.09 -42.94 40.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -78.76 -43.39 25.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.551 ' CE1' HD12 ' A' ' 298' ' ' LEU . 64.9 t-80 -57.9 -33.83 69.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.842 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -94.38 -40.02 10.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.565 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.5 t80 -42.4 -36.56 1.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.479 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 16.3 pt20 -51.89 -41.07 61.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.736 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 63.7 m-85 -60.88 -49.23 78.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -178.95 -163.45 30.06 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -69.74 130.51 42.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.841 0.353 . . . . 0.0 110.883 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.565 HD11 ' N ' ' A' ' 260' ' ' TYR . 79.1 mt -99.98 109.66 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.486 ' HG3' ' N ' ' A' ' 282' ' ' ALA . 22.7 mtt-85 -51.39 -53.07 40.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.0 t -164.07 165.41 22.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 98.3 mt -139.65 105.57 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.092 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 25.2 m -98.06 99.98 11.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.127 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.633 HG21 ' HB2' ' A' ' 252' ' ' GLU . 66.7 t -93.59 106.02 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.784 HG12 ' HG2' ' A' ' 273' ' ' ARG . 4.4 t -91.15 99.67 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -60.79 -47.76 84.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.914 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.784 ' HG2' HG12 ' A' ' 271' ' ' VAL . 6.0 ptm180 -55.18 -20.1 9.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.475 ' O ' ' C ' ' A' ' 275' ' ' GLN . 28.2 mm-40 -121.28 15.74 11.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 274' ' ' GLN . 31.6 mt-30 32.25 50.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.942 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 22.6 p -142.51 168.24 20.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -148.28 153.41 38.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 53.5 m-85 -124.65 108.96 12.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.843 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.564 HG22 ' CE1' ' A' ' 281' ' ' PHE . 4.5 mp -94.72 120.7 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.126 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 266' ' ' ARG . 53.0 tt0 -109.49 147.47 32.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.966 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.564 ' CE1' HG22 ' A' ' 279' ' ' ILE . 87.8 m-85 -126.95 139.86 52.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.866 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.486 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -59.7 -36.29 76.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 284' ' ' ARG . 38.3 p -123.1 116.66 23.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.443 ' NH1' ' O ' ' A' ' 236' ' ' LYS . 14.5 tpt180 -36.0 -37.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 284' ' ' ARG . 0.9 OUTLIER -35.65 -63.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.89 80.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.083 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -56.07 -45.84 79.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.122 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -62.94 -54.04 44.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.489 HG12 ' CE1' ' A' ' 262' ' ' PHE . 49.0 t -50.42 -58.97 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.069 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.736 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -57.47 -45.26 85.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.079 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -41.61 -67.82 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.046 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.58 -40.85 69.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -76.94 1.84 16.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.709 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.3 m -118.41 -25.0 6.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -57.13 104.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 15.3 m120 41.46 30.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.912 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -126.8 -32.83 2.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.551 HD12 ' CE1' ' A' ' 258' ' ' HIS . 5.0 tp -65.96 96.4 0.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 56.0 mt -114.7 95.58 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 77.4 t -100.82 142.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.131 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 57.9 41.4 24.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 49.86 33.19 19.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -134.93 104.4 5.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 0.0 110.889 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.402 ' O ' HD23 ' A' ' 305' ' ' LEU . 17.4 ttm180 -49.96 145.06 5.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.645 HD21 ' CD1' ' A' ' 250' ' ' ILE . 27.1 mt -129.64 133.39 47.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.44 98.73 10.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 243' ' ' VAL . 93.8 t -96.45 145.01 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.195 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.556 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 0.6 OUTLIER -158.42 145.39 17.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -52.32 148.97 5.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -97.37 -136.43 9.11 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 238' ' ' ILE . 14.4 ttp180 . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 120.787 0.327 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 15.2 m -98.81 90.62 4.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.896 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.3 t -107.76 161.59 14.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.85 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 148.55 89.68 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 12.9 t -175.0 134.31 0.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.896 0.379 . . . . 0.0 110.826 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 42.8 t -154.78 158.96 40.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -160.79 44.75 0.41 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.458 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -62.05 -42.05 98.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.367 . . . . 0.0 110.856 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -57.4 109.12 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -102.26 -69.48 0.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 82.0 p -119.48 30.28 7.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.146 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.537 ' N ' HH11 ' A' ' 284' ' ' ARG . 69.3 mt -78.24 114.68 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.107 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.402 HG22 ' CA ' ' A' ' 284' ' ' ARG . 46.2 p -98.75 38.34 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.501 ' H ' HG22 ' A' ' 238' ' ' ILE . 14.2 m -133.4 143.14 48.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.117 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 22.7 mt -133.28 122.18 23.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.914 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.606 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -79.84 143.65 34.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.955 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.768 HG22 HG22 ' A' ' 307' ' ' VAL . 88.2 t -133.36 131.4 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.134 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -121.58 176.8 16.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.464 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 64.15 44.33 95.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.547 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.692 ' HA ' HD12 ' A' ' 250' ' ' ILE . 92.7 mt -86.78 -56.32 3.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.828 0.347 . . . . 0.0 110.95 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.5 155.58 0.37 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.555 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -46.59 -34.25 4.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.847 0.356 . . . . 0.0 110.858 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.8 p -53.83 -56.71 15.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.693 ' CD1' HD21 ' A' ' 305' ' ' LEU . 76.3 mt -75.41 140.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 32.9 p -117.15 179.64 3.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.109 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.74 -55.72 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 92.8 m -45.35 -47.22 13.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.459 ' HB3' HG11 ' A' ' 300' ' ' VAL . 0.7 OUTLIER -49.41 -38.42 28.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 30.4 mt -83.82 -50.0 8.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 49.7 ttm-85 -46.65 -41.74 15.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.884 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -76.55 -43.2 40.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.617 ' CE1' HD12 ' A' ' 298' ' ' LEU . 56.7 t-80 -58.64 -33.8 70.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -94.19 -40.4 10.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.547 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.5 t80 -42.01 -36.52 1.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.2 pt20 -51.98 -42.06 62.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.579 ' CE1' HG12 ' A' ' 289' ' ' VAL . 63.1 m-85 -59.77 -49.93 75.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -175.23 -145.12 5.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -88.53 129.42 35.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.346 . . . . 0.0 110.918 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.547 HD11 ' N ' ' A' ' 260' ' ' TYR . 65.3 mt -96.55 110.59 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.433 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.7 mtp85 -54.98 -54.55 41.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 11.9 t -162.14 166.49 25.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.153 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.494 HG23 HD13 ' A' ' 279' ' ' ILE . 87.1 mt -142.67 110.91 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 87.8 m -104.18 98.87 8.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 67.0 t -89.47 111.1 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.683 HG12 ' HG2' ' A' ' 273' ' ' ARG . 3.8 t -95.85 101.83 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -60.68 -47.13 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.683 ' HG2' HG12 ' A' ' 271' ' ' VAL . 4.7 ptm180 -53.18 -30.29 36.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 275' ' ' GLN . 55.7 mm-40 -112.76 13.64 19.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 274' ' ' GLN . 46.1 mt-30 34.91 53.21 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 11.4 p -143.57 172.01 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.515 ' CB ' HD11 ' A' ' 246' ' ' LEU . . . -152.77 132.1 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 18.4 m-85 -98.91 109.99 22.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.494 HD13 HG23 ' A' ' 268' ' ' ILE . 6.1 mm -94.14 116.29 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.149 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 266' ' ' ARG . 17.7 tt0 -105.86 141.71 36.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.413 ' C ' ' HG3' ' A' ' 266' ' ' ARG . 97.5 m-85 -119.56 151.95 37.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.16 77.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.087 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 33.8 p -126.08 126.17 43.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.131 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.537 HH11 ' N ' ' A' ' 238' ' ' ILE . 9.7 tpt180 -40.3 -32.19 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 32.6 tp60 -40.99 -65.76 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.959 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.3 77.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.084 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -54.46 -58.06 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.101 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -48.82 -57.05 7.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.948 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.579 HG12 ' CE1' ' A' ' 262' ' ' PHE . 23.7 t -51.15 -54.28 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -57.06 -39.56 75.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.102 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -52.91 -66.38 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -53.42 -43.2 67.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -75.25 2.51 10.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.65 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.4 m -116.37 -30.9 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -52.43 95.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.1 m120 48.1 29.37 1.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 53.2 tttt -126.05 -31.01 2.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.617 HD12 ' CE1' ' A' ' 258' ' ' HIS . 5.4 tp -69.47 101.34 1.56 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 53.3 mt -118.72 94.4 3.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.465 HG22 ' CD2' ' A' ' 258' ' ' HIS . 53.5 t -93.53 133.36 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.085 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.426 ' ND2' HG12 ' A' ' 300' ' ' VAL . 78.1 m-20 57.31 54.32 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 41.84 32.11 0.89 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . 0.501 ' HD2' HD11 ' A' ' 250' ' ' ILE . 26.9 ttm-85 -130.57 102.08 5.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.779 0.323 . . . . 0.0 110.86 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.563 ' O ' HD23 ' A' ' 305' ' ' LEU . 11.3 ttp180 -49.2 146.7 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.693 HD21 ' CD1' ' A' ' 250' ' ' ILE . 29.3 mt -134.03 133.62 41.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -87.98 101.91 14.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.768 HG22 HG22 ' A' ' 243' ' ' VAL . 92.9 t -97.62 145.61 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.591 ' HE3' ' CE1' ' A' ' 242' ' ' TYR . 4.8 pttt -156.45 144.6 19.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.886 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -53.12 145.51 13.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -88.47 -153.09 26.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 18.0 mmm-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.783 0.325 . . . . 0.0 110.886 -179.86 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 69.2 m -74.63 149.5 39.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.389 . . . . 0.0 110.814 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 13.0 t -132.83 90.24 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.838 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 123.56 -177.07 16.72 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.464 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 2.3 m -149.14 117.53 6.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.876 0.37 . . . . 0.0 110.835 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 28.5 m -116.15 102.11 9.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.828 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 174.22 -71.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.452 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -43.63 117.13 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.368 . . . . 0.0 110.86 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.442 ' CB ' HD12 ' A' ' 238' ' ' ILE . 4.9 p30 -148.98 116.71 6.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -81.78 92.35 6.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.4 p 43.21 33.92 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.136 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 240' ' ' THR . 66.6 mt -72.56 114.39 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.0 p -102.19 29.81 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.195 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.517 ' H ' HG22 ' A' ' 238' ' ' ILE . 15.5 m -128.44 143.12 50.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 31.8 mt -131.96 124.69 29.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.6 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.3 OUTLIER -82.09 149.75 27.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.848 HG22 HG22 ' A' ' 307' ' ' VAL . 66.8 t -140.28 129.32 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.124 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.69 173.75 14.93 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 65.68 51.45 47.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.517 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.568 HD11 ' C ' ' A' ' 276' ' ' CYS . 79.3 mt -77.12 -61.58 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 110.905 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.12 145.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.476 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -40.13 -31.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.382 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 34.4 p -56.36 -45.9 80.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.626 ' CD1' HD21 ' A' ' 305' ' ' LEU . 61.8 mt -97.27 141.6 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.139 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 16.6 p -123.9 -177.5 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -66.46 -55.97 13.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 7.9 m -43.56 -59.14 2.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.476 ' HA ' ' ND2' ' A' ' 257' ' ' ASN . 18.7 m-20 -40.14 -59.28 1.28 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.432 HD11 HD22 ' A' ' 246' ' ' LEU . 14.9 mt -57.51 -52.12 66.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.91 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 41.8 ttt85 -48.87 -38.58 22.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . 0.523 ' C ' ' OD1' ' A' ' 257' ' ' ASN . 0.4 OUTLIER -77.97 -40.47 39.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.648 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 58.2 t-80 -61.57 -33.08 73.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.49 ' CE2' HG13 ' A' ' 279' ' ' ILE . 72.5 m-85 -94.31 -40.39 9.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.629 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.4 t80 -41.99 -35.48 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.937 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 26.2 pt20 -55.17 -50.2 69.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.76 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 56.9 m-85 -53.1 -50.16 65.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.837 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -172.72 -155.09 10.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.488 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -83.35 127.95 34.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.868 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.629 HD11 ' N ' ' A' ' 260' ' ' TYR . 45.1 mt -93.61 114.19 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 280' ' ' GLN . 16.0 mtt180 -57.74 -50.61 72.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.9 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.5 t -165.45 170.96 13.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.124 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 86.8 mt -145.43 116.12 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 55.2 m -107.16 100.04 9.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.553 HG13 ' CD1' ' A' ' 246' ' ' LEU . 93.0 t -93.47 107.1 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.158 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 44.1 t -92.73 100.01 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.195 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -59.68 -38.76 82.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 -64.33 -10.22 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -130.44 6.0 4.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 41.81 45.11 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.568 ' C ' HD11 ' A' ' 246' ' ' LEU . 14.1 p -137.24 166.62 23.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -146.21 135.68 23.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.093 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.494 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 26.2 m-85 -104.18 108.5 19.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.49 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.8 mm -91.72 119.87 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.17 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 266' ' ' ARG . 42.2 tt0 -107.77 141.92 38.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.08 148.21 44.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.45 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -70.54 -37.36 74.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.096 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 284' ' ' ARG . 17.4 p -126.06 121.49 33.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.513 ' HD2' ' HB3' ' A' ' 287' ' ' ALA . 12.6 tpt180 -36.93 -40.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 284' ' ' ARG . 36.4 tp60 -34.46 -63.9 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.57 -44.88 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.513 ' HB3' ' HD2' ' A' ' 284' ' ' ARG . . . -50.78 -57.47 8.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.133 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 19.9 mt-10 -49.95 -65.04 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.498 HG12 ' CE1' ' A' ' 262' ' ' PHE . 59.7 t -39.08 -59.74 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.76 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -58.95 -37.69 77.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.101 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.585 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -49.9 -54.56 18.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.103 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -69.17 -28.59 66.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -90.3 4.98 49.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.914 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 58.2 p -117.37 -30.1 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 5.0 m-30 -55.57 105.76 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 40.67 29.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 27.0 tttp -124.4 -35.81 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.648 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 11.1 tp -67.04 93.33 0.28 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 304' ' ' ARG . 42.5 mt -113.47 91.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.119 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 41.3 t -92.29 146.32 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.095 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 50.87 46.98 25.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.16 31.3 6.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -133.16 104.0 6.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.78 0.324 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.518 ' O ' HD23 ' A' ' 305' ' ' LEU . 12.6 ttm-85 -50.11 148.64 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.626 HD21 ' CD1' ' A' ' 250' ' ' ILE . 21.9 mt -131.45 132.52 44.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -86.21 99.75 11.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.848 HG22 HG22 ' A' ' 243' ' ' VAL . 72.9 t -101.92 140.37 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.532 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 11.7 pttt -149.17 149.07 30.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -52.77 136.3 33.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.913 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -82.79 -124.06 0.85 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.5 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.402 ' C ' HG23 ' A' ' 238' ' ' ILE . 50.1 ttt180 . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.35 . . . . 0.0 110.867 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 32.8 t -64.52 151.63 43.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.922 0.392 . . . . 0.0 110.847 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.3 p -49.28 -43.86 43.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.88 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.8 95.77 2.28 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.488 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 84.1 p -103.0 116.3 32.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.907 0.384 . . . . 0.0 110.859 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 23.0 t -165.41 148.7 8.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.859 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 145.52 147.15 4.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.449 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -100.0 69.23 1.52 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 110.899 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.3 113.17 25.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -124.46 -56.48 1.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 78.8 p -126.68 26.15 6.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.161 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 34.0 mt -76.07 107.95 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.132 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.448 HG22 ' CA ' ' A' ' 284' ' ' ARG . 30.2 p -99.2 36.27 1.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 30.1 m -137.18 138.46 40.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 22.0 mt -125.28 156.94 37.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.562 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.3 OUTLIER -109.7 149.29 29.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.913 HG22 HG22 ' A' ' 307' ' ' VAL . 91.4 t -141.95 119.19 7.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.32 -175.04 20.65 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.534 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 55.69 45.82 84.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.509 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.479 ' HA ' HD12 ' A' ' 250' ' ' ILE . 44.7 mt -78.62 -59.13 2.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 0.0 110.943 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 62.72 153.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.507 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -42.12 -37.93 1.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.891 0.377 . . . . 0.0 110.86 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 43.3 p -49.4 -44.43 45.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.835 ' CD1' HD21 ' A' ' 305' ' ' LEU . 65.3 mt -97.17 146.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.138 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 68.7 p -126.23 -178.78 4.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' A' ' 270' ' ' VAL . 1.2 tm-20 -66.39 -57.28 7.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.8 m -47.15 -54.36 10.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -40.81 -45.77 2.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 9.1 mt -74.07 -45.64 48.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -48.8 -46.03 41.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -76.25 -38.69 55.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.529 ' CD2' HG22 ' A' ' 300' ' ' VAL . 43.4 t-80 -61.07 -34.56 75.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.499 ' CE2' HG13 ' A' ' 279' ' ' ILE . 58.4 m-85 -94.34 -39.67 10.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.863 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.677 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.7 t80 -43.48 -38.93 3.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.957 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 29.0 pt20 -50.28 -43.55 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 85.1 m-85 -60.54 -47.8 84.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -177.69 -167.01 35.21 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -69.03 127.22 32.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.343 . . . . 0.0 110.873 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.677 HD11 ' N ' ' A' ' 260' ' ' TYR . 84.3 mt -95.72 110.67 24.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.128 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.4 mtp180 -54.01 -51.5 63.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.8 t -164.71 169.47 16.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.194 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.463 HD11 HG21 ' A' ' 265' ' ' ILE . 88.6 mt -145.87 114.29 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.18 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 85.3 m -109.18 99.02 8.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.619 HG22 ' CB ' ' A' ' 277' ' ' ALA . 96.2 t -92.65 111.01 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.404 ' CG1' ' HG2' ' A' ' 273' ' ' ARG . 38.5 t -94.2 101.4 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . 0.422 ' HG3' ' N ' ' A' ' 273' ' ' ARG . 5.2 pt20 -59.23 -40.61 86.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.924 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.422 ' N ' ' HG3' ' A' ' 272' ' ' GLN . 6.6 ptp85 -62.16 -21.55 65.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.448 ' O ' ' C ' ' A' ' 275' ' ' GLN . 74.0 mt-30 -117.31 14.27 14.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.94 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 274' ' ' GLN . 71.3 mt-30 34.38 43.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 21.7 p -141.04 173.51 11.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.619 ' CB ' HG22 ' A' ' 270' ' ' VAL . . . -157.36 140.28 15.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -105.12 121.86 44.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.499 HG13 ' CE2' ' A' ' 259' ' ' PHE . 5.1 mm -102.32 117.03 47.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.186 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . 0.471 ' O ' ' N ' ' A' ' 266' ' ' ARG . 16.3 tt0 -105.17 140.3 38.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.411 ' C ' ' HG3' ' A' ' 266' ' ' ARG . 97.5 m-85 -120.72 148.3 44.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.884 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.444 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -70.23 -34.01 72.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 284' ' ' ARG . 22.4 p -125.82 116.6 21.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.178 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.631 ' HD2' ' HB3' ' A' ' 287' ' ' ALA . 16.7 tpt180 -36.14 -39.3 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.508 ' O ' HG23 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -33.56 -64.42 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.02 -46.68 82.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.097 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.631 ' HB3' ' HD2' ' A' ' 284' ' ' ARG . . . -50.5 -53.26 31.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.05 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.453 ' HG3' ' NE ' ' A' ' 284' ' ' ARG . 6.2 mt-10 -55.24 -48.87 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 285' ' ' GLN . 42.1 t -57.88 -59.96 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.564 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -56.12 -33.97 65.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -53.16 -67.94 0.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.42 -39.71 73.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -75.08 1.59 12.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.604 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.4 m -115.81 -33.38 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.2 102.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 9.0 m120 44.23 31.72 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -129.83 -31.14 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.475 HD12 ' CE1' ' A' ' 258' ' ' HIS . 6.6 tp -70.06 103.69 2.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.464 HG23 ' N ' ' A' ' 304' ' ' ARG . 27.0 mt -119.74 96.76 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.529 HG22 ' CD2' ' A' ' 258' ' ' HIS . 31.1 t -96.28 138.31 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.097 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 56.95 47.19 18.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.15 29.64 6.95 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.496 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 18.0 ttt85 -130.49 103.85 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 110.859 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.464 ' N ' HG23 ' A' ' 299' ' ' ILE . 13.7 ttm180 -48.23 137.67 10.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.835 HD21 ' CD1' ' A' ' 250' ' ' ILE . 26.3 mt -124.19 133.55 53.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -87.54 107.24 18.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.867 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.913 HG22 HG22 ' A' ' 243' ' ' VAL . 53.4 t -105.13 143.46 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.562 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -146.15 165.15 29.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -74.25 122.12 22.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -68.24 -151.89 0.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.482 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 14.3 ttp-105 . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.89 -179.883 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.441 -0.264 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 59.5 p -53.94 115.66 2.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.888 0.375 . . . . 0.0 110.821 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 43.7 m -56.67 126.8 28.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.817 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -142.73 -41.85 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 4.3 t -103.66 88.16 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.83 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 2.6 m -88.35 128.5 35.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.894 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -161.86 90.26 0.11 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.454 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -43.26 126.99 4.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.86 0.362 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -91.03 101.85 14.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.87 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.0 pttt -115.25 101.7 9.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 66.6 p 36.44 44.82 0.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 14.3 mt -85.57 98.43 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.153 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 284' ' ' ARG . 51.0 p -90.95 23.47 3.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 26.4 m -121.14 141.76 50.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.155 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 291' ' ' ALA . 26.7 mt -128.59 146.86 50.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.586 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -102.6 143.41 32.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.905 HG22 HG22 ' A' ' 307' ' ' VAL . 93.3 t -136.83 114.18 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -100.97 179.27 28.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.523 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.467 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 61.92 51.88 54.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.677 HD11 ' C ' ' A' ' 276' ' ' CYS . 88.0 mt -81.46 -59.65 2.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 110.922 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.11 149.97 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.459 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -43.9 -29.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.92 0.39 . . . . 0.0 110.842 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 23.8 p -57.94 -41.81 83.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.139 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.647 ' CD1' HD21 ' A' ' 305' ' ' LEU . 79.2 mt -99.13 146.16 8.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 40.6 p -127.04 -176.41 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.152 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.432 ' HB2' HG21 ' A' ' 270' ' ' VAL . 48.6 tt0 -71.51 -56.23 6.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 96.0 m -45.01 -48.86 11.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -49.53 -50.91 39.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.7 mt -67.32 -43.55 81.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -51.49 -45.01 62.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -78.69 -33.02 47.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.563 ' CE1' HD12 ' A' ' 298' ' ' LEU . 38.2 t-80 -65.75 -34.87 79.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.435 ' CE2' HG13 ' A' ' 279' ' ' ILE . 60.4 m-85 -94.08 -37.58 11.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.601 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.3 t80 -44.77 -26.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.476 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 11.4 pt20 -63.96 -41.74 97.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.887 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.878 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 56.8 m-85 -62.21 -39.08 91.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 286' ' ' ALA . . . 174.71 -154.35 18.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.491 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -79.0 141.69 37.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.878 0.371 . . . . 0.0 110.87 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.601 HD11 ' N ' ' A' ' 260' ' ' TYR . 70.9 mt -112.28 111.88 38.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 280' ' ' GLN . 20.5 mtt180 -59.97 -49.14 78.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.7 t -165.11 171.25 14.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.16 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 94.4 mt -144.4 106.96 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.133 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 26.4 m -96.61 100.66 12.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.136 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.432 HG21 ' HB2' ' A' ' 252' ' ' GLU . 94.6 t -94.79 109.54 22.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.082 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 274' ' ' GLN . 60.9 t -99.44 99.91 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -40.62 89.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -50.35 -39.02 45.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.524 ' H ' HG12 ' A' ' 271' ' ' VAL . 26.1 mt-30 -108.65 10.49 26.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 42.71 52.12 5.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.677 ' C ' HD11 ' A' ' 246' ' ' LEU . 25.7 p -140.58 168.66 19.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -148.29 130.23 15.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.126 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -100.14 109.56 21.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.435 HG13 ' CE2' ' A' ' 259' ' ' PHE . 2.9 mm -92.66 123.04 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.094 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 266' ' ' ARG . 38.6 tt0 -108.3 141.05 40.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -120.96 144.67 48.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.856 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.91 -37.09 78.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.101 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 284' ' ' ARG . 22.8 p -120.75 117.18 26.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.098 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.518 ' HA ' HG22 ' A' ' 239' ' ' THR . 13.7 tpt180 -37.21 -38.83 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 284' ' ' ARG . 12.7 tp60 -37.79 -67.39 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . 0.477 ' HB2' ' HA3' ' A' ' 263' ' ' GLY . . . -52.86 -43.15 65.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 284' ' ' ARG . . . -52.44 -57.74 8.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 18.7 mt-10 -50.45 -63.15 1.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.415 HG12 ' HE3' ' A' ' 293' ' ' LYS . 28.8 t -41.21 -66.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.878 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -50.29 -46.4 55.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.128 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.457 ' HB2' HD11 ' A' ' 241' ' ' LEU . . . -47.26 -67.71 0.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -55.41 -38.76 69.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.415 ' HE3' HG12 ' A' ' 289' ' ' VAL . 14.5 mtmt -84.28 6.07 24.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.554 ' HB3' HG21 ' A' ' 307' ' ' VAL . 16.9 m -118.57 -13.22 9.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.406 ' O ' ' N ' ' A' ' 297' ' ' LYS . 3.8 m-30 -71.27 113.92 8.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.405 ' HA ' ' NH1' ' A' ' 304' ' ' ARG . 1.2 m-20 41.9 25.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.877 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 295' ' ' PHE . 3.0 ttmm -126.21 -31.88 2.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.563 HD12 ' CE1' ' A' ' 258' ' ' HIS . 5.3 tp -71.62 101.4 2.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 304' ' ' ARG . 39.3 mt -115.88 95.43 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 32.8 t -90.36 136.61 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 53.74 51.19 15.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.61 28.84 2.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.506 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 18.2 ttt-85 -129.14 98.22 4.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 110.852 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.526 ' N ' HG23 ' A' ' 299' ' ' ILE . 32.2 ttp85 -42.25 145.9 0.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.647 HD21 ' CD1' ' A' ' 250' ' ' ILE . 49.7 mt -130.59 135.97 48.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -89.55 99.47 12.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.905 HG22 HG22 ' A' ' 243' ' ' VAL . 75.2 t -95.72 142.39 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.075 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.586 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 11.9 ptpt -145.77 171.94 14.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -85.06 122.02 28.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -67.25 -133.8 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.469 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.8 tpp85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 110.849 -179.837 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 2.7 t -157.0 154.42 29.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 110.89 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.5 m -94.7 -46.3 6.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 142.6 84.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.487 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 82.6 p -55.95 -44.04 78.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 110.87 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 24.8 t -60.4 163.56 5.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.885 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 169.86 -173.98 44.03 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.488 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -95.59 111.86 23.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.359 . . . . 0.0 110.948 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.539 ' HB3' HD12 ' A' ' 238' ' ' ILE . 60.7 m-20 -115.53 119.62 36.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 237' ' ' THR . 22.8 mmmt -83.48 99.33 10.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.498 ' N ' HH21 ' A' ' 284' ' ' ARG . 72.6 p 35.84 40.64 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.168 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 235' ' ' ASP . 65.4 mt -77.01 117.71 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.131 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 29.1 p -108.41 26.59 10.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.473 ' H ' HG22 ' A' ' 238' ' ' ILE . 18.3 m -117.75 140.98 48.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.16 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 30.6 mt -128.49 133.24 48.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.603 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -97.92 140.72 31.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.969 HG22 HG22 ' A' ' 307' ' ' VAL . 89.5 t -135.5 127.31 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.162 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.51 174.89 16.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.503 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.436 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 70.66 42.29 62.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.483 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.575 ' CD1' HG13 ' A' ' 270' ' ' VAL . 24.3 mt -70.64 -62.9 1.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.826 0.346 . . . . 0.0 110.919 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.71 158.98 0.75 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.443 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -56.65 -15.58 4.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.8 p -74.26 -32.49 62.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.588 HD13 HD11 ' A' ' 305' ' ' LEU . 68.6 mt -108.97 145.26 16.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 12.4 p -128.56 177.19 7.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.151 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -59.55 -61.25 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 94.6 m -38.66 -56.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.151 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -40.31 -56.03 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.829 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.9 mt -65.42 -48.86 71.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.44 ' HA ' ' CD1' ' A' ' 268' ' ' ILE . 44.0 ttt180 -45.92 -43.13 13.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -79.46 -41.21 28.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.649 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 59.6 t-80 -57.91 -33.66 69.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.564 ' CD2' HG12 ' A' ' 279' ' ' ILE . 60.1 m-85 -94.22 -42.8 8.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.601 ' N ' HD11 ' A' ' 265' ' ' ILE . 2.0 t80 -42.29 -36.06 1.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.464 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.8 pt20 -54.3 -41.28 68.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.959 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 86.3 m-85 -64.84 -42.86 94.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 176.36 -172.22 45.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.477 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -61.47 142.27 57.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 110.922 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.601 HD11 ' N ' ' A' ' 260' ' ' TYR . 70.6 mt -111.93 111.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -55.02 -50.25 69.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.8 t -168.85 162.24 11.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.474 HD11 HD13 ' A' ' 265' ' ' ILE . 79.7 mt -138.4 108.46 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 92.4 m -99.63 100.34 11.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.575 HG13 ' CD1' ' A' ' 246' ' ' LEU . 76.8 t -92.62 103.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 274' ' ' GLN . 82.6 t -86.4 99.88 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.132 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -60.25 -31.68 70.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -59.23 -38.08 79.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.695 ' H ' HG12 ' A' ' 271' ' ' VAL . 77.0 mt-30 -112.52 21.66 15.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.943 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.459 ' HA ' ' NE2' ' A' ' 275' ' ' GLN . 14.5 mm100 33.73 50.82 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 29.3 p -140.62 167.9 21.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.441 ' HB2' HG22 ' A' ' 270' ' ' VAL . . . -146.14 146.8 31.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.571 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 33.7 m-85 -115.21 107.72 15.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.598 HG22 ' CE1' ' A' ' 281' ' ' PHE . 3.9 mp -90.86 121.03 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.144 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -106.94 142.95 35.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.598 ' CE1' HG22 ' A' ' 279' ' ' ILE . 96.9 m-85 -122.75 142.03 51.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.43 74.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.046 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 36.8 p -131.81 123.88 28.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.134 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.498 HH21 ' N ' ' A' ' 237' ' ' THR . 6.0 tpp85 -39.0 -33.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.676 ' O ' HG23 ' A' ' 289' ' ' VAL . 21.6 tp60 -37.97 -65.9 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -58.23 -53.83 53.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -41.59 -63.45 0.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.096 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.585 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 4.7 mm-40 -46.3 -64.31 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.869 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 285' ' ' GLN . 18.6 t -40.25 -62.72 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.561 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -57.02 -33.98 67.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.119 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.59 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -53.86 -60.71 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.131 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -63.79 -36.53 84.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.425 ' HD2' ' CE2' ' A' ' 262' ' ' PHE . 17.7 mttm -75.97 -8.49 57.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.822 ' HB3' HG21 ' A' ' 307' ' ' VAL . 29.6 m -114.18 -9.82 12.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.59 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.8 m-30 -65.4 105.71 1.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.835 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 21.1 m120 43.36 27.79 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -127.68 -28.61 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.649 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 4.7 tp -67.8 97.37 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.961 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.419 HG23 ' N ' ' A' ' 304' ' ' ARG . 38.4 mt -116.13 94.53 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 49.8 t -95.85 145.2 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 50.93 50.03 19.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 45.9 34.18 5.47 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.534 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -136.9 108.92 7.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 110.883 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.523 ' O ' HD23 ' A' ' 305' ' ' LEU . 24.5 ttm180 -56.84 143.69 36.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.588 HD11 HD13 ' A' ' 250' ' ' ILE . 43.0 mt -126.78 137.95 53.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -88.74 98.89 11.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.969 HG22 HG22 ' A' ' 243' ' ' VAL . 79.0 t -93.22 138.65 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.549 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.3 ptpt -151.56 141.52 22.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -50.7 135.19 23.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -72.25 -119.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.841 0.353 . . . . 0.0 110.88 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 93.9 p -50.59 131.24 25.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.889 0.376 . . . . 0.0 110.834 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 22.0 p -45.84 -22.37 0.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.917 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -105.44 45.83 1.25 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.535 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 36.4 t -108.26 80.81 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.884 0.373 . . . . 0.0 110.91 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 233' ' ' GLY . 55.6 p -170.0 158.92 7.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.882 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 232' ' ' SER . . . -36.61 148.94 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.45 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -97.57 80.7 2.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.84 0.352 . . . . 0.0 110.869 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.44 109.64 2.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -115.92 -62.68 1.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 21.1 p -122.35 35.73 4.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.464 HG22 ' H ' ' A' ' 240' ' ' THR . 58.5 mt -75.33 110.2 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.11 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 284' ' ' ARG . 39.0 p -99.61 32.2 2.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.464 ' H ' HG22 ' A' ' 238' ' ' ILE . 9.4 m -130.22 149.37 51.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 291' ' ' ALA . 28.8 mt -132.3 156.85 45.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.817 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.3 OUTLIER -108.36 146.18 33.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 58.2 t -140.77 113.84 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.098 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -107.0 -177.42 22.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.485 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.519 ' O ' HD22 ' A' ' 305' ' ' LEU . . . 57.7 47.33 89.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.477 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.449 HD11 ' CB ' ' A' ' 277' ' ' ALA . 95.4 mt -83.22 -57.82 3.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.827 0.346 . . . . 0.0 110.915 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.26 158.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.477 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -47.02 -33.95 5.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.912 0.387 . . . . 0.0 110.857 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.9 p -52.75 -44.38 66.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.774 ' CD1' HD21 ' A' ' 305' ' ' LEU . 70.4 mt -97.88 143.52 12.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 42.7 p -121.83 -176.65 3.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -70.1 -57.09 5.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.96 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.5 m -44.55 -50.1 9.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.124 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -46.99 -42.67 18.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 21.1 mt -77.34 -48.92 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.403 ' O ' ' CB ' ' A' ' 260' ' ' TYR . 28.0 ttm180 -46.46 -44.44 17.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -76.3 -40.11 52.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.523 ' CE1' HD12 ' A' ' 298' ' ' LEU . 51.3 t-80 -60.19 -34.45 73.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.837 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -94.22 -40.68 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.668 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.6 t80 -42.05 -34.82 0.77 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.484 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 13.0 pt20 -54.16 -43.2 70.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.934 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.577 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 60.8 m-85 -57.68 -50.93 71.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -173.62 -150.1 7.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -85.13 122.61 29.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.367 . . . . 0.0 110.848 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.668 HD11 ' N ' ' A' ' 260' ' ' TYR . 77.2 mt -90.71 116.88 32.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -63.11 -51.67 65.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.3 t -165.13 161.59 19.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.105 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.615 HG23 HD13 ' A' ' 279' ' ' ILE . 76.7 mt -137.71 109.72 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 60.7 m -100.45 99.58 10.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.148 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.495 HG22 ' CB ' ' A' ' 277' ' ' ALA . 93.4 t -91.13 115.11 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.163 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.544 HG12 ' HG2' ' A' ' 273' ' ' ARG . 5.0 t -97.18 102.04 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.131 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -60.23 -49.49 77.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.544 ' HG2' HG12 ' A' ' 271' ' ' VAL . 5.0 ptm180 -54.03 -30.14 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 275' ' ' GLN . 16.6 mt-30 -108.33 13.79 25.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 274' ' ' GLN . 43.6 mt-30 34.32 47.26 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.428 ' C ' ' CD1' ' A' ' 246' ' ' LEU . 20.7 p -142.2 177.54 8.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.495 ' CB ' HG22 ' A' ' 270' ' ' VAL . . . -159.59 140.2 12.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.083 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -107.06 119.5 39.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.615 HD13 HG23 ' A' ' 268' ' ' ILE . 3.8 mm -98.51 118.63 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.15 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -104.47 141.23 36.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.928 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -122.88 150.52 42.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -71.2 -41.84 69.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 33.1 p -118.99 122.5 42.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.12 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.412 ' HA ' HG22 ' A' ' 239' ' ' THR . 17.0 tpt180 -38.44 -35.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.852 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -39.55 -65.86 0.35 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -53.67 -48.94 68.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.108 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -47.49 -63.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 5.7 mt-10 -43.42 -64.1 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.518 HG12 ' CE1' ' A' ' 262' ' ' PHE . 41.5 t -42.51 -58.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.577 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -54.6 -39.55 67.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.513 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -52.22 -65.82 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -54.7 -39.52 68.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.7 mttt -80.41 2.42 25.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.781 ' HB3' HG11 ' A' ' 307' ' ' VAL . 24.0 m -117.36 -26.58 6.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -58.19 102.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.0 m120 43.69 32.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -129.74 -31.09 2.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.523 HD12 ' CE1' ' A' ' 258' ' ' HIS . 4.9 tp -68.65 98.53 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 304' ' ' ARG . 28.4 mt -113.72 94.47 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.147 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.433 ' HB ' HD11 ' A' ' 305' ' ' LEU . 59.2 t -92.07 139.36 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 53.71 47.35 23.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.885 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.31 27.02 5.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 20.8 ttt85 -126.92 97.63 5.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.772 0.32 . . . . 0.0 110.907 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.486 ' N ' HG23 ' A' ' 299' ' ' ILE . 34.3 ttm-85 -42.41 139.76 1.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.774 HD21 ' CD1' ' A' ' 250' ' ' ILE . 29.2 mt -126.7 138.09 53.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -87.99 113.66 23.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.817 HG13 ' O ' ' A' ' 242' ' ' TYR . 47.0 t -113.79 143.63 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.59 ' HE2' ' CD1' ' A' ' 242' ' ' TYR . 18.7 pttt -152.65 161.26 42.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -67.68 123.53 20.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -72.23 -157.5 3.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.797 0.332 . . . . 0.0 110.892 -179.856 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 97.5 p -88.28 42.26 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.901 0.382 . . . . 0.0 110.844 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 77.5 p -102.95 130.78 50.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.868 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 179.74 -165.37 33.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.497 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 88.3 p -105.7 -45.8 4.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.844 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 89.0 p -79.43 101.33 8.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -117.85 -151.33 9.21 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -134.29 63.63 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.897 0.379 . . . . 0.0 110.894 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.444 ' HA ' ' CD1' ' A' ' 238' ' ' ILE . 10.3 p-10 -134.02 105.14 6.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -118.48 -63.68 1.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 41.1 p -120.78 37.17 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 240' ' ' THR . 79.9 mt -74.84 118.75 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.135 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 43.1 p -102.41 35.14 2.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.577 ' H ' HG22 ' A' ' 238' ' ' ILE . 17.2 m -138.72 143.2 38.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 19.5 mt -129.11 141.72 51.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.564 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -104.64 137.02 43.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.06 131.62 69.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.156 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.59 158.23 15.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 82.84 37.87 12.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.434 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.546 HD11 ' C ' ' A' ' 276' ' ' CYS . 63.6 mt -63.62 -66.08 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.425 ' HA3' ' NH1' ' A' ' 303' ' ' ARG . . . 66.01 148.32 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.5 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -40.0 -37.88 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 0.0 110.845 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 50.9 p -52.9 -46.58 68.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.151 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.893 ' CD1' HD21 ' A' ' 305' ' ' LEU . 53.0 mt -94.24 143.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.115 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 33.2 p -129.31 177.31 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.15 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.503 ' OE1' ' CG2' ' A' ' 270' ' ' VAL . 3.7 tp10 -60.35 -61.14 2.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.1 m -41.43 -52.61 3.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.134 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -42.51 -51.5 5.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.0 mt -70.03 -45.26 67.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.94 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -48.88 -47.27 43.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -76.59 -38.93 54.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.573 ' CE1' HD12 ' A' ' 298' ' ' LEU . 34.6 t-80 -60.44 -34.24 73.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.567 ' CD2' HG12 ' A' ' 279' ' ' ILE . 51.3 m-85 -94.87 -41.34 9.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.838 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.432 ' N ' HD11 ' A' ' 265' ' ' ILE . 2.0 t80 -41.8 -38.17 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 27.4 pt20 -52.32 -41.71 63.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 70.2 m-85 -63.25 -48.29 78.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 177.13 174.29 43.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.545 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -45.81 147.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.807 0.337 . . . . 0.0 110.918 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.432 HD11 ' N ' ' A' ' 260' ' ' TYR . 65.8 mt -117.03 112.35 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.8 mtp180 -55.19 -50.98 67.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.1 t -167.03 158.84 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.485 HG22 ' OE2' ' A' ' 252' ' ' GLU . 21.0 mt -136.2 110.31 9.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.07 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 91.2 m -105.14 126.33 51.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.108 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.503 ' CG2' ' OE1' ' A' ' 252' ' ' GLU . 25.5 t -109.8 123.48 65.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.419 HG12 ' HG2' ' A' ' 273' ' ' ARG . 22.8 t -106.75 99.93 9.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.144 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -59.89 -50.0 75.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.419 ' HG2' HG12 ' A' ' 271' ' ' VAL . 9.4 ptt85 -53.79 -24.83 16.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.457 ' O ' ' C ' ' A' ' 275' ' ' GLN . 17.8 mt-30 -116.68 10.98 14.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.946 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 274' ' ' GLN . 66.8 mt-30 33.34 53.79 0.44 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.546 ' C ' HD11 ' A' ' 246' ' ' LEU . 26.9 p -142.86 172.21 13.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -146.3 151.2 37.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.065 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 49.6 m-85 -121.47 108.24 13.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.612 HG22 ' CE1' ' A' ' 281' ' ' PHE . 4.5 mp -94.24 118.52 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.126 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 266' ' ' ARG . 7.9 tt0 -105.91 142.52 35.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.612 ' CE1' HG22 ' A' ' 279' ' ' ILE . 87.7 m-85 -121.49 149.95 42.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.39 91.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.069 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 284' ' ' ARG . 35.8 p -125.81 125.34 42.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.15 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.461 ' O ' ' C ' ' A' ' 285' ' ' GLN . 4.9 tpt180 -35.97 -39.46 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.843 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.578 ' O ' HG23 ' A' ' 289' ' ' VAL . 36.2 tp60 -32.87 -65.64 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.94 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -56.56 -43.56 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.061 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -55.08 -60.88 2.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.102 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 8.4 mt-10 -47.58 -53.35 14.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 285' ' ' GLN . 45.5 t -53.17 -54.87 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.561 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -60.39 -32.79 71.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.448 ' O ' ' CD1' ' A' ' 295' ' ' PHE . . . -56.41 -50.99 70.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.121 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -70.87 -26.86 63.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.466 ' HD2' ' CZ ' ' A' ' 262' ' ' PHE . 20.5 mttt -92.51 -1.34 57.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.705 ' HB2' HG11 ' A' ' 307' ' ' VAL . 61.3 p -112.29 -32.14 6.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 2.9 m-85 -53.73 106.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 29.5 t30 40.84 34.0 0.24 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -131.02 -33.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.573 HD12 ' CE1' ' A' ' 258' ' ' HIS . 4.3 tp -66.9 98.17 0.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 53.8 mt -113.53 96.29 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.43 HG12 ' ND2' ' A' ' 301' ' ' ASN . 59.6 t -95.84 141.89 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.11 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.43 ' ND2' HG12 ' A' ' 300' ' ' VAL . 65.6 m-80 53.82 43.88 30.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 50.79 32.94 26.7 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.461 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . 0.425 ' NH1' ' HA3' ' A' ' 247' ' ' GLY . 30.4 ttt180 -135.0 108.31 7.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.873 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.524 ' O ' HD23 ' A' ' 305' ' ' LEU . 39.9 ttp180 -51.42 146.37 7.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.893 HD21 ' CD1' ' A' ' 250' ' ' ILE . 31.1 mt -132.45 135.15 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.97 97.92 9.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.705 HG11 ' HB2' ' A' ' 294' ' ' SER . 39.1 t -94.89 141.79 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.549 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.5 ptpt -153.47 145.27 23.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -50.9 143.98 9.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.922 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -93.41 -132.7 6.36 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.444 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 43.7 ttt85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 110.869 -179.85 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 11.6 t -57.36 108.04 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 110.872 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 99.9 p -83.37 99.65 10.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.87 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -52.73 106.19 0.36 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.447 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 3.8 m -58.46 125.47 23.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.372 . . . . 0.0 110.866 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 51.8 p -127.26 97.34 4.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -161.39 -161.19 11.46 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.455 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -86.43 155.75 20.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 0.0 110.878 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.71 93.37 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 237' ' ' THR . 2.7 mmmp? -55.17 94.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.463 ' C ' ' O ' ' A' ' 236' ' ' LYS . 0.2 OUTLIER 31.9 46.74 0.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.538 HD13 ' O ' ' A' ' 311' ' ' ARG . 52.2 mt -78.91 98.25 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 37.3 p -86.34 30.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.422 ' H ' HG22 ' A' ' 238' ' ' ILE . 56.5 m -126.27 140.39 52.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.142 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 291' ' ' ALA . 25.2 mt -129.27 131.46 47.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.611 ' C ' ' CD1' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -87.65 145.95 25.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.744 HG22 HG22 ' A' ' 307' ' ' VAL . 85.6 t -137.22 130.3 44.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.131 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -121.96 177.98 16.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.49 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.412 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 66.53 46.51 76.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.465 ' CD2' HD11 ' A' ' 255' ' ' LEU . 52.1 mt -77.12 -59.69 2.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.382 . . . . 0.0 110.906 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.87 148.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -42.18 -25.91 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 110.843 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.8 p -61.57 -45.96 91.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.112 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.868 ' CD1' HD21 ' A' ' 305' ' ' LEU . 53.7 mt -97.3 148.77 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.138 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 31.0 p -128.48 -176.47 3.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.478 ' HB2' HG21 ' A' ' 270' ' ' VAL . 30.7 tt0 -66.83 -59.56 3.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 93.9 m -42.11 -55.33 3.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -41.95 -47.17 4.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.465 HD11 ' CD2' ' A' ' 246' ' ' LEU . 19.5 mt -72.34 -53.76 11.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.956 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -42.08 -45.85 4.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -75.87 -42.65 48.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.551 ' CE1' HD12 ' A' ' 298' ' ' LEU . 37.7 t-80 -56.62 -33.95 66.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.456 ' CE2' HG13 ' A' ' 279' ' ' ILE . 67.5 m-85 -94.19 -44.04 8.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.592 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.9 t80 -39.94 -36.73 0.49 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 258' ' ' HIS . 14.4 pt20 -51.63 -46.88 63.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.932 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.478 ' CE1' HG12 ' A' ' 289' ' ' VAL . 67.4 m-85 -57.99 -45.94 86.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -176.33 -157.54 17.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.48 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -80.72 131.24 35.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.592 HD11 ' N ' ' A' ' 260' ' ' TYR . 62.5 mt -97.56 112.41 29.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.127 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -57.86 -50.18 74.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 3.7 t -163.6 168.56 19.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.439 HD11 HD13 ' A' ' 265' ' ' ILE . 82.2 mt -145.73 111.52 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.144 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 88.8 m -102.21 101.81 12.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.478 HG21 ' HB2' ' A' ' 252' ' ' GLU . 60.5 t -91.17 114.64 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.076 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.544 HG12 ' HG2' ' A' ' 273' ' ' ARG . 11.1 t -101.71 100.06 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -60.07 -44.22 94.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.544 ' HG2' HG12 ' A' ' 271' ' ' VAL . 1.6 ptm180 -52.99 -32.95 49.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.829 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.465 ' N ' ' HG2' ' A' ' 273' ' ' ARG . 61.8 mm-40 -112.42 15.12 20.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 274' ' ' GLN . 46.9 mm-40 34.66 52.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . . . . . . . . . 9.5 p -142.24 174.18 10.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -152.72 135.53 15.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.108 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 27.1 m-85 -101.62 109.44 21.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.456 HG13 ' CE2' ' A' ' 259' ' ' PHE . 3.5 mm -93.75 121.0 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -109.79 139.08 45.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -117.38 144.64 44.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.88 -35.15 78.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.082 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 284' ' ' ARG . 31.1 p -125.14 118.73 26.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' A' ' 283' ' ' THR . 15.7 tpt180 -37.94 -32.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.705 ' O ' HG23 ' A' ' 289' ' ' VAL . 5.2 tt0 -40.35 -67.91 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -56.36 -39.43 72.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -53.49 -62.23 1.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -49.63 -49.62 46.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 285' ' ' GLN . 16.8 t -52.82 -64.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 294' ' ' SER . . . -53.27 -41.5 65.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.509 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -51.34 -54.76 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.438 ' O ' ' NZ ' ' A' ' 297' ' ' LYS . 12.9 tm-20 -67.65 -26.71 66.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.843 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 18.9 mttm -94.84 4.6 53.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.711 ' OG ' HG11 ' A' ' 307' ' ' VAL . 78.9 p -116.47 -26.91 6.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . 0.448 ' CD1' ' O ' ' A' ' 291' ' ' ALA . 3.4 m-30 -58.73 104.86 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 1.7 m120 47.82 29.12 1.51 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 292' ' ' GLU . 0.5 OUTLIER -127.86 -34.94 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.628 ' HG ' HD12 ' A' ' 305' ' ' LEU . 7.4 tp -67.81 97.04 0.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 304' ' ' ARG . 42.1 mt -114.76 98.6 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.119 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.42 146.76 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.127 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 45.78 47.24 11.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 48.54 33.4 11.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 11.2 ttt85 -133.96 101.5 5.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.792 0.329 . . . . 0.0 110.892 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.467 ' N ' HG23 ' A' ' 299' ' ' ILE . 14.8 ttm180 -43.3 145.72 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.868 HD21 ' CD1' ' A' ' 250' ' ' ILE . 23.4 mt -129.71 134.02 47.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.57 101.38 11.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.744 HG22 HG22 ' A' ' 243' ' ' VAL . 72.5 t -103.85 133.29 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.599 ' HG3' ' CD1' ' A' ' 242' ' ' TYR . 5.0 pttt -145.59 152.52 39.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -55.91 130.38 43.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -58.84 -117.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.538 ' O ' HD13 ' A' ' 238' ' ' ILE . 79.1 mtt180 . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.789 0.328 . . . . 0.0 110.907 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 79.9 p -101.01 152.53 20.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 0.0 110.841 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.4 t -162.81 147.28 11.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 79.46 98.14 0.28 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.501 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 58.4 m -97.9 90.46 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.833 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 76.6 p -75.72 -52.05 11.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.803 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 64.49 86.01 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.514 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 235' ' ' ASP . 4.7 mm-40 -99.09 162.95 12.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.861 0.362 . . . . 0.0 110.867 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.478 ' HA ' ' CD1' ' A' ' 238' ' ' ILE . 2.9 p30 34.71 45.81 0.16 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 237' ' ' THR . 32.5 mtmt -73.32 101.03 3.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 236' ' ' LYS . 28.6 p 34.43 39.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.146 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.478 ' CD1' ' HA ' ' A' ' 235' ' ' ASP . 6.7 mt -65.17 105.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.142 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.8 p -98.45 39.83 1.22 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 18.4 m -138.91 139.62 38.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.403 HD11 ' O ' ' A' ' 287' ' ' ALA . 44.1 mt -126.33 153.71 44.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.83 ' O ' HG13 ' A' ' 307' ' ' VAL . 0.3 OUTLIER -105.53 146.18 29.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 307' ' ' VAL . 93.5 t -142.49 122.3 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.127 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -115.15 173.18 14.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.494 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.72 56.53 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.524 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.601 HD11 ' HB2' ' A' ' 277' ' ' ALA . 57.4 mt -70.23 -62.37 1.41 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.868 0.365 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 61.47 155.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.473 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -47.44 -30.36 3.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.5 p -58.12 -43.03 87.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.546 ' CD1' HD21 ' A' ' 305' ' ' LEU . 61.3 mt -102.18 143.53 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 30.4 p -121.26 -177.31 3.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.183 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.592 ' HB2' HG21 ' A' ' 270' ' ' VAL . 63.4 tt0 -70.02 -52.25 25.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.899 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 92.2 m -48.9 -54.98 13.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.154 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -40.24 -44.94 1.97 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 258' ' ' HIS . 16.7 mt -75.25 -59.08 2.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 255' ' ' LEU . 20.3 ttm-85 -36.29 -42.25 0.31 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -78.12 -40.17 39.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.609 ' NE2' HD13 ' A' ' 298' ' ' LEU . 13.9 t60 -59.56 -37.53 78.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 261' ' ' GLN . 73.5 m-85 -90.03 -39.06 13.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.665 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.1 t80 -45.02 -21.31 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.926 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.407 ' N ' ' C ' ' A' ' 259' ' ' PHE . 24.4 pt20 -69.32 -43.3 74.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.901 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 290' ' ' ALA . 81.4 m-85 -61.31 -42.52 98.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 179.96 -167.19 36.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.466 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -71.56 130.11 40.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.913 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.665 HD11 ' N ' ' A' ' 260' ' ' TYR . 60.3 mt -98.29 112.13 29.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.112 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 280' ' ' GLN . 2.5 mtp85 -56.89 -49.36 75.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 t -165.6 168.98 15.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.176 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.418 HD11 ' HA ' ' A' ' 256' ' ' ARG . 85.9 mt -144.01 110.95 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.174 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.8 m -100.92 102.21 13.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 252' ' ' GLU . 40.3 t -96.18 104.68 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 274' ' ' GLN . 99.8 t -92.52 99.95 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.11 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.01 -37.75 80.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -55.99 -35.55 66.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.628 ' H ' HG12 ' A' ' 271' ' ' VAL . 69.8 mt-30 -106.42 4.13 28.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 47.25 48.02 16.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.946 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.453 ' C ' HD11 ' A' ' 246' ' ' LEU . 1.8 p -139.69 178.63 7.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.601 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -155.26 139.55 16.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -111.33 109.95 20.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 2.8 mm -92.46 126.84 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.15 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 266' ' ' ARG . 8.5 tt0 -113.52 142.16 46.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.955 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -121.49 149.82 42.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.844 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.0 -32.71 71.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.102 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 284' ' ' ARG . 16.0 p -127.1 117.4 22.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 283' ' ' THR . 15.1 tpt180 -37.29 -32.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 283' ' ' THR . 3.5 tt0 -39.22 -68.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -55.5 -47.66 75.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.403 ' O ' HD11 ' A' ' 241' ' ' LEU . . . -43.8 -54.05 5.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.138 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 7.2 mt-10 -56.46 -60.72 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.848 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 21.0 t -45.12 -56.34 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.561 ' HA ' ' CE2' ' A' ' 262' ' ' PHE . . . -58.09 -37.25 74.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.088 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -52.23 -65.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.102 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -56.13 -39.53 72.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.832 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.505 ' HD2' ' CZ ' ' A' ' 262' ' ' PHE . 20.8 mttp -76.86 1.06 18.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.581 ' HB3' HG11 ' A' ' 307' ' ' VAL . 3.2 m -118.03 -28.14 5.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -54.81 106.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 57.5 t30 42.27 25.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -123.83 -27.32 3.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.609 HD13 ' NE2' ' A' ' 258' ' ' HIS . 5.9 tp -70.32 100.5 1.74 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.931 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 304' ' ' ARG . 22.4 mt -120.17 99.89 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 59.2 t -105.36 138.91 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 60.64 45.87 9.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 47.85 34.53 11.21 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -137.67 106.24 5.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 0.0 110.872 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.77 ' O ' HD23 ' A' ' 305' ' ' LEU . 16.9 ttm105 -50.58 150.2 2.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.919 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.77 HD23 ' O ' ' A' ' 304' ' ' ARG . 38.7 mt -135.43 137.64 42.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.959 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -90.38 113.36 25.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.83 HG13 ' O ' ' A' ' 242' ' ' TYR . 35.4 t -112.4 143.17 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.584 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 5.1 ptpp? -150.12 160.37 43.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -67.67 129.56 40.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -79.55 -158.42 14.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.494 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.799 0.333 . . . . 0.0 110.909 -179.884 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 228' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 227' ' ' GLY . 63.1 m -36.97 -46.16 0.62 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.892 0.377 . . . . 0.0 110.843 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.5 t -144.53 148.61 34.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.82 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -167.29 171.57 42.02 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 26.3 t -80.13 -43.98 20.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.921 0.391 . . . . 0.0 110.86 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 74.8 m -62.05 139.63 58.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.872 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -173.19 -104.09 0.17 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.464 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -92.69 83.94 4.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.821 0.343 . . . . 0.0 110.884 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.04 96.8 9.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.91 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.631 ' HD3' HG23 ' A' ' 237' ' ' THR . 0.0 OUTLIER -132.69 -36.13 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.631 HG23 ' HD3' ' A' ' 236' ' ' LYS . 17.0 p -134.43 27.62 3.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.164 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 240' ' ' THR . 48.9 mt -81.78 107.74 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.156 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.5 p -98.51 30.01 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 238' ' ' ILE . 40.1 m -128.88 136.3 50.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 23.5 mt -126.66 126.43 43.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.585 ' CD1' ' HG2' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -82.56 140.59 33.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.886 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.49 131.72 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.171 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.07 -174.9 16.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.465 ' O ' HD22 ' A' ' 305' ' ' LEU . . . 56.2 54.79 33.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.523 HD22 HD11 ' A' ' 255' ' ' LEU . 77.8 mt -87.4 -57.81 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.912 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.78 156.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.66 -24.63 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.847 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 22.8 p -62.13 -35.27 78.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.127 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.777 ' CD1' HD21 ' A' ' 305' ' ' LEU . 73.6 mt -107.24 142.32 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 35.8 p -117.74 -179.93 3.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.84 -54.26 24.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 89.3 m -48.56 -54.89 12.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.222 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -39.15 -45.96 1.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.523 HD11 HD22 ' A' ' 246' ' ' LEU . 15.0 mt -75.95 -49.55 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -45.35 -44.25 11.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -76.41 -44.37 36.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.519 ' CE1' ' CD1' ' A' ' 298' ' ' LEU . 39.5 t-80 -56.37 -33.82 66.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -94.12 -42.71 8.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.614 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.8 t80 -41.14 -44.46 2.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.479 ' HG3' ' N ' ' A' ' 262' ' ' PHE . 20.8 pt20 -44.5 -41.02 6.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.703 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 53.4 m-85 -60.8 -49.84 75.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -175.63 -160.95 24.16 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.454 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -75.36 121.93 22.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.865 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.614 HD11 ' N ' ' A' ' 260' ' ' TYR . 87.0 mt -89.83 108.98 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 282' ' ' ALA . 9.2 mtt-85 -52.46 -52.49 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 13.7 t -162.23 170.9 18.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.419 HD11 HG21 ' A' ' 265' ' ' ILE . 75.3 mt -146.08 110.26 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.131 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 19.2 m -103.1 98.9 8.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.194 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.17 107.06 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.638 HG12 ' HG3' ' A' ' 273' ' ' ARG . 5.3 t -91.3 100.84 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -60.21 -45.43 93.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.638 ' HG3' HG12 ' A' ' 271' ' ' VAL . 0.0 OUTLIER -57.39 -19.22 21.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 275' ' ' GLN . 15.2 mt-30 -121.39 11.93 10.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 274' ' ' GLN . 92.9 mt-30 36.87 44.3 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.486 ' C ' HD11 ' A' ' 246' ' ' LEU . 28.4 p -133.59 175.07 9.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' A' ' 246' ' ' LEU . . . -156.73 131.94 9.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 42.9 m-85 -100.74 111.91 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . . . . . . . . . 4.6 mm -94.85 114.71 31.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -102.52 144.84 30.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.64 148.09 49.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.471 ' N ' ' HG3' ' A' ' 266' ' ' ARG . . . -68.91 -38.26 79.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.111 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 284' ' ' ARG . 25.1 p -125.24 119.22 27.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.168 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 283' ' ' THR . 16.9 tpt180 -35.89 -36.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.901 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.61 ' O ' HG23 ' A' ' 289' ' ' VAL . 13.0 tp60 -36.96 -63.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -60.4 -36.77 78.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.127 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -57.71 -62.09 2.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.055 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 20.9 mt-10 -47.44 -56.6 6.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.888 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 285' ' ' GLN . 29.3 t -47.21 -62.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.703 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -54.04 -39.85 66.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -51.34 -64.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.108 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -54.99 -40.95 70.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -77.31 3.07 13.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.729 ' HB3' HG11 ' A' ' 307' ' ' VAL . 1.9 m -116.65 -31.72 5.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -48.32 98.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.854 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 43.96 30.85 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.69 -35.79 2.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.519 ' CD1' ' CE1' ' A' ' 258' ' ' HIS . 6.6 tp -66.45 97.75 0.44 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 304' ' ' ARG . 54.1 mt -114.53 91.82 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 58.1 t -85.62 147.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.118 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 43.73 48.7 6.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 46.5 33.57 6.1 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.474 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 24.9 ttt-85 -132.9 100.14 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.866 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.432 ' N ' HG23 ' A' ' 299' ' ' ILE . 20.3 ttm-85 -43.84 139.3 2.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.777 HD21 ' CD1' ' A' ' 250' ' ' ILE . 29.6 mt -122.12 133.35 54.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -82.67 101.3 10.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.729 HG11 ' HB3' ' A' ' 294' ' ' SER . 53.8 t -103.77 146.65 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.585 ' HG2' ' CD1' ' A' ' 242' ' ' TYR . 10.5 ptpt -156.96 169.73 24.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -80.79 125.47 30.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 311' ' ' ARG . . . -59.29 -120.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.437 ' C ' ' O ' ' A' ' 310' ' ' GLY . 56.6 mtm180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.84 0.353 . . . . 0.0 110.901 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 23.8 t -101.41 99.68 10.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.883 0.373 . . . . 0.0 110.891 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 65.7 m -76.27 -49.96 15.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.876 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 111.45 -153.91 17.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.488 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 89.0 p -159.47 116.11 2.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 110.836 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 10.7 t -66.1 134.51 52.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.818 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 65.77 179.83 9.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.511 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -143.14 170.33 15.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.859 0.361 . . . . 0.0 110.875 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.91 107.61 7.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 237' ' ' THR . 62.2 mmtt -79.06 89.1 4.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 236' ' ' LYS . 73.0 p 37.62 40.37 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.097 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 57.2 mt -70.25 96.5 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.118 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 30.3 p -93.92 38.11 1.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.147 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 24.9 m -131.38 144.28 51.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 291' ' ' ALA . 28.6 mt -134.71 128.61 33.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.941 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.588 ' CE1' ' HE2' ' A' ' 308' ' ' LYS . 0.2 OUTLIER -85.6 143.99 28.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 307' ' ' VAL . 66.0 t -140.5 106.67 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.115 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -102.17 178.18 26.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.495 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.488 ' O ' ' CD2' ' A' ' 305' ' ' LEU . . . 71.94 41.43 55.12 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.606 ' CD2' HD11 ' A' ' 255' ' ' LEU . 96.5 mt -70.08 -63.11 1.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.841 0.353 . . . . 0.0 110.926 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 249' ' ' THR . . . 71.77 143.45 0.38 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.477 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -40.1 -29.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 247' ' ' GLY . 34.5 p -61.59 -53.12 60.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.646 ' CD1' HD21 ' A' ' 305' ' ' LEU . 59.2 mt -84.53 153.82 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.148 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.437 ' N ' HG22 ' A' ' 250' ' ' ILE . 55.9 p -134.68 178.37 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.488 ' HB2' HG21 ' A' ' 270' ' ' VAL . 30.9 tt0 -62.77 -59.57 4.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 97.4 m -44.02 -55.14 4.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.156 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -39.75 -47.01 2.0 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.606 HD11 ' CD2' ' A' ' 246' ' ' LEU . 12.9 mt -75.86 -52.88 9.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . 0.406 ' O ' ' HB3' ' A' ' 260' ' ' TYR . 50.1 ttp85 -42.06 -44.01 3.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -74.97 -46.86 32.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.47 ' NE2' HD13 ' A' ' 298' ' ' LEU . 8.8 t60 -52.63 -39.39 61.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 261' ' ' GLN . 76.7 m-85 -87.84 -45.16 10.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.826 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' TYR . . . . . 0.696 ' N ' HD11 ' A' ' 265' ' ' ILE . 1.1 t80 -39.84 -27.58 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 259' ' ' PHE . 23.6 pt20 -62.28 -46.25 89.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.637 ' CD2' ' HB2' ' A' ' 290' ' ' ALA . 60.8 m-85 -54.39 -50.27 67.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . -172.6 -146.99 5.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.511 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -90.29 123.02 33.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.696 HD11 ' N ' ' A' ' 260' ' ' TYR . 47.1 mt -91.01 113.76 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.144 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -56.6 -48.82 76.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 5.3 t -165.2 170.28 15.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.165 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.407 HG23 HD13 ' A' ' 279' ' ' ILE . 92.6 mt -144.79 110.93 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.118 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 39.2 m -103.14 98.86 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.493 HG13 ' CD1' ' A' ' 246' ' ' LEU . 90.1 t -90.34 110.07 21.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.489 HG11 ' NE2' ' A' ' 274' ' ' GLN . 38.6 t -95.57 100.01 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 275' ' ' GLN . 10.4 tt0 -60.01 -57.8 11.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -45.11 -22.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.489 ' NE2' HG11 ' A' ' 271' ' ' VAL . 43.2 mt-30 -109.12 -16.44 14.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.962 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 272' ' ' GLN . 34.3 mt-30 64.37 45.14 3.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.953 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' CYS . . . . . 0.521 ' C ' HD11 ' A' ' 246' ' ' LEU . 5.3 m -145.76 177.52 8.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.426 ' HB2' HG22 ' A' ' 270' ' ' VAL . . . -153.29 142.18 21.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 242' ' ' TYR . 33.1 m-85 -106.63 107.16 18.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ILE . . . . . 0.407 HD13 HG23 ' A' ' 268' ' ' ILE . 7.3 mm -90.1 117.44 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.179 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' GLN . . . . . 0.484 ' O ' HG23 ' A' ' 265' ' ' ILE . 9.8 tt0 -105.79 150.19 25.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -130.79 151.83 50.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -74.53 -32.97 62.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.116 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 284' ' ' ARG . 24.9 p -127.17 118.08 23.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.142 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 285' ' ' GLN . 5.7 tpp85 -36.01 -38.12 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.696 ' O ' HG23 ' A' ' 289' ' ' VAL . 12.0 tt0 -35.9 -64.83 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.905 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -57.59 -45.73 84.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . 0.4 ' O ' HD11 ' A' ' 241' ' ' LEU . . . -52.0 -66.31 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 291' ' ' ALA . 12.7 mt-10 -43.29 -52.39 5.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 285' ' ' GLN . 46.3 t -52.72 -64.21 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.637 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -48.84 -43.1 38.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.067 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . 0.56 ' HB2' HD21 ' A' ' 241' ' ' LEU . . . -46.18 -67.66 0.26 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.092 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -53.14 -44.48 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -70.7 -0.94 9.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.773 ' HB3' HG21 ' A' ' 307' ' ' VAL . 12.6 m -119.14 -24.26 6.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.869 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -53.95 103.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 43.51 26.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -124.92 -26.77 3.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.592 ' HG ' HD12 ' A' ' 305' ' ' LEU . 12.5 tp -68.03 98.26 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.947 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.55 96.64 4.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.159 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 85.7 t -103.69 145.37 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.149 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 55.56 40.48 31.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 51.53 32.05 30.41 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.52 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ARG . . . . . . . . . . . . . 19.4 ttt-85 -133.56 105.63 6.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.92 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.528 ' O ' HD23 ' A' ' 305' ' ' LEU . 13.7 ttp180 -49.95 147.12 4.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.861 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.646 HD21 ' CD1' ' A' ' 250' ' ' ILE . 40.4 mt -132.29 145.76 51.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.954 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -98.01 106.84 19.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.773 HG21 ' HB3' ' A' ' 294' ' ' SER . 98.3 t -105.25 137.7 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.588 ' HE2' ' CE1' ' A' ' 242' ' ' TYR . 3.4 pttt -151.26 148.94 28.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.935 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -56.61 141.06 44.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -80.23 -124.45 0.54 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 26.6 ttt-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.796 0.332 . . . . 0.0 110.86 -179.824 . . . . . . . . 0 0 . 1 stop_ save_